{"doc_id": 0, "doc": {"person_id": 115969091, "visit_occurrence_id": 59078513, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2014-01-24 13:03:56", "visit_end_datetime": "2014-01-24 14:11:02", "visit_length_in_hours": 1.1183333333333334, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2014-01-24 13:03:56, ended at 2014-01-24 14:11:02\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 90, "patient_first_visit_date": "2008-12-02 18:31:00", "patient_last_visit_date": "2016-03-04 14:12:40", "end_obs_date": "2015-01-24", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 17, "cumulated_visit_num": 17, "cumulated_approximate_token_count": 4183, "visit_cumulated": "## Visit\nThis visit record, was from Inpatient Visit, started at 2008-12-02 18:31:00, ended at 2008-12-12 10:53:00\nThe patient in this visit was 55 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 46.7 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 207 (picogram per milliliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.1 (microgram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.34 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.59 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 27.8 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 6.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 44 (microgram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 92 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 379 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 88.7 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte sedimentation rate: 70 (millimeter per hour)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 23 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Body height: 5' 2\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 190 (microgram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Prothrombin time (PT): 15.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 483 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acquired hypothyroidism\n- Disorder of carotid artery\n- Essential hypertension\n- Postoperative infection\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-10\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-09\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-12\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2008-12-05, presumably until 2008-12-12\n- tobramycin 40 MG/ML Injectable Solution, started on 2008-12-09, presumably until 2008-12-10\n- zinc sulfate 220 MG Oral Capsule, through Oral route, started on 2008-12-07, presumably until 2008-12-12\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-05, presumably until 2008-12-05\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2008-12-09, presumably until 2008-12-09\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-03\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-11\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2008-12-08, presumably until 2008-12-09\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-06, presumably until 2008-12-08\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-03\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2008-12-03, presumably until 2008-12-06\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2008-12-10, presumably until 2008-12-12\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-01-05, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- aspirin 81 MG Oral Tablet, through Oral route. Instructions: take  by mouth. 162.5mg\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-12-12, with quantity of 30.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-03\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2008-12-06, presumably until 2009-12-12, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2008-12-10, presumably until 2008-12-11\n- ferrous sulfate 160 MG Extended Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-12\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-12-02, presumably until 2008-12-09\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-12-11, presumably until 2008-12-11\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-02\n- labetalol hydrochloride 200 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-12-12, with quantity of 90.0, with intended 3 refill(s). Instructions: take 4 Tabs by mouth 3 times a day. \n- labetalol hydrochloride 300 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-11\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2008-12-03, presumably until 2008-12-05\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2008-12-10, presumably until 2008-12-10\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2008-12-03, presumably until 2008-12-05\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2008-12-04, presumably until 2008-12-11\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2012-07-27. Instructions: take 88 mcg by mouth.\n- 6 ML gentamicin 10 MG/ML Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-10\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2008-12-09, presumably until 2008-12-10\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2008-12-12, presumably until 2009-12-12, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-12-02, presumably until 2008-12-03\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2008-12-09, presumably until 2008-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-15 00:00:00, ended at 2008-12-15 00:00:00\nThe patient in this visit was 55 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-14 12:16:00, ended at 2009-12-14 23:59:00\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n- Cerebrovascular disease\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-14 12:17:02, ended at 2009-12-14 16:54:55\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n- Primary diagnosis: Cerebrovascular disease\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2012-07-27. Instructions: take by mouth daily. \n- amlodipine 5 MG Oral Tablet, through Oral route, presumably until 2012-02-13. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 12:52:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-05 12:52:53, ended at 2010-07-05 15:37:49\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-02-13 00:00:00, ended at 2012-02-13 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-13 10:30:00, ended at 2012-02-13 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-13 11:37:20, ended at 2012-02-13 12:25:34\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-27 12:45:00, ended at 2012-07-27 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-27 14:10:26, ended at 2012-07-27 14:55:07\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- levothyroxine sodium 0.088 MG Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth. 1 milligram now\n- lisinopril 20 MG Oral Tablet, through Oral route, presumably until 2013-07-26. Instructions: take 20 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-19 00:00:00, ended at 2013-07-19 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-26 12:53:00, ended at 2013-07-26 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-26 12:55:18, ended at 2013-07-26 14:23:15\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- nebivolol 5 MG Oral Tablet, through Oral route. Instructions: take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-17 00:00:00, ended at 2014-01-17 00:00:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-24 13:03:00, ended at 2014-01-24 23:59:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-24 13:03:56, ended at 2014-01-24 14:11:02\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-12-02 18:31:00, ended at 2008-12-12 10:53:00\nThe patient in this visit was 55 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 46.7 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 207 (picogram per milliliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.1 (microgram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.34 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.59 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 27.8 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 6.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 44 (microgram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 92 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 379 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 88.7 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte sedimentation rate: 70 (millimeter per hour)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 23 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Body height: 5' 2\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 190 (microgram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Prothrombin time (PT): 15.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 483 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acquired hypothyroidism\n- Disorder of carotid artery\n- Essential hypertension\n- Postoperative infection\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-10\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-09\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-12\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2008-12-05, presumably until 2008-12-12\n- tobramycin 40 MG/ML Injectable Solution, started on 2008-12-09, presumably until 2008-12-10\n- zinc sulfate 220 MG Oral Capsule, through Oral route, started on 2008-12-07, presumably until 2008-12-12\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-05, presumably until 2008-12-05\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2008-12-09, presumably until 2008-12-09\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-03\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-11\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2008-12-08, presumably until 2008-12-09\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-06, presumably until 2008-12-08\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-03\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2008-12-03, presumably until 2008-12-06\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2008-12-10, presumably until 2008-12-12\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-01-05, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- aspirin 81 MG Oral Tablet, through Oral route. Instructions: take  by mouth. 162.5mg\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-12-12, with quantity of 30.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-03\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2008-12-06, presumably until 2009-12-12, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2008-12-10, presumably until 2008-12-11\n- ferrous sulfate 160 MG Extended Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-12\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-12-02, presumably until 2008-12-09\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-12-11, presumably until 2008-12-11\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-02\n- labetalol hydrochloride 200 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-12-12, with quantity of 90.0, with intended 3 refill(s). Instructions: take 4 Tabs by mouth 3 times a day. \n- labetalol hydrochloride 300 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-11\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2008-12-03, presumably until 2008-12-05\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2008-12-10, presumably until 2008-12-10\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2008-12-03, presumably until 2008-12-05\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2008-12-04, presumably until 2008-12-11\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2012-07-27. Instructions: take 88 mcg by mouth.\n- 6 ML gentamicin 10 MG/ML Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-10\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2008-12-09, presumably until 2008-12-10\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2008-12-12, presumably until 2009-12-12, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-12-02, presumably until 2008-12-03\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2008-12-09, presumably until 2008-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-15 00:00:00, ended at 2008-12-15 00:00:00\nThe patient in this visit was 55 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-14 12:16:00, ended at 2009-12-14 23:59:00\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n- Cerebrovascular disease\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-14 12:17:02, ended at 2009-12-14 16:54:55\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n- Primary diagnosis: Cerebrovascular disease\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2012-07-27. Instructions: take by mouth daily. \n- amlodipine 5 MG Oral Tablet, through Oral route, presumably until 2012-02-13. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 12:52:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-05 12:52:53, ended at 2010-07-05 15:37:49\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-02-13 00:00:00, ended at 2012-02-13 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-13 10:30:00, ended at 2012-02-13 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-13 11:37:20, ended at 2012-02-13 12:25:34\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-27 12:45:00, ended at 2012-07-27 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-27 14:10:26, ended at 2012-07-27 14:55:07\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- levothyroxine sodium 0.088 MG Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth. 1 milligram now\n- lisinopril 20 MG Oral Tablet, through Oral route, presumably until 2013-07-26. Instructions: take 20 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-19 00:00:00, ended at 2013-07-19 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-26 12:53:00, ended at 2013-07-26 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-26 12:55:18, ended at 2013-07-26 14:23:15\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- nebivolol 5 MG Oral Tablet, through Oral route. Instructions: take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-17 00:00:00, ended at 2014-01-17 00:00:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-24 13:03:00, ended at 2014-01-24 23:59:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-24 13:03:56, ended at 2014-01-24 14:11:02\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of ischemic_stroke means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "67104261d607135d7f6cbde842c95ec7f340822c97714d80c28691b404603f87", "prompt_hash": "f9a85fd2657a54e6703120b119a9b940ec4b89e47b0809461e5e4b1456a184fd", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 0.0, "f1_gu_yn": [0, 1], "recall_gu_yn": [0, 1]}
{"doc_id": 1, "doc": {"person_id": 115969466, "visit_occurrence_id": 173590087, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2021-01-27 00:00:00", "visit_end_datetime": "2021-01-27 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-27 00:00:00, ended at 2021-01-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated moderate persistent asthma\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2021-01-27, presumably until 2021-02-09, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n", "approximate_token_count": 137, "patient_first_visit_date": "2014-03-21 01:58:00", "patient_last_visit_date": "2023-02-02 00:00:00", "end_obs_date": "2022-01-27", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 1, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 1, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 1, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 379, "cumulated_visit_num": 379, "cumulated_approximate_token_count": 81213, "visit_cumulated": "## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-21 01:58:00, ended at 2014-03-29 16:27:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.51 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 338 (milligram per deciliter)\n- Osmolality of Urine: 574 (milliosmole per kilogram)\n- Thrombin time: 15.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 229 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.31 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 5.25 (milli-international unit per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.1 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 4\" (inch (US))\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 83 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Prothrombin time (PT): 16.0 (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 9.82 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 357 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.4 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 94 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 12.4 (microgram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 25 (millimeter per hour)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n\n### Procedure\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Magnetic resonance angiography, head; without contrast material(s)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time int\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Radiologic examination, chest; single view, frontal\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n- Hospital discharge day management; more than 30 minutes\n- Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professio\n- Nerve conduction studies; 5-6 studies\n- Occupational therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Magnetic resonance angiography, neck; without contrast material(s)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Lumbar puncture\n- Open biopsy of cranial or peripheral nerve or ganglion\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Collection of venous blood by venipuncture\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Open biopsy of soft tissue\n- Standardized cognitive performance testing (eg, Ross Information Processing Assessment) per hour of a qualified health care professional's time, both face-to-face time administering tests to the patient and time interpreting these test results and prepari\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Acute renal failure syndrome\n- Arteritis\n- Diffuse cerebrovascular disease\n- Acquired deformity of ankle AND/OR foot\n- Altered mental status\n- Congestive heart failure\n- Disorder of brain\n- Eosinophil count raised\n- Eruption\n- Hyperkalemia\n- Cardiomegaly\n- Cerebral ischemia\n- Disorder of lower extremity\n- Disorder of posterior pituitary\n- Granulomatosis with polyangiitis\n- Hypo-osmolality and or hyponatremia\n- Polyarteritis nodosa\n- Primary diagnosis: Visual field defect\n- Disorder of skeletal muscle\n- Essential hypertension\n- Primary cardiomyopathy\n- Anemia in chronic kidney disease\n- First degree atrioventricular block\n- Renal function tests abnormal\n- Spontaneous ecchymosis\n- Organic mental disorder\n- Abnormal findings on diagnostic imaging of skull and head\n- Backache\n- Cardiomyopathy associated with another disorder\n- Chronic diastolic heart failure\n- Chronic kidney disease\n- Disorder of nervous system\n- Herpes simplex without complication\n- Electrocardiogram abnormal\n- Mononeuritis\n- Subarachnoid hemorrhage\n\n### Drug\n- ramipril 5 MG Oral Capsule, through Oral route, started on 2014-03-21, presumably until 2014-03-23\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-21\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2014-03-25, presumably until 2014-05-14, with intended 0 refill(s). Instructions: 3 mL by Nebulization route every 4 hours as needed for Bronchospasm/Wheezing.\n- calcium carbonate 625 MG / cholecalciferol 125 UNT Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2023-01-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2014-03-22, presumably until 2017-12-26, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route daily.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-03-23, presumably until 2014-05-14, with intended 0 refill(s). Instructions: 40 mg by Intravenous route daily.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-03-22, presumably until 2014-07-31, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed (pain or fever).\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-03-21, presumably until 2014-03-21\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2014-03-21, presumably until 2014-03-24\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-03-24, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-23\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2014-03-23, presumably until 2015-03-29, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 12 hours as needed.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, through Subcutaneous route, started on 2014-03-21, presumably until 2014-05-14, with intended 0 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 8 hours.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-03-23, presumably until 2014-07-31, with intended 0 refill(s). Instructions: take 1 Singhal by mouth every bedtime.\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-03-27, presumably until 2014-03-29\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2014-03-24\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2014-10-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2014-03-25, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2014-03-29, presumably until 2014-03-29\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-03-26, presumably until 2014-03-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-23, presumably until 2014-03-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-03-26, presumably until 2014-03-26\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-03-25 00:00:00, ended at 2014-03-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-25 00:00:00, ended at 2014-03-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on nerves, muscles, tendons, and fascia of lower leg, ankle, and foot; not otherwise specified\n\n### Condition\n- Muscle weakness\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2014-03-25, presumably until 2014-03-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-25, presumably until 2014-03-25\n- midazolam 1 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-09 10:06:18, ended at 2014-04-09 16:27:50\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-24 11:44:00, ended at 2014-04-24 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-04-24, presumably until 2014-04-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-04-24, presumably until 2014-04-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-04-24, presumably until 2014-04-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-24 15:16:36, ended at 2014-04-24 15:16:45\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-14 00:00:00, ended at 2014-05-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 2.1EF(MOD-sp4) (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-14 09:16:31, ended at 2014-05-14 10:23:33\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-05-14, presumably until 2014-09-04, with intended 6 refill(s). Instructions: take 4 Tabs by mouth daily.\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2014-05-14, presumably until 2015-01-06, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-14 09:30:00, ended at 2014-05-14 10:28:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n\n### Condition\n- Localized swelling, mass and lump, trunk\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-14 10:29:00, ended at 2014-05-14 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCV [Entitic volume] by Automated count: 92.5 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.17 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-27 11:59:00, ended at 2014-05-27 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-27, presumably until 2014-05-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-27, presumably until 2014-05-27\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-05-27, presumably until 2014-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-27 12:40:23, ended at 2014-05-27 12:41:49\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-06-11 00:00:00, ended at 2014-06-11 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arteritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-26 09:44:00, ended at 2014-06-26 10:55:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 12.65 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Ulcerative colitis\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-26 10:56:00, ended at 2014-06-26 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.488\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Ulcerative colitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-06-26\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-06-26, presumably until 2014-06-26\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-06-26, presumably until 2014-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-26 12:33:34, ended at 2014-06-26 12:34:17\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Ulcerative colitis\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2014-06-26, presumably until 2014-10-14, with intended 3 refill(s). Instructions: take 40 mg by mouth daily.\n- prednisone 5 MG Oral Tablet, started on 2014-06-26, presumably until 2014-07-31, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- cyclophosphamide 25 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-08-01, with intended 1 refill(s). Instructions: take 4 Tabs by mouth daily.\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-10-14, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-31 09:56:00, ended at 2014-07-31 11:17:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 12.59 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 34 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Age related macular degeneration\n- Cataract\n- Presbyopia\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-31 10:22:03, ended at 2014-07-31 11:10:54\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2018-09-06, with intended 0 refill(s). Instructions: take 81 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-31 11:18:00, ended at 2014-07-31 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 10 (milligram per gram)\n- Albumin [Mass/volume] in Urine: 10 (milligram per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-05 09:30:00, ended at 2014-08-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-08-05, presumably until 2014-08-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-05, presumably until 2014-08-05\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-08-05, presumably until 2014-08-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-05 14:28:42, ended at 2014-08-05 17:01:53\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Arteritis\n- Inflammatory and toxic neuropathy\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-08-18 00:00:00, ended at 2014-08-18 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-08-18, presumably until 2014-09-04, with intended 3 refill(s). Instructions: take 2 tablets by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-04 00:00:00, ended at 2014-09-04 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-09-04, presumably until 2014-11-11, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- prednisone 10 MG Oral Tablet, started on 2014-09-04, presumably until 2014-11-06, with intended 6 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-22 00:00:00, ended at 2014-09-22 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-14 11:53:00, ended at 2014-10-14 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 17 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.00 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.90 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cataract\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-14 15:17:41, ended at 2014-10-14 16:01:17\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Ma..., through Intramuscular route, started on 2014-10-14, presumably until 2014-10-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, presumably until 2014-11-11, with intended 0 refill(s). Instructions: take  by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-04 00:00:00, ended at 2014-11-04 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myocardial infarction of anterior wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 12:34:00, ended at 2014-11-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte sedimentation rate: 13 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.23 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.2 (thousand per microliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 9 (milligram per gram)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 294 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-05 13:51:43, ended at 2014-11-05 14:20:57\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation\n\n### Condition\n- Primary diagnosis: Cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-06 00:00:00, ended at 2014-11-06 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2014-11-06, presumably until 2015-01-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. Taper as instructed by MD.\n- prednisone 5 MG Oral Tablet, started on 2014-11-06, presumably until 2015-01-06, with intended 3 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-11-10 00:00:00, ended at 2014-11-10 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hyaluronate, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- chondroitin sulfates, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- povidone-iodine 50 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- chondroitin 4-sulfate, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- cefazolin 1000 MG Injection, started on 2014-11-10, presumably until 2014-11-10\n- 1 ML epinephrine 1 MG/ML Injection, started on 2014-11-10, presumably until 2014-11-10\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-11-10, presumably until 2014-11-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-10 11:50:00, ended at 2014-11-10 14:31:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); without endoscopic cyclophotocoagulation\n- One stage extracapsular extraction of lens and insertion of prosthetic intraocular lens\n- Aspiration of cataract by phacoemulsification\n\n### Condition\n- Visual field defect\n- Hypermetropia\n- Presbyopia\n- Cataract\n- Asthma\n- Gastroesophageal reflux disease\n- Age related macular degeneration\n- Cardiac arrhythmia\n- Chronic kidney disease\n\n### Drug\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-11 13:56:14, ended at 2014-11-11 14:39:52\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-11-11, presumably until 2015-01-06, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-18 10:24:00, ended at 2014-11-18 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 19 (milligram per gram)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils [#/volume] in Blood by Automated count: 7.61 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 331 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Urine: 11 (milligram per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-12-15 00:00:00, ended at 2014-12-15 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hyaluronate, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- chondroitin sulfates, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- povidone-iodine 50 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- chondroitin 4-sulfate, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- cefazolin 1000 MG Injection, started on 2014-12-15, presumably until 2014-12-15\n- 1 ML epinephrine 1 MG/ML Injection, started on 2014-12-15, presumably until 2014-12-15\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-12-15, presumably until 2014-12-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-15 11:18:00, ended at 2014-12-15 14:40:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Aspiration of cataract by phacoemulsification\n- Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); without endoscopic cyclophotocoagulation\n- One stage extracapsular extraction of lens and insertion of prosthetic intraocular lens\n\n### Condition\n- Asthma\n- Chronic kidney disease\n- Cataract\n- Heart failure\n- Disorder of kidney and/or ureter\n- Granulomatosis with polyangiitis\n- Age related macular degeneration\n- Allergic disposition\n- Chronic sinusitis\n- Allergic rhinitis\n- Gastroesophageal reflux disease\n\n### Drug\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-12-15, presumably until 2014-12-15\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-12-24 00:00:00, ended at 2014-12-24 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-24 12:07:00, ended at 2014-12-24 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.76 (thousand per microliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Age related macular degeneration\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-06 09:29:01, ended at 2015-01-06 10:29:13\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Age related macular degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-06 11:18:21, ended at 2015-01-06 12:06:39\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Age related macular degeneration\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-01-06, presumably until 2015-04-30, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- prednisone 1 MG Oral Tablet, started on 2015-01-06, presumably until 2015-05-05, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- prednisone 5 MG Oral Tablet, started on 2015-01-06, presumably until 2015-03-27, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- carvedilol 6.25 MG Oral Tablet, through Oral route, presumably until 2016-10-20, with intended 0 refill(s). Instructions: take 6.25 mg by mouth 2 times a day with meals \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-10 00:00:00, ended at 2015-02-10 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 10:04:24, ended at 2015-02-10 12:34:34\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n\n### Condition\n- Eruption\n- Primary diagnosis: Chronic rhinitis\n- Chronic sinusitis\n- Asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 14:51:30, ended at 2015-02-10 16:38:58\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Chronic rhinitis\n- Eruption\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 16:11:09, ended at 2015-02-10 17:15:16\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-03 00:00:00, ended at 2015-03-03 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 09:01:58, ended at 2015-03-03 10:32:17\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 11 (millimeter mercury column)\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Age related macular degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 11:10:19, ended at 2015-03-03 13:37:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Granulomatosis with polyangiitis\n- IgE-mediated allergic asthma\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-03-03, presumably until 2015-05-05, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-03 12:47:00, ended at 2015-03-03 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.1 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Acute myocardial infarction of anterior wall\n- Cerebral infarction due to embolism of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 15:08:13, ended at 2015-03-03 16:51:51\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-04-16, presumably until 2015-06-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-27 00:00:00, ended at 2015-03-27 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2015-03-31, presumably until 2015-08-25, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-17 00:00:00, ended at 2015-04-17 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 12.5 MG Oral Tablet, started on 2015-04-17, presumably until 2015-04-17, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-30 00:00:00, ended at 2015-04-30 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Allergic rhinitis due to animal hair and dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-04-30, presumably until 2015-06-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-05-05 00:00:00, ended at 2015-05-05 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-05 09:35:00, ended at 2015-05-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 18 (milligram per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 129.70 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 21 - 50 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Monocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.73 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.98 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypokalemia\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-05 10:09:27, ended at 2015-05-05 10:55:28\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- potassium chloride 25 MEQ Effervescent Oral Tablet, through Oral route, started on 2015-05-05, presumably until 2016-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-24 10:42:00, ended at 2015-06-24 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 10.64 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Creatinine [Mass/volume] in Urine: 32.50 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-24 12:52:33, ended at 2015-06-24 14:33:10\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 1\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-24 14:50:21, ended at 2015-06-24 15:40:13\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Allergic rhinitis due to animal hair and dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-06-24, presumably until 2015-08-25, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-07-07 00:00:00, ended at 2015-07-07 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-21 10:22:00, ended at 2015-07-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 79.1 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.74 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n- Chronic sinusitis\n- Chronic kidney disease stage 1\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-21 13:38:44, ended at 2015-07-21 14:47:40\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-07-21, presumably until 2016-05-19, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- cephalexin 500 MG Oral Capsule, through Oral route, presumably until 2015-07-21, with intended 0 refill(s). Instructions: take by mouth 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-25 10:45:00, ended at 2015-08-25 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Creatinine [Mass/volume] in Urine: 55.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.85 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of muscle\n- Allergic rhinitis due to animal hair and dander\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-25 11:35:10, ended at 2015-08-25 12:35:45\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n- Asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2016-08-24, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-25 14:05:22, ended at 2015-08-25 15:02:39\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.04 (micro-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Disorder of muscle\n- Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2016-04-20, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, started on 2015-08-25, presumably until 2015-12-23, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-26 00:00:00, ended at 2015-08-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-28 00:00:00, ended at 2015-09-28 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-12 00:00:00, ended at 2015-11-12 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-11-17 00:00:00, ended at 2015-11-17 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-18 10:21:00, ended at 2015-11-18 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: <0.10 (milligram per milligram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 168 (picogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 120.7 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Neutrophils [#/volume] in Blood by Automated count: 9.83 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-18 11:04:02, ended at 2015-11-18 11:46:02\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-23 10:30:00, ended at 2015-12-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 8 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: <0.10 (milligram per milligram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 123.8 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.64 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of bone\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-23 11:24:15, ended at 2015-12-23 11:52:17\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Disorder of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-01-05 00:00:00, ended at 2016-01-05 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-04 14:12:49, ended at 2016-02-04 16:12:30\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-04 16:10:44, ended at 2016-02-04 16:53:21\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, presumably until 2019-04-30, with intended 0 refill(s). Instructions: take 20 mEq by mouth 2 times a day Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-04-19 00:00:00, ended at 2016-04-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-20 11:37:00, ended at 2016-04-20 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 59.99 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.40 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 292 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Osteoporosis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-20 12:00:20, ended at 2016-04-20 12:18:01\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2016-04-20, presumably until 2016-09-20, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 1 MG Oral Tablet, started on 2016-04-20, presumably until 2016-09-19, with intended 2 refill(s). Instructions: Take 3mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-29 00:00:00, ended at 2016-04-29 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-05-18 00:00:00, ended at 2016-05-18 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-19 10:46:24, ended at 2016-05-19 12:06:35\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 60 minutes\n\n### Condition\n- No conditions.\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, started on 2016-05-19, presumably until 2017-04-12, with intended 0 refill(s). Instructions: Take 2 tablets by mouth initially then 1 tablet by mouth following each loose stool. Not to exceed 8 tablets per day\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection, through Intramuscular route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: inject 1,440 Units into a muscle One Time\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 3 days\n- typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution, through Intramuscular route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, through Oral route, started on 2016-05-19, presumably until 2017-01-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily Take one tablet daily, starting 1-2 days prior to travel to malarious area. Continue daily while in malarious area and for 7 days after leaving area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-19 13:25:31, ended at 2016-05-19 14:01:55\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2016-05-19, presumably until 2016-10-10, with intended 6 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- fexofenadine hydrochloride 180 MG Oral Tablet, through Oral route, presumably until 2018-09-06, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-09 00:00:00, ended at 2016-06-09 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-09 15:45:46, ended at 2016-06-09 16:14:23\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypokalemia\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-13 00:00:00, ended at 2016-06-13 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-14 00:00:00, ended at 2016-07-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-14 12:20:00, ended at 2016-07-14 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Urine: 32.09 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-14 14:04:01, ended at 2016-07-14 14:32:54\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2016-07-14, presumably until 2016-09-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2016-07-14, presumably until 2016-10-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-08-09 00:00:00, ended at 2016-08-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-09-06 00:00:00, ended at 2016-09-06 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-15 00:00:00, ended at 2016-09-15 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2016-09-15, presumably until 2016-09-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-16 00:00:00, ended at 2016-09-16 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Urine: 24 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 199 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 21 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10635 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Protein [Mass/volume] in Urine: 5 (milligram per deciliter)\n- Bacteria [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Basophils [#/volume] in Blood by Automated count: 0 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 445 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 208 (milligram per gram of creatinine)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 300 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 2.0 (calculated)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- MCV [Entitic volume] by Automated count: 94.3 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.13 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 421 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Hyaline casts [#/area] in Urine sediment by Microscopy low power field: NONE SEEN (per low powered field)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.9 (percent)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-19 00:00:00, ended at 2016-09-19 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Essential hypertension\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2016-09-19, presumably until 2017-04-12, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-20 00:00:00, ended at 2016-09-20 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2016-09-20, presumably until 2017-01-19, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-09-28 00:00:00, ended at 2016-09-28 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2016-09-28, presumably until 2017-01-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-30 00:00:00, ended at 2016-09-30 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-10 00:00:00, ended at 2016-10-10 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, started on 2016-10-10, presumably until 2017-01-19, with intended 3 refill(s). Instructions: SPRAY 1 SPRAY NASALLY 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-14 00:00:00, ended at 2016-10-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-20 12:33:00, ended at 2016-10-20 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 18.05 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.39 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-20 14:20:04, ended at 2016-10-20 14:56:33\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-28 00:00:00, ended at 2016-10-28 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-11 00:00:00, ended at 2016-11-11 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2016-11-14, presumably until 2017-01-19, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-14 11:39:00, ended at 2016-12-14 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.30 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.8 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 10.31 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-14 14:17:25, ended at 2016-12-14 15:07:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 10:48:04, ended at 2017-01-19 10:48:30\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Inhalation, started on 2017-01-19, presumably until 2017-12-26, with intended 3 refill(s). Instructions: 1 Spray by Inhalation route 2 times a day as needed (rhinitis)\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-01-19, presumably until 2017-07-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-01-19, presumably until 2017-04-12, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 14:07:24, ended at 2017-01-19 14:50:33\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-01-19, presumably until 2017-04-12, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n- prednisone 1 MG Oral Tablet, started on 2017-01-19, presumably until 2017-04-12, with intended 3 refill(s). Instructions: Take 4mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-07 00:00:00, ended at 2017-02-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-09 00:00:00, ended at 2017-02-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-02-14, presumably until 2017-03-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-09 11:18:15, ended at 2017-02-09 12:28:04\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.913\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-09 12:38:08, ended at 2017-02-09 13:15:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Disorder of nasal cavity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-14 00:00:00, ended at 2017-02-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-22 00:00:00, ended at 2017-02-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2017-02-23, presumably until 2017-02-23, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-21 00:00:00, ended at 2017-03-21 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-03-21, presumably until 2017-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-12 10:51:00, ended at 2017-04-12 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 26.74 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Erythrocyte sedimentation rate: 14 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 10.02 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 284 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Osteoporosis\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-12 11:17:25, ended at 2017-04-12 12:11:15\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.795\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2017-04-12, presumably until 2018-01-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2017-01-04, presumably until 2017-08-10, with intended 0 refill(s). Instructions:   </br>1 Puff Aerosol, INH, BID, 6 gm, 0, Maintenance\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-12 14:58:04, ended at 2017-04-12 15:24:37\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-04-12, presumably until 2017-07-17, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n- prednisone 1 MG Oral Tablet, started on 2017-04-12, presumably until 2017-09-05, with intended 3 refill(s). Instructions: Take 3mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-24 00:00:00, ended at 2017-05-24 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-31 00:00:00, ended at 2017-05-31 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n\n### Drug\n- levalbuterol 0.417 MG/ML Inhalation Solution, through Inhalation, started on 2017-05-31, presumably until 2017-12-26, with intended 0 refill(s). Instructions: 3 mL by Nebulization route 4 times a day as needed\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2017-05-31, presumably until 2017-06-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 7 days\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2017-05-31, presumably until 2018-02-01, with intended 1 refill(s). Instructions: 2 mL by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-07 00:00:00, ended at 2017-06-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2017-06-07, presumably until 2018-06-07, with intended 1 refill(s). Instructions: TAPER AS PRESCRIBED BY DR\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-07-17, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily Or as directed by MD.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-12 00:00:00, ended at 2017-06-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-06-12, presumably until 2017-09-05, with intended 0 refill(s). Instructions: Take as directed by MD for tapering\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-12 00:00:00, ended at 2017-06-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-06-13, presumably until 2017-06-13, with intended 6 refill(s). Instructions: TAKE 4 TABLETS ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-15 12:56:20, ended at 2017-06-15 15:15:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Allergic rhinitis due to pollen\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-15 14:25:08, ended at 2017-06-15 15:08:23\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Exacerbation of mild persistent asthma\n- Allergic rhinitis due to pollen\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-16 00:00:00, ended at 2017-06-16 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-22 00:00:00, ended at 2017-06-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2017-06-22, presumably until 2017-06-22, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-06 00:00:00, ended at 2017-07-06 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-07-06, presumably until 2017-12-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-12 00:00:00, ended at 2017-07-12 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-07-17, presumably until 2017-09-05, with intended 0 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2017-07-17, presumably until 2017-07-18, with intended 1 refill(s). Instructions: TAPER AS PRESCRIBED BY MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-18 00:00:00, ended at 2017-07-18 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-07-18, presumably until 2018-01-04, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-02 00:00:00, ended at 2017-08-02 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-10 11:38:00, ended at 2017-08-10 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 11.83 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.63 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-10 13:51:08, ended at 2017-08-10 15:20:24\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2017-01-04, presumably until 2018-09-06, with intended 0 refill(s). Instructions: 1 Cris Burt, Oliver, every 12 hours, PRN, as needed for pain, 0, Maintenance\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-08-10, presumably until 2017-12-26, with intended 11 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-01-04, presumably until 2019-10-22, with intended 0 refill(s). Instructions: take 3.125 mg by mouth daily as needed\n- citalopram 10 MG Oral Tablet, through Oral route, presumably until 2019-03-07, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-22 00:00:00, ended at 2017-08-22 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-08-22, presumably until 2018-08-22, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-24 15:25:49, ended at 2017-08-24 16:47:09\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-25 00:00:00, ended at 2017-08-25 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on nose and accessory sinuses; not otherwise specified\n\n### Condition\n- Heart failure\n- Transient cerebral ischemia\n- Deviated nasal septum\n- Hypertrophy of nasal turbinates\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- cefazolin 1000 MG Injection, started on 2017-08-25, presumably until 2017-08-25\n- remifentanil 2 MG Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-08-25, presumably until 2017-08-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-25 00:00:00, ended at 2017-08-25 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-08-25, presumably until 2017-08-25\n- fluorescein dilaurate, through Intraocular route, started on 2017-08-25, presumably until 2017-08-25\n- epinephrine 1 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- fluorescein, through Intraocular route, started on 2017-08-25, presumably until 2017-08-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-25 05:47:00, ended at 2017-08-25 12:19:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Replacement of Nasal Septum with Autologous Tissue Substitute, Open Approach\n- Submucous resection inferior turbinate, partial or complete, any method\n- Excision of Nasal Turbinate, Percutaneous Approach\n- Nasal/sinus endoscopy, surgical, with frontal sinus exploration, including removal of tissue from frontal sinus, when performed\n- Nasal/sinus endoscopy, surgical, with maxillary antrostomy\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Computer Assisted Procedure of Head and Neck Region\n- Excision of Right Sphenoid Sinus, Percutaneous Endoscopic Approach\n- Excision of Left Ethmoid Sinus, Percutaneous Endoscopic Approach\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Nasal/sinus endoscopy, surgical, with sphenoidotomy\n- Repair Right Maxillary Sinus, Percutaneous Endoscopic Approach\n- Excision of Left Sphenoid Sinus, Percutaneous Endoscopic Approach\n- Excision of Right Frontal Sinus, Percutaneous Endoscopic Approach\n- Repair Left Maxillary Sinus, Percutaneous Endoscopic Approach\n- Septoplasty or submucous resection, with or without cartilage scoring, contouring or replacement with graft\n- Nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior)\n- Excision of Left Frontal Sinus, Percutaneous Endoscopic Approach\n- Excision of Right Ethmoid Sinus, Percutaneous Endoscopic Approach\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Degenerative disorder of macula\n- Deviated nasal septum\n- Hypertrophy of nasal turbinates\n- Osteoporosis\n- Seasonal allergic rhinitis\n- Presbyopia\n- Allergic rhinitis\n- Disorder of nasal cavity\n- Chronic sinusitis\n- Disorder of kidney and/or ureter\n- Essential hypertension\n- Heart failure\n- Uncomplicated asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-05 12:31:57, ended at 2017-09-05 13:01:26\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2017-09-05, presumably until 2018-01-04, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-05 15:21:00, ended at 2017-09-05 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Disorder of nasal cavity\n- Allergic rhinitis due to animal dander\n- Disorder of bone\n- Chronic sinusitis\n- Osteoporosis\n- Uncomplicated asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-28 13:12:56, ended at 2017-09-28 14:17:14\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal/sinus endoscopy, surgical; with biopsy, polypectomy or debridement (separate procedure)\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-10 00:00:00, ended at 2017-10-10 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-12 11:00:00, ended at 2017-10-12 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 332 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.11 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 24.94 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 300 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Hypo-osmolality and or hyponatremia\n- Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 11:34:28, ended at 2017-10-12 12:34:37\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Hypo-osmolality and or hyponatremia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 13:54:53, ended at 2017-10-12 15:07:57\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Eosinophilic asthma\n- Allergic rhinitis due to pollen\n- Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-10-12, presumably until 2017-10-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 15:15:57, ended at 2017-10-12 16:10:38\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.99\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-19 00:00:00, ended at 2017-10-19 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n- Acute asthma\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-10-19, presumably until 2017-12-26, with intended 0 refill(s). Instructions: Take 20 mg PO Qday x 7 days, then 10 mg PO Qday x 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-02 12:54:42, ended at 2017-11-02 13:31:24\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Disorder of nasal cavity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-26 12:07:41, ended at 2017-12-26 12:43:08\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to pollen\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated mild persistent asthma\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-12-26, presumably until 2018-10-09, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-12-26, presumably until 2018-02-01, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-12-26, presumably until 2018-10-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-12-26, presumably until 2019-01-01, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-12-26, presumably until 2019-03-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-26 13:09:03, ended at 2017-12-26 14:24:20\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 14:27:00, ended at 2017-12-26 14:49:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 51.71 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 275 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.34 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- IgE [Units/volume] in Serum or Plasma by Immunoassay: 19 (kilounit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 14:50:00, ended at 2017-12-26 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Uncomplicated asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-01-03 00:00:00, ended at 2018-01-03 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2018-01-03, presumably until 2018-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-03 00:00:00, ended at 2018-01-03 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperparathyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-04 12:55:22, ended at 2018-01-04 13:29:56\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-04 15:01:13, ended at 2018-01-04 16:10:33\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-01-04, presumably until 2018-03-21, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-01-04, presumably until 2018-03-21, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 11:22:54, ended at 2018-02-01 12:51:04\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Allergic rhinitis due to pollen\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic maxillary sinusitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n\n### Drug\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-02-01, presumably until 2018-09-06, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2018-02-01, presumably until 2018-09-06, with intended 1 refill(s). Instructions: 2 mL by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 13:32:31, ended at 2018-02-01 14:52:49\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Mononeuritis multiplex\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-10 00:00:00, ended at 2018-03-10 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2018-03-12, presumably until 2019-03-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-21 10:25:18, ended at 2018-03-21 10:50:18\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-03-21, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-03-21, presumably until 2018-07-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-21 11:12:00, ended at 2018-03-21 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.30 (thousand per microliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 49 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Urine: <5.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.27 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 60.51 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 8 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 49 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.13 (milligram per milligram)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- IgE [Units/volume] in Serum or Plasma by Immunoassay: 16 (kilounit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 182 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Osteoporosis\n- Allergic rhinitis\n- Hyperparathyroidism\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-21 11:22:44, ended at 2018-03-21 12:13:39\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.417\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-24 10:49:00, ended at 2018-04-24 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Chronic sinusitis\n- Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-24 14:54:36, ended at 2018-04-24 16:30:41\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-09 00:00:00, ended at 2018-05-09 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-26 13:43:37, ended at 2018-06-26 14:46:12\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-04 00:00:00, ended at 2018-07-04 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2018-07-12, presumably until 2018-07-12, with intended 0 refill(s). Instructions: TAKE 2 TABLETS EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-19 14:18:37, ended at 2018-07-19 14:45:47\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-10-11, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-10-11, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-19 15:26:30, ended at 2018-07-19 16:01:36\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Exacerbation of mild persistent asthma\n- Allergic rhinitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-14 11:59:13, ended at 2018-08-14 13:15:54\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-04 00:00:00, ended at 2018-09-04 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe, started on 2018-09-05, presumably until 2018-09-05, with intended 0 refill(s). Instructions: LA:[000000]:05/18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-06 12:58:46, ended at 2018-09-06 14:41:57\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebral infarction\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Visual field defect\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, presumably until 2019-03-20, with intended 0 refill(s). Instructions: take 81 mg by mouth every morning with breakfast Takes 2-3 a day for pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-06 14:15:00, ended at 2018-09-06 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Cerebral infarction\n- Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-10-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-09-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-08, presumably until 2018-10-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-08, presumably until 2018-10-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-09 00:00:00, ended at 2018-10-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Anemia in chronic kidney disease\n- Primary diagnosis: Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-09 00:00:00, ended at 2018-10-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-10-09, presumably until 2019-01-31, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 10:40:45, ended at 2018-10-11 11:28:07\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n- Acute upper respiratory infection\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 12:08:12, ended at 2018-10-11 12:34:03\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 14:10:39, ended at 2018-10-11 14:36:43\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-10-11, presumably until 2019-01-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-10-11, presumably until 2019-01-24, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-12 00:00:00, ended at 2018-10-12 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-15 00:00:00, ended at 2018-10-15 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-18, presumably until 2018-10-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-24 00:00:00, ended at 2018-10-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2018-10-29, presumably until 2019-01-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-01 00:00:00, ended at 2018-11-01 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-01 00:00:00, ended at 2018-11-01 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 14 days\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2018-12-13, presumably until 2019-12-13, with intended 1 refill(s). Instructions: TAKE 2 TABLETS EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-12 11:00:00, ended at 2018-12-12 14:56:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.6 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Chronic kidney disease\n- Cerebral infarction\n- Anemia in chronic kidney disease\n- Valvular endocarditis\n- Visual field defect\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-12 14:57:00, ended at 2018-12-12 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine collected for unspecified duration: 13.0 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.15 (milligram per milligram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.1 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.0 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 88.78 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 5 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 152 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.93 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 108.0 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 259 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-01 10:43:30, ended at 2019-01-01 12:48:12\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic pansinusitis\n- Uncomplicated mild persistent asthma\n- Primary diagnosis: Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2019-01-01, presumably until 2020-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-01-01, presumably until 2019-04-04, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-01 12:52:22, ended at 2019-01-01 15:15:25\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Uncomplicated asthma\n- Chronic sinusitis\n- Primary diagnosis: Loss of sense of smell\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, started on 2019-01-01, presumably until 2019-03-20, with intended 11 refill(s). Instructions: Use 1 ampule as directed BID.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-24 14:46:39, ended at 2019-01-24 15:22:41\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-01-29, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-06-18, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-02-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-29 00:00:00, ended at 2019-01-29 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-01-29, presumably until 2019-08-13, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-31 00:00:00, ended at 2019-01-31 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-01-31, presumably until 2020-03-02, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-12 15:03:19, ended at 2019-02-12 16:29:50\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysphonia\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-07 11:37:58, ended at 2019-03-07 12:21:35\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Chronic rhinitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- fexofenadine hydrochloride 60 MG Oral Tablet, through Oral route, started on 2019-03-07, presumably until 2019-03-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-03-07, presumably until 2019-05-13, with intended 11 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-03-07, presumably until 2019-07-29, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-07 15:33:11, ended at 2019-03-07 17:03:08\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-19 12:17:38, ended at 2019-03-19 14:02:29\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n- Disorder of the larynx\n\n### Drug\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2019-03-19, presumably until 2019-05-13, with intended 3 refill(s). Instructions: take 5 mL by mouth 4 times a day\n- fluconazole 150 MG Oral Tablet, started on 2019-03-19, presumably until 2019-03-20, with intended 0 refill(s). Instructions: 150mg orally once and may repeat one tablet in 4 days if symptoms persist.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 07:23:00, ended at 2019-03-20 15:22:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance angiography, head; without contrast material(s)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 07:23:00, ended at 2019-03-20 15:22:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Hypertrophic condition of skin\n- Essential hypertension\n- Osteoporosis\n- Pain in right foot\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- gadobenate, through Intravenous route, started on 2019-03-20, presumably until 2019-03-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-20 09:56:33, ended at 2019-03-20 10:25:36\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2019-03-20, presumably until 2020-03-04, with intended 3 refill(s). Instructions: take 1 Tab (70 mg total) by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-20 13:31:38, ended at 2019-03-20 15:07:49\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hypertrophic condition of skin\n- Primary diagnosis: Pain in right foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-03-20, presumably until 2019-03-20, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-26 00:00:00, ended at 2019-03-26 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-03-27, presumably until 2019-03-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-04 11:42:40, ended at 2019-04-04 12:33:34\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.81\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-04 14:09:00, ended at 2019-04-04 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.63 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.17 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 30.13 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 5.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-24 00:00:00, ended at 2019-04-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in right foot\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-30 00:00:00, ended at 2019-04-30 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2019-05-01, presumably until 2019-09-23, with intended 12 refill(s). Instructions: take 1 Packet (20 mEq total) by mouth daily Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-30 12:05:26, ended at 2019-04-30 15:57:31\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 0.6 to 1.0 cm\n\n### Condition\n- Primary diagnosis: Neoplastic disease of uncertain behavior\n- Neoplasm of uncertain behavior of skin\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-30 13:14:52, ended at 2019-04-30 14:18:49\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.81\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated moderate persistent asthma\n- Dysphonia\n- Neoplasm of uncertain behavior of skin\n- Senile hyperkeratosis\n- Neoplastic disease of uncertain behavior\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-13 10:55:27, ended at 2019-05-13 12:12:51\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olopatadine 1 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-05-08, presumably until 2019-05-08, with intended 0 refill(s). Instructions: Instill 1 drop to both eyes as needed\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-05-13, presumably until 2019-05-13, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2019-04-14, presumably until 2019-05-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 12:15:00, ended at 2019-05-13 12:29:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Tailor's bunion\n- Pain in right foot\n- Talipes planus\n- Acquired hallux varus\n- Essential hypertension\n- Pain in left foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 12:30:00, ended at 2019-05-13 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in left foot\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-15 00:00:00, ended at 2019-05-15 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-05-15, presumably until 2020-05-11, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-18 10:57:51, ended at 2019-06-18 12:08:03\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2019-06-18, presumably until 2019-10-09, with intended 3 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n- gabapentin 100 MG Oral Capsule, through Oral route, presumably until 2019-08-13, with intended 0 refill(s). Instructions: take 100 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-09 11:00:00, ended at 2019-07-09 11:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-16 00:00:00, ended at 2019-07-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-17 00:00:00, ended at 2019-07-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n\n### Drug\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-07-29, presumably until 2019-12-25, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-13 10:36:00, ended at 2019-08-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- MCV [Entitic volume] by Automated count: 96.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 26.70 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <4.0 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Bunion\n- Follicular cysts of skin and subcutaneous tissue\n- Low back pain\n- Pain of left knee region\n- Chronic pain\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-13 13:18:06, ended at 2019-08-13 13:37:04\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Primary diagnosis: Follicular cysts of skin and subcutaneous tissue\n- Low back pain\n- Pain of left knee region\n- Bunion\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-08-13, presumably until 2019-09-20, with intended 2 refill(s). Instructions: take 1 Tab (50 mg total) by mouth as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-13 14:05:12, ended at 2019-08-13 14:51:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-08-13, presumably until 2020-02-04, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2019-08-26, presumably until 2019-08-27, with intended 2 refill(s). Instructions: take 2 Tabs (2,000 mg total) by mouth 2 times a day for 1 day PRN cold sores\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-05 00:00:00, ended at 2019-09-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-12 09:26:05, ended at 2019-09-12 14:45:38\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, started on 2019-08-30, presumably until 2019-09-13, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-12 11:31:14, ended at 2019-09-12 13:11:07\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n- Eosinophilic asthma\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-13 07:30:00, ended at 2019-09-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Supraventricular tachycardia\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-20 00:00:00, ended at 2019-09-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-09-20, presumably until 2019-10-25, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every bedtime as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2020-04-07, with intended 12 refill(s). Instructions: take 20 Tabs by mouth every day\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2019-09-23, presumably until 2019-09-23, with intended 12 refill(s). Instructions: take 1 Packet (20 mEq total) by mouth daily Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-09 00:00:00, ended at 2019-10-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-09 08:15:00, ended at 2019-10-09 11:14:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone length studies (orthoroentgenogram, scanogram)\n\n### Condition\n- Osteoarthritis of knee\n- Acquired genu valgum\n- Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-09 08:55:12, ended at 2019-10-09 09:27:51\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2019-10-09, presumably until 2020-02-04, with intended 3 refill(s). Instructions: take 2 Tabs (2 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-09 11:15:00, ended at 2019-10-09 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Osteoporosis\n- Disorder of bone\n- Pain in thoracic spine\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Acquired hallux varus\n- Pain of left knee region\n- Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-09 15:03:15, ended at 2019-10-09 15:53:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in thoracic spine\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pansinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-10-17, presumably until 2019-10-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-21 00:00:00, ended at 2019-10-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2019-10-22, presumably until 2020-04-07, with intended 12 refill(s). Instructions: take 1 Tab (3.125 mg total) by mouth daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-25 00:00:00, ended at 2019-10-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2019-10-28, presumably until 2019-12-05, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-28 00:00:00, ended at 2019-10-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pansinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2019-11-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-04 00:00:00, ended at 2019-11-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 09:50:06, ended at 2019-11-05 10:25:56\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 11:12:09, ended at 2019-11-05 12:04:23\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Uncomplicated severe persistent asthma\n- Chronic rhinitis\n- Primary diagnosis: Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 12:22:32, ended at 2019-11-05 14:38:39\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 13:22:35, ended at 2019-11-05 14:31:38\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 3\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-05 13:50:00, ended at 2019-11-05 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 15 (milligram per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 20 (milligram per gram)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.10 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 319 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Dysphonia\n- Anemia in chronic kidney disease\n- Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-08 00:00:00, ended at 2019-11-08 08:07:41\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-25 00:00:00, ended at 2019-11-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-11-25, presumably until 2019-12-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-02 00:00:00, ended at 2019-12-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.417 MG/ML Inhalation Solution, through Inhalation, started on 2019-12-05, presumably until 2019-12-10, with intended 1 refill(s). Instructions: 3 mL (1.25 mg total) by Nebulization route every 4 hours as needed for Bronchospasm/Wheezing (cough)\n- prednisone 5 MG Oral Tablet, started on 2019-12-05, presumably until 2020-02-04, with intended 0 refill(s). Instructions: Take 10 mg x 1 week, then 5 mg x 1 week\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-12-05, presumably until 2020-02-20, with intended 2 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-05 00:00:00, ended at 2019-12-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2019-12-05, presumably until 2020-01-22, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-10 00:00:00, ended at 2019-12-10 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2019-12-10, presumably until 2021-02-09, with intended 1 refill(s). Instructions: 1 Dose by Injection route every 4 hours as needed Use as directed\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2019-12-10, presumably until 2020-01-09, with intended 1 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-11 08:59:06, ended at 2019-12-11 09:45:31\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute sinusitis\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Acute bronchitis\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-11 10:29:00, ended at 2019-12-11 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Melanocytic nevus of trunk\n- Acute sinusitis\n- Disorder of immune function\n- Hyperpigmentation of skin\n- Melanocytic nevus of lower limb\n- Temporomandibular joint disorder\n- Scar conditions and fibrosis of skin\n- Essential hypertension\n- Acute bronchitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n- Melanocytic nevus of upper limb\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-11 12:17:22, ended at 2019-12-11 13:40:55\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Scar conditions and fibrosis of skin\n- Hyperpigmentation of skin\n- Primary diagnosis: Melanocytic nevus of lower limb\n- Disorder of immune function\n- Primary diagnosis: Melanocytic nevus of trunk\n- Primary diagnosis: Melanocytic nevus of upper limb\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-19 00:00:00, ended at 2019-12-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-25 00:00:00, ended at 2019-12-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n\n### Drug\n- levocetirizine dihydrochloride 5 MG Oral Tablet, started on 2019-12-25, presumably until 2020-10-06, with intended 10 refill(s). Instructions: TAKE ONE TABLET (5MG) BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-01-22, presumably until 2020-02-29, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated mild persistent asthma\n- Eosinophilic asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2020-01-22, presumably until 2020-07-21, with intended 3 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-04 09:13:00, ended at 2020-02-04 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 20 (milligram per gram)\n- Basophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 6.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 39.80 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Erythrocyte sedimentation rate: 5 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 73.8 (picogram per milliliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.15 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Dysphonia\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 09:50:25, ended at 2020-02-04 10:17:09\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 10:45:37, ended at 2020-02-04 12:08:30\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Joint pain\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 12:20:34, ended at 2020-02-04 13:04:58\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-05-19, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Reduced mobility\n- Primary diagnosis: Closed fracture of lower leg\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-18 00:00:00, ended at 2020-02-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed fracture of lower leg\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 12:15:00, ended at 2020-02-20 13:41:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Closed bimalleolar fracture\n- Closed fracture of lower leg\n- Arthralgia of the ankle and/or foot\n- Closed fracture of fibula\n- Closed fracture of medial malleolus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 13:42:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; 2 views\n\n### Condition\n- Closed fracture of lateral malleolus\n- Closed fracture of lower leg\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-21 00:00:00, ended at 2020-02-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nonunion of fracture\n- Primary diagnosis: Closed bimalleolar fracture\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2020-02-21, presumably until 2020-02-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed (for pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; not otherwise specified\n\n### Condition\n- Closed fracture of lateral malleolus\n- Sprain of deltoid ligament of ankle\n- Sprain of ankle\n\n### Drug\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- cefazolin 1000 MG Injection, started on 2020-02-27, presumably until 2020-02-27\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- ketamine 100 MG/ML Injectable Solution, started on 2020-02-27, presumably until 2020-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 30 ML ropivacaine hydrochloride 5 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Open treatment of distal fibular fracture (lateral malleolus), includes internal fixation, when performed\n- Manual application of stress performed by physician or other qualified health care professional for joint radiography, including contralateral joint if indicated\n- Open treatment of distal tibiofibular joint (syndesmosis) disruption, includes internal fixation, when performed\n\n### Condition\n- Closed fracture of lateral malleolus\n- Sprain of ankle\n- Sprain of deltoid ligament of ankle\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-02-27 07:19:00, ended at 2020-02-29 13:20:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Left ventricular Ejection fraction: 61.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n\n### Procedure\n- Repair Right Ankle Bursa and Ligament, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Reposition Right Fibula with Internal Fixation Device, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Collection of venous blood by venipuncture\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n\n### Condition\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Pain\n- Closed bimalleolar fracture\n- Primary diagnosis: Loss of consciousness\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated asthma\n- Essential hypertension\n- First degree atrioventricular block\n- Illness\n- Persistent pain following procedure\n- Chronic systolic heart failure\n- Gastroesophageal reflux disease without esophagitis\n- Closed fracture of lower leg\n- Sprain of deltoid ligament of ankle\n- Electrocardiogram abnormal\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2020-02-28, presumably until 2020-02-29\n- calcium carbonate 625 MG / cholecalciferol 125 UNT Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2020-02-27, presumably until 2020-03-10, with intended 0 refill(s). Instructions: take 2 Caps (200 mg total) by mouth 2 times a day as needed for Constipation\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-28\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-02-29, presumably until 2020-02-29\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-02-28, presumably until 2020-03-10, with intended 1 refill(s). Instructions: take 1 Packet (17 g total) by mouth daily as needed\n- 8 HR acetaminophen 650 MG Extended Release Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-03-10, with intended 0 refill(s). Instructions: take 1 Tab (650 mg total) by mouth every 6 hours\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-02-27, presumably until 2020-02-28\n- carboxymethylcellulose sodium 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2020-02-28, presumably until 2020-02-29\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-04-07, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed for Pain\n- 30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2020-02-29, presumably until 2020-02-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-02 00:00:00, ended at 2020-03-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-04 00:00:00, ended at 2020-03-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2021-05-21, with intended 3 refill(s). Instructions: take 1 Tab (70 mg total) by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-10 09:00:00, ended at 2020-03-10 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Closed fracture of medial malleolus\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-16 00:00:00, ended at 2020-03-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left foot\n- Pain in right foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-04-07 10:41:24, ended at 2020-04-07 12:14:11\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic pansinusitis\n- Primary diagnosis: Eosinophilic asthma\n- Chronic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-04-07 12:40:59, ended at 2020-04-07 13:56:39\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed bimalleolar fracture\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-04-07, presumably until 2020-12-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2020-04-07, presumably until 2020-10-23, with intended 0 refill(s). Instructions: take 1 Tab (3.125 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-07 13:56:18, ended at 2020-04-07 13:56:28\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Loss of consciousness\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-08 00:00:00, ended at 2020-04-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-13 00:00:00, ended at 2020-04-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-20 00:00:00, ended at 2020-04-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-04-28, presumably until 2020-05-26, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-23 09:50:00, ended at 2020-04-23 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Closed fracture of lateral malleolus\n- Tailor's bunion\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-24 00:00:00, ended at 2020-04-24 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed bimalleolar fracture\n- Arthralgia of the ankle and/or foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-09 00:00:00, ended at 2020-05-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-05-11, presumably until 2020-08-11, with intended 2 refill(s). Instructions: INHALE TWO PUFFS BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-15 00:00:00, ended at 2020-05-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-19 00:00:00, ended at 2020-05-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-05-19, presumably until 2020-12-23, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-05-26, presumably until 2020-06-02, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2020-05-25, presumably until 2020-06-01, with intended 5 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-26 00:00:00, ended at 2020-05-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n- Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-27 00:00:00, ended at 2020-05-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-01 00:00:00, ended at 2020-06-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-01, presumably until 2020-06-16, with intended 5 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-02 00:00:00, ended at 2020-06-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-06-02, presumably until 2020-07-13, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-04 00:00:00, ended at 2020-06-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-16 09:23:00, ended at 2020-06-16 15:41:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Late effect of fracture of lower extremities\n- Melanocytic nevus\n- Postoperative state\n- Closed bimalleolar fracture\n- Supraventricular tachycardia\n- Arthralgia of the ankle and/or foot\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 11:49:33, ended at 2020-06-16 13:26:49\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nasal cavity\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-16, presumably until 2020-06-25, with intended 3 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n- mupirocin 0.02 MG/MG Nasal Ointment, through Nasal route, started on 2020-06-16, presumably until 2020-06-18, with intended 0 refill(s). Instructions: by Nasal route 2 times a day\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2020-06-16, presumably until 2020-06-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 13:05:45, ended at 2020-06-16 15:41:51\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Melanocytic nevus\n- Primary diagnosis: Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 14:48:32, ended at 2020-06-16 15:36:44\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-16 15:42:00, ended at 2020-06-16 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine collected for unspecified duration: 9.0 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.12 (milligram per milligram)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Creatinine [Mass/volume] in Urine: 77.29 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-17 00:00:00, ended at 2020-06-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-18 00:00:00, ended at 2020-06-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nasal cavity\n\n### Drug\n- mupirocin 0.02 MG/MG Nasal Ointment, through Nasal route, started on 2020-06-18, presumably until 2020-08-21, with intended 0 refill(s). Instructions: by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-19 00:00:00, ended at 2020-06-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 0.83 MG/ML Inhalation Solution, started on 2020-06-19, presumably until 2021-11-19, with intended 0 refill(s). Instructions: USE ONE VIAL BY INHALATION ROUTE EVERY 4 HOURS AS NEEDED FOR COUGH/WHEEZE\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-25 00:00:00, ended at 2020-06-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-25, presumably until 2020-08-20, with intended 3 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-25 00:00:00, ended at 2020-06-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-25, presumably until 2020-07-07, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-02 00:00:00, ended at 2020-07-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n- Primary diagnosis: Bacterial infectious disease\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2020-07-02, presumably until 2020-08-27, with intended 1 refill(s). Instructions: Apply to affected areas BID x 5-7 days until improved\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-02 00:00:00, ended at 2020-07-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-07 11:06:14, ended at 2020-07-07 16:16:38\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated mild persistent asthma\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-07-07, presumably until 2020-08-17, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n- prednisone 5 MG Oral Tablet, started on 2020-07-07, presumably until 2020-07-09, with intended 0 refill(s). Instructions: Take 20 mg by mouth x 5 days, 15 mg x 5 days, 10 mg x 5 days, 5 mg x 5 days\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2020-07-07, presumably until 2020-11-03, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-09 00:00:00, ended at 2020-07-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-09 00:00:00, ended at 2020-07-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2020-07-09, presumably until 2020-07-21, with intended 0 refill(s). Instructions: Take 20 mg by mouth x 5 days, 15 mg x 5 days, 10 mg x 5 days, 5 mg x 5 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-10 00:00:00, ended at 2020-07-10 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-07-13, presumably until 2020-10-23, with intended 2 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-14 12:46:03, ended at 2020-07-14 13:10:35\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eosinophilic asthma\n- Recurrent acute sinusitis\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Acute pansinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2020-07-21, presumably until 2020-10-06, with intended 11 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2020-07-21, presumably until 2020-08-13, with intended 0 refill(s). Instructions: 30 mg x 7 days, 20 mg x 7 days, 10 mg x 7 days, 5 mg x 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-10 00:00:00, ended at 2020-08-10 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-11, presumably until 2021-01-26, with intended 0 refill(s). Instructions: INHALE TWO PUFFS BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-13 11:05:59, ended at 2020-08-13 15:45:04\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eosinophilic asthma\n- Uncomplicated severe persistent asthma\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2020-08-13, presumably until 2020-12-07, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-17 00:00:00, ended at 2020-08-17 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated severe persistent asthma\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-08-17, presumably until 2020-08-20, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-08-20, presumably until 2021-05-21, with intended 1 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-18 00:00:00, ended at 2020-08-18 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-20 00:00:00, ended at 2020-08-20 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, started on 2020-08-20, presumably until 2020-08-21, with intended 0 refill(s). Instructions: 3mL mixed with budesonide by inhalation route BID PRN cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-08-20 10:05:43, ended at 2020-08-20 11:13:04\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pansinusitis\n- Spasm\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Blood chemistry abnormal\n- Primary diagnosis: Disorder of bone\n- Lymphocytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-20 10:45:00, ended at 2020-08-20 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Arthralgia of the ankle and/or foot\n- Metatarsalgia\n- Pain in right foot\n- Postoperative state\n- Closed bimalleolar fracture\n- Closed fracture of lateral malleolus\n- Acquired hallux varus\n- Hammer toe\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-21 00:00:00, ended at 2020-08-21 08:04:46\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Eosinophilic asthma\n- Primary diagnosis: Insomnia\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 M..., through Intramuscular route, started on 2020-08-21, presumably until 2020-08-21, with intended 0 refill(s). Instructions: inject into a muscle\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2020-08-21, presumably until 2021-08-21, with intended 12 refill(s). Instructions: take 1 Tab (3 mg total) by mouth every bedtime as needed (insomnia)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-21 00:00:00, ended at 2020-08-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, started on 2020-08-21, presumably until 2020-12-07, with intended 3 refill(s). Instructions: 3mL mixed with budesonide by inhalation route BID PRN cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-24 00:00:00, ended at 2020-08-24 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-24 00:00:00, ended at 2020-08-24 10:20:37\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Candidiasis of mouth\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-26 00:00:00, ended at 2020-08-26 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2020-08-27, presumably until 2020-12-07, with intended 0 refill(s). Instructions: APPLY TO THE AFFECTED AREA(S) TWICE DAILY FOR 5 TO 7 DAYS UNTIL IMPROVED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-08 11:04:53, ended at 2020-09-08 12:09:27\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lymphocytopenia\n- Uncomplicated severe persistent asthma\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-10 11:26:40, ended at 2020-09-10 13:35:18\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea and vomiting\n- Primary diagnosis: Tailor's bunion\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-17 00:00:00, ended at 2020-09-17 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-09-17, presumably until 2020-12-07, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-09-21 00:00:00, ended at 2020-09-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Open bimalleolar fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-23 00:00:00, ended at 2020-09-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-23 11:15:00, ended at 2020-09-23 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Dysphonia\n- Pain in right foot\n- Chronic pansinusitis\n- Disorder of bone\n- Spasm\n- Lymphocytopenia\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-09-24 00:00:00, ended at 2020-09-24 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2020-09-24, presumably until 2020-09-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-09-24, presumably until 2020-09-24\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2020-09-24, presumably until 2020-09-24\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2020-09-24, presumably until 2020-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-24 08:30:00, ended at 2020-09-24 12:10:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Ostectomy, partial excision, fifth metatarsal head (bunionette) (separate procedure)\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Pain in right foot\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Eosinophilic asthma\n- Osteoporosis\n- Tailor's bunion\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-09-24, presumably until 2020-11-23, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every 6 hours as needed\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-09-24, presumably until 2020-09-24\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-24, presumably until 2020-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-25 00:00:00, ended at 2020-09-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tailor's bunion\n- Pain in right foot\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-25, presumably until 2020-09-26, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-26 00:00:00, ended at 2020-09-26 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in right foot\n- Tailor's bunion\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-26, presumably until 2020-10-08, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-05 00:00:00, ended at 2020-10-05 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n- Uncomplicated mild persistent asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2020-10-06, presumably until 2021-02-09, with intended 3 refill(s). Instructions: Take by mouth every bedtime\n- levocetirizine dihydrochloride 5 MG Oral Tablet, started on 2020-10-06, presumably until 2021-07-05, with intended 3 refill(s). Instructions: TAKE ONE TABLET (5MG) BY MOUTH ONE TIME DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-08 09:35:08, ended at 2020-10-08 10:27:46\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Candidiasis of mouth\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Acute exacerbation of chronic obstructive airways disease\n\n### Drug\n- prednisone 1 MG Oral Tablet, started on 2020-10-08, presumably until 2020-12-07, with intended 0 refill(s). Instructions: 4 mg x 7 days, then 3 mg x 7 days, 2 mg x 7 days, 1 mg x 7 days\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2020-10-13, presumably until 2020-10-15, with intended 3 refill(s). Instructions: 1 Plunkett (18 mcg total) by Inhalation route daily\n- fluconazole 150 MG Oral Tablet, started on 2020-10-08, presumably until 2020-12-07, with intended 0 refill(s). Instructions: 150mg orally once and may repeat one tablet in 72 hour if not improved\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-09 00:00:00, ended at 2020-10-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clotrimazole 10 MG Oral Lozenge, through Oral route, started on 2020-10-09, presumably until 2021-01-26, with intended 3 refill(s). Instructions: take 1 Lozenge (10 mg total) by mouth 5 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-13 00:00:00, ended at 2020-10-13 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative disorder of macula\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n- Chronic kidney disease\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in right foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-10-23, presumably until 2020-11-23, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-23 00:00:00, ended at 2020-10-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 3.125 MG Oral Tablet, started on 2020-10-23, presumably until 2020-11-02, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 09:51:00, ended at 2020-10-26 12:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Postoperative state\n- Metatarsal bone fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-26 09:51:03, ended at 2020-10-26 12:26:39\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tailor's bunion\n- Primary diagnosis: Postoperative state\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 13:00:00, ended at 2020-10-26 14:02:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease stage 3\n- Pain in right foot\n- Postoperative state\n- Uncomplicated severe persistent asthma\n- Tailor's bunion\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 14:03:00, ended at 2020-10-26 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.3 (ratio)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 147 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 97.0 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 27 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 32 (milligram per gram)\n- Neutrophils [#/volume] in Blood by Automated count: 7.05 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.20 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-27 12:43:28, ended at 2020-10-27 13:54:28\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-03 15:51:11, ended at 2020-11-03 16:43:27\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2020-11-03, presumably until 2021-01-25, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-11-10 13:09:35, ended at 2020-11-10 14:05:34\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.417\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease\n- Chronic kidney disease stage 3A\n- Essential hypertension\n- Primary diagnosis: Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-20 00:00:00, ended at 2020-11-20 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-23 00:00:00, ended at 2020-11-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-11-23, presumably until 2021-11-23, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-25 00:00:00, ended at 2020-11-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in right foot\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-07 00:00:00, ended at 2020-12-07 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Tablet, through Oral route, started on 2020-12-07, presumably until 2020-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth every day\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2020-12-07, presumably until 2021-11-19, with intended 12 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-12-08 11:45:37, ended at 2020-12-08 12:18:16\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Cellulitis\n- Chronic sinusitis\n- Chronic obstructive lung disease\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2020-12-08, presumably until 2020-12-18, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 3 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-14 08:30:00, ended at 2020-12-14 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Dysphonia\n- Hammer toe\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Metatarsal bone fracture\n- Closed bimalleolar fracture\n- Metatarsalgia\n- Acquired hallux varus\n- Pain in right foot\n- Postoperative state\n- Tailor's bunion\n- Chronic frontal sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-15 00:00:00, ended at 2020-12-15 12:19:53\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2020-12-15, presumably until 2021-01-04, with intended 0 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-22 00:00:00, ended at 2020-12-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2020-12-23, presumably until 2021-01-06, with intended 0 refill(s). Instructions: TAKE TWO TABLETS BY MOUTH DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-22 00:00:00, ended at 2020-12-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, started on 2020-12-23, presumably until 2022-01-20, with intended 12 refill(s). Instructions: TAKE 1 TABLET (20MEQ) BY MOUT HEVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-01 00:00:00, ended at 2021-01-01 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2021-01-05, presumably until 2021-02-08, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN, APPOINTMENT NEEDED BEFORE NEXT REFILL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-02 00:00:00, ended at 2021-01-02 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2021-01-04, presumably until 2021-01-04, with intended 0 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-04 00:00:00, ended at 2021-01-04 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-01-04, presumably until 2021-02-09, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 00:00:00, ended at 2021-01-06 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-04-15, with intended 0 refill(s). Instructions: take 1.5 Tabs (75 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-25 00:00:00, ended at 2021-01-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated moderate persistent asthma\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2021-01-25, presumably until 2021-01-27, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-01-26 08:44:00, ended at 2021-01-26 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 20.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.11 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 275 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 89.00 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.22 (milligram per milligram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Acquired hallux varus\n- Hammer toe\n- Metatarsalgia\n- Non-rheumatic aortic sclerosis\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-01-26 09:16:50, ended at 2021-01-26 10:35:10\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-rheumatic aortic sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-01-26 10:42:23, ended at 2021-01-26 12:24:26\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated severe persistent asthma\n- Osteoporosis\n- Non-rheumatic aortic sclerosis\n- Uncomplicated moderate persistent asthma\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-27 00:00:00, ended at 2021-01-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated moderate persistent asthma\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2021-01-27, presumably until 2021-02-09, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-21 01:58:00, ended at 2014-03-29 16:27:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.51 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 338 (milligram per deciliter)\n- Osmolality of Urine: 574 (milliosmole per kilogram)\n- Thrombin time: 15.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 229 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.31 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 5.25 (milli-international unit per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.1 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 4\" (inch (US))\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 83 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Prothrombin time (PT): 16.0 (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 9.82 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 357 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.4 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 94 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 12.4 (microgram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 25 (millimeter per hour)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n\n### Procedure\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Magnetic resonance angiography, head; without contrast material(s)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time int\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Radiologic examination, chest; single view, frontal\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n- Hospital discharge day management; more than 30 minutes\n- Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professio\n- Nerve conduction studies; 5-6 studies\n- Occupational therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Magnetic resonance angiography, neck; without contrast material(s)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Lumbar puncture\n- Open biopsy of cranial or peripheral nerve or ganglion\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Collection of venous blood by venipuncture\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Open biopsy of soft tissue\n- Standardized cognitive performance testing (eg, Ross Information Processing Assessment) per hour of a qualified health care professional's time, both face-to-face time administering tests to the patient and time interpreting these test results and prepari\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Acute renal failure syndrome\n- Arteritis\n- Diffuse cerebrovascular disease\n- Acquired deformity of ankle AND/OR foot\n- Altered mental status\n- Congestive heart failure\n- Disorder of brain\n- Eosinophil count raised\n- Eruption\n- Hyperkalemia\n- Cardiomegaly\n- Cerebral ischemia\n- Disorder of lower extremity\n- Disorder of posterior pituitary\n- Granulomatosis with polyangiitis\n- Hypo-osmolality and or hyponatremia\n- Polyarteritis nodosa\n- Primary diagnosis: Visual field defect\n- Disorder of skeletal muscle\n- Essential hypertension\n- Primary cardiomyopathy\n- Anemia in chronic kidney disease\n- First degree atrioventricular block\n- Renal function tests abnormal\n- Spontaneous ecchymosis\n- Organic mental disorder\n- Abnormal findings on diagnostic imaging of skull and head\n- Backache\n- Cardiomyopathy associated with another disorder\n- Chronic diastolic heart failure\n- Chronic kidney disease\n- Disorder of nervous system\n- Herpes simplex without complication\n- Electrocardiogram abnormal\n- Mononeuritis\n- Subarachnoid hemorrhage\n\n### Drug\n- ramipril 5 MG Oral Capsule, through Oral route, started on 2014-03-21, presumably until 2014-03-23\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-21\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2014-03-25, presumably until 2014-05-14, with intended 0 refill(s). Instructions: 3 mL by Nebulization route every 4 hours as needed for Bronchospasm/Wheezing.\n- calcium carbonate 625 MG / cholecalciferol 125 UNT Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2023-01-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2014-03-22, presumably until 2017-12-26, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route daily.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-03-23, presumably until 2014-05-14, with intended 0 refill(s). Instructions: 40 mg by Intravenous route daily.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-03-22, presumably until 2014-07-31, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed (pain or fever).\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-03-21, presumably until 2014-03-21\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2014-03-21, presumably until 2014-03-24\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-03-24, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-23\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2014-03-23, presumably until 2015-03-29, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 12 hours as needed.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, through Subcutaneous route, started on 2014-03-21, presumably until 2014-05-14, with intended 0 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 8 hours.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-03-23, presumably until 2014-07-31, with intended 0 refill(s). Instructions: take 1 Singhal by mouth every bedtime.\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-03-27, presumably until 2014-03-29\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2014-03-24\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2014-10-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2014-03-25, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2014-03-29, presumably until 2014-03-29\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-03-26, presumably until 2014-03-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-23, presumably until 2014-03-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-03-26, presumably until 2014-03-26\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-03-25 00:00:00, ended at 2014-03-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-25 00:00:00, ended at 2014-03-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on nerves, muscles, tendons, and fascia of lower leg, ankle, and foot; not otherwise specified\n\n### Condition\n- Muscle weakness\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2014-03-25, presumably until 2014-03-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-25, presumably until 2014-03-25\n- midazolam 1 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-09 10:06:18, ended at 2014-04-09 16:27:50\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-24 11:44:00, ended at 2014-04-24 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-04-24, presumably until 2014-04-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-04-24, presumably until 2014-04-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-04-24, presumably until 2014-04-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-24 15:16:36, ended at 2014-04-24 15:16:45\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-14 00:00:00, ended at 2014-05-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 2.1EF(MOD-sp4) (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-14 09:16:31, ended at 2014-05-14 10:23:33\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-05-14, presumably until 2014-09-04, with intended 6 refill(s). Instructions: take 4 Tabs by mouth daily.\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2014-05-14, presumably until 2015-01-06, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-14 09:30:00, ended at 2014-05-14 10:28:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n\n### Condition\n- Localized swelling, mass and lump, trunk\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-14 10:29:00, ended at 2014-05-14 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCV [Entitic volume] by Automated count: 92.5 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.17 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-27 11:59:00, ended at 2014-05-27 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-27, presumably until 2014-05-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-27, presumably until 2014-05-27\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-05-27, presumably until 2014-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-27 12:40:23, ended at 2014-05-27 12:41:49\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-06-11 00:00:00, ended at 2014-06-11 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arteritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-26 09:44:00, ended at 2014-06-26 10:55:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 12.65 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Ulcerative colitis\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-26 10:56:00, ended at 2014-06-26 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.488\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Ulcerative colitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-06-26\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-06-26, presumably until 2014-06-26\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-06-26, presumably until 2014-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-26 12:33:34, ended at 2014-06-26 12:34:17\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Ulcerative colitis\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2014-06-26, presumably until 2014-10-14, with intended 3 refill(s). Instructions: take 40 mg by mouth daily.\n- prednisone 5 MG Oral Tablet, started on 2014-06-26, presumably until 2014-07-31, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- cyclophosphamide 25 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-08-01, with intended 1 refill(s). Instructions: take 4 Tabs by mouth daily.\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-10-14, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-31 09:56:00, ended at 2014-07-31 11:17:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 12.59 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 34 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Age related macular degeneration\n- Cataract\n- Presbyopia\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-31 10:22:03, ended at 2014-07-31 11:10:54\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2018-09-06, with intended 0 refill(s). Instructions: take 81 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-31 11:18:00, ended at 2014-07-31 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 10 (milligram per gram)\n- Albumin [Mass/volume] in Urine: 10 (milligram per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-05 09:30:00, ended at 2014-08-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-08-05, presumably until 2014-08-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-05, presumably until 2014-08-05\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-08-05, presumably until 2014-08-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-05 14:28:42, ended at 2014-08-05 17:01:53\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Arteritis\n- Inflammatory and toxic neuropathy\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-08-18 00:00:00, ended at 2014-08-18 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-08-18, presumably until 2014-09-04, with intended 3 refill(s). Instructions: take 2 tablets by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-04 00:00:00, ended at 2014-09-04 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-09-04, presumably until 2014-11-11, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- prednisone 10 MG Oral Tablet, started on 2014-09-04, presumably until 2014-11-06, with intended 6 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-22 00:00:00, ended at 2014-09-22 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-14 11:53:00, ended at 2014-10-14 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 17 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.00 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.90 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cataract\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-14 15:17:41, ended at 2014-10-14 16:01:17\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Ma..., through Intramuscular route, started on 2014-10-14, presumably until 2014-10-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, presumably until 2014-11-11, with intended 0 refill(s). Instructions: take  by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-04 00:00:00, ended at 2014-11-04 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myocardial infarction of anterior wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 12:34:00, ended at 2014-11-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte sedimentation rate: 13 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.23 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.2 (thousand per microliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 9 (milligram per gram)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 294 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-05 13:51:43, ended at 2014-11-05 14:20:57\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation\n\n### Condition\n- Primary diagnosis: Cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-06 00:00:00, ended at 2014-11-06 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2014-11-06, presumably until 2015-01-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. Taper as instructed by MD.\n- prednisone 5 MG Oral Tablet, started on 2014-11-06, presumably until 2015-01-06, with intended 3 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-11-10 00:00:00, ended at 2014-11-10 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hyaluronate, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- chondroitin sulfates, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- povidone-iodine 50 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- chondroitin 4-sulfate, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- cefazolin 1000 MG Injection, started on 2014-11-10, presumably until 2014-11-10\n- 1 ML epinephrine 1 MG/ML Injection, started on 2014-11-10, presumably until 2014-11-10\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-11-10, presumably until 2014-11-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-10 11:50:00, ended at 2014-11-10 14:31:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); without endoscopic cyclophotocoagulation\n- One stage extracapsular extraction of lens and insertion of prosthetic intraocular lens\n- Aspiration of cataract by phacoemulsification\n\n### Condition\n- Visual field defect\n- Hypermetropia\n- Presbyopia\n- Cataract\n- Asthma\n- Gastroesophageal reflux disease\n- Age related macular degeneration\n- Cardiac arrhythmia\n- Chronic kidney disease\n\n### Drug\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-11 13:56:14, ended at 2014-11-11 14:39:52\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-11-11, presumably until 2015-01-06, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-18 10:24:00, ended at 2014-11-18 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 19 (milligram per gram)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils [#/volume] in Blood by Automated count: 7.61 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 331 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Urine: 11 (milligram per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-12-15 00:00:00, ended at 2014-12-15 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hyaluronate, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- chondroitin sulfates, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- povidone-iodine 50 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- chondroitin 4-sulfate, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- cefazolin 1000 MG Injection, started on 2014-12-15, presumably until 2014-12-15\n- 1 ML epinephrine 1 MG/ML Injection, started on 2014-12-15, presumably until 2014-12-15\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-12-15, presumably until 2014-12-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-15 11:18:00, ended at 2014-12-15 14:40:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Aspiration of cataract by phacoemulsification\n- Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); without endoscopic cyclophotocoagulation\n- One stage extracapsular extraction of lens and insertion of prosthetic intraocular lens\n\n### Condition\n- Asthma\n- Chronic kidney disease\n- Cataract\n- Heart failure\n- Disorder of kidney and/or ureter\n- Granulomatosis with polyangiitis\n- Age related macular degeneration\n- Allergic disposition\n- Chronic sinusitis\n- Allergic rhinitis\n- Gastroesophageal reflux disease\n\n### Drug\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-12-15, presumably until 2014-12-15\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-12-24 00:00:00, ended at 2014-12-24 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-24 12:07:00, ended at 2014-12-24 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.76 (thousand per microliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Age related macular degeneration\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-06 09:29:01, ended at 2015-01-06 10:29:13\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Age related macular degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-06 11:18:21, ended at 2015-01-06 12:06:39\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Age related macular degeneration\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-01-06, presumably until 2015-04-30, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- prednisone 1 MG Oral Tablet, started on 2015-01-06, presumably until 2015-05-05, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- prednisone 5 MG Oral Tablet, started on 2015-01-06, presumably until 2015-03-27, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- carvedilol 6.25 MG Oral Tablet, through Oral route, presumably until 2016-10-20, with intended 0 refill(s). Instructions: take 6.25 mg by mouth 2 times a day with meals \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-10 00:00:00, ended at 2015-02-10 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 10:04:24, ended at 2015-02-10 12:34:34\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n\n### Condition\n- Eruption\n- Primary diagnosis: Chronic rhinitis\n- Chronic sinusitis\n- Asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 14:51:30, ended at 2015-02-10 16:38:58\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Chronic rhinitis\n- Eruption\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 16:11:09, ended at 2015-02-10 17:15:16\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-03 00:00:00, ended at 2015-03-03 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 09:01:58, ended at 2015-03-03 10:32:17\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 11 (millimeter mercury column)\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Age related macular degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 11:10:19, ended at 2015-03-03 13:37:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Granulomatosis with polyangiitis\n- IgE-mediated allergic asthma\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-03-03, presumably until 2015-05-05, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-03 12:47:00, ended at 2015-03-03 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.1 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Acute myocardial infarction of anterior wall\n- Cerebral infarction due to embolism of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 15:08:13, ended at 2015-03-03 16:51:51\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-04-16, presumably until 2015-06-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-27 00:00:00, ended at 2015-03-27 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2015-03-31, presumably until 2015-08-25, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-17 00:00:00, ended at 2015-04-17 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 12.5 MG Oral Tablet, started on 2015-04-17, presumably until 2015-04-17, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-30 00:00:00, ended at 2015-04-30 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Allergic rhinitis due to animal hair and dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-04-30, presumably until 2015-06-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-05-05 00:00:00, ended at 2015-05-05 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-05 09:35:00, ended at 2015-05-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 18 (milligram per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 129.70 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 21 - 50 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Monocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.73 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.98 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypokalemia\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-05 10:09:27, ended at 2015-05-05 10:55:28\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- potassium chloride 25 MEQ Effervescent Oral Tablet, through Oral route, started on 2015-05-05, presumably until 2016-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-24 10:42:00, ended at 2015-06-24 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 10.64 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Creatinine [Mass/volume] in Urine: 32.50 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-24 12:52:33, ended at 2015-06-24 14:33:10\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 1\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-24 14:50:21, ended at 2015-06-24 15:40:13\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Allergic rhinitis due to animal hair and dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-06-24, presumably until 2015-08-25, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-07-07 00:00:00, ended at 2015-07-07 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-21 10:22:00, ended at 2015-07-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 79.1 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.74 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n- Chronic sinusitis\n- Chronic kidney disease stage 1\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-21 13:38:44, ended at 2015-07-21 14:47:40\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-07-21, presumably until 2016-05-19, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- cephalexin 500 MG Oral Capsule, through Oral route, presumably until 2015-07-21, with intended 0 refill(s). Instructions: take by mouth 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-25 10:45:00, ended at 2015-08-25 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Creatinine [Mass/volume] in Urine: 55.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.85 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of muscle\n- Allergic rhinitis due to animal hair and dander\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-25 11:35:10, ended at 2015-08-25 12:35:45\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n- Asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2016-08-24, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-25 14:05:22, ended at 2015-08-25 15:02:39\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.04 (micro-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Disorder of muscle\n- Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2016-04-20, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, started on 2015-08-25, presumably until 2015-12-23, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-26 00:00:00, ended at 2015-08-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-28 00:00:00, ended at 2015-09-28 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-12 00:00:00, ended at 2015-11-12 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-11-17 00:00:00, ended at 2015-11-17 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-18 10:21:00, ended at 2015-11-18 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: <0.10 (milligram per milligram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 168 (picogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 120.7 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Neutrophils [#/volume] in Blood by Automated count: 9.83 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-18 11:04:02, ended at 2015-11-18 11:46:02\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-23 10:30:00, ended at 2015-12-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 8 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: <0.10 (milligram per milligram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 123.8 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.64 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of bone\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-23 11:24:15, ended at 2015-12-23 11:52:17\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Disorder of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-01-05 00:00:00, ended at 2016-01-05 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-04 14:12:49, ended at 2016-02-04 16:12:30\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-04 16:10:44, ended at 2016-02-04 16:53:21\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, presumably until 2019-04-30, with intended 0 refill(s). Instructions: take 20 mEq by mouth 2 times a day Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-04-19 00:00:00, ended at 2016-04-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-20 11:37:00, ended at 2016-04-20 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 59.99 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.40 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 292 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Osteoporosis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-20 12:00:20, ended at 2016-04-20 12:18:01\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2016-04-20, presumably until 2016-09-20, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 1 MG Oral Tablet, started on 2016-04-20, presumably until 2016-09-19, with intended 2 refill(s). Instructions: Take 3mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-29 00:00:00, ended at 2016-04-29 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-05-18 00:00:00, ended at 2016-05-18 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-19 10:46:24, ended at 2016-05-19 12:06:35\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 60 minutes\n\n### Condition\n- No conditions.\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, started on 2016-05-19, presumably until 2017-04-12, with intended 0 refill(s). Instructions: Take 2 tablets by mouth initially then 1 tablet by mouth following each loose stool. Not to exceed 8 tablets per day\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection, through Intramuscular route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: inject 1,440 Units into a muscle One Time\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 3 days\n- typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution, through Intramuscular route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, through Oral route, started on 2016-05-19, presumably until 2017-01-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily Take one tablet daily, starting 1-2 days prior to travel to malarious area. Continue daily while in malarious area and for 7 days after leaving area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-19 13:25:31, ended at 2016-05-19 14:01:55\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2016-05-19, presumably until 2016-10-10, with intended 6 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- fexofenadine hydrochloride 180 MG Oral Tablet, through Oral route, presumably until 2018-09-06, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-09 00:00:00, ended at 2016-06-09 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-09 15:45:46, ended at 2016-06-09 16:14:23\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypokalemia\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-13 00:00:00, ended at 2016-06-13 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-14 00:00:00, ended at 2016-07-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-14 12:20:00, ended at 2016-07-14 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Urine: 32.09 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-14 14:04:01, ended at 2016-07-14 14:32:54\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2016-07-14, presumably until 2016-09-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2016-07-14, presumably until 2016-10-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-08-09 00:00:00, ended at 2016-08-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-09-06 00:00:00, ended at 2016-09-06 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-15 00:00:00, ended at 2016-09-15 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2016-09-15, presumably until 2016-09-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-16 00:00:00, ended at 2016-09-16 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Urine: 24 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 199 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 21 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10635 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Protein [Mass/volume] in Urine: 5 (milligram per deciliter)\n- Bacteria [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Basophils [#/volume] in Blood by Automated count: 0 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 445 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 208 (milligram per gram of creatinine)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 300 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 2.0 (calculated)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- MCV [Entitic volume] by Automated count: 94.3 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.13 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 421 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Hyaline casts [#/area] in Urine sediment by Microscopy low power field: NONE SEEN (per low powered field)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.9 (percent)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-19 00:00:00, ended at 2016-09-19 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Essential hypertension\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2016-09-19, presumably until 2017-04-12, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-20 00:00:00, ended at 2016-09-20 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2016-09-20, presumably until 2017-01-19, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-09-28 00:00:00, ended at 2016-09-28 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2016-09-28, presumably until 2017-01-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-30 00:00:00, ended at 2016-09-30 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-10 00:00:00, ended at 2016-10-10 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, started on 2016-10-10, presumably until 2017-01-19, with intended 3 refill(s). Instructions: SPRAY 1 SPRAY NASALLY 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-14 00:00:00, ended at 2016-10-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-20 12:33:00, ended at 2016-10-20 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 18.05 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.39 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-20 14:20:04, ended at 2016-10-20 14:56:33\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-28 00:00:00, ended at 2016-10-28 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-11 00:00:00, ended at 2016-11-11 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2016-11-14, presumably until 2017-01-19, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-14 11:39:00, ended at 2016-12-14 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.30 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.8 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 10.31 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-14 14:17:25, ended at 2016-12-14 15:07:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 10:48:04, ended at 2017-01-19 10:48:30\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Inhalation, started on 2017-01-19, presumably until 2017-12-26, with intended 3 refill(s). Instructions: 1 Spray by Inhalation route 2 times a day as needed (rhinitis)\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-01-19, presumably until 2017-07-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-01-19, presumably until 2017-04-12, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 14:07:24, ended at 2017-01-19 14:50:33\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-01-19, presumably until 2017-04-12, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n- prednisone 1 MG Oral Tablet, started on 2017-01-19, presumably until 2017-04-12, with intended 3 refill(s). Instructions: Take 4mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-07 00:00:00, ended at 2017-02-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-09 00:00:00, ended at 2017-02-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-02-14, presumably until 2017-03-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-09 11:18:15, ended at 2017-02-09 12:28:04\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.913\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-09 12:38:08, ended at 2017-02-09 13:15:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Disorder of nasal cavity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-14 00:00:00, ended at 2017-02-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-22 00:00:00, ended at 2017-02-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2017-02-23, presumably until 2017-02-23, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-21 00:00:00, ended at 2017-03-21 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-03-21, presumably until 2017-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-12 10:51:00, ended at 2017-04-12 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 26.74 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Erythrocyte sedimentation rate: 14 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 10.02 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 284 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Osteoporosis\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-12 11:17:25, ended at 2017-04-12 12:11:15\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.795\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2017-04-12, presumably until 2018-01-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2017-01-04, presumably until 2017-08-10, with intended 0 refill(s). Instructions:   </br>1 Puff Aerosol, INH, BID, 6 gm, 0, Maintenance\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-12 14:58:04, ended at 2017-04-12 15:24:37\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-04-12, presumably until 2017-07-17, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n- prednisone 1 MG Oral Tablet, started on 2017-04-12, presumably until 2017-09-05, with intended 3 refill(s). Instructions: Take 3mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-24 00:00:00, ended at 2017-05-24 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-31 00:00:00, ended at 2017-05-31 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n\n### Drug\n- levalbuterol 0.417 MG/ML Inhalation Solution, through Inhalation, started on 2017-05-31, presumably until 2017-12-26, with intended 0 refill(s). Instructions: 3 mL by Nebulization route 4 times a day as needed\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2017-05-31, presumably until 2017-06-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 7 days\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2017-05-31, presumably until 2018-02-01, with intended 1 refill(s). Instructions: 2 mL by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-07 00:00:00, ended at 2017-06-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2017-06-07, presumably until 2018-06-07, with intended 1 refill(s). Instructions: TAPER AS PRESCRIBED BY DR\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-07-17, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily Or as directed by MD.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-12 00:00:00, ended at 2017-06-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-06-12, presumably until 2017-09-05, with intended 0 refill(s). Instructions: Take as directed by MD for tapering\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-12 00:00:00, ended at 2017-06-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-06-13, presumably until 2017-06-13, with intended 6 refill(s). Instructions: TAKE 4 TABLETS ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-15 12:56:20, ended at 2017-06-15 15:15:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Allergic rhinitis due to pollen\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-15 14:25:08, ended at 2017-06-15 15:08:23\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Exacerbation of mild persistent asthma\n- Allergic rhinitis due to pollen\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-16 00:00:00, ended at 2017-06-16 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-22 00:00:00, ended at 2017-06-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2017-06-22, presumably until 2017-06-22, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-06 00:00:00, ended at 2017-07-06 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-07-06, presumably until 2017-12-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-12 00:00:00, ended at 2017-07-12 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-07-17, presumably until 2017-09-05, with intended 0 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2017-07-17, presumably until 2017-07-18, with intended 1 refill(s). Instructions: TAPER AS PRESCRIBED BY MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-18 00:00:00, ended at 2017-07-18 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-07-18, presumably until 2018-01-04, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-02 00:00:00, ended at 2017-08-02 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-10 11:38:00, ended at 2017-08-10 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 11.83 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.63 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-10 13:51:08, ended at 2017-08-10 15:20:24\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2017-01-04, presumably until 2018-09-06, with intended 0 refill(s). Instructions: 1 Cris Burt, Oliver, every 12 hours, PRN, as needed for pain, 0, Maintenance\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-08-10, presumably until 2017-12-26, with intended 11 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-01-04, presumably until 2019-10-22, with intended 0 refill(s). Instructions: take 3.125 mg by mouth daily as needed\n- citalopram 10 MG Oral Tablet, through Oral route, presumably until 2019-03-07, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-22 00:00:00, ended at 2017-08-22 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-08-22, presumably until 2018-08-22, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-24 15:25:49, ended at 2017-08-24 16:47:09\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-25 00:00:00, ended at 2017-08-25 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on nose and accessory sinuses; not otherwise specified\n\n### Condition\n- Heart failure\n- Transient cerebral ischemia\n- Deviated nasal septum\n- Hypertrophy of nasal turbinates\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- cefazolin 1000 MG Injection, started on 2017-08-25, presumably until 2017-08-25\n- remifentanil 2 MG Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-08-25, presumably until 2017-08-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-25 00:00:00, ended at 2017-08-25 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-08-25, presumably until 2017-08-25\n- fluorescein dilaurate, through Intraocular route, started on 2017-08-25, presumably until 2017-08-25\n- epinephrine 1 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- fluorescein, through Intraocular route, started on 2017-08-25, presumably until 2017-08-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-25 05:47:00, ended at 2017-08-25 12:19:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Replacement of Nasal Septum with Autologous Tissue Substitute, Open Approach\n- Submucous resection inferior turbinate, partial or complete, any method\n- Excision of Nasal Turbinate, Percutaneous Approach\n- Nasal/sinus endoscopy, surgical, with frontal sinus exploration, including removal of tissue from frontal sinus, when performed\n- Nasal/sinus endoscopy, surgical, with maxillary antrostomy\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Computer Assisted Procedure of Head and Neck Region\n- Excision of Right Sphenoid Sinus, Percutaneous Endoscopic Approach\n- Excision of Left Ethmoid Sinus, Percutaneous Endoscopic Approach\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Nasal/sinus endoscopy, surgical, with sphenoidotomy\n- Repair Right Maxillary Sinus, Percutaneous Endoscopic Approach\n- Excision of Left Sphenoid Sinus, Percutaneous Endoscopic Approach\n- Excision of Right Frontal Sinus, Percutaneous Endoscopic Approach\n- Repair Left Maxillary Sinus, Percutaneous Endoscopic Approach\n- Septoplasty or submucous resection, with or without cartilage scoring, contouring or replacement with graft\n- Nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior)\n- Excision of Left Frontal Sinus, Percutaneous Endoscopic Approach\n- Excision of Right Ethmoid Sinus, Percutaneous Endoscopic Approach\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Degenerative disorder of macula\n- Deviated nasal septum\n- Hypertrophy of nasal turbinates\n- Osteoporosis\n- Seasonal allergic rhinitis\n- Presbyopia\n- Allergic rhinitis\n- Disorder of nasal cavity\n- Chronic sinusitis\n- Disorder of kidney and/or ureter\n- Essential hypertension\n- Heart failure\n- Uncomplicated asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-05 12:31:57, ended at 2017-09-05 13:01:26\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2017-09-05, presumably until 2018-01-04, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-05 15:21:00, ended at 2017-09-05 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Disorder of nasal cavity\n- Allergic rhinitis due to animal dander\n- Disorder of bone\n- Chronic sinusitis\n- Osteoporosis\n- Uncomplicated asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-28 13:12:56, ended at 2017-09-28 14:17:14\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal/sinus endoscopy, surgical; with biopsy, polypectomy or debridement (separate procedure)\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-10 00:00:00, ended at 2017-10-10 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-12 11:00:00, ended at 2017-10-12 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 332 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.11 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 24.94 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 300 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Hypo-osmolality and or hyponatremia\n- Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 11:34:28, ended at 2017-10-12 12:34:37\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Hypo-osmolality and or hyponatremia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 13:54:53, ended at 2017-10-12 15:07:57\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Eosinophilic asthma\n- Allergic rhinitis due to pollen\n- Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-10-12, presumably until 2017-10-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 15:15:57, ended at 2017-10-12 16:10:38\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.99\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-19 00:00:00, ended at 2017-10-19 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n- Acute asthma\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-10-19, presumably until 2017-12-26, with intended 0 refill(s). Instructions: Take 20 mg PO Qday x 7 days, then 10 mg PO Qday x 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-02 12:54:42, ended at 2017-11-02 13:31:24\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Disorder of nasal cavity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-26 12:07:41, ended at 2017-12-26 12:43:08\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to pollen\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated mild persistent asthma\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-12-26, presumably until 2018-10-09, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-12-26, presumably until 2018-02-01, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-12-26, presumably until 2018-10-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-12-26, presumably until 2019-01-01, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-12-26, presumably until 2019-03-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-26 13:09:03, ended at 2017-12-26 14:24:20\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 14:27:00, ended at 2017-12-26 14:49:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 51.71 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 275 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.34 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- IgE [Units/volume] in Serum or Plasma by Immunoassay: 19 (kilounit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 14:50:00, ended at 2017-12-26 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Uncomplicated asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-01-03 00:00:00, ended at 2018-01-03 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2018-01-03, presumably until 2018-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-03 00:00:00, ended at 2018-01-03 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperparathyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-04 12:55:22, ended at 2018-01-04 13:29:56\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-04 15:01:13, ended at 2018-01-04 16:10:33\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-01-04, presumably until 2018-03-21, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-01-04, presumably until 2018-03-21, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 11:22:54, ended at 2018-02-01 12:51:04\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Allergic rhinitis due to pollen\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic maxillary sinusitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n\n### Drug\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-02-01, presumably until 2018-09-06, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2018-02-01, presumably until 2018-09-06, with intended 1 refill(s). Instructions: 2 mL by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 13:32:31, ended at 2018-02-01 14:52:49\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Mononeuritis multiplex\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-10 00:00:00, ended at 2018-03-10 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2018-03-12, presumably until 2019-03-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-21 10:25:18, ended at 2018-03-21 10:50:18\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-03-21, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-03-21, presumably until 2018-07-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-21 11:12:00, ended at 2018-03-21 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.30 (thousand per microliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 49 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Urine: <5.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.27 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 60.51 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 8 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 49 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.13 (milligram per milligram)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- IgE [Units/volume] in Serum or Plasma by Immunoassay: 16 (kilounit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 182 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Osteoporosis\n- Allergic rhinitis\n- Hyperparathyroidism\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-21 11:22:44, ended at 2018-03-21 12:13:39\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.417\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-24 10:49:00, ended at 2018-04-24 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Chronic sinusitis\n- Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-24 14:54:36, ended at 2018-04-24 16:30:41\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-09 00:00:00, ended at 2018-05-09 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-26 13:43:37, ended at 2018-06-26 14:46:12\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-04 00:00:00, ended at 2018-07-04 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2018-07-12, presumably until 2018-07-12, with intended 0 refill(s). Instructions: TAKE 2 TABLETS EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-19 14:18:37, ended at 2018-07-19 14:45:47\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-10-11, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-10-11, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-19 15:26:30, ended at 2018-07-19 16:01:36\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Exacerbation of mild persistent asthma\n- Allergic rhinitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-14 11:59:13, ended at 2018-08-14 13:15:54\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-04 00:00:00, ended at 2018-09-04 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe, started on 2018-09-05, presumably until 2018-09-05, with intended 0 refill(s). Instructions: LA:[000000]:05/18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-06 12:58:46, ended at 2018-09-06 14:41:57\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebral infarction\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Visual field defect\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, presumably until 2019-03-20, with intended 0 refill(s). Instructions: take 81 mg by mouth every morning with breakfast Takes 2-3 a day for pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-06 14:15:00, ended at 2018-09-06 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Cerebral infarction\n- Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-10-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-09-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-08, presumably until 2018-10-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-08, presumably until 2018-10-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-09 00:00:00, ended at 2018-10-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Anemia in chronic kidney disease\n- Primary diagnosis: Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-09 00:00:00, ended at 2018-10-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-10-09, presumably until 2019-01-31, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 10:40:45, ended at 2018-10-11 11:28:07\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n- Acute upper respiratory infection\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 12:08:12, ended at 2018-10-11 12:34:03\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 14:10:39, ended at 2018-10-11 14:36:43\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-10-11, presumably until 2019-01-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-10-11, presumably until 2019-01-24, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-12 00:00:00, ended at 2018-10-12 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-15 00:00:00, ended at 2018-10-15 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-18, presumably until 2018-10-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-24 00:00:00, ended at 2018-10-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2018-10-29, presumably until 2019-01-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-01 00:00:00, ended at 2018-11-01 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-01 00:00:00, ended at 2018-11-01 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 14 days\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2018-12-13, presumably until 2019-12-13, with intended 1 refill(s). Instructions: TAKE 2 TABLETS EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-12 11:00:00, ended at 2018-12-12 14:56:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.6 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Chronic kidney disease\n- Cerebral infarction\n- Anemia in chronic kidney disease\n- Valvular endocarditis\n- Visual field defect\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-12 14:57:00, ended at 2018-12-12 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine collected for unspecified duration: 13.0 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.15 (milligram per milligram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.1 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.0 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 88.78 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 5 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 152 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.93 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 108.0 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 259 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-01 10:43:30, ended at 2019-01-01 12:48:12\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic pansinusitis\n- Uncomplicated mild persistent asthma\n- Primary diagnosis: Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2019-01-01, presumably until 2020-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-01-01, presumably until 2019-04-04, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-01 12:52:22, ended at 2019-01-01 15:15:25\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Uncomplicated asthma\n- Chronic sinusitis\n- Primary diagnosis: Loss of sense of smell\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, started on 2019-01-01, presumably until 2019-03-20, with intended 11 refill(s). Instructions: Use 1 ampule as directed BID.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-24 14:46:39, ended at 2019-01-24 15:22:41\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-01-29, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-06-18, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-02-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-29 00:00:00, ended at 2019-01-29 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-01-29, presumably until 2019-08-13, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-31 00:00:00, ended at 2019-01-31 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-01-31, presumably until 2020-03-02, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-12 15:03:19, ended at 2019-02-12 16:29:50\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysphonia\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-07 11:37:58, ended at 2019-03-07 12:21:35\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Chronic rhinitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- fexofenadine hydrochloride 60 MG Oral Tablet, through Oral route, started on 2019-03-07, presumably until 2019-03-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-03-07, presumably until 2019-05-13, with intended 11 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-03-07, presumably until 2019-07-29, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-07 15:33:11, ended at 2019-03-07 17:03:08\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-19 12:17:38, ended at 2019-03-19 14:02:29\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n- Disorder of the larynx\n\n### Drug\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2019-03-19, presumably until 2019-05-13, with intended 3 refill(s). Instructions: take 5 mL by mouth 4 times a day\n- fluconazole 150 MG Oral Tablet, started on 2019-03-19, presumably until 2019-03-20, with intended 0 refill(s). Instructions: 150mg orally once and may repeat one tablet in 4 days if symptoms persist.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 07:23:00, ended at 2019-03-20 15:22:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance angiography, head; without contrast material(s)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 07:23:00, ended at 2019-03-20 15:22:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Hypertrophic condition of skin\n- Essential hypertension\n- Osteoporosis\n- Pain in right foot\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- gadobenate, through Intravenous route, started on 2019-03-20, presumably until 2019-03-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-20 09:56:33, ended at 2019-03-20 10:25:36\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2019-03-20, presumably until 2020-03-04, with intended 3 refill(s). Instructions: take 1 Tab (70 mg total) by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-20 13:31:38, ended at 2019-03-20 15:07:49\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hypertrophic condition of skin\n- Primary diagnosis: Pain in right foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-03-20, presumably until 2019-03-20, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-26 00:00:00, ended at 2019-03-26 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-03-27, presumably until 2019-03-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-04 11:42:40, ended at 2019-04-04 12:33:34\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.81\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-04 14:09:00, ended at 2019-04-04 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.63 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.17 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 30.13 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 5.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-24 00:00:00, ended at 2019-04-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in right foot\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-30 00:00:00, ended at 2019-04-30 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2019-05-01, presumably until 2019-09-23, with intended 12 refill(s). Instructions: take 1 Packet (20 mEq total) by mouth daily Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-30 12:05:26, ended at 2019-04-30 15:57:31\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 0.6 to 1.0 cm\n\n### Condition\n- Primary diagnosis: Neoplastic disease of uncertain behavior\n- Neoplasm of uncertain behavior of skin\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-30 13:14:52, ended at 2019-04-30 14:18:49\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.81\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated moderate persistent asthma\n- Dysphonia\n- Neoplasm of uncertain behavior of skin\n- Senile hyperkeratosis\n- Neoplastic disease of uncertain behavior\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-13 10:55:27, ended at 2019-05-13 12:12:51\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olopatadine 1 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-05-08, presumably until 2019-05-08, with intended 0 refill(s). Instructions: Instill 1 drop to both eyes as needed\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-05-13, presumably until 2019-05-13, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2019-04-14, presumably until 2019-05-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 12:15:00, ended at 2019-05-13 12:29:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Tailor's bunion\n- Pain in right foot\n- Talipes planus\n- Acquired hallux varus\n- Essential hypertension\n- Pain in left foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 12:30:00, ended at 2019-05-13 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in left foot\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-15 00:00:00, ended at 2019-05-15 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-05-15, presumably until 2020-05-11, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-18 10:57:51, ended at 2019-06-18 12:08:03\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2019-06-18, presumably until 2019-10-09, with intended 3 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n- gabapentin 100 MG Oral Capsule, through Oral route, presumably until 2019-08-13, with intended 0 refill(s). Instructions: take 100 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-09 11:00:00, ended at 2019-07-09 11:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-16 00:00:00, ended at 2019-07-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-17 00:00:00, ended at 2019-07-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n\n### Drug\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-07-29, presumably until 2019-12-25, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-13 10:36:00, ended at 2019-08-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- MCV [Entitic volume] by Automated count: 96.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 26.70 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <4.0 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Bunion\n- Follicular cysts of skin and subcutaneous tissue\n- Low back pain\n- Pain of left knee region\n- Chronic pain\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-13 13:18:06, ended at 2019-08-13 13:37:04\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Primary diagnosis: Follicular cysts of skin and subcutaneous tissue\n- Low back pain\n- Pain of left knee region\n- Bunion\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-08-13, presumably until 2019-09-20, with intended 2 refill(s). Instructions: take 1 Tab (50 mg total) by mouth as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-13 14:05:12, ended at 2019-08-13 14:51:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-08-13, presumably until 2020-02-04, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2019-08-26, presumably until 2019-08-27, with intended 2 refill(s). Instructions: take 2 Tabs (2,000 mg total) by mouth 2 times a day for 1 day PRN cold sores\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-05 00:00:00, ended at 2019-09-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-12 09:26:05, ended at 2019-09-12 14:45:38\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, started on 2019-08-30, presumably until 2019-09-13, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-12 11:31:14, ended at 2019-09-12 13:11:07\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n- Eosinophilic asthma\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-13 07:30:00, ended at 2019-09-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Supraventricular tachycardia\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-20 00:00:00, ended at 2019-09-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-09-20, presumably until 2019-10-25, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every bedtime as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2020-04-07, with intended 12 refill(s). Instructions: take 20 Tabs by mouth every day\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2019-09-23, presumably until 2019-09-23, with intended 12 refill(s). Instructions: take 1 Packet (20 mEq total) by mouth daily Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-09 00:00:00, ended at 2019-10-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-09 08:15:00, ended at 2019-10-09 11:14:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone length studies (orthoroentgenogram, scanogram)\n\n### Condition\n- Osteoarthritis of knee\n- Acquired genu valgum\n- Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-09 08:55:12, ended at 2019-10-09 09:27:51\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2019-10-09, presumably until 2020-02-04, with intended 3 refill(s). Instructions: take 2 Tabs (2 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-09 11:15:00, ended at 2019-10-09 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Osteoporosis\n- Disorder of bone\n- Pain in thoracic spine\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Acquired hallux varus\n- Pain of left knee region\n- Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-09 15:03:15, ended at 2019-10-09 15:53:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in thoracic spine\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pansinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-10-17, presumably until 2019-10-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-21 00:00:00, ended at 2019-10-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2019-10-22, presumably until 2020-04-07, with intended 12 refill(s). Instructions: take 1 Tab (3.125 mg total) by mouth daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-25 00:00:00, ended at 2019-10-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2019-10-28, presumably until 2019-12-05, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-28 00:00:00, ended at 2019-10-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pansinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2019-11-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-04 00:00:00, ended at 2019-11-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 09:50:06, ended at 2019-11-05 10:25:56\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 11:12:09, ended at 2019-11-05 12:04:23\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Uncomplicated severe persistent asthma\n- Chronic rhinitis\n- Primary diagnosis: Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 12:22:32, ended at 2019-11-05 14:38:39\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 13:22:35, ended at 2019-11-05 14:31:38\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 3\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-05 13:50:00, ended at 2019-11-05 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 15 (milligram per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 20 (milligram per gram)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.10 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 319 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Dysphonia\n- Anemia in chronic kidney disease\n- Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-08 00:00:00, ended at 2019-11-08 08:07:41\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-25 00:00:00, ended at 2019-11-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-11-25, presumably until 2019-12-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-02 00:00:00, ended at 2019-12-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.417 MG/ML Inhalation Solution, through Inhalation, started on 2019-12-05, presumably until 2019-12-10, with intended 1 refill(s). Instructions: 3 mL (1.25 mg total) by Nebulization route every 4 hours as needed for Bronchospasm/Wheezing (cough)\n- prednisone 5 MG Oral Tablet, started on 2019-12-05, presumably until 2020-02-04, with intended 0 refill(s). Instructions: Take 10 mg x 1 week, then 5 mg x 1 week\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-12-05, presumably until 2020-02-20, with intended 2 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-05 00:00:00, ended at 2019-12-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2019-12-05, presumably until 2020-01-22, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-10 00:00:00, ended at 2019-12-10 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2019-12-10, presumably until 2021-02-09, with intended 1 refill(s). Instructions: 1 Dose by Injection route every 4 hours as needed Use as directed\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2019-12-10, presumably until 2020-01-09, with intended 1 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-11 08:59:06, ended at 2019-12-11 09:45:31\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute sinusitis\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Acute bronchitis\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-11 10:29:00, ended at 2019-12-11 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Melanocytic nevus of trunk\n- Acute sinusitis\n- Disorder of immune function\n- Hyperpigmentation of skin\n- Melanocytic nevus of lower limb\n- Temporomandibular joint disorder\n- Scar conditions and fibrosis of skin\n- Essential hypertension\n- Acute bronchitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n- Melanocytic nevus of upper limb\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-11 12:17:22, ended at 2019-12-11 13:40:55\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Scar conditions and fibrosis of skin\n- Hyperpigmentation of skin\n- Primary diagnosis: Melanocytic nevus of lower limb\n- Disorder of immune function\n- Primary diagnosis: Melanocytic nevus of trunk\n- Primary diagnosis: Melanocytic nevus of upper limb\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-19 00:00:00, ended at 2019-12-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-25 00:00:00, ended at 2019-12-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n\n### Drug\n- levocetirizine dihydrochloride 5 MG Oral Tablet, started on 2019-12-25, presumably until 2020-10-06, with intended 10 refill(s). Instructions: TAKE ONE TABLET (5MG) BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-01-22, presumably until 2020-02-29, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated mild persistent asthma\n- Eosinophilic asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2020-01-22, presumably until 2020-07-21, with intended 3 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-04 09:13:00, ended at 2020-02-04 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 20 (milligram per gram)\n- Basophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 6.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 39.80 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Erythrocyte sedimentation rate: 5 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 73.8 (picogram per milliliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.15 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Dysphonia\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 09:50:25, ended at 2020-02-04 10:17:09\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 10:45:37, ended at 2020-02-04 12:08:30\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Joint pain\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 12:20:34, ended at 2020-02-04 13:04:58\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-05-19, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Reduced mobility\n- Primary diagnosis: Closed fracture of lower leg\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-18 00:00:00, ended at 2020-02-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed fracture of lower leg\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 12:15:00, ended at 2020-02-20 13:41:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Closed bimalleolar fracture\n- Closed fracture of lower leg\n- Arthralgia of the ankle and/or foot\n- Closed fracture of fibula\n- Closed fracture of medial malleolus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 13:42:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; 2 views\n\n### Condition\n- Closed fracture of lateral malleolus\n- Closed fracture of lower leg\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-21 00:00:00, ended at 2020-02-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nonunion of fracture\n- Primary diagnosis: Closed bimalleolar fracture\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2020-02-21, presumably until 2020-02-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed (for pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; not otherwise specified\n\n### Condition\n- Closed fracture of lateral malleolus\n- Sprain of deltoid ligament of ankle\n- Sprain of ankle\n\n### Drug\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- cefazolin 1000 MG Injection, started on 2020-02-27, presumably until 2020-02-27\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- ketamine 100 MG/ML Injectable Solution, started on 2020-02-27, presumably until 2020-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 30 ML ropivacaine hydrochloride 5 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Open treatment of distal fibular fracture (lateral malleolus), includes internal fixation, when performed\n- Manual application of stress performed by physician or other qualified health care professional for joint radiography, including contralateral joint if indicated\n- Open treatment of distal tibiofibular joint (syndesmosis) disruption, includes internal fixation, when performed\n\n### Condition\n- Closed fracture of lateral malleolus\n- Sprain of ankle\n- Sprain of deltoid ligament of ankle\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-02-27 07:19:00, ended at 2020-02-29 13:20:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Left ventricular Ejection fraction: 61.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n\n### Procedure\n- Repair Right Ankle Bursa and Ligament, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Reposition Right Fibula with Internal Fixation Device, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Collection of venous blood by venipuncture\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n\n### Condition\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Pain\n- Closed bimalleolar fracture\n- Primary diagnosis: Loss of consciousness\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated asthma\n- Essential hypertension\n- First degree atrioventricular block\n- Illness\n- Persistent pain following procedure\n- Chronic systolic heart failure\n- Gastroesophageal reflux disease without esophagitis\n- Closed fracture of lower leg\n- Sprain of deltoid ligament of ankle\n- Electrocardiogram abnormal\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2020-02-28, presumably until 2020-02-29\n- calcium carbonate 625 MG / cholecalciferol 125 UNT Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2020-02-27, presumably until 2020-03-10, with intended 0 refill(s). Instructions: take 2 Caps (200 mg total) by mouth 2 times a day as needed for Constipation\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-28\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-02-29, presumably until 2020-02-29\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-02-28, presumably until 2020-03-10, with intended 1 refill(s). Instructions: take 1 Packet (17 g total) by mouth daily as needed\n- 8 HR acetaminophen 650 MG Extended Release Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-03-10, with intended 0 refill(s). Instructions: take 1 Tab (650 mg total) by mouth every 6 hours\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-02-27, presumably until 2020-02-28\n- carboxymethylcellulose sodium 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2020-02-28, presumably until 2020-02-29\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-04-07, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed for Pain\n- 30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2020-02-29, presumably until 2020-02-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-02 00:00:00, ended at 2020-03-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-04 00:00:00, ended at 2020-03-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2021-05-21, with intended 3 refill(s). Instructions: take 1 Tab (70 mg total) by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-10 09:00:00, ended at 2020-03-10 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Closed fracture of medial malleolus\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-16 00:00:00, ended at 2020-03-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left foot\n- Pain in right foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-04-07 10:41:24, ended at 2020-04-07 12:14:11\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic pansinusitis\n- Primary diagnosis: Eosinophilic asthma\n- Chronic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-04-07 12:40:59, ended at 2020-04-07 13:56:39\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed bimalleolar fracture\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-04-07, presumably until 2020-12-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2020-04-07, presumably until 2020-10-23, with intended 0 refill(s). Instructions: take 1 Tab (3.125 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-07 13:56:18, ended at 2020-04-07 13:56:28\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Loss of consciousness\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-08 00:00:00, ended at 2020-04-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-13 00:00:00, ended at 2020-04-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-20 00:00:00, ended at 2020-04-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-04-28, presumably until 2020-05-26, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-23 09:50:00, ended at 2020-04-23 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Closed fracture of lateral malleolus\n- Tailor's bunion\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-24 00:00:00, ended at 2020-04-24 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed bimalleolar fracture\n- Arthralgia of the ankle and/or foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-09 00:00:00, ended at 2020-05-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-05-11, presumably until 2020-08-11, with intended 2 refill(s). Instructions: INHALE TWO PUFFS BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-15 00:00:00, ended at 2020-05-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-19 00:00:00, ended at 2020-05-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-05-19, presumably until 2020-12-23, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-05-26, presumably until 2020-06-02, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2020-05-25, presumably until 2020-06-01, with intended 5 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-26 00:00:00, ended at 2020-05-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n- Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-27 00:00:00, ended at 2020-05-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-01 00:00:00, ended at 2020-06-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-01, presumably until 2020-06-16, with intended 5 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-02 00:00:00, ended at 2020-06-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-06-02, presumably until 2020-07-13, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-04 00:00:00, ended at 2020-06-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-16 09:23:00, ended at 2020-06-16 15:41:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Late effect of fracture of lower extremities\n- Melanocytic nevus\n- Postoperative state\n- Closed bimalleolar fracture\n- Supraventricular tachycardia\n- Arthralgia of the ankle and/or foot\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 11:49:33, ended at 2020-06-16 13:26:49\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nasal cavity\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-16, presumably until 2020-06-25, with intended 3 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n- mupirocin 0.02 MG/MG Nasal Ointment, through Nasal route, started on 2020-06-16, presumably until 2020-06-18, with intended 0 refill(s). Instructions: by Nasal route 2 times a day\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2020-06-16, presumably until 2020-06-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 13:05:45, ended at 2020-06-16 15:41:51\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Melanocytic nevus\n- Primary diagnosis: Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 14:48:32, ended at 2020-06-16 15:36:44\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-16 15:42:00, ended at 2020-06-16 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine collected for unspecified duration: 9.0 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.12 (milligram per milligram)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Creatinine [Mass/volume] in Urine: 77.29 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-17 00:00:00, ended at 2020-06-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-18 00:00:00, ended at 2020-06-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nasal cavity\n\n### Drug\n- mupirocin 0.02 MG/MG Nasal Ointment, through Nasal route, started on 2020-06-18, presumably until 2020-08-21, with intended 0 refill(s). Instructions: by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-19 00:00:00, ended at 2020-06-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 0.83 MG/ML Inhalation Solution, started on 2020-06-19, presumably until 2021-11-19, with intended 0 refill(s). Instructions: USE ONE VIAL BY INHALATION ROUTE EVERY 4 HOURS AS NEEDED FOR COUGH/WHEEZE\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-25 00:00:00, ended at 2020-06-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-25, presumably until 2020-08-20, with intended 3 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-25 00:00:00, ended at 2020-06-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-25, presumably until 2020-07-07, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-02 00:00:00, ended at 2020-07-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n- Primary diagnosis: Bacterial infectious disease\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2020-07-02, presumably until 2020-08-27, with intended 1 refill(s). Instructions: Apply to affected areas BID x 5-7 days until improved\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-02 00:00:00, ended at 2020-07-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-07 11:06:14, ended at 2020-07-07 16:16:38\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated mild persistent asthma\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-07-07, presumably until 2020-08-17, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n- prednisone 5 MG Oral Tablet, started on 2020-07-07, presumably until 2020-07-09, with intended 0 refill(s). Instructions: Take 20 mg by mouth x 5 days, 15 mg x 5 days, 10 mg x 5 days, 5 mg x 5 days\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2020-07-07, presumably until 2020-11-03, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-09 00:00:00, ended at 2020-07-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-09 00:00:00, ended at 2020-07-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2020-07-09, presumably until 2020-07-21, with intended 0 refill(s). Instructions: Take 20 mg by mouth x 5 days, 15 mg x 5 days, 10 mg x 5 days, 5 mg x 5 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-10 00:00:00, ended at 2020-07-10 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-07-13, presumably until 2020-10-23, with intended 2 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-14 12:46:03, ended at 2020-07-14 13:10:35\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eosinophilic asthma\n- Recurrent acute sinusitis\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Acute pansinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2020-07-21, presumably until 2020-10-06, with intended 11 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2020-07-21, presumably until 2020-08-13, with intended 0 refill(s). Instructions: 30 mg x 7 days, 20 mg x 7 days, 10 mg x 7 days, 5 mg x 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-10 00:00:00, ended at 2020-08-10 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-11, presumably until 2021-01-26, with intended 0 refill(s). Instructions: INHALE TWO PUFFS BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-13 11:05:59, ended at 2020-08-13 15:45:04\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eosinophilic asthma\n- Uncomplicated severe persistent asthma\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2020-08-13, presumably until 2020-12-07, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-17 00:00:00, ended at 2020-08-17 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated severe persistent asthma\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-08-17, presumably until 2020-08-20, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-08-20, presumably until 2021-05-21, with intended 1 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-18 00:00:00, ended at 2020-08-18 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-20 00:00:00, ended at 2020-08-20 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, started on 2020-08-20, presumably until 2020-08-21, with intended 0 refill(s). Instructions: 3mL mixed with budesonide by inhalation route BID PRN cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-08-20 10:05:43, ended at 2020-08-20 11:13:04\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pansinusitis\n- Spasm\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Blood chemistry abnormal\n- Primary diagnosis: Disorder of bone\n- Lymphocytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-20 10:45:00, ended at 2020-08-20 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Arthralgia of the ankle and/or foot\n- Metatarsalgia\n- Pain in right foot\n- Postoperative state\n- Closed bimalleolar fracture\n- Closed fracture of lateral malleolus\n- Acquired hallux varus\n- Hammer toe\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-21 00:00:00, ended at 2020-08-21 08:04:46\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Eosinophilic asthma\n- Primary diagnosis: Insomnia\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 M..., through Intramuscular route, started on 2020-08-21, presumably until 2020-08-21, with intended 0 refill(s). Instructions: inject into a muscle\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2020-08-21, presumably until 2021-08-21, with intended 12 refill(s). Instructions: take 1 Tab (3 mg total) by mouth every bedtime as needed (insomnia)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-21 00:00:00, ended at 2020-08-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, started on 2020-08-21, presumably until 2020-12-07, with intended 3 refill(s). Instructions: 3mL mixed with budesonide by inhalation route BID PRN cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-24 00:00:00, ended at 2020-08-24 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-24 00:00:00, ended at 2020-08-24 10:20:37\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Candidiasis of mouth\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-26 00:00:00, ended at 2020-08-26 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2020-08-27, presumably until 2020-12-07, with intended 0 refill(s). Instructions: APPLY TO THE AFFECTED AREA(S) TWICE DAILY FOR 5 TO 7 DAYS UNTIL IMPROVED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-08 11:04:53, ended at 2020-09-08 12:09:27\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lymphocytopenia\n- Uncomplicated severe persistent asthma\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-10 11:26:40, ended at 2020-09-10 13:35:18\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea and vomiting\n- Primary diagnosis: Tailor's bunion\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-17 00:00:00, ended at 2020-09-17 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-09-17, presumably until 2020-12-07, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-09-21 00:00:00, ended at 2020-09-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Open bimalleolar fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-23 00:00:00, ended at 2020-09-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-23 11:15:00, ended at 2020-09-23 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Dysphonia\n- Pain in right foot\n- Chronic pansinusitis\n- Disorder of bone\n- Spasm\n- Lymphocytopenia\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-09-24 00:00:00, ended at 2020-09-24 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2020-09-24, presumably until 2020-09-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-09-24, presumably until 2020-09-24\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2020-09-24, presumably until 2020-09-24\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2020-09-24, presumably until 2020-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-24 08:30:00, ended at 2020-09-24 12:10:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Ostectomy, partial excision, fifth metatarsal head (bunionette) (separate procedure)\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Pain in right foot\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Eosinophilic asthma\n- Osteoporosis\n- Tailor's bunion\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-09-24, presumably until 2020-11-23, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every 6 hours as needed\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-09-24, presumably until 2020-09-24\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-24, presumably until 2020-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-25 00:00:00, ended at 2020-09-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tailor's bunion\n- Pain in right foot\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-25, presumably until 2020-09-26, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-26 00:00:00, ended at 2020-09-26 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in right foot\n- Tailor's bunion\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-26, presumably until 2020-10-08, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-05 00:00:00, ended at 2020-10-05 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n- Uncomplicated mild persistent asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2020-10-06, presumably until 2021-02-09, with intended 3 refill(s). Instructions: Take by mouth every bedtime\n- levocetirizine dihydrochloride 5 MG Oral Tablet, started on 2020-10-06, presumably until 2021-07-05, with intended 3 refill(s). Instructions: TAKE ONE TABLET (5MG) BY MOUTH ONE TIME DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-08 09:35:08, ended at 2020-10-08 10:27:46\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Candidiasis of mouth\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Acute exacerbation of chronic obstructive airways disease\n\n### Drug\n- prednisone 1 MG Oral Tablet, started on 2020-10-08, presumably until 2020-12-07, with intended 0 refill(s). Instructions: 4 mg x 7 days, then 3 mg x 7 days, 2 mg x 7 days, 1 mg x 7 days\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2020-10-13, presumably until 2020-10-15, with intended 3 refill(s). Instructions: 1 Plunkett (18 mcg total) by Inhalation route daily\n- fluconazole 150 MG Oral Tablet, started on 2020-10-08, presumably until 2020-12-07, with intended 0 refill(s). Instructions: 150mg orally once and may repeat one tablet in 72 hour if not improved\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-09 00:00:00, ended at 2020-10-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clotrimazole 10 MG Oral Lozenge, through Oral route, started on 2020-10-09, presumably until 2021-01-26, with intended 3 refill(s). Instructions: take 1 Lozenge (10 mg total) by mouth 5 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-13 00:00:00, ended at 2020-10-13 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative disorder of macula\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n- Chronic kidney disease\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in right foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-10-23, presumably until 2020-11-23, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-23 00:00:00, ended at 2020-10-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 3.125 MG Oral Tablet, started on 2020-10-23, presumably until 2020-11-02, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 09:51:00, ended at 2020-10-26 12:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Postoperative state\n- Metatarsal bone fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-26 09:51:03, ended at 2020-10-26 12:26:39\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tailor's bunion\n- Primary diagnosis: Postoperative state\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 13:00:00, ended at 2020-10-26 14:02:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease stage 3\n- Pain in right foot\n- Postoperative state\n- Uncomplicated severe persistent asthma\n- Tailor's bunion\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 14:03:00, ended at 2020-10-26 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.3 (ratio)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 147 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 97.0 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 27 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 32 (milligram per gram)\n- Neutrophils [#/volume] in Blood by Automated count: 7.05 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.20 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-27 12:43:28, ended at 2020-10-27 13:54:28\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-03 15:51:11, ended at 2020-11-03 16:43:27\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2020-11-03, presumably until 2021-01-25, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-11-10 13:09:35, ended at 2020-11-10 14:05:34\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.417\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease\n- Chronic kidney disease stage 3A\n- Essential hypertension\n- Primary diagnosis: Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-20 00:00:00, ended at 2020-11-20 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-23 00:00:00, ended at 2020-11-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-11-23, presumably until 2021-11-23, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-25 00:00:00, ended at 2020-11-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in right foot\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-07 00:00:00, ended at 2020-12-07 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Tablet, through Oral route, started on 2020-12-07, presumably until 2020-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth every day\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2020-12-07, presumably until 2021-11-19, with intended 12 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-12-08 11:45:37, ended at 2020-12-08 12:18:16\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Cellulitis\n- Chronic sinusitis\n- Chronic obstructive lung disease\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2020-12-08, presumably until 2020-12-18, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 3 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-14 08:30:00, ended at 2020-12-14 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Dysphonia\n- Hammer toe\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Metatarsal bone fracture\n- Closed bimalleolar fracture\n- Metatarsalgia\n- Acquired hallux varus\n- Pain in right foot\n- Postoperative state\n- Tailor's bunion\n- Chronic frontal sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-15 00:00:00, ended at 2020-12-15 12:19:53\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2020-12-15, presumably until 2021-01-04, with intended 0 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-22 00:00:00, ended at 2020-12-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2020-12-23, presumably until 2021-01-06, with intended 0 refill(s). Instructions: TAKE TWO TABLETS BY MOUTH DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-22 00:00:00, ended at 2020-12-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, started on 2020-12-23, presumably until 2022-01-20, with intended 12 refill(s). Instructions: TAKE 1 TABLET (20MEQ) BY MOUT HEVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-01 00:00:00, ended at 2021-01-01 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2021-01-05, presumably until 2021-02-08, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN, APPOINTMENT NEEDED BEFORE NEXT REFILL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-02 00:00:00, ended at 2021-01-02 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2021-01-04, presumably until 2021-01-04, with intended 0 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-04 00:00:00, ended at 2021-01-04 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-01-04, presumably until 2021-02-09, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 00:00:00, ended at 2021-01-06 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-04-15, with intended 0 refill(s). Instructions: take 1.5 Tabs (75 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-25 00:00:00, ended at 2021-01-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated moderate persistent asthma\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2021-01-25, presumably until 2021-01-27, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-01-26 08:44:00, ended at 2021-01-26 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 20.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.11 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 275 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 89.00 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.22 (milligram per milligram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Acquired hallux varus\n- Hammer toe\n- Metatarsalgia\n- Non-rheumatic aortic sclerosis\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-01-26 09:16:50, ended at 2021-01-26 10:35:10\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-rheumatic aortic sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-01-26 10:42:23, ended at 2021-01-26 12:24:26\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated severe persistent asthma\n- Osteoporosis\n- Non-rheumatic aortic sclerosis\n- Uncomplicated moderate persistent asthma\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-27 00:00:00, ended at 2021-01-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated moderate persistent asthma\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2021-01-27, presumably until 2021-02-09, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of ischemic_stroke means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "b683f88bc101cd0b5ef4926f40a5b15e4ec57da197b188dcddb595d1e2eee06b", "prompt_hash": "a4e49f824974dc4c79401018bbb352fb32d793fbb06529610aa6acf1ce1b2035", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 2, "doc": {"person_id": 115969703, "visit_occurrence_id": 83107325, "death_date": "2017-06-24", "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2016-02-19 09:00:00", "visit_end_datetime": "2016-02-19 23:59:00", "visit_length_in_hours": 14.983333333333333, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 09:00:00, ended at 2016-02-19 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 129.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.89 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1224 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 75.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.47 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.99 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 922, "patient_first_visit_date": "2011-10-29 00:00:00", "patient_last_visit_date": "2017-06-18 10:23:00", "end_obs_date": "2017-02-18", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 137, "cumulated_visit_num": 137, "cumulated_approximate_token_count": 61094, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-29 00:00:00, ended at 2011-10-29 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-29 11:11:50, ended at 2011-10-29 12:34:54\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-26 00:00:00, ended at 2013-04-26 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-04-26, presumably until 2013-04-26, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-02 00:00:00, ended at 2013-09-02 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-02, presumably until 2013-09-02, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-09 00:00:00, ended at 2013-09-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-09, presumably until 2015-06-25, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-09 09:23:43, ended at 2013-11-09 10:40:25\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Contracture of palmar fascia\n- Disorder of transplanted kidney\n- Left bundle branch hemiblock\n- Primary diagnosis: Transplanted kidney present\n- Electrocardiogram abnormal\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Inflammatory dermatosis\n- Tachycardia\n\n### Drug\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2015-06-25. Instructions: inject 15 Units subcutaneous (under the skin) every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-09 10:44:00, ended at 2013-11-09 11:23:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 240 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.44 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 5.7 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-14 00:00:00, ended at 2013-11-14 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Kidney lesion\n- Transplanted kidney present\n- Primary diagnosis: Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-23 13:54:00, ended at 2013-11-23 21:40:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n- aPTT in Platelet poor plasma by Coagulation assay: 30.3 (second)\n- Prothrombin time (PT): 12.4 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Renal biopsy; percutaneous, by trocar or needle\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Closed [percutaneous] [needle] biopsy of kidney\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Hydronephrosis\n- Nephrosclerosis\n- Primary diagnosis: Nephrotic syndrome\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Disorder of calcium metabolism\n- Renal function tests abnormal\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-23 14:44:14, ended at 2013-11-23 17:25:06\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-02 00:00:00, ended at 2013-12-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-14 00:00:00, ended at 2013-12-14 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired renal cystic disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-16 00:00:00, ended at 2013-12-16 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-21 00:00:00, ended at 2013-12-21 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-21 11:29:00, ended at 2013-12-21 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-23 13:32:00, ended at 2013-12-23 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions\n\n### Condition\n- Acquired renal cystic disease\n- Disorder of kidney and/or ureter\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-16 08:37:00, ended at 2014-01-16 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.12 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-23 10:29:18, ended at 2014-01-23 11:31:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Gout\n- Membranous glomerulonephritis\n- Secondary diabetes mellitus\n- Hyperlipidemia\n- Nephrotic syndrome\n- Kidney lesion\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2015-01-23, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. Take 1 PO every HS\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2014-05-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-07 14:09:59, ended at 2014-02-07 15:55:57\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-02 08:47:31, ended at 2014-03-02 09:21:27\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Left bundle branch hemiblock\n- Electrocardiogram abnormal\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-02 09:22:00, ended at 2014-03-02 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Pre-surgery evaluation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-04 09:26:00, ended at 2014-05-04 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.4 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 238 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Peripheral neuritis\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-09, with intended 0 refill(s). Instructions: Take one cap at night. May increase to 3 capsules at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n- Primary diagnosis: Low back pain\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-17, with intended 1 refill(s). Instructions: Take one capsule by mouth at night. Increase by one capsule, daily, up to 3 capsules, 3 times per day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-09 09:05:33, ended at 2014-05-09 10:51:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral neuritis\n- Altered sensation of skin\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-17 09:55:07, ended at 2014-05-17 11:19:08\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Contracture of palmar fascia\n- Essential hypertension\n- Transplanted kidney present\n- Gastroesophageal reflux disease\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2015-06-25. Instructions: take 300 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-19 14:58:00, ended at 2014-05-19 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Altered sensation of skin\n- Low back pain\n- Displacement of lumbar intervertebral disc without myelopathy\n- Lumbosacral spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-23 00:00:00, ended at 2014-05-23 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-31 00:00:00, ended at 2014-05-31 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Acquired renal cystic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-06-02 00:00:00, ended at 2014-06-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-06-02, presumably until 2014-06-02\n- iohexol, through Intravenous route, started on 2014-06-02, presumably until 2014-06-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 14:19:00, ended at 2014-06-02 15:55:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Other x-ray of lumbosacral spine\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, each additional level (List separately in addition to code for primary procedure)\n- Injection of steroid\n- Injection of other agent into spinal canal\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n\n### Condition\n- Displacement of lumbar intervertebral disc without myelopathy\n- Gastroesophageal reflux disease\n- Transplanted kidney present\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:12, ended at 2014-06-02 15:42:38\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:13, ended at 2014-06-02 15:42:39\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine, single view, specify level\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-15 09:17:00, ended at 2014-06-15 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 108 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.45 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.00 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.6 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.2 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-10 00:00:00, ended at 2014-07-10 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n- Primary diagnosis: Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-10 15:41:35, ended at 2014-07-10 16:54:36\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Displacement of lumbar intervertebral disc without myelopathy\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-16 00:00:00, ended at 2015-03-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Urine: 12200 (milligram per liter)\n- Creatinine [Mass/volume] in Urine: 133.30 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 11 - 20 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 9152 (milligram per gram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-06-24 23:33:00, ended at 2015-07-03 14:50:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.7 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 82 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.0 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 114 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.0 (ratio)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 756 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 0.8 (microgram per milliliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Adenosine deaminase [Enzymatic activity/volume] in Peritoneal fluid: 3.3 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 45.1 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 116 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 35 (percent)\n- Protein [Mass/volume] in Urine: 5857 (milligram per volume)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.1 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 83.4 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 3.56 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.22 (milligram per milligram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 269 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Base excess in Blood by calculation: -2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.2 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 23 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of kidney\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Renal biopsy; percutaneous, by trocar or needle\n- Plasmapheresis\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Insertion of graft for vascular access\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Abdominal paracentesis\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n\n### Condition\n- Immune defect\n- Nephrosclerosis\n- Breathing painful\n- Disorder of transplanted kidney\n- Essential hypertension\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Nephrotic syndrome\n- Non-infectious disorder of lymphatics\n- Right lower quadrant pain\n- Acute renal papillary necrosis with renal failure\n- Disorder of calcium metabolism\n- Flatulence, eructation and gas pain\n- Nephrotic syndrome with membranous glomerulonephritis\n- Transplanted kidney present\n- Atherosclerosis of aorta\n- Disorder affecting transplanted structure\n- Disorder of plasma protein metabolism\n- Late effect of medical and surgical care complication\n- Edema\n- Hypervolemia\n- Tobacco dependence syndrome\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cardiac arrhythmia\n- Hydronephrosis\n- Primary diagnosis: Membranous glomerulonephritis\n- Gout\n- Hyperlipidemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-06-14, presumably until 2015-08-09, with intended 11 refill(s). Instructions: take 750 mg by mouth 2 times a day\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-01, presumably until 2015-07-01\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-06-27, presumably until 2015-07-03\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 2.5 mg by mouth 2 times a day\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-06-25, presumably until 2015-06-27\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-06-18, presumably until 2015-08-10, with intended 2 refill(s). Instructions: take 1 mg by mouth as directed Take 1 cap (1 mg) in the morning and 2 caps (2 mg) in the evenings daily.\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-03, presumably until 2015-07-12, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-08-09, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 3 refill(s). Instructions: take 30 mg by mouth every morning\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-06-26, presumably until 2015-06-26\n- 24 HR nifedipine 60 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-15, presumably until 2015-07-03, with intended 0 refill(s). Instructions: take 30 mg by mouth 2 times a day\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-06-28, presumably until 2015-06-28\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2015-07-03, presumably until 2015-07-26, with intended 1 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 1 refill(s). Instructions: take 20 mg by mouth every morning\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-06-25, presumably until 2015-06-27\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-06-25, presumably until 2015-07-02\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-07-03\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-06-30\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-06-25, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-06-26, presumably until 2015-06-26\n- hypromellose 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2015-06-30, presumably until 2015-10-30, with intended 2 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day as needed\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2015-06-25, presumably until 2015-06-25\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-06-28, presumably until 2015-07-03\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-07-04, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-09-28, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-07-03\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-25, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 81 mg by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-30 12:30:00, ended at 2015-06-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 355 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-01 13:00:00, ended at 2015-07-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 313 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-02 10:48:00, ended at 2015-07-02 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-04 12:53:00, ended at 2015-07-04 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.94 (million per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 260 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 163 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-04, presumably until 2015-07-04\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-05 12:49:00, ended at 2015-07-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-05, presumably until 2015-07-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-05, presumably until 2015-07-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-05, presumably until 2015-07-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-06 00:00:00, ended at 2015-07-06 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-06 12:52:00, ended at 2015-07-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 64.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Transplanted kidney present\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-06, presumably until 2015-07-06\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-06, presumably until 2015-07-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-07-05, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth daily Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-09 00:00:00, ended at 2015-07-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine: 26531 (milligram per volume)\n- Creatinine [Mass/volume] in Urine: 44.4 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1255 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-09 12:55:00, ended at 2015-07-09 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 108.7 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-09, presumably until 2015-07-09\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-09, presumably until 2015-07-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-10 00:00:00, ended at 2015-07-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-10 13:00:00, ended at 2015-07-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 148 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.19 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.59 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-10, presumably until 2015-07-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-10, presumably until 2015-07-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-12 00:00:00, ended at 2015-07-12 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-12, presumably until 2015-07-22, with intended 3 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 11:00:00, ended at 2015-07-12 12:26:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Late effect of medical and surgical care complication\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-12 11:33:26, ended at 2015-07-12 12:22:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Renovascular hypertension\n- Nephrotic syndrome\n- Primary diagnosis: Transplanted kidney present\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 12:27:00, ended at 2015-07-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 30.62 (milligram per milligram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 2.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 81.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 2483 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Constipation\n\n### Drug\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-07-16, presumably until 2015-07-16, with intended 2 refill(s). Instructions: take 1 Packet by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-16 10:37:00, ended at 2015-07-16 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 286 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-16, presumably until 2015-07-16\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-16, presumably until 2015-07-16\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-16, presumably until 2015-07-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-17 13:30:00, ended at 2015-07-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 117 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-17, presumably until 2015-07-17\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-17, presumably until 2015-07-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-17, presumably until 2015-07-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-18 00:00:00, ended at 2015-07-18 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Constipation\n- Primary diagnosis: Kidney lesion\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-18, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-18 13:30:00, ended at 2015-07-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.50 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 204 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-18, presumably until 2015-07-18\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-18, presumably until 2015-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-08, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-24, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-20 13:00:00, ended at 2015-07-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 114 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 195 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-20, presumably until 2015-07-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-20, presumably until 2015-07-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-23 13:30:00, ended at 2015-07-23 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 101 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 2.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 271 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-24 00:00:00, ended at 2015-07-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-24, presumably until 2015-07-26, with intended 2 refill(s). Instructions: take 10 g by mouth 3 times a day X 2 days OR AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-25 13:30:00, ended at 2015-07-25 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 259 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-25, presumably until 2015-07-25\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-25, presumably until 2015-07-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 3 refill(s). Instructions: take 15 mL by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-26 10:02:29, ended at 2015-07-26 11:33:18\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n- Primary diagnosis: Transplanted kidney present\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Spinal stenosis of lumbar region\n- Renovascular hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-27 08:37:00, ended at 2015-07-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 155 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.93 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.82 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-27, presumably until 2015-07-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-27, presumably until 2015-07-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-30 13:30:00, ended at 2015-07-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.69 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 212 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 157 (milligram per deciliter)\n- Prothrombin time (PT): 14.0 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-30, presumably until 2015-07-30\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 08:25:00, ended at 2015-08-01 08:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Creatinine [Mass/volume] in Urine: 79.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.87 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1540 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.27 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 1.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 09:00:00, ended at 2015-08-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 214 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-01, presumably until 2015-08-01\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-03 09:00:00, ended at 2015-08-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 320 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-03, presumably until 2015-08-03\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-03, presumably until 2015-08-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-06 08:47:00, ended at 2015-08-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1189 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 66.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 215 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.99 (milligram per milligram)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-08-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-06, presumably until 2015-08-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-06, presumably until 2015-08-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-08 00:00:00, ended at 2015-08-08 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-08, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-08 08:48:00, ended at 2015-08-08 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.28 (milligram per milligram)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 153 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 121 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.30 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1639 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-08, presumably until 2015-08-08\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-08, presumably until 2015-08-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-09, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-03-13, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-09-19, with intended 11 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-05-14, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2017-06-18, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-10, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 10:25:28, ended at 2015-08-09 11:35:20\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Disorder of phosphorus metabolism\n- Tobacco dependence syndrome\n- Transplanted kidney present\n- Chronic kidney disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 15:19:02, ended at 2015-08-09 16:16:35\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-08-24, with intended 4 refill(s). Instructions: take 20 mg by mouth daily \n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-08-07, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 30 mg by mouth daily \n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 0.1 mg by mouth every bedtime \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-10, presumably until 2015-08-17, with intended 11 refill(s). Instructions: Take 1mg QAM and 2mg QPM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-10 08:30:00, ended at 2015-08-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.8 (percent)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.23 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 112 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 166 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-10, presumably until 2015-08-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-10, presumably until 2015-08-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-13 08:29:00, ended at 2015-08-13 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.95 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 111 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1417 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 216 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.38 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 16.50 (milligram per milligram)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Nephrotic syndrome\n- Membranous glomerulonephritis\n- Disorder of phosphorus metabolism\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-13, presumably until 2015-08-13\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-13, presumably until 2015-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-15 08:23:00, ended at 2015-08-15 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 172 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 104 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-15, presumably until 2015-08-15\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-15, presumably until 2015-08-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-17 00:00:00, ended at 2015-08-17 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-17, presumably until 2015-10-06, with intended 11 refill(s). Instructions: Take 2mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-17 08:13:00, ended at 2015-08-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 70.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 183 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.88 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-17, presumably until 2015-08-17\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-20, presumably until 2015-08-21, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-20 08:22:00, ended at 2015-08-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 90 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 974 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Body height: 5' 4.173\" (inch (US))\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.79 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 245 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.98 (milligram per milligram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.77 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-20, presumably until 2015-08-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-20, presumably until 2015-08-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-21 00:00:00, ended at 2015-08-21 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-21, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-22 08:30:00, ended at 2015-08-22 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 962 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.47 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.63 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 55.5 (nanogram per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 179 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 21 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.62 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.9 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 174 (microgram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 36 (microgram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Anemia in chronic kidney disease\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-22, presumably until 2015-08-22\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-22, presumably until 2015-08-22\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) daily in the morning Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-23 09:34:11, ended at 2015-08-23 11:50:56\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Disorder of kidney due to diabetes mellitus\n- Nephrotic syndrome\n- Disorder of transplanted kidney\n- Hyperlipidemia\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Secondary thrombocytopenia\n- Primary diagnosis: Membranous glomerulonephritis\n- Poisoning by drug AND/OR medicinal substance\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-24 00:00:00, ended at 2015-08-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-24 12:58:00, ended at 2015-08-24 17:51:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 312 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 175 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 243 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.35 (million per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 397 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 504 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-24, presumably until 2015-08-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-08-24 17:52:00, ended at 2015-09-04 10:24:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Urine: 36 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Folate [Mass/volume] in Serum or Plasma: 9.3 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prothrombin time (PT): 15.6 (second)\n- Tacrolimus [Mass/volume] in Blood: 9.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 4.15 (log international unit per milliliter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 928 (international unit per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 631 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 309 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 73 (percent)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 21.25 (milligram per milligram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 17.4 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 63.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 28 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.11 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.4 (nanogram per milliliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 29 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 850 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 3007 (nanogram per milliliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 72.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Thrombin time: 18.4 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Body height: 5' 5.98\" (inch (US))\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 7.4 (milli-international unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.05 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -7.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 68.5 (nanogram per milliliter)\n- Glucose [Mass/volume] in Blood: 60 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 43 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.32 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 36.2 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.80 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.60 (micro-international unit per milliliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Potassium [Moles/volume] in 24 hour Urine: 33.9 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Plasmapheresis\n- Ultrasound, abdominal, real time with image documentation; complete\n- Hemodialysis\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; more than 30 minutes\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Occupational therapy evaluation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Acidosis\n- Hypervolemia\n- Lymphocytosis\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cytomegalovirus infection\n- Nephrotic syndrome with membranous glomerulonephritis\n- Ascites\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Late effect of medical and surgical care complication\n- Monoclonal gammopathy (clinical)\n- Tobacco dependence syndrome\n- Coronary arteriosclerosis\n- Pancytopenia\n- Chronic kidney disease\n- Iron deficiency anemia\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Edema\n- Hydronephrosis\n- Proteinuria\n- Secondary diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Benign hypertensive renal disease with renal failure\n- Complication due to diabetes mellitus\n- Disorder affecting transplanted structure\n- Disorder of hematopoietic structure\n- Disorder of plasma protein metabolism\n- Hyperlipidemia\n- Postprocedural state finding\n- Anemia in chronic kidney disease\n- Disorder of kidney due to diabetes mellitus\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Renovascular hypertension\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-01\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2015-08-28, presumably until 2015-10-18, with intended 0 refill(s). Instructions: insert 1 Suppository into the rectum daily as needed\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-09-01, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 10 mL by mouth every morning with breakfast\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-09-03, presumably until 2015-09-04\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed for Pain or Fever\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-28, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) 3 times a week\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-08-26, presumably until 2015-09-04\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-03\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-09-04, presumably until 2015-09-04\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-29\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-29, presumably until 2015-09-03\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-08-24, presumably until 2015-08-25\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-08-30, presumably until 2015-09-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed (leg edema)\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2016-09-02, with intended 0 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-08-26, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 10 mg by mouth 2 times a day\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-08-27, presumably until 2015-08-28, with intended 0 refill(s). Instructions: take 10 g by mouth 2 times a day\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-09-01, presumably until 2015-09-01\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-31\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2015-10-06, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-08-28, presumably until 2015-08-31\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-08-27, presumably until 2015-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday for 30 days\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2015-09-01, presumably until 2015-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-27 07:26:00, ended at 2015-08-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 83 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-27, presumably until 2015-08-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 07:53:00, ended at 2015-08-29 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 268 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-31 08:01:00, ended at 2015-08-31 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 91 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-31, presumably until 2015-08-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-03 08:57:00, ended at 2015-09-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 49 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-05 08:30:00, ended at 2015-09-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 168 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-05, presumably until 2015-09-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-07 08:30:00, ended at 2015-09-07 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1093 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 20.90 (milligram per milligram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 52.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-07, presumably until 2015-09-07\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-07, presumably until 2015-09-07\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-07, presumably until 2015-09-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-10 08:30:00, ended at 2015-09-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 202 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 213 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-10, presumably until 2015-09-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-10, presumably until 2015-09-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 07:30:00, ended at 2015-09-12 13:07:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 197 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Nephrotic syndrome\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Kidney lesion\n- Disorder of phosphorus metabolism\n- Membranous glomerulonephritis\n- Essential hypertension\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-12, presumably until 2015-09-12\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-12, presumably until 2015-09-12\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-12, presumably until 2015-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 13:08:00, ended at 2015-09-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired renal cystic disease\n- Hyperlipidemia\n- Contracture of palmar fascia\n- Kidney lesion\n- Poisoning by drug AND/OR medicinal substance\n- Tobacco dependence syndrome\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Peripheral neuritis\n- Chronic kidney disease\n- Cytomegalovirus infection\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Nephrotic syndrome\n- Secondary thrombocytopenia\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-14 09:32:00, ended at 2015-09-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-14, presumably until 2015-09-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-17 09:00:00, ended at 2015-09-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 185 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 67 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- End-stage renal disease\n- Anemia in chronic kidney disease\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-09-19, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 2 Tabs by mouth daily Reduce to 10 mg daily on 10/08/2015\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-19 09:00:00, ended at 2015-09-19 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-19, presumably until 2015-09-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-20 00:00:00, ended at 2015-09-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-26 09:35:16, ended at 2015-09-26 10:39:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Type 2 diabetes mellitus without complication\n- Anemia in chronic kidney disease\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Nephrotic syndrome\n- Cytomegalovirus infection\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Renovascular hypertension\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-26 10:44:00, ended at 2015-09-26 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.9 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 144.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 112 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.19 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Neutropenia associated with infectious disease\n- Cytomegalovirus infection\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-03 09:39:30, ended at 2015-10-03 11:52:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Chronic kidney disease\n- Kidney disease\n- Hyperlipidemia\n- Disorder of kidney due to diabetes mellitus\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Kidney lesion\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-03 13:08:00, ended at 2015-10-03 16:12:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-03, presumably until 2015-10-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-10-03 16:13:00, ended at 2015-10-06 13:29:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 486 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.3 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.08 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 87 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, chest; single view, frontal\n- Initial observation care, per day, for the evaluation and management of a patient which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or o\n- Hemodialysis\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n- Late effect of medical and surgical care complication\n- Pure hypercholesterolemia\n- Renovascular hypertension\n- Tobacco dependence syndrome\n- Lung field abnormal\n- Abnormal glucose level\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Leukocytosis\n- Membranous glomerulonephritis\n- Proteinuria\n- Transplanted kidney present\n- Disorder affecting transplanted structure\n- Disorder due to type 2 diabetes mellitus\n- Primary diagnosis: Nephrotic syndrome\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Contracture of joint of hand\n- Diabetic - poor control\n- Hyperlipidemia\n- Renal failure syndrome\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-06\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-10-04, presumably until 2015-10-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-03, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed for Constipation\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-10-04, presumably until 2015-10-04\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-03\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-07-18, with intended 6 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2015-10-04, presumably until 2015-10-04\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-04, presumably until 2016-10-04, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-10-05, with intended 6 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) every bedtime\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2015-10-04, presumably until 2015-10-04\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-06, presumably until 2015-10-06\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-17 10:41:42, ended at 2015-10-17 11:33:01\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Disorder of kidney and/or ureter\n- Renal hypertension\n- Hyperparathyroidism due to renal insufficiency\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Hyperlipidemia\n- Failed renal transplant\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- Nephrotic syndrome\n- Transplanted kidney present\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-18 11:47:00, ended at 2015-10-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.25 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 28 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.5 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 151 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 169.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 4.0 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-18 12:10:29, ended at 2015-10-18 13:45:06\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Reticulocytes [#/volume] in Blood by Automated count: 130.9 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.42 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 857 (picogram per milliliter)\n- Body height: 5' 4.567\" (inch (US))\n- Iron [Mass/volume] in Serum or Plasma: 51 (microgram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 597.9 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 20 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Thrombocytopenic disorder\n- Primary diagnosis: Anemia\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-19 00:00:00, ended at 2015-10-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-10-30 12:04:00, ended at 2015-11-02 16:20:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.6 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 11.18 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.49 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Body height: 5' 6\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 340 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 362 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1043 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 93.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Physical therapy evaluation\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, thorax, diagnostic; without contrast material\n- Performance of Urinary Filtration, Multiple (Deprecated)\n\n### Condition\n- Closed fracture of multiple ribs\n- Failed renal transplant\n- Late effect of fracture of spine AND/OR trunk without spinal cord lesion\n- Shoulder joint pain\n- Acute renal failure syndrome\n- Electrocardiogram abnormal\n- Essential hypertension\n- Gout\n- Renal hypertension\n- Chronic graft-versus-host disease\n- Late effect of complications of procedure\n- Transplanted kidney present\n- Atelectasis\n- Contracture of joint of hand\n- Pleural effusion\n- Renal disorder due to type 2 diabetes mellitus\n- Atrial premature complex\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Nephrotic syndrome\n- Nicotine dependence\n- Disorder of joint of shoulder region\n- End-stage renal disease\n- Hyperlipidemia\n- Hypertensive renal failure\n- Cerebral infarction\n- Primary diagnosis: Closed fracture of one rib\n- Disorder of kidney and/or ureter\n- Gastroesophageal reflux disease without esophagitis\n- Ventricular premature complex\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe, through Intramuscular route, started on 2015-10-31, presumably until 2015-10-31\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-11-01, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Caps by mouth daily\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily as needed (constipation)\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2017-02-21, with intended 1 refill(s). Instructions: take 20 mg by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-11-01, presumably until 2015-11-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-10-07, presumably until 2016-02-27, with intended 9 refill(s). Instructions: take 10 mg by mouth 2 times a day as needed \n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-31, presumably until 2015-11-02\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2015-10-30, presumably until 2015-10-30\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-30, presumably until 2015-11-01\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-31, presumably until 2015-11-02\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-14 09:19:00, ended at 2015-11-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.77 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 707 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.96 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.1 (femtoliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.06 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.1 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 37.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-14 09:34:44, ended at 2015-11-14 10:43:05\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.236\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia of chronic disease\n- Dupuytren's disease of palm\n- Transplanted kidney present\n- End-stage renal disease\n- Nephrotic syndrome\n- Acquired renal cystic disease\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Renal disorder due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-15 10:34:51, ended at 2015-11-15 11:25:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Renal disorder due to type 2 diabetes mellitus\n- Contracture of joint of hand\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid va..., through Intramuscular route, started on 2015-11-15, presumably until 2015-11-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-14 08:58:00, ended at 2015-12-14 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- MCV [Entitic volume] by Automated count: 78.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 13.31 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.48 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.7 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 989 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 238 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-19 09:02:32, ended at 2015-12-19 09:37:10\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Dupuytren's disease of palm\n- Renal hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Chronic kidney disease\n- Disorder of kidney and/or ureter\n- Disorder of lung\n- Failed renal transplant\n- Contracture of joint of hand\n- Hyperparathyroidism due to renal insufficiency\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- End-stage renal disease\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-02 00:00:00, ended at 2016-01-02 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-31 06:59:00, ended at 2016-01-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 204 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 95 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1541 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.88 (milligram per milligram)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.3 (percent)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 155.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.72 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-31 12:39:47, ended at 2016-01-31 15:24:19\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-14 09:30:52, ended at 2016-02-14 10:37:55\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Solitary nodule of lung\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 09:00:00, ended at 2016-02-19 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 129.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.89 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1224 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 75.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.47 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.99 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-29 00:00:00, ended at 2011-10-29 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-29 11:11:50, ended at 2011-10-29 12:34:54\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-26 00:00:00, ended at 2013-04-26 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-04-26, presumably until 2013-04-26, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-02 00:00:00, ended at 2013-09-02 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-02, presumably until 2013-09-02, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-09 00:00:00, ended at 2013-09-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-09, presumably until 2015-06-25, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-09 09:23:43, ended at 2013-11-09 10:40:25\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Contracture of palmar fascia\n- Disorder of transplanted kidney\n- Left bundle branch hemiblock\n- Primary diagnosis: Transplanted kidney present\n- Electrocardiogram abnormal\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Inflammatory dermatosis\n- Tachycardia\n\n### Drug\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2015-06-25. Instructions: inject 15 Units subcutaneous (under the skin) every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-09 10:44:00, ended at 2013-11-09 11:23:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 240 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.44 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 5.7 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-14 00:00:00, ended at 2013-11-14 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Kidney lesion\n- Transplanted kidney present\n- Primary diagnosis: Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-23 13:54:00, ended at 2013-11-23 21:40:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n- aPTT in Platelet poor plasma by Coagulation assay: 30.3 (second)\n- Prothrombin time (PT): 12.4 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Renal biopsy; percutaneous, by trocar or needle\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Closed [percutaneous] [needle] biopsy of kidney\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Hydronephrosis\n- Nephrosclerosis\n- Primary diagnosis: Nephrotic syndrome\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Disorder of calcium metabolism\n- Renal function tests abnormal\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-23 14:44:14, ended at 2013-11-23 17:25:06\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-02 00:00:00, ended at 2013-12-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-14 00:00:00, ended at 2013-12-14 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired renal cystic disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-16 00:00:00, ended at 2013-12-16 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-21 00:00:00, ended at 2013-12-21 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-21 11:29:00, ended at 2013-12-21 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-23 13:32:00, ended at 2013-12-23 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions\n\n### Condition\n- Acquired renal cystic disease\n- Disorder of kidney and/or ureter\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-16 08:37:00, ended at 2014-01-16 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.12 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-23 10:29:18, ended at 2014-01-23 11:31:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Gout\n- Membranous glomerulonephritis\n- Secondary diabetes mellitus\n- Hyperlipidemia\n- Nephrotic syndrome\n- Kidney lesion\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2015-01-23, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. Take 1 PO every HS\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2014-05-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-07 14:09:59, ended at 2014-02-07 15:55:57\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-02 08:47:31, ended at 2014-03-02 09:21:27\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Left bundle branch hemiblock\n- Electrocardiogram abnormal\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-02 09:22:00, ended at 2014-03-02 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Pre-surgery evaluation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-04 09:26:00, ended at 2014-05-04 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.4 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 238 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Peripheral neuritis\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-09, with intended 0 refill(s). Instructions: Take one cap at night. May increase to 3 capsules at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n- Primary diagnosis: Low back pain\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-17, with intended 1 refill(s). Instructions: Take one capsule by mouth at night. Increase by one capsule, daily, up to 3 capsules, 3 times per day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-09 09:05:33, ended at 2014-05-09 10:51:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral neuritis\n- Altered sensation of skin\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-17 09:55:07, ended at 2014-05-17 11:19:08\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Contracture of palmar fascia\n- Essential hypertension\n- Transplanted kidney present\n- Gastroesophageal reflux disease\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2015-06-25. Instructions: take 300 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-19 14:58:00, ended at 2014-05-19 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Altered sensation of skin\n- Low back pain\n- Displacement of lumbar intervertebral disc without myelopathy\n- Lumbosacral spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-23 00:00:00, ended at 2014-05-23 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-31 00:00:00, ended at 2014-05-31 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Acquired renal cystic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-06-02 00:00:00, ended at 2014-06-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-06-02, presumably until 2014-06-02\n- iohexol, through Intravenous route, started on 2014-06-02, presumably until 2014-06-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 14:19:00, ended at 2014-06-02 15:55:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Other x-ray of lumbosacral spine\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, each additional level (List separately in addition to code for primary procedure)\n- Injection of steroid\n- Injection of other agent into spinal canal\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n\n### Condition\n- Displacement of lumbar intervertebral disc without myelopathy\n- Gastroesophageal reflux disease\n- Transplanted kidney present\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:12, ended at 2014-06-02 15:42:38\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:13, ended at 2014-06-02 15:42:39\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine, single view, specify level\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-15 09:17:00, ended at 2014-06-15 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 108 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.45 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.00 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.6 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.2 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-10 00:00:00, ended at 2014-07-10 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n- Primary diagnosis: Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-10 15:41:35, ended at 2014-07-10 16:54:36\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Displacement of lumbar intervertebral disc without myelopathy\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-16 00:00:00, ended at 2015-03-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Urine: 12200 (milligram per liter)\n- Creatinine [Mass/volume] in Urine: 133.30 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 11 - 20 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 9152 (milligram per gram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-06-24 23:33:00, ended at 2015-07-03 14:50:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.7 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 82 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.0 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 114 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.0 (ratio)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 756 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 0.8 (microgram per milliliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Adenosine deaminase [Enzymatic activity/volume] in Peritoneal fluid: 3.3 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 45.1 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 116 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 35 (percent)\n- Protein [Mass/volume] in Urine: 5857 (milligram per volume)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.1 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 83.4 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 3.56 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.22 (milligram per milligram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 269 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Base excess in Blood by calculation: -2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.2 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 23 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of kidney\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Renal biopsy; percutaneous, by trocar or needle\n- Plasmapheresis\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Insertion of graft for vascular access\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Abdominal paracentesis\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n\n### Condition\n- Immune defect\n- Nephrosclerosis\n- Breathing painful\n- Disorder of transplanted kidney\n- Essential hypertension\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Nephrotic syndrome\n- Non-infectious disorder of lymphatics\n- Right lower quadrant pain\n- Acute renal papillary necrosis with renal failure\n- Disorder of calcium metabolism\n- Flatulence, eructation and gas pain\n- Nephrotic syndrome with membranous glomerulonephritis\n- Transplanted kidney present\n- Atherosclerosis of aorta\n- Disorder affecting transplanted structure\n- Disorder of plasma protein metabolism\n- Late effect of medical and surgical care complication\n- Edema\n- Hypervolemia\n- Tobacco dependence syndrome\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cardiac arrhythmia\n- Hydronephrosis\n- Primary diagnosis: Membranous glomerulonephritis\n- Gout\n- Hyperlipidemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-06-14, presumably until 2015-08-09, with intended 11 refill(s). Instructions: take 750 mg by mouth 2 times a day\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-01, presumably until 2015-07-01\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-06-27, presumably until 2015-07-03\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 2.5 mg by mouth 2 times a day\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-06-25, presumably until 2015-06-27\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-06-18, presumably until 2015-08-10, with intended 2 refill(s). Instructions: take 1 mg by mouth as directed Take 1 cap (1 mg) in the morning and 2 caps (2 mg) in the evenings daily.\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-03, presumably until 2015-07-12, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-08-09, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 3 refill(s). Instructions: take 30 mg by mouth every morning\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-06-26, presumably until 2015-06-26\n- 24 HR nifedipine 60 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-15, presumably until 2015-07-03, with intended 0 refill(s). Instructions: take 30 mg by mouth 2 times a day\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-06-28, presumably until 2015-06-28\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2015-07-03, presumably until 2015-07-26, with intended 1 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 1 refill(s). Instructions: take 20 mg by mouth every morning\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-06-25, presumably until 2015-06-27\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-06-25, presumably until 2015-07-02\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-07-03\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-06-30\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-06-25, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-06-26, presumably until 2015-06-26\n- hypromellose 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2015-06-30, presumably until 2015-10-30, with intended 2 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day as needed\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2015-06-25, presumably until 2015-06-25\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-06-28, presumably until 2015-07-03\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-07-04, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-09-28, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-07-03\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-25, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 81 mg by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-30 12:30:00, ended at 2015-06-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 355 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-01 13:00:00, ended at 2015-07-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 313 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-02 10:48:00, ended at 2015-07-02 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-04 12:53:00, ended at 2015-07-04 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.94 (million per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 260 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 163 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-04, presumably until 2015-07-04\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-05 12:49:00, ended at 2015-07-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-05, presumably until 2015-07-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-05, presumably until 2015-07-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-05, presumably until 2015-07-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-06 00:00:00, ended at 2015-07-06 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-06 12:52:00, ended at 2015-07-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 64.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Transplanted kidney present\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-06, presumably until 2015-07-06\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-06, presumably until 2015-07-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-07-05, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth daily Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-09 00:00:00, ended at 2015-07-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine: 26531 (milligram per volume)\n- Creatinine [Mass/volume] in Urine: 44.4 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1255 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-09 12:55:00, ended at 2015-07-09 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 108.7 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-09, presumably until 2015-07-09\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-09, presumably until 2015-07-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-10 00:00:00, ended at 2015-07-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-10 13:00:00, ended at 2015-07-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 148 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.19 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.59 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-10, presumably until 2015-07-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-10, presumably until 2015-07-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-12 00:00:00, ended at 2015-07-12 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-12, presumably until 2015-07-22, with intended 3 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 11:00:00, ended at 2015-07-12 12:26:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Late effect of medical and surgical care complication\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-12 11:33:26, ended at 2015-07-12 12:22:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Renovascular hypertension\n- Nephrotic syndrome\n- Primary diagnosis: Transplanted kidney present\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 12:27:00, ended at 2015-07-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 30.62 (milligram per milligram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 2.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 81.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 2483 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Constipation\n\n### Drug\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-07-16, presumably until 2015-07-16, with intended 2 refill(s). Instructions: take 1 Packet by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-16 10:37:00, ended at 2015-07-16 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 286 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-16, presumably until 2015-07-16\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-16, presumably until 2015-07-16\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-16, presumably until 2015-07-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-17 13:30:00, ended at 2015-07-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 117 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-17, presumably until 2015-07-17\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-17, presumably until 2015-07-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-17, presumably until 2015-07-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-18 00:00:00, ended at 2015-07-18 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Constipation\n- Primary diagnosis: Kidney lesion\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-18, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-18 13:30:00, ended at 2015-07-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.50 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 204 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-18, presumably until 2015-07-18\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-18, presumably until 2015-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-08, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-24, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-20 13:00:00, ended at 2015-07-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 114 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 195 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-20, presumably until 2015-07-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-20, presumably until 2015-07-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-23 13:30:00, ended at 2015-07-23 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 101 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 2.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 271 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-24 00:00:00, ended at 2015-07-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-24, presumably until 2015-07-26, with intended 2 refill(s). Instructions: take 10 g by mouth 3 times a day X 2 days OR AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-25 13:30:00, ended at 2015-07-25 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 259 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-25, presumably until 2015-07-25\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-25, presumably until 2015-07-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 3 refill(s). Instructions: take 15 mL by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-26 10:02:29, ended at 2015-07-26 11:33:18\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n- Primary diagnosis: Transplanted kidney present\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Spinal stenosis of lumbar region\n- Renovascular hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-27 08:37:00, ended at 2015-07-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 155 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.93 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.82 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-27, presumably until 2015-07-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-27, presumably until 2015-07-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-30 13:30:00, ended at 2015-07-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.69 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 212 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 157 (milligram per deciliter)\n- Prothrombin time (PT): 14.0 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-30, presumably until 2015-07-30\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 08:25:00, ended at 2015-08-01 08:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Creatinine [Mass/volume] in Urine: 79.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.87 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1540 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.27 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 1.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 09:00:00, ended at 2015-08-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 214 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-01, presumably until 2015-08-01\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-03 09:00:00, ended at 2015-08-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 320 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-03, presumably until 2015-08-03\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-03, presumably until 2015-08-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-06 08:47:00, ended at 2015-08-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1189 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 66.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 215 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.99 (milligram per milligram)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-08-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-06, presumably until 2015-08-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-06, presumably until 2015-08-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-08 00:00:00, ended at 2015-08-08 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-08, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-08 08:48:00, ended at 2015-08-08 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.28 (milligram per milligram)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 153 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 121 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.30 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1639 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-08, presumably until 2015-08-08\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-08, presumably until 2015-08-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-09, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-03-13, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-09-19, with intended 11 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-05-14, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2017-06-18, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-10, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 10:25:28, ended at 2015-08-09 11:35:20\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Disorder of phosphorus metabolism\n- Tobacco dependence syndrome\n- Transplanted kidney present\n- Chronic kidney disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 15:19:02, ended at 2015-08-09 16:16:35\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-08-24, with intended 4 refill(s). Instructions: take 20 mg by mouth daily \n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-08-07, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 30 mg by mouth daily \n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 0.1 mg by mouth every bedtime \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-10, presumably until 2015-08-17, with intended 11 refill(s). Instructions: Take 1mg QAM and 2mg QPM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-10 08:30:00, ended at 2015-08-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.8 (percent)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.23 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 112 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 166 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-10, presumably until 2015-08-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-10, presumably until 2015-08-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-13 08:29:00, ended at 2015-08-13 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.95 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 111 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1417 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 216 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.38 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 16.50 (milligram per milligram)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Nephrotic syndrome\n- Membranous glomerulonephritis\n- Disorder of phosphorus metabolism\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-13, presumably until 2015-08-13\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-13, presumably until 2015-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-15 08:23:00, ended at 2015-08-15 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 172 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 104 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-15, presumably until 2015-08-15\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-15, presumably until 2015-08-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-17 00:00:00, ended at 2015-08-17 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-17, presumably until 2015-10-06, with intended 11 refill(s). Instructions: Take 2mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-17 08:13:00, ended at 2015-08-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 70.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 183 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.88 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-17, presumably until 2015-08-17\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-20, presumably until 2015-08-21, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-20 08:22:00, ended at 2015-08-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 90 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 974 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Body height: 5' 4.173\" (inch (US))\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.79 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 245 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.98 (milligram per milligram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.77 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-20, presumably until 2015-08-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-20, presumably until 2015-08-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-21 00:00:00, ended at 2015-08-21 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-21, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-22 08:30:00, ended at 2015-08-22 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 962 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.47 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.63 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 55.5 (nanogram per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 179 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 21 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.62 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.9 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 174 (microgram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 36 (microgram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Anemia in chronic kidney disease\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-22, presumably until 2015-08-22\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-22, presumably until 2015-08-22\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) daily in the morning Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-23 09:34:11, ended at 2015-08-23 11:50:56\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Disorder of kidney due to diabetes mellitus\n- Nephrotic syndrome\n- Disorder of transplanted kidney\n- Hyperlipidemia\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Secondary thrombocytopenia\n- Primary diagnosis: Membranous glomerulonephritis\n- Poisoning by drug AND/OR medicinal substance\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-24 00:00:00, ended at 2015-08-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-24 12:58:00, ended at 2015-08-24 17:51:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 312 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 175 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 243 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.35 (million per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 397 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 504 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-24, presumably until 2015-08-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-08-24 17:52:00, ended at 2015-09-04 10:24:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Urine: 36 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Folate [Mass/volume] in Serum or Plasma: 9.3 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prothrombin time (PT): 15.6 (second)\n- Tacrolimus [Mass/volume] in Blood: 9.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 4.15 (log international unit per milliliter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 928 (international unit per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 631 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 309 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 73 (percent)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 21.25 (milligram per milligram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 17.4 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 63.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 28 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.11 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.4 (nanogram per milliliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 29 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 850 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 3007 (nanogram per milliliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 72.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Thrombin time: 18.4 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Body height: 5' 5.98\" (inch (US))\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 7.4 (milli-international unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.05 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -7.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 68.5 (nanogram per milliliter)\n- Glucose [Mass/volume] in Blood: 60 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 43 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.32 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 36.2 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.80 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.60 (micro-international unit per milliliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Potassium [Moles/volume] in 24 hour Urine: 33.9 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Plasmapheresis\n- Ultrasound, abdominal, real time with image documentation; complete\n- Hemodialysis\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; more than 30 minutes\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Occupational therapy evaluation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Acidosis\n- Hypervolemia\n- Lymphocytosis\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cytomegalovirus infection\n- Nephrotic syndrome with membranous glomerulonephritis\n- Ascites\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Late effect of medical and surgical care complication\n- Monoclonal gammopathy (clinical)\n- Tobacco dependence syndrome\n- Coronary arteriosclerosis\n- Pancytopenia\n- Chronic kidney disease\n- Iron deficiency anemia\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Edema\n- Hydronephrosis\n- Proteinuria\n- Secondary diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Benign hypertensive renal disease with renal failure\n- Complication due to diabetes mellitus\n- Disorder affecting transplanted structure\n- Disorder of hematopoietic structure\n- Disorder of plasma protein metabolism\n- Hyperlipidemia\n- Postprocedural state finding\n- Anemia in chronic kidney disease\n- Disorder of kidney due to diabetes mellitus\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Renovascular hypertension\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-01\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2015-08-28, presumably until 2015-10-18, with intended 0 refill(s). Instructions: insert 1 Suppository into the rectum daily as needed\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-09-01, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 10 mL by mouth every morning with breakfast\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-09-03, presumably until 2015-09-04\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed for Pain or Fever\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-28, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) 3 times a week\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-08-26, presumably until 2015-09-04\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-03\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-09-04, presumably until 2015-09-04\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-29\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-29, presumably until 2015-09-03\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-08-24, presumably until 2015-08-25\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-08-30, presumably until 2015-09-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed (leg edema)\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2016-09-02, with intended 0 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-08-26, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 10 mg by mouth 2 times a day\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-08-27, presumably until 2015-08-28, with intended 0 refill(s). Instructions: take 10 g by mouth 2 times a day\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-09-01, presumably until 2015-09-01\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-31\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2015-10-06, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-08-28, presumably until 2015-08-31\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-08-27, presumably until 2015-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday for 30 days\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2015-09-01, presumably until 2015-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-27 07:26:00, ended at 2015-08-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 83 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-27, presumably until 2015-08-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 07:53:00, ended at 2015-08-29 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 268 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-31 08:01:00, ended at 2015-08-31 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 91 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-31, presumably until 2015-08-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-03 08:57:00, ended at 2015-09-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 49 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-05 08:30:00, ended at 2015-09-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 168 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-05, presumably until 2015-09-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-07 08:30:00, ended at 2015-09-07 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1093 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 20.90 (milligram per milligram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 52.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-07, presumably until 2015-09-07\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-07, presumably until 2015-09-07\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-07, presumably until 2015-09-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-10 08:30:00, ended at 2015-09-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 202 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 213 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-10, presumably until 2015-09-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-10, presumably until 2015-09-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 07:30:00, ended at 2015-09-12 13:07:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 197 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Nephrotic syndrome\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Kidney lesion\n- Disorder of phosphorus metabolism\n- Membranous glomerulonephritis\n- Essential hypertension\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-12, presumably until 2015-09-12\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-12, presumably until 2015-09-12\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-12, presumably until 2015-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 13:08:00, ended at 2015-09-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired renal cystic disease\n- Hyperlipidemia\n- Contracture of palmar fascia\n- Kidney lesion\n- Poisoning by drug AND/OR medicinal substance\n- Tobacco dependence syndrome\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Peripheral neuritis\n- Chronic kidney disease\n- Cytomegalovirus infection\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Nephrotic syndrome\n- Secondary thrombocytopenia\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-14 09:32:00, ended at 2015-09-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-14, presumably until 2015-09-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-17 09:00:00, ended at 2015-09-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 185 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 67 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- End-stage renal disease\n- Anemia in chronic kidney disease\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-09-19, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 2 Tabs by mouth daily Reduce to 10 mg daily on 10/08/2015\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-19 09:00:00, ended at 2015-09-19 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-19, presumably until 2015-09-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-20 00:00:00, ended at 2015-09-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-26 09:35:16, ended at 2015-09-26 10:39:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Type 2 diabetes mellitus without complication\n- Anemia in chronic kidney disease\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Nephrotic syndrome\n- Cytomegalovirus infection\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Renovascular hypertension\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-26 10:44:00, ended at 2015-09-26 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.9 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 144.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 112 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.19 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Neutropenia associated with infectious disease\n- Cytomegalovirus infection\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-03 09:39:30, ended at 2015-10-03 11:52:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Chronic kidney disease\n- Kidney disease\n- Hyperlipidemia\n- Disorder of kidney due to diabetes mellitus\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Kidney lesion\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-03 13:08:00, ended at 2015-10-03 16:12:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-03, presumably until 2015-10-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-10-03 16:13:00, ended at 2015-10-06 13:29:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 486 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.3 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.08 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 87 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, chest; single view, frontal\n- Initial observation care, per day, for the evaluation and management of a patient which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or o\n- Hemodialysis\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n- Late effect of medical and surgical care complication\n- Pure hypercholesterolemia\n- Renovascular hypertension\n- Tobacco dependence syndrome\n- Lung field abnormal\n- Abnormal glucose level\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Leukocytosis\n- Membranous glomerulonephritis\n- Proteinuria\n- Transplanted kidney present\n- Disorder affecting transplanted structure\n- Disorder due to type 2 diabetes mellitus\n- Primary diagnosis: Nephrotic syndrome\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Contracture of joint of hand\n- Diabetic - poor control\n- Hyperlipidemia\n- Renal failure syndrome\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-06\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-10-04, presumably until 2015-10-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-03, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed for Constipation\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-10-04, presumably until 2015-10-04\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-03\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-07-18, with intended 6 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2015-10-04, presumably until 2015-10-04\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-04, presumably until 2016-10-04, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-10-05, with intended 6 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) every bedtime\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2015-10-04, presumably until 2015-10-04\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-06, presumably until 2015-10-06\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-17 10:41:42, ended at 2015-10-17 11:33:01\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Disorder of kidney and/or ureter\n- Renal hypertension\n- Hyperparathyroidism due to renal insufficiency\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Hyperlipidemia\n- Failed renal transplant\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- Nephrotic syndrome\n- Transplanted kidney present\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-18 11:47:00, ended at 2015-10-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.25 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 28 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.5 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 151 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 169.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 4.0 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-18 12:10:29, ended at 2015-10-18 13:45:06\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Reticulocytes [#/volume] in Blood by Automated count: 130.9 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.42 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 857 (picogram per milliliter)\n- Body height: 5' 4.567\" (inch (US))\n- Iron [Mass/volume] in Serum or Plasma: 51 (microgram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 597.9 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 20 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Thrombocytopenic disorder\n- Primary diagnosis: Anemia\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-19 00:00:00, ended at 2015-10-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-10-30 12:04:00, ended at 2015-11-02 16:20:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.6 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 11.18 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.49 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Body height: 5' 6\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 340 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 362 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1043 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 93.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Physical therapy evaluation\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, thorax, diagnostic; without contrast material\n- Performance of Urinary Filtration, Multiple (Deprecated)\n\n### Condition\n- Closed fracture of multiple ribs\n- Failed renal transplant\n- Late effect of fracture of spine AND/OR trunk without spinal cord lesion\n- Shoulder joint pain\n- Acute renal failure syndrome\n- Electrocardiogram abnormal\n- Essential hypertension\n- Gout\n- Renal hypertension\n- Chronic graft-versus-host disease\n- Late effect of complications of procedure\n- Transplanted kidney present\n- Atelectasis\n- Contracture of joint of hand\n- Pleural effusion\n- Renal disorder due to type 2 diabetes mellitus\n- Atrial premature complex\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Nephrotic syndrome\n- Nicotine dependence\n- Disorder of joint of shoulder region\n- End-stage renal disease\n- Hyperlipidemia\n- Hypertensive renal failure\n- Cerebral infarction\n- Primary diagnosis: Closed fracture of one rib\n- Disorder of kidney and/or ureter\n- Gastroesophageal reflux disease without esophagitis\n- Ventricular premature complex\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe, through Intramuscular route, started on 2015-10-31, presumably until 2015-10-31\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-11-01, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Caps by mouth daily\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily as needed (constipation)\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2017-02-21, with intended 1 refill(s). Instructions: take 20 mg by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-11-01, presumably until 2015-11-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-10-07, presumably until 2016-02-27, with intended 9 refill(s). Instructions: take 10 mg by mouth 2 times a day as needed \n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-31, presumably until 2015-11-02\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2015-10-30, presumably until 2015-10-30\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-30, presumably until 2015-11-01\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-31, presumably until 2015-11-02\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-14 09:19:00, ended at 2015-11-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.77 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 707 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.96 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.1 (femtoliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.06 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.1 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 37.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-14 09:34:44, ended at 2015-11-14 10:43:05\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.236\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia of chronic disease\n- Dupuytren's disease of palm\n- Transplanted kidney present\n- End-stage renal disease\n- Nephrotic syndrome\n- Acquired renal cystic disease\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Renal disorder due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-15 10:34:51, ended at 2015-11-15 11:25:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Renal disorder due to type 2 diabetes mellitus\n- Contracture of joint of hand\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid va..., through Intramuscular route, started on 2015-11-15, presumably until 2015-11-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-14 08:58:00, ended at 2015-12-14 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- MCV [Entitic volume] by Automated count: 78.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 13.31 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.48 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.7 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 989 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 238 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-19 09:02:32, ended at 2015-12-19 09:37:10\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Dupuytren's disease of palm\n- Renal hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Chronic kidney disease\n- Disorder of kidney and/or ureter\n- Disorder of lung\n- Failed renal transplant\n- Contracture of joint of hand\n- Hyperparathyroidism due to renal insufficiency\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- End-stage renal disease\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-02 00:00:00, ended at 2016-01-02 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-31 06:59:00, ended at 2016-01-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 204 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 95 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1541 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.88 (milligram per milligram)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.3 (percent)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 155.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.72 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-31 12:39:47, ended at 2016-01-31 15:24:19\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-14 09:30:52, ended at 2016-02-14 10:37:55\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Solitary nodule of lung\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 09:00:00, ended at 2016-02-19 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 129.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.89 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1224 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 75.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.47 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.99 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of ischemic_stroke means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c8ee45243a225287597a35ea571ac01271121eb2a26ab770d2c90aa6e46db81b", "prompt_hash": "5f722983cf3818738a1b9ed83c8bca19e22043a176986fbd66430623b80b00b1", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 0.0, "f1_gu_yn": [0, 1], "recall_gu_yn": [0, 1]}
{"doc_id": 3, "doc": {"person_id": 115969842, "visit_occurrence_id": 59369756, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2014-01-17 00:00:00", "visit_end_datetime": "2014-01-17 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-17 00:00:00, ended at 2014-01-17 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2014-01-17, presumably until 2014-05-02, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY AT BEDTIME\n\n", "approximate_token_count": 120, "patient_first_visit_date": "2009-01-08 00:00:00", "patient_last_visit_date": "2023-02-08 00:00:00", "end_obs_date": "2015-01-17", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 1, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 75, "cumulated_visit_num": 75, "cumulated_approximate_token_count": 19240, "visit_cumulated": "## Visit\nThis visit record, was from Pharmacy visit, started at 2009-01-08 00:00:00, ended at 2009-01-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-22 12:55:31, ended at 2009-11-22 17:40:53\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-29 09:44:00, ended at 2009-11-29 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 119 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.4 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-30 09:30:00, ended at 2009-12-30 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; complete study\n\n### Condition\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-03 00:00:00, ended at 2010-01-03 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-01-04 00:00:00, ended at 2010-01-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-26 11:20:22, ended at 2010-01-26 15:28:03\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-01-26 13:39:00, ended at 2010-01-26 20:14:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.47 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Disorder of cardiovascular system\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-28 00:00:00, ended at 2010-01-28 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cyanosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-28 08:19:58, ended at 2010-01-28 09:43:49\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-28 09:51:00, ended at 2010-01-28 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-11 14:17:57, ended at 2010-02-11 14:42:27\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-23 08:56:07, ended at 2010-11-23 11:57:55\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Visual disturbance\n- Hyperlipidemia\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., through Subcutaneous route, started on 2010-11-23, presumably until 2010-11-24, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.5 mL by SUBCUTANEOUS route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-23 10:21:00, ended at 2010-11-23 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 104 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-28 13:16:40, ended at 2010-12-28 13:55:25\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-02 09:54:08, ended at 2011-01-02 10:38:28\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-28 10:53:15, ended at 2011-02-28 13:13:17\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-07-28 00:00:00, ended at 2011-07-28 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-04 22:20:00, ended at 2011-08-05 03:26:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.03 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- MCH [Entitic mass] by Automated count: 36.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Hyperlipidemia\n- Dizziness and giddiness\n- Nuclear senile cataract\n- Essential hypertension\n- Gastroesophageal reflux disease\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- meclizine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-05 10:45:10, ended at 2011-09-05 11:33:54\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Right lower quadrant pain\n- Diarrhea\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2011-09-05, presumably until 2011-10-30, with intended 0 refill(s). Instructions: take 420 g by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Deficiency anemias\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-20 08:40:00, ended at 2011-09-20 12:30:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.04 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 455 (picogram per milliliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Colonoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopic biopsy of large intestine\n\n### Condition\n- Right lower quadrant pain\n- Deficiency anemias\n- Diarrhea\n- Disorder of intestine\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n- midazolam 1 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-10-21 21:47:00, ended at 2011-10-22 00:08:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 36.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.8 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Essential hypertension\n- Nausea and vomiting\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n- Chest pain\n- Dizziness and giddiness\n- Disorder of function of stomach\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-10-21, presumably until 2011-10-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-30 11:03:49, ended at 2011-10-30 11:52:44\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Irritable bowel syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-11-07 00:00:00, ended at 2011-11-07 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-21 08:54:05, ended at 2011-11-21 10:26:50\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2012-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2013-02-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-21 10:44:00, ended at 2011-11-21 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 123 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.8 (ratio)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 343 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Disorder of hematopoietic structure\n- Benign paroxysmal positional vertigo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-11-27 00:00:00, ended at 2011-11-27 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Vitamin D deficiency\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2011-11-27, presumably until 2012-06-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 7 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-12 09:22:22, ended at 2011-12-12 16:14:17\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Epidemic vertigo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-12 10:36:00, ended at 2011-12-12 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Homocysteine [Moles/volume] in Serum or Plasma: 9.7 (micromole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Epidemic vertigo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-20 09:47:02, ended at 2011-12-20 10:51:57\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Vitamin D deficiency\n- Epidemic vertigo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-04 10:53:00, ended at 2012-01-04 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Irritable bowel syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-21 08:54:35, ended at 2012-06-21 10:07:38\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Vitamin D deficiency\n\n### Drug\n- 0.65 ML varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection, through Subcutaneous route, started on 2012-06-21, presumably until 2012-06-22, with intended 0 refill(s). Instructions: inject 0.65 mL subcutaneous (under the skin) One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-21 11:11:00, ended at 2012-06-21 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: 5 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 26 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Vitamin D deficiency\n- Irritable bowel syndrome\n- Cataract\n- Disorder of hematopoietic structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-25 15:58:09, ended at 2012-09-25 16:58:48\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.25\" (inch (US))\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Visual disturbance\n- Transient cerebral ischemia\n- Malaise\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-09-25 17:29:00, ended at 2012-09-27 19:46:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Body height: 5' 5\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.5 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.41 (milli-international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 36.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 5.57 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 25.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 93 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Erythrocyte sedimentation rate: 14 (millimeter per hour)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Prothrombin time (PT): 13.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 307 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n\n### Procedure\n- Physical therapy evaluation\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Radiologic examination, chest; single view, frontal\n- Magnetic resonance angiography, head; without contrast material(s)\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Computed tomography, head or brain; without contrast material\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- General examination of patient\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Echocardiography\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination \n\n### Condition\n- Epidemic vertigo\n- Nuclear senile cataract\n- Ostium secundum type atrial septal defect\n- Acute tonsillitis\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Gastroesophageal reflux disease\n- Muscle weakness\n- Transient cerebral ischemia\n- Acute cerebrovascular insufficiency\n- Irritable bowel syndrome\n- Altered sensation of skin\n- Essential hypertension\n- Malaise\n- Cerebral infarction due to embolism of cerebral arteries\n- Abnormal glucose level\n- Disorder of carotid artery\n- Hyperlipidemia\n- Musculoskeletal symptom\n- Presbyopia\n- Visual disturbance\n- Vitamin D deficiency\n- Tear film insufficiency\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2012-09-26, presumably until 2012-09-26\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2012-09-27, presumably until 2012-09-27\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2012-09-26, presumably until 2012-10-24, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-09-26, presumably until 2012-09-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-09-27, presumably until 2012-09-27\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2012-09-26, presumably until 2012-09-27\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2012-09-26, presumably until 2012-09-27\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2012-09-26, presumably until 2012-10-24, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- midazolam 1 MG/ML Injectable Solution, started on 2012-09-27, presumably until 2012-09-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-26 08:28:00, ended at 2012-09-26 11:36:48\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transient cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-27 15:00:00, ended at 2012-09-27 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Cerebral infarction due to embolism of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-04 10:35:16, ended at 2012-10-04 11:11:23\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-23 12:03:00, ended at 2012-10-23 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 53 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 62 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-24 12:59:59, ended at 2012-10-24 14:06:31\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2012-10-24, presumably until 2013-07-01, with intended 4 refill(s). Instructions: take 2 Tabs by mouth daily. Take one 80mg tablet po qPM\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2012-10-24, presumably until 2013-03-27, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-19 11:20:00, ended at 2012-11-19 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Cerebrovascular disease\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-19 15:14:43, ended at 2012-11-19 16:27:50\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.386\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-20 10:00:42, ended at 2012-12-20 12:37:47\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.15\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-20 10:45:00, ended at 2012-12-20 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 52 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 36.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 57 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.8 (percent)\n- MCV [Entitic volume] by Automated count: 104.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.58 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.06 (milli-international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-07 13:12:00, ended at 2013-01-07 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Transient cerebral ischemia\n- Hyperlipidemia\n- Abnormal glucose level\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Essential hypertension\n- Disorder of artery\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-07 14:40:20, ended at 2013-01-07 17:51:10\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Disorder of artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-01-09 00:00:00, ended at 2013-01-09 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-03 11:17:33, ended at 2013-02-03 16:51:49\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.15\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Disorder of carotid artery\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-02-06 00:00:00, ended at 2013-02-06 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2013-02-06, presumably until 2013-07-01, with intended 2 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-11 00:00:00, ended at 2013-02-11 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-03-25 13:49:10, ended at 2013-03-25 14:49:49\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-03-26 00:00:00, ended at 2013-03-26 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for procedures on major vessels of neck; not otherwise specified\n\n### Condition\n- Cerebrovascular disease\n- Disorder of carotid artery\n- Cerebral infarction\n\n### Drug\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2013-03-26, presumably until 2013-03-26\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-03-26, presumably until 2013-03-26\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- remifentanil 2 MG Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-03-26, presumably until 2013-03-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- midazolam 1 MG/ML Injectable Solution, started on 2013-03-26, presumably until 2013-03-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-03-26 00:00:00, ended at 2013-03-26 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- epinephrine 0.005 MG/ML / lidocaine hydrochloride 5 MG/ML Injectable Solution, started on 2013-03-26, presumably until 2013-03-26\n- bacitracin 5000 UNT/ML Injectable Solution, through Intramuscular route, started on 2013-03-26, presumably until 2013-03-26\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-03-26, presumably until 2013-03-26\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2013-03-26, presumably until 2013-03-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-03-26 05:28:00, ended at 2013-03-27 13:05:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.1 (percent)\n- Body height: 5' 4\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.09 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 102.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n\n### Procedure\n- Continuous intraoperative neurophysiology monitoring in the operating room, one on one monitoring requiring personal attendance, each 15 minutes (List separately in addition to code for primary procedure)\n- Electroencephalogram (EEG); recording in coma or sleep only\n- Procedure on single vessel\n- Short-latency somatosensory evoked potential study, stimulation of any/all peripheral nerves or skin sites, recording from the central nervous system; in upper limbs\n- Short-latency somatosensory evoked potential study, stimulation of any/all peripheral nerves or skin sites, recording from the central nervous system; in upper and lower limbs\n- Endarterectomy, other vessels of head and neck\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Disorder of carotid artery\n- Essential hypertension\n- Hyperlipidemia\n- Cataract\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- cefazolin 1000 MG Injection, started on 2013-03-26, presumably until 2013-03-27\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2013-03-26, presumably until 2013-03-26\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-03-27, presumably until 2013-07-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-27\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2013-03-26, presumably until 2013-03-26\n- benzocaine 15 MG / menthol 2.6 MG Oral Lozenge, through Submucosal route, started on 2013-03-27, presumably until 2013-07-01, with intended 0 refill(s). Instructions: 1 Tab by Mucous Membrane route every 6 hours as needed.\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-03-27, presumably until 2013-07-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2013-03-26, presumably until 2013-07-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-28 00:00:00, ended at 2013-03-28 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-03-28 11:25:30, ended at 2013-03-28 16:22:44\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-02 11:01:13, ended at 2013-04-02 15:39:50\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-01 09:27:21, ended at 2013-07-01 10:36:18\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperplasia of prostate\n- Essential hypertension\n- Anemia\n\n### Drug\n- atorvastatin 80 MG Oral Tablet, presumably until 2013-10-29. Instructions: Take 1 tablet by mouth at bedtime.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2013-07-01, presumably until 2013-08-04, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n- olmesartan medoxomil 20 MG Oral Tablet, presumably until 2013-07-16. Instructions: Take 1 tablet by mouth at bedtime.\n- clopidogrel 75 MG Oral Tablet, presumably until 2013-10-29. Instructions: Take 1 tablet by mouth at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-01 10:44:00, ended at 2013-07-01 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 215 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 143 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.2 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Essential hypertension\n- Hyperplasia of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-03 14:01:22, ended at 2013-07-03 15:23:12\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of carotid artery\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-16 12:41:02, ended at 2013-07-16 15:14:36\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-07-16, presumably until 2013-07-17, with intended 3 refill(s). Instructions: take 1.5 Tabs by mouth Every Day. Take 1 tablet by mouth at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-17 00:00:00, ended at 2013-07-17 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-07-17, presumably until 2013-07-24, with intended 3 refill(s). Instructions: take 1.5 Tabs by mouth Every Day. Take 1 tablet by mouth at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-24 00:00:00, ended at 2013-07-24 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-07-24, presumably until 2013-11-26, with intended 3 refill(s). Instructions: take 1.5 Tabs by mouth Every Day. Take 1 tablet by mouth at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-08-04 00:00:00, ended at 2013-08-04 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperplasia of prostate\n- Essential hypertension\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2013-08-04, presumably until 2014-06-15, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-05 00:00:00, ended at 2013-09-05 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-30 14:44:00, ended at 2013-09-30 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Dizziness and giddiness\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-28 00:00:00, ended at 2013-10-28 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- atorvastatin 80 MG Oral Tablet, started on 2013-10-28, presumably until 2014-10-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET EVERY EVENING\n- clopidogrel 75 MG Oral Tablet, started on 2013-10-28, presumably until 2014-10-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-28 00:00:00, ended at 2013-10-28 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2013-10-28, presumably until 2013-10-28, with intended 1 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-26 00:00:00, ended at 2013-11-26 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-11-26, presumably until 2013-11-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-11-26 00:00:00, ended at 2013-11-26 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-11-26, presumably until 2013-11-26, with intended 2 refill(s). Instructions: take 1.5 Tabs by mouth Every Day. Take 1 tablet by mouth at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-26 00:00:00, ended at 2013-11-26 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-11-26, presumably until 2014-01-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-12-31 09:14:16, ended at 2013-12-31 11:02:26\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- General examination of patient\n\n### Condition\n- Hyperlipidemia\n- Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- 0.65 ML varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection, through Subcutaneous route, started on 2013-12-31, presumably until 2014-01-01, with intended 0 refill(s). Instructions: inject 0.65 mL subcutaneous (under the skin) One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-31 11:12:00, ended at 2013-12-31 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 73 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.02 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.05 (milli-international unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 318 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.7 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 85 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Disorder of skin and/or subcutaneous tissue\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-17 00:00:00, ended at 2014-01-17 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2014-01-17, presumably until 2014-05-02, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY AT BEDTIME\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-01-08 00:00:00, ended at 2009-01-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-22 12:55:31, ended at 2009-11-22 17:40:53\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-29 09:44:00, ended at 2009-11-29 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 119 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.4 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-30 09:30:00, ended at 2009-12-30 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; complete study\n\n### Condition\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-03 00:00:00, ended at 2010-01-03 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-01-04 00:00:00, ended at 2010-01-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-26 11:20:22, ended at 2010-01-26 15:28:03\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-01-26 13:39:00, ended at 2010-01-26 20:14:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.47 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Disorder of cardiovascular system\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-28 00:00:00, ended at 2010-01-28 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cyanosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-28 08:19:58, ended at 2010-01-28 09:43:49\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-28 09:51:00, ended at 2010-01-28 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-11 14:17:57, ended at 2010-02-11 14:42:27\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-23 08:56:07, ended at 2010-11-23 11:57:55\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Visual disturbance\n- Hyperlipidemia\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., through Subcutaneous route, started on 2010-11-23, presumably until 2010-11-24, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.5 mL by SUBCUTANEOUS route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-23 10:21:00, ended at 2010-11-23 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 104 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-28 13:16:40, ended at 2010-12-28 13:55:25\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-02 09:54:08, ended at 2011-01-02 10:38:28\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-28 10:53:15, ended at 2011-02-28 13:13:17\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-07-28 00:00:00, ended at 2011-07-28 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-04 22:20:00, ended at 2011-08-05 03:26:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.03 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- MCH [Entitic mass] by Automated count: 36.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Hyperlipidemia\n- Dizziness and giddiness\n- Nuclear senile cataract\n- Essential hypertension\n- Gastroesophageal reflux disease\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- meclizine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-05 10:45:10, ended at 2011-09-05 11:33:54\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Right lower quadrant pain\n- Diarrhea\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2011-09-05, presumably until 2011-10-30, with intended 0 refill(s). Instructions: take 420 g by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Deficiency anemias\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-20 08:40:00, ended at 2011-09-20 12:30:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.04 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 455 (picogram per milliliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Colonoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopic biopsy of large intestine\n\n### Condition\n- Right lower quadrant pain\n- Deficiency anemias\n- Diarrhea\n- Disorder of intestine\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n- midazolam 1 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-10-21 21:47:00, ended at 2011-10-22 00:08:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 36.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.8 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Essential hypertension\n- Nausea and vomiting\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n- Chest pain\n- Dizziness and giddiness\n- Disorder of function of stomach\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-10-21, presumably until 2011-10-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-30 11:03:49, ended at 2011-10-30 11:52:44\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Irritable bowel syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-11-07 00:00:00, ended at 2011-11-07 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-21 08:54:05, ended at 2011-11-21 10:26:50\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2012-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2013-02-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-21 10:44:00, ended at 2011-11-21 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 123 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.8 (ratio)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 343 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Disorder of hematopoietic structure\n- Benign paroxysmal positional vertigo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-11-27 00:00:00, ended at 2011-11-27 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Vitamin D deficiency\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2011-11-27, presumably until 2012-06-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 7 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-12 09:22:22, ended at 2011-12-12 16:14:17\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Epidemic vertigo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-12 10:36:00, ended at 2011-12-12 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Homocysteine [Moles/volume] in Serum or Plasma: 9.7 (micromole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Epidemic vertigo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-20 09:47:02, ended at 2011-12-20 10:51:57\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Vitamin D deficiency\n- Epidemic vertigo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-04 10:53:00, ended at 2012-01-04 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Irritable bowel syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-21 08:54:35, ended at 2012-06-21 10:07:38\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Vitamin D deficiency\n\n### Drug\n- 0.65 ML varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection, through Subcutaneous route, started on 2012-06-21, presumably until 2012-06-22, with intended 0 refill(s). Instructions: inject 0.65 mL subcutaneous (under the skin) One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-21 11:11:00, ended at 2012-06-21 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: 5 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 26 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Vitamin D deficiency\n- Irritable bowel syndrome\n- Cataract\n- Disorder of hematopoietic structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-25 15:58:09, ended at 2012-09-25 16:58:48\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.25\" (inch (US))\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Visual disturbance\n- Transient cerebral ischemia\n- Malaise\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-09-25 17:29:00, ended at 2012-09-27 19:46:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Body height: 5' 5\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.5 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.41 (milli-international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 36.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 5.57 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 25.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 93 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Erythrocyte sedimentation rate: 14 (millimeter per hour)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Prothrombin time (PT): 13.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 307 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n\n### Procedure\n- Physical therapy evaluation\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Radiologic examination, chest; single view, frontal\n- Magnetic resonance angiography, head; without contrast material(s)\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Computed tomography, head or brain; without contrast material\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- General examination of patient\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Echocardiography\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination \n\n### Condition\n- Epidemic vertigo\n- Nuclear senile cataract\n- Ostium secundum type atrial septal defect\n- Acute tonsillitis\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Gastroesophageal reflux disease\n- Muscle weakness\n- Transient cerebral ischemia\n- Acute cerebrovascular insufficiency\n- Irritable bowel syndrome\n- Altered sensation of skin\n- Essential hypertension\n- Malaise\n- Cerebral infarction due to embolism of cerebral arteries\n- Abnormal glucose level\n- Disorder of carotid artery\n- Hyperlipidemia\n- Musculoskeletal symptom\n- Presbyopia\n- Visual disturbance\n- Vitamin D deficiency\n- Tear film insufficiency\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2012-09-26, presumably until 2012-09-26\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2012-09-27, presumably until 2012-09-27\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2012-09-26, presumably until 2012-10-24, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-09-26, presumably until 2012-09-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-09-27, presumably until 2012-09-27\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2012-09-26, presumably until 2012-09-27\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2012-09-26, presumably until 2012-09-27\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2012-09-26, presumably until 2012-10-24, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- midazolam 1 MG/ML Injectable Solution, started on 2012-09-27, presumably until 2012-09-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-26 08:28:00, ended at 2012-09-26 11:36:48\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transient cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-27 15:00:00, ended at 2012-09-27 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Cerebral infarction due to embolism of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-04 10:35:16, ended at 2012-10-04 11:11:23\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-23 12:03:00, ended at 2012-10-23 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 53 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 62 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-24 12:59:59, ended at 2012-10-24 14:06:31\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2012-10-24, presumably until 2013-07-01, with intended 4 refill(s). Instructions: take 2 Tabs by mouth daily. Take one 80mg tablet po qPM\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2012-10-24, presumably until 2013-03-27, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-19 11:20:00, ended at 2012-11-19 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Cerebrovascular disease\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-19 15:14:43, ended at 2012-11-19 16:27:50\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.386\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-20 10:00:42, ended at 2012-12-20 12:37:47\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.15\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-20 10:45:00, ended at 2012-12-20 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 52 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 36.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 57 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.8 (percent)\n- MCV [Entitic volume] by Automated count: 104.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.58 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.06 (milli-international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-07 13:12:00, ended at 2013-01-07 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Transient cerebral ischemia\n- Hyperlipidemia\n- Abnormal glucose level\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Essential hypertension\n- Disorder of artery\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-07 14:40:20, ended at 2013-01-07 17:51:10\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Disorder of artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-01-09 00:00:00, ended at 2013-01-09 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-03 11:17:33, ended at 2013-02-03 16:51:49\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.15\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Disorder of carotid artery\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-02-06 00:00:00, ended at 2013-02-06 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2013-02-06, presumably until 2013-07-01, with intended 2 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-11 00:00:00, ended at 2013-02-11 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-03-25 13:49:10, ended at 2013-03-25 14:49:49\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-03-26 00:00:00, ended at 2013-03-26 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for procedures on major vessels of neck; not otherwise specified\n\n### Condition\n- Cerebrovascular disease\n- Disorder of carotid artery\n- Cerebral infarction\n\n### Drug\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2013-03-26, presumably until 2013-03-26\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-03-26, presumably until 2013-03-26\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- remifentanil 2 MG Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-03-26, presumably until 2013-03-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- midazolam 1 MG/ML Injectable Solution, started on 2013-03-26, presumably until 2013-03-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-03-26 00:00:00, ended at 2013-03-26 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- epinephrine 0.005 MG/ML / lidocaine hydrochloride 5 MG/ML Injectable Solution, started on 2013-03-26, presumably until 2013-03-26\n- bacitracin 5000 UNT/ML Injectable Solution, through Intramuscular route, started on 2013-03-26, presumably until 2013-03-26\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-03-26, presumably until 2013-03-26\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2013-03-26, presumably until 2013-03-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-03-26 05:28:00, ended at 2013-03-27 13:05:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.1 (percent)\n- Body height: 5' 4\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.09 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 102.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n\n### Procedure\n- Continuous intraoperative neurophysiology monitoring in the operating room, one on one monitoring requiring personal attendance, each 15 minutes (List separately in addition to code for primary procedure)\n- Electroencephalogram (EEG); recording in coma or sleep only\n- Procedure on single vessel\n- Short-latency somatosensory evoked potential study, stimulation of any/all peripheral nerves or skin sites, recording from the central nervous system; in upper limbs\n- Short-latency somatosensory evoked potential study, stimulation of any/all peripheral nerves or skin sites, recording from the central nervous system; in upper and lower limbs\n- Endarterectomy, other vessels of head and neck\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Disorder of carotid artery\n- Essential hypertension\n- Hyperlipidemia\n- Cataract\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- cefazolin 1000 MG Injection, started on 2013-03-26, presumably until 2013-03-27\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2013-03-26, presumably until 2013-03-26\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-03-27, presumably until 2013-07-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-26\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-03-26, presumably until 2013-03-27\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2013-03-26, presumably until 2013-03-26\n- benzocaine 15 MG / menthol 2.6 MG Oral Lozenge, through Submucosal route, started on 2013-03-27, presumably until 2013-07-01, with intended 0 refill(s). Instructions: 1 Tab by Mucous Membrane route every 6 hours as needed.\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-03-27, presumably until 2013-07-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2013-03-26, presumably until 2013-07-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-28 00:00:00, ended at 2013-03-28 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-03-28 11:25:30, ended at 2013-03-28 16:22:44\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-02 11:01:13, ended at 2013-04-02 15:39:50\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-01 09:27:21, ended at 2013-07-01 10:36:18\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperplasia of prostate\n- Essential hypertension\n- Anemia\n\n### Drug\n- atorvastatin 80 MG Oral Tablet, presumably until 2013-10-29. Instructions: Take 1 tablet by mouth at bedtime.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2013-07-01, presumably until 2013-08-04, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n- olmesartan medoxomil 20 MG Oral Tablet, presumably until 2013-07-16. Instructions: Take 1 tablet by mouth at bedtime.\n- clopidogrel 75 MG Oral Tablet, presumably until 2013-10-29. Instructions: Take 1 tablet by mouth at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-01 10:44:00, ended at 2013-07-01 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 215 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 143 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.2 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Essential hypertension\n- Hyperplasia of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-03 14:01:22, ended at 2013-07-03 15:23:12\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of carotid artery\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-16 12:41:02, ended at 2013-07-16 15:14:36\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-07-16, presumably until 2013-07-17, with intended 3 refill(s). Instructions: take 1.5 Tabs by mouth Every Day. Take 1 tablet by mouth at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-17 00:00:00, ended at 2013-07-17 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-07-17, presumably until 2013-07-24, with intended 3 refill(s). Instructions: take 1.5 Tabs by mouth Every Day. Take 1 tablet by mouth at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-24 00:00:00, ended at 2013-07-24 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-07-24, presumably until 2013-11-26, with intended 3 refill(s). Instructions: take 1.5 Tabs by mouth Every Day. Take 1 tablet by mouth at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-08-04 00:00:00, ended at 2013-08-04 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperplasia of prostate\n- Essential hypertension\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2013-08-04, presumably until 2014-06-15, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-05 00:00:00, ended at 2013-09-05 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-30 14:44:00, ended at 2013-09-30 23:59:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Dizziness and giddiness\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-28 00:00:00, ended at 2013-10-28 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- atorvastatin 80 MG Oral Tablet, started on 2013-10-28, presumably until 2014-10-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET EVERY EVENING\n- clopidogrel 75 MG Oral Tablet, started on 2013-10-28, presumably until 2014-10-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-28 00:00:00, ended at 2013-10-28 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2013-10-28, presumably until 2013-10-28, with intended 1 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-26 00:00:00, ended at 2013-11-26 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-11-26, presumably until 2013-11-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-11-26 00:00:00, ended at 2013-11-26 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-11-26, presumably until 2013-11-26, with intended 2 refill(s). Instructions: take 1.5 Tabs by mouth Every Day. Take 1 tablet by mouth at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-26 00:00:00, ended at 2013-11-26 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2013-11-26, presumably until 2014-01-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-12-31 09:14:16, ended at 2013-12-31 11:02:26\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- General examination of patient\n\n### Condition\n- Hyperlipidemia\n- Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- 0.65 ML varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection, through Subcutaneous route, started on 2013-12-31, presumably until 2014-01-01, with intended 0 refill(s). Instructions: inject 0.65 mL subcutaneous (under the skin) One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-31 11:12:00, ended at 2013-12-31 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 73 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.02 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.05 (milli-international unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 318 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.7 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 85 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Disorder of skin and/or subcutaneous tissue\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-17 00:00:00, ended at 2014-01-17 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2014-01-17, presumably until 2014-05-02, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY AT BEDTIME\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of ischemic_stroke means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "9ada994ee68efc313e0e9379fb7c93f93b31e69118a7a86791f60322b03b72eb", "prompt_hash": "85adaaf55bf5e7fee09575bf6780195bb0ba3f9a708ba125201c53a6998c8227", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 1.0, "f1_gu_yn": [1, 1], "recall_gu_yn": [1, 1]}
{"doc_id": 4, "doc": {"person_id": 115968113, "visit_occurrence_id": 162048724, "death_date": "2021-01-11", "visit_concept_name": "Emergency Room Visit", "visit_start_datetime": "2020-08-23 11:01:00", "visit_end_datetime": "2020-08-23 18:55:00", "visit_length_in_hours": 7.9, "integrated_visit_record": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2020-08-23 11:01:00, ended at 2020-08-23 18:55:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ammonia [Mass/volume] in Plasma: <10 (micromole per liter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 214 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.76 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Base excess in Blood by calculation: -4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 747 (picogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.67 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.030 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.2 (percent)\n- Glucose [Mass/volume] in Blood: 206 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 213 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Radiologic examination, chest; single view\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Hyperlipidemia\n- Primary diagnosis: Nausea and vomiting\n- Type 2 diabetes mellitus\n- Atrial fibrillation\n- Atrial flutter\n- Dizziness and giddiness\n- Electrocardiogram abnormal\n- Altered mental status\n- Heart failure\n- Chronic kidney disease\n- Disorientated\n- Vomiting\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 1168, "patient_first_visit_date": "2010-10-02 23:23:00", "patient_last_visit_date": "2021-01-03 01:38:00", "end_obs_date": "2021-01-11", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 1, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 19, "cumulated_visit_num": 19, "cumulated_approximate_token_count": 14893, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-10-02 23:23:00, ended at 2010-10-05 16:45:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Osmolality of Serum or Plasma: 317 (milliosmole per kilogram)\n- Platelets [#/volume] in Blood by Automated count: 203 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.7 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Body height: 5' 9\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.19 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 487 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.44 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 12.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 394 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 956 (microgram of fibrinogen equivalent unit per milliliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 86.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 109 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n\n### Procedure\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Radiologic examination, ankle; complete, minimum of 3 views\n- Application of splint\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination; tibia and fibula, 2 views\n- Application of short leg splint\n\n### Condition\n- Abnormal glucose level\n- Hematopoietic system finding\n- Closed fracture of upper end of fibula\n- Disturbance of consciousness\n- Syncope and collapse\n- Tachycardia\n- Leukocytosis\n- Acute subendocardial infarction\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-10-05, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-10-03, presumably until 2010-10-05\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-10-03, presumably until 2010-10-03\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-10-05, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n- glipizide 5 MG Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-10-05, with quantity of 60.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day before meals. \n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2010-10-03, presumably until 2010-10-05\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2010-10-03, presumably until 2010-10-03\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2010-10-03, presumably until 2010-10-05\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2010-10-03, presumably until 2011-10-05, with quantity of 30.0, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast. \n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-10-05, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-10-03, presumably until 2010-10-03\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-09-21, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals. \n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2010-10-05, presumably until 2011-10-05, with quantity of 10.0, with intended 0 refill(s). Instructions: take 4 Tabs by mouth as needed For hypoglycemia \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-10-04 16:16:30, ended at 2010-10-04 16:48:02\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Precordial pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-10-28 00:00:00, ended at 2010-10-28 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Closed fracture of upper end of fibula\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-09-20 22:31:00, ended at 2011-09-21 20:02:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 2.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Blood: 2.9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.86 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- Body height: 5' 9\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.68 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 46 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 398 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 11.0 (percent)\n- Prothrombin time (PT): 13.2 (second)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Computed tomography, head or brain; without contrast material\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view, frontal\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Diabetic - poor control\n- Coronary atherosclerosis\n- Disorder of phosphorus metabolism\n- Lung field abnormal\n- Malaise\n- Right bundle branch block\n- Diabetes mellitus without complication\n- Hypokalemia\n- Type 2 diabetes mellitus without complication\n- Old myocardial infarction\n- Seizure\n- Abnormal glucose level\n- Syncope and collapse\n- Disorder of the peripheral nervous system\n\n### Drug\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-09-21, presumably until 2011-09-21\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-09-21, presumably until 2011-09-21\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-09-21, presumably until 2011-09-21\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-09-20, presumably until 2011-09-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-08-26 15:17:20, ended at 2012-08-26 17:20:59\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n- Intraocular pressure of left eye: 16 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Diabetes mellitus without complication\n- Diabetic - poor control\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-25 15:43:11, ended at 2013-08-25 17:15:42\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n- Intraocular pressure of left eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diabetes mellitus without complication\n- Primary diagnosis: Diabetic - poor control\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-28 13:40:17, ended at 2013-08-28 14:56:03\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diabetic - poor control\n- Primary diagnosis: Nuclear senile cataract\n- Diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-18 17:30:28, ended at 2014-09-18 17:30:56\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 18 (millimeter mercury column)\n- Intraocular pressure of right eye: 19 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Epiretinal membrane\n- Diabetes mellitus without complication\n- Diabetic - poor control\n- Primary diagnosis: Mild nonproliferative retinopathy due to diabetes mellitus\n- Disorder of eye due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-17 14:59:05, ended at 2015-09-17 15:44:51\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Diabetes mellitus without complication\n- Disorder of eye due to diabetes mellitus\n- Diabetic - poor control\n- Epiretinal membrane\n- Primary diagnosis: Mild nonproliferative retinopathy due to diabetes mellitus\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-03-06 13:55:00, ended at 2017-03-20 15:41:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: <1.0 (gram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 48.5 (millimeter mercury column)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: <1 (per microliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 1 (per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 95 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 35.7 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 43.4 (millimeter mercury column)\n- Cortisol [Mass/volume] in Serum or Plasma: 25.0 (microgram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 793 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.6 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 16.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Blood: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Cerebral spinal fluid: 110 (milligram per deciliter)\n- Thrombin time: 16.6 (second)\n- Body height: 5' 5\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 115 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Lactate [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 18.36 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 14.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Insulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA): <0.4 (unit per milliliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 23 (percent)\n- Ammonia [Mass/volume] in Plasma: 28 (micromole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 37 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 322.9 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood: 47 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Salicylates [Presence] in Urine: <10 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 16.3 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.9 (second)\n- Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay: <5 (international unit per milliliter)\n- Islet cell 512 Ab [Units/volume] in Serum: <0.8 (unit per milliliter)\n- Lactate [Moles/volume] in Blood: 4.4 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.95 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.75 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 6331 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: <20 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 88.6 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 397 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 146 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 151 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Base excess in Arterial blood by calculation: 9.0 (millimole per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: 1.21 (millimole per liter)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 21 (microgram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.95 (thousand per microliter)\n\n### Procedure\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Arterial puncture, withdrawal of blood for diagnosis\n- Radiologic examination, abdomen; single anteroposterior view\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Computed tomography, head or brain; without contrast material\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Evaluation of oral and pharyngeal swallowing function\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Flexible endoscopic evaluation of swallowing by cine or video recording\n- Controlled ventilation procedure and therapy, initiation and management\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Respiratory Ventilation, Greater than 96 Consecutive Hours\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Hospital discharge day management; 30 minutes or less\n- Performance of Cardiac Output, Single, Manual\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Insertion of Endotracheal Airway into Trachea, Via Natural or Artificial Opening\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Ultrasound, chest (includes mediastinum), real time with image documentation\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Intubation, endotracheal, emergency procedure\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Monitoring of Central Nervous Electrical Activity, External Approach\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drainage of Spinal Canal, Percutaneous Approach, Diagnostic\n\n### Condition\n- Bifascicular block\n- Delirium\n- Diabetic ketoacidosis without coma\n- Minimal cognitive impairment\n- Otitis externa\n- Retention of urine\n- Bacteremia\n- Diabetes mellitus\n- Gastrointestinal hemorrhage\n- Hypoxemia\n- Acute renal failure syndrome\n- Mixed acid-base balance disorder\n- Pneumonitis due to inhaled substance\n- Upper respiratory tract infection due to Influenza\n- Ventricular fibrillation\n- Abnormal findings on diagnostic imaging of lung\n- Acute hypoxemic respiratory failure\n- Atherosclerosis of coronary artery without angina pectoris\n- Dependence on respirator\n- Electrocardiogram abnormal\n- Hypoglycemia\n- Ketoacidotic coma due to diabetes mellitus\n- Mental alertness - finding\n- Elevated level of transaminase and lactic acid dehydrogenase\n- First degree atrioventricular block\n- Hyperglycemia\n- Pleural effusion\n- Respiratory failure\n- Right bundle branch block\n- Old myocardial infarction\n- Pneumonia\n- Pneumonia due to methicillin susceptible Staphylococcus aureus\n- Sepsis due to Streptococcus pneumoniae\n- Septic shock\n- Abdominal distension, gaseous\n- Altered mental status\n- Electroencephalogram abnormal\n- Pulmonary embolism\n- Sepsis\n- Acidosis\n- Acute hypercapnic respiratory failure\n- Secondary diabetes mellitus\n\n### Drug\n- benzocaine 15 MG / menthol 3.6 MG Oral Lozenge, through Submucosal route, started on 2017-03-16, presumably until 2017-03-16\n- ofloxacin 3 MG/ML Otic Solution, through Otic route, started on 2017-03-12, presumably until 2017-03-19\n- hydrocortisone 100 MG Injection, started on 2017-03-08, presumably until 2017-03-16\n- vitamin K1 5 MG Oral Tablet, through Oral route, started on 2017-03-09, presumably until 2017-03-11\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2017-03-16, presumably until 2017-03-18\n- thiamine 100 MG Oral Tablet, through Oral route, started on 2017-03-08, presumably until 2017-03-17\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2017-03-07, presumably until 2017-03-07\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-10\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2017-03-12, presumably until 2017-03-17\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-03-07, presumably until 2017-03-15\n- haloperidol 5 MG/ML Injectable Solution, started on 2017-03-10, presumably until 2017-03-16\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-06\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-03-18, presumably until 2018-03-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day before meals\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2017-03-12, presumably until 2017-03-12\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-03-20, presumably until 2017-03-20\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2017-03-07, presumably until 2017-03-16\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-17\n- melatonin 1 MG Oral Tablet, through Oral route, started on 2017-03-14, presumably until 2017-03-15\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2017-03-12, presumably until 2017-03-12\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2017-03-07, presumably until 2017-03-07\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2017-03-06, presumably until 2017-03-17\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-07\n- quetiapine 25 MG Oral Tablet, through Oral route, started on 2017-03-08, presumably until 2017-03-17\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-03-16, presumably until 2017-03-16\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-03-14, presumably until 2018-03-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2017-03-19, presumably until 2019-10-09, with intended 0 refill(s). Instructions: take 30 mL by mouth daily as needed (constipation)\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-03-07, presumably until 2017-06-29, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 2 times a day with meals\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-03-08, presumably until 2017-03-13\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-03-07, presumably until 2017-03-20\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2017-03-09, presumably until 2017-03-17\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2017-03-13, presumably until 2017-06-29, with intended 0 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2017-03-08, presumably until 2017-03-08\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-03-08, presumably until 2017-03-20\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-03-06, presumably until 2017-03-06\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-10\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-03-06, presumably until 2017-03-06\n- guanfacine 1 MG Oral Tablet, through Oral route, started on 2017-03-12, presumably until 2017-03-17\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-03-16, presumably until 2017-03-16\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-11\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2017-03-08, presumably until 2017-03-16\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-03-16, presumably until 2018-03-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-03-08, presumably until 2017-03-10\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2017-03-15, presumably until 2017-03-15\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2017-03-08, presumably until 2017-03-08\n- oseltamivir 6 MG/ML Oral Suspension, through Oral route, started on 2017-03-08, presumably until 2017-03-14\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-06\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-03-07, presumably until 2017-03-12\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-03-17, presumably until 2017-03-18\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2017-03-11, presumably until 2017-03-11\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-13\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-29 11:39:51, ended at 2017-06-29 12:30:55\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.142\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Primary diagnosis: Complication due to diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2017-04-25, presumably until 2019-10-09, with intended 2 refill(s). Instructions: TK SS  T PO BID WITH THE MORNING AND EVE MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-09 13:54:10, ended at 2019-10-09 16:07:52\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2019-10-02, presumably until 2019-10-02, with intended 1 refill(s). Instructions: take 10 mg by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-09-09, presumably until 2019-12-30, with intended 0 refill(s). Instructions: INJECT 17 UNITS PER DAY OR UTD\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-09-10, presumably until 2019-12-30, with intended 1 refill(s). Instructions: take 100 mg by mouth daily\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-09-10, presumably until 2019-09-10, with intended 1 refill(s). Instructions: take 40 mg by mouth daily\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2019-10-01, presumably until 2019-12-30, with intended 0 refill(s). Instructions: take 75 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-10 06:15:00, ended at 2019-10-10 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-12-23 12:45:00, ended at 2019-12-30 14:36:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.30 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.75 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 239 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.1 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.40 (percent)\n- Body height: 5' 5\" (inch (US))\n- Folate [Mass/volume] in Red Blood Cells: 1768 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 243 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 8.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 17 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 10 (percent)\n- Left ventricular Ejection fraction: 61.6 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.21 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.71 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 75 (percent)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.22 (nanogram per milliliter)\n- Base excess in Arterial blood by calculation: -7.1 (milliequivalent per liter)\n- Creatinine [Mass/volume] in Urine: 76.43 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.93 (million per microliter)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 27.8 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 18.4 (milliequivalent per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 1109 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.40 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood: 21.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.1 (millimole per liter)\n- Sodium/Creatinine [Molar ratio] in Urine: 60 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.041 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocyte sedimentation rate: 71 (millimeter per hour)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 299 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 442 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Reticulocytes [#/volume] in Blood by Automated count: 31.8 (thousand per microliter)\n- Lactate [Moles/volume] in Blood: 1.5 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1170 (picogram per milliliter)\n\n### Procedure\n- Radiologic examination, chest; single view\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Computed tomography, abdomen and pelvis; without contrast material\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Evaluation of oral and pharyngeal swallowing function\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Ultrasound, chest (includes mediastinum), real time with image documentation\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; limited\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Hospital discharge day management; 30 minutes or less\n- Radiologic examination, chest; 2 views\n- Computed tomography, thorax, diagnostic; without contrast material\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n\n### Condition\n- Backache\n- Ventricular premature complex\n- Acute on chronic diastolic heart failure\n- Electrocardiogram abnormal\n- Heart failure\n- Iron deficiency anemia\n- Low back pain\n- Atrial flutter\n- Primary diagnosis: Hypervolemia\n- Atrial fibrillation\n- Retention of urine\n- Torticollis\n- Abnormal findings on diagnostic imaging of lung\n- Chronic pulmonary edema\n- Hypertensive heart failure\n- Hypoxemia\n- Right bundle branch block\n- Suicidal thoughts\n- Abdominal pain\n- Acute renal failure syndrome\n- Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Benign prostatic hyperplasia with outflow obstruction\n- Congestive heart failure\n- Neck pain\n- Hyperlipidemia\n- Pleural effusion\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2019-12-31, presumably until 2020-12-30, with intended 0 refill(s). Instructions: take 1 Tab (325 mg total) by mouth every Monday, Wednesday and Friday\n- menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream, through Topical route, started on 2019-12-25, presumably until 2020-12-29, with intended 0 refill(s). Instructions: by Topical route 3 times a day\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2019-12-23\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth every 8 hours as needed\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2019-12-24\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2019-12-24\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2019-12-23, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 2 Caps (200 mg total) by mouth 2 times a day\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 3 times a day\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2019-12-24\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-12-25, presumably until 2019-12-30\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-12-23, presumably until 2019-12-26\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2019-12-28, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day as needed\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-12-27, presumably until 2019-12-30\n- isosorbide dinitrate 20 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 1 Tab (20 mg total) by mouth 3 times a day before meals\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2019-12-27\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2019-12-25, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 1 Ghafoor (0.4 mg total) by mouth daily\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2019-12-25, presumably until 2019-12-25\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2019-12-25, presumably until 2019-12-29\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2019-12-24, presumably until 2019-12-30\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2019-12-30\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-12-24, presumably until 2019-12-24\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2019-12-30\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2019-12-30, presumably until 2020-12-29, with intended 0 refill(s). Instructions: 1 Spray by Nasal route as needed (nasal congestion)\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2019-12-23, presumably until 2019-12-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-30 00:00:00, ended at 2019-12-30 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- isosorbide dinitrate 20 MG Oral Tablet, started on 2020-03-01, presumably until 2020-03-01, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-14 00:00:00, ended at 2020-03-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2020-03-15, presumably until 2020-03-15, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY 30 MINUTES AFTER THE SAME MEAL EACH DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-09 00:00:00, ended at 2020-08-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2020-08-10, presumably until 2020-08-10, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY 30 MINUTES AFTER THE SAME MEAL EACH DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2020-08-23 11:01:00, ended at 2020-08-23 18:55:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ammonia [Mass/volume] in Plasma: <10 (micromole per liter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 214 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.76 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Base excess in Blood by calculation: -4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 747 (picogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.67 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.030 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.2 (percent)\n- Glucose [Mass/volume] in Blood: 206 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 213 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Radiologic examination, chest; single view\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Hyperlipidemia\n- Primary diagnosis: Nausea and vomiting\n- Type 2 diabetes mellitus\n- Atrial fibrillation\n- Atrial flutter\n- Dizziness and giddiness\n- Electrocardiogram abnormal\n- Altered mental status\n- Heart failure\n- Chronic kidney disease\n- Disorientated\n- Vomiting\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-10-02 23:23:00, ended at 2010-10-05 16:45:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Osmolality of Serum or Plasma: 317 (milliosmole per kilogram)\n- Platelets [#/volume] in Blood by Automated count: 203 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.7 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Body height: 5' 9\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.19 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 487 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.44 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 12.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 394 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 956 (microgram of fibrinogen equivalent unit per milliliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 86.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 109 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n\n### Procedure\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Radiologic examination, ankle; complete, minimum of 3 views\n- Application of splint\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination; tibia and fibula, 2 views\n- Application of short leg splint\n\n### Condition\n- Abnormal glucose level\n- Hematopoietic system finding\n- Closed fracture of upper end of fibula\n- Disturbance of consciousness\n- Syncope and collapse\n- Tachycardia\n- Leukocytosis\n- Acute subendocardial infarction\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-10-05, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-10-03, presumably until 2010-10-05\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-10-03, presumably until 2010-10-03\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-10-05, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n- glipizide 5 MG Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-10-05, with quantity of 60.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day before meals. \n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2010-10-03, presumably until 2010-10-05\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2010-10-03, presumably until 2010-10-03\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2010-10-03, presumably until 2010-10-05\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2010-10-03, presumably until 2011-10-05, with quantity of 30.0, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast. \n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-10-05, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-10-03, presumably until 2010-10-03\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2010-10-05, presumably until 2011-09-21, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals. \n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2010-10-05, presumably until 2011-10-05, with quantity of 10.0, with intended 0 refill(s). Instructions: take 4 Tabs by mouth as needed For hypoglycemia \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-10-04 16:16:30, ended at 2010-10-04 16:48:02\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Precordial pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-10-28 00:00:00, ended at 2010-10-28 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Closed fracture of upper end of fibula\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-09-20 22:31:00, ended at 2011-09-21 20:02:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 2.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Blood: 2.9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.86 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- Body height: 5' 9\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.68 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 46 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 398 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 11.0 (percent)\n- Prothrombin time (PT): 13.2 (second)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Computed tomography, head or brain; without contrast material\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view, frontal\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Diabetic - poor control\n- Coronary atherosclerosis\n- Disorder of phosphorus metabolism\n- Lung field abnormal\n- Malaise\n- Right bundle branch block\n- Diabetes mellitus without complication\n- Hypokalemia\n- Type 2 diabetes mellitus without complication\n- Old myocardial infarction\n- Seizure\n- Abnormal glucose level\n- Syncope and collapse\n- Disorder of the peripheral nervous system\n\n### Drug\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-09-21, presumably until 2011-09-21\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-09-21, presumably until 2011-09-21\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-09-21, presumably until 2011-09-21\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-09-20, presumably until 2011-09-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-08-26 15:17:20, ended at 2012-08-26 17:20:59\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n- Intraocular pressure of left eye: 16 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Diabetes mellitus without complication\n- Diabetic - poor control\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-25 15:43:11, ended at 2013-08-25 17:15:42\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n- Intraocular pressure of left eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diabetes mellitus without complication\n- Primary diagnosis: Diabetic - poor control\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-28 13:40:17, ended at 2013-08-28 14:56:03\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diabetic - poor control\n- Primary diagnosis: Nuclear senile cataract\n- Diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-18 17:30:28, ended at 2014-09-18 17:30:56\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 18 (millimeter mercury column)\n- Intraocular pressure of right eye: 19 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Epiretinal membrane\n- Diabetes mellitus without complication\n- Diabetic - poor control\n- Primary diagnosis: Mild nonproliferative retinopathy due to diabetes mellitus\n- Disorder of eye due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-17 14:59:05, ended at 2015-09-17 15:44:51\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Diabetes mellitus without complication\n- Disorder of eye due to diabetes mellitus\n- Diabetic - poor control\n- Epiretinal membrane\n- Primary diagnosis: Mild nonproliferative retinopathy due to diabetes mellitus\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-03-06 13:55:00, ended at 2017-03-20 15:41:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: <1.0 (gram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 48.5 (millimeter mercury column)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: <1 (per microliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 1 (per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 95 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 35.7 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 43.4 (millimeter mercury column)\n- Cortisol [Mass/volume] in Serum or Plasma: 25.0 (microgram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 793 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.6 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 16.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Blood: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Cerebral spinal fluid: 110 (milligram per deciliter)\n- Thrombin time: 16.6 (second)\n- Body height: 5' 5\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 115 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Lactate [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 18.36 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 14.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Insulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA): <0.4 (unit per milliliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 23 (percent)\n- Ammonia [Mass/volume] in Plasma: 28 (micromole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 37 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 322.9 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood: 47 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Salicylates [Presence] in Urine: <10 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 16.3 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.9 (second)\n- Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay: <5 (international unit per milliliter)\n- Islet cell 512 Ab [Units/volume] in Serum: <0.8 (unit per milliliter)\n- Lactate [Moles/volume] in Blood: 4.4 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.95 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.75 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 6331 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: <20 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 88.6 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 397 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 146 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 151 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Base excess in Arterial blood by calculation: 9.0 (millimole per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: 1.21 (millimole per liter)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 21 (microgram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.95 (thousand per microliter)\n\n### Procedure\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Arterial puncture, withdrawal of blood for diagnosis\n- Radiologic examination, abdomen; single anteroposterior view\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Computed tomography, head or brain; without contrast material\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Evaluation of oral and pharyngeal swallowing function\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Flexible endoscopic evaluation of swallowing by cine or video recording\n- Controlled ventilation procedure and therapy, initiation and management\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Respiratory Ventilation, Greater than 96 Consecutive Hours\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Hospital discharge day management; 30 minutes or less\n- Performance of Cardiac Output, Single, Manual\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Insertion of Endotracheal Airway into Trachea, Via Natural or Artificial Opening\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Ultrasound, chest (includes mediastinum), real time with image documentation\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Intubation, endotracheal, emergency procedure\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Monitoring of Central Nervous Electrical Activity, External Approach\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drainage of Spinal Canal, Percutaneous Approach, Diagnostic\n\n### Condition\n- Bifascicular block\n- Delirium\n- Diabetic ketoacidosis without coma\n- Minimal cognitive impairment\n- Otitis externa\n- Retention of urine\n- Bacteremia\n- Diabetes mellitus\n- Gastrointestinal hemorrhage\n- Hypoxemia\n- Acute renal failure syndrome\n- Mixed acid-base balance disorder\n- Pneumonitis due to inhaled substance\n- Upper respiratory tract infection due to Influenza\n- Ventricular fibrillation\n- Abnormal findings on diagnostic imaging of lung\n- Acute hypoxemic respiratory failure\n- Atherosclerosis of coronary artery without angina pectoris\n- Dependence on respirator\n- Electrocardiogram abnormal\n- Hypoglycemia\n- Ketoacidotic coma due to diabetes mellitus\n- Mental alertness - finding\n- Elevated level of transaminase and lactic acid dehydrogenase\n- First degree atrioventricular block\n- Hyperglycemia\n- Pleural effusion\n- Respiratory failure\n- Right bundle branch block\n- Old myocardial infarction\n- Pneumonia\n- Pneumonia due to methicillin susceptible Staphylococcus aureus\n- Sepsis due to Streptococcus pneumoniae\n- Septic shock\n- Abdominal distension, gaseous\n- Altered mental status\n- Electroencephalogram abnormal\n- Pulmonary embolism\n- Sepsis\n- Acidosis\n- Acute hypercapnic respiratory failure\n- Secondary diabetes mellitus\n\n### Drug\n- benzocaine 15 MG / menthol 3.6 MG Oral Lozenge, through Submucosal route, started on 2017-03-16, presumably until 2017-03-16\n- ofloxacin 3 MG/ML Otic Solution, through Otic route, started on 2017-03-12, presumably until 2017-03-19\n- hydrocortisone 100 MG Injection, started on 2017-03-08, presumably until 2017-03-16\n- vitamin K1 5 MG Oral Tablet, through Oral route, started on 2017-03-09, presumably until 2017-03-11\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2017-03-16, presumably until 2017-03-18\n- thiamine 100 MG Oral Tablet, through Oral route, started on 2017-03-08, presumably until 2017-03-17\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2017-03-07, presumably until 2017-03-07\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-10\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2017-03-12, presumably until 2017-03-17\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-03-07, presumably until 2017-03-15\n- haloperidol 5 MG/ML Injectable Solution, started on 2017-03-10, presumably until 2017-03-16\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-06\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-03-18, presumably until 2018-03-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day before meals\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2017-03-12, presumably until 2017-03-12\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-03-20, presumably until 2017-03-20\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2017-03-07, presumably until 2017-03-16\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-17\n- melatonin 1 MG Oral Tablet, through Oral route, started on 2017-03-14, presumably until 2017-03-15\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2017-03-12, presumably until 2017-03-12\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2017-03-07, presumably until 2017-03-07\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2017-03-06, presumably until 2017-03-17\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-07\n- quetiapine 25 MG Oral Tablet, through Oral route, started on 2017-03-08, presumably until 2017-03-17\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-03-16, presumably until 2017-03-16\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-03-14, presumably until 2018-03-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2017-03-19, presumably until 2019-10-09, with intended 0 refill(s). Instructions: take 30 mL by mouth daily as needed (constipation)\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-03-07, presumably until 2017-06-29, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 2 times a day with meals\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-03-08, presumably until 2017-03-13\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-03-07, presumably until 2017-03-20\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2017-03-09, presumably until 2017-03-17\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2017-03-13, presumably until 2017-06-29, with intended 0 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2017-03-08, presumably until 2017-03-08\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-03-08, presumably until 2017-03-20\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-03-06, presumably until 2017-03-06\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-10\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-03-06, presumably until 2017-03-06\n- guanfacine 1 MG Oral Tablet, through Oral route, started on 2017-03-12, presumably until 2017-03-17\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-03-16, presumably until 2017-03-16\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-11\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2017-03-08, presumably until 2017-03-16\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-03-16, presumably until 2018-03-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-03-08, presumably until 2017-03-10\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2017-03-15, presumably until 2017-03-15\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2017-03-08, presumably until 2017-03-08\n- oseltamivir 6 MG/ML Oral Suspension, through Oral route, started on 2017-03-08, presumably until 2017-03-14\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-06\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-03-07, presumably until 2017-03-12\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-03-17, presumably until 2017-03-18\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2017-03-11, presumably until 2017-03-11\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-13\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-03-06, presumably until 2017-03-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-29 11:39:51, ended at 2017-06-29 12:30:55\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.142\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Primary diagnosis: Complication due to diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2017-04-25, presumably until 2019-10-09, with intended 2 refill(s). Instructions: TK SS  T PO BID WITH THE MORNING AND EVE MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-09 13:54:10, ended at 2019-10-09 16:07:52\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2019-10-02, presumably until 2019-10-02, with intended 1 refill(s). Instructions: take 10 mg by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-09-09, presumably until 2019-12-30, with intended 0 refill(s). Instructions: INJECT 17 UNITS PER DAY OR UTD\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-09-10, presumably until 2019-12-30, with intended 1 refill(s). Instructions: take 100 mg by mouth daily\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-09-10, presumably until 2019-09-10, with intended 1 refill(s). Instructions: take 40 mg by mouth daily\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2019-10-01, presumably until 2019-12-30, with intended 0 refill(s). Instructions: take 75 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-10 06:15:00, ended at 2019-10-10 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-12-23 12:45:00, ended at 2019-12-30 14:36:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.30 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.75 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 239 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.1 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.40 (percent)\n- Body height: 5' 5\" (inch (US))\n- Folate [Mass/volume] in Red Blood Cells: 1768 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 243 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 8.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 17 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 10 (percent)\n- Left ventricular Ejection fraction: 61.6 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.21 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.71 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 75 (percent)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.22 (nanogram per milliliter)\n- Base excess in Arterial blood by calculation: -7.1 (milliequivalent per liter)\n- Creatinine [Mass/volume] in Urine: 76.43 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.93 (million per microliter)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 27.8 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 18.4 (milliequivalent per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 1109 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.40 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood: 21.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.1 (millimole per liter)\n- Sodium/Creatinine [Molar ratio] in Urine: 60 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.041 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocyte sedimentation rate: 71 (millimeter per hour)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 299 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 442 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Reticulocytes [#/volume] in Blood by Automated count: 31.8 (thousand per microliter)\n- Lactate [Moles/volume] in Blood: 1.5 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1170 (picogram per milliliter)\n\n### Procedure\n- Radiologic examination, chest; single view\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Computed tomography, abdomen and pelvis; without contrast material\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Evaluation of oral and pharyngeal swallowing function\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Ultrasound, chest (includes mediastinum), real time with image documentation\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; limited\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Hospital discharge day management; 30 minutes or less\n- Radiologic examination, chest; 2 views\n- Computed tomography, thorax, diagnostic; without contrast material\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n\n### Condition\n- Backache\n- Ventricular premature complex\n- Acute on chronic diastolic heart failure\n- Electrocardiogram abnormal\n- Heart failure\n- Iron deficiency anemia\n- Low back pain\n- Atrial flutter\n- Primary diagnosis: Hypervolemia\n- Atrial fibrillation\n- Retention of urine\n- Torticollis\n- Abnormal findings on diagnostic imaging of lung\n- Chronic pulmonary edema\n- Hypertensive heart failure\n- Hypoxemia\n- Right bundle branch block\n- Suicidal thoughts\n- Abdominal pain\n- Acute renal failure syndrome\n- Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Benign prostatic hyperplasia with outflow obstruction\n- Congestive heart failure\n- Neck pain\n- Hyperlipidemia\n- Pleural effusion\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2019-12-31, presumably until 2020-12-30, with intended 0 refill(s). Instructions: take 1 Tab (325 mg total) by mouth every Monday, Wednesday and Friday\n- menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream, through Topical route, started on 2019-12-25, presumably until 2020-12-29, with intended 0 refill(s). Instructions: by Topical route 3 times a day\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2019-12-23\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth every 8 hours as needed\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2019-12-24\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2019-12-24\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2019-12-23, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 2 Caps (200 mg total) by mouth 2 times a day\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 3 times a day\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2019-12-24\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-12-25, presumably until 2019-12-30\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-12-23, presumably until 2019-12-26\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2019-12-28, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day as needed\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-12-27, presumably until 2019-12-30\n- isosorbide dinitrate 20 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 1 Tab (20 mg total) by mouth 3 times a day before meals\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2019-12-27\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2019-12-25, presumably until 2020-12-29, with intended 0 refill(s). Instructions: take 1 Ghafoor (0.4 mg total) by mouth daily\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2019-12-25, presumably until 2019-12-25\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2019-12-25, presumably until 2019-12-29\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2019-12-24, presumably until 2019-12-30\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2019-12-30\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-12-24, presumably until 2019-12-24\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2019-12-30\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2019-12-30, presumably until 2020-12-29, with intended 0 refill(s). Instructions: 1 Spray by Nasal route as needed (nasal congestion)\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2019-12-23, presumably until 2019-12-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-30 00:00:00, ended at 2019-12-30 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- isosorbide dinitrate 20 MG Oral Tablet, started on 2020-03-01, presumably until 2020-03-01, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-14 00:00:00, ended at 2020-03-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2020-03-15, presumably until 2020-03-15, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY 30 MINUTES AFTER THE SAME MEAL EACH DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-09 00:00:00, ended at 2020-08-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2020-08-10, presumably until 2020-08-10, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY 30 MINUTES AFTER THE SAME MEAL EACH DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2020-08-23 11:01:00, ended at 2020-08-23 18:55:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ammonia [Mass/volume] in Plasma: <10 (micromole per liter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 214 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.76 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Base excess in Blood by calculation: -4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 747 (picogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.67 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.030 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.2 (percent)\n- Glucose [Mass/volume] in Blood: 206 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 213 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Radiologic examination, chest; single view\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Hyperlipidemia\n- Primary diagnosis: Nausea and vomiting\n- Type 2 diabetes mellitus\n- Atrial fibrillation\n- Atrial flutter\n- Dizziness and giddiness\n- Electrocardiogram abnormal\n- Altered mental status\n- Heart failure\n- Chronic kidney disease\n- Disorientated\n- Vomiting\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of ischemic_stroke means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "907d03ba65a1b485297cca13b42476878c8f5de5f484001634df5892065c1e20", "prompt_hash": "18d5f07b52db4671cb6a3493b1f6e2325bd73b3b03a2dcc57e8665e10080f1a3", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 0.0, "f1_gu_yn": [0, 1], "recall_gu_yn": [0, 1]}
{"doc_id": 5, "doc": {"person_id": 115970843, "visit_occurrence_id": 93733570, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2016-11-08 11:00:16", "visit_end_datetime": "2016-11-08 11:52:09", "visit_length_in_hours": 0.8647222222222222, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-08 11:00:16, ended at 2016-11-08 11:52:09\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 104, "patient_first_visit_date": "2014-12-21 10:04:34", "patient_last_visit_date": "2023-01-15 00:00:00", "end_obs_date": "2017-11-08", "hypertension_type": "new", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 1, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 59, "cumulated_visit_num": 59, "cumulated_approximate_token_count": 7658, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2014-12-21 10:04:34, ended at 2014-12-21 11:15:46\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging\n\n### Condition\n- Atrophic vulva\n- Primary diagnosis: Low compliance bladder\n- Mixed urinary incontinence\n- Incomplete emptying of bladder\n\n### Drug\n- topiramate 100 MG Oral Tablet, through Oral route, presumably until 2017-12-04, with intended 0 refill(s). Instructions: take  by mouth 2 times a day.\n- estrogens, conjugated (USP) 0.625 MG/ML Vaginal Cream, through Vaginal route, started on 2014-12-21, presumably until 2017-05-18, with intended 0 refill(s). Instructions: insert 0.5 g into the vagina every 7 days.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2015-05-11, with intended 0 refill(s). Instructions: by Nasal route.\n- aripiprazole 20 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 0.75 Tablets (15 mg total) by mouth\n- simvastatin 20 MG Oral Tablet, through Oral route, presumably until 2017-02-06, with intended 0 refill(s). Instructions: take 20 mg by mouth every bedtime.\n- lisinopril 2.5 MG Oral Tablet, through Oral route, presumably until 2015-07-06, with intended 0 refill(s). Instructions: take 2.5 mg by mouth daily.\n- citalopram 20 MG Oral Tablet, through Oral route, presumably until 2015-07-06, with intended 0 refill(s). Instructions: take  by mouth.\n- amlodipine 2.5 MG Oral Tablet, through Oral route, presumably until 2015-11-16, with intended 0 refill(s). Instructions: take 2.5 mg by mouth daily.\n- citalopram 40 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take  by mouth.\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2019-04-29, with intended 0 refill(s). Instructions: take 81 mg by mouth daily.\n- sitagliptin 100 MG Oral Tablet, through Oral route, presumably until 2022-07-20, with intended 0 refill(s). Instructions: take by mouth every morning with breakfast \n- tolterodine tartrate 1 MG Oral Tablet, through Oral route, started on 2014-12-21, presumably until 2015-02-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-17 00:00:00, ended at 2015-02-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Trauma and postoperative pulmonary insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-22 09:15:49, ended at 2015-02-22 09:51:29\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low compliance bladder\n\n### Drug\n- 24 HR tolterodine tartrate 4 MG Extended Release Oral Capsule, through Oral route, started on 2015-02-22, presumably until 2015-04-15, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-25 14:04:00, ended at 2015-03-25 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 11 - 20 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-29 10:36:44, ended at 2015-03-29 11:47:58\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low compliance bladder\n\n### Drug\n- solifenacin succinate 10 MG Oral Tablet, through Oral route, started on 2015-03-29, presumably until 2015-04-05, with intended 0 refill(s). Instructions: take 5 mg by mouth daily.\n- levofloxacin 500 MG Oral Tablet, through Oral route, presumably until 2015-05-11, with intended 0 refill(s). Instructions: take 500 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-30 10:00:00, ended at 2015-03-30 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] in Arterial blood: 41.6 (millimeter mercury column)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.31 (millimole per liter)\n- Oxygen [Partial pressure] in Arterial blood: 91.4 (millimeter mercury column)\n- Base excess in Arterial blood by calculation: -1.1 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 145 (milligram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 23.5 (millimole per liter)\n\n### Procedure\n- Arterial puncture, withdrawal of blood for diagnosis\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Trauma and postoperative pulmonary insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-30 11:02:16, ended at 2015-03-30 13:07:44\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n- Primary diagnosis: Cough\n- Gastroesophageal reflux disease\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2015-04-01, presumably until 2015-05-31, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-02 00:00:00, ended at 2015-04-02 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- solifenacin succinate 10 MG Oral Tablet, through Oral route, started on 2015-04-05, presumably until 2015-04-15, with intended 0 refill(s). Instructions: take 10 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-06 00:00:00, ended at 2015-04-06 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR oxybutynin chloride 15 MG Extended Release Oral Tablet, through Oral route, started on 2015-04-08, presumably until 2015-04-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-14 00:00:00, ended at 2015-04-14 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oxybutynin chloride 5 MG Oral Tablet, through Oral route, started on 2015-04-19, presumably until 2015-06-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-23 07:43:00, ended at 2015-04-23 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, soft tissue neck; without contrast material\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-23 07:43:00, ended at 2015-04-23 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Lung field abnormal\n- Cough\n- Diaphragmatic hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-11 08:07:03, ended at 2015-05-11 09:32:54\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal breathing\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-05-11, presumably until 2017-12-04, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-31 00:00:00, ended at 2015-05-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2015-06-08, presumably until 2015-06-22, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-15 00:00:00, ended at 2015-06-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Solitary cyst of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-15 10:07:09, ended at 2015-06-15 14:03:16\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.748\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast signs and symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-18 00:00:00, ended at 2015-06-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Primary diagnosis: Breast signs and symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-21 00:00:00, ended at 2015-06-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oxybutynin chloride 5 MG Oral Tablet, started on 2015-06-21, presumably until 2016-02-06, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-22 00:00:00, ended at 2015-06-22 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-22 00:00:00, ended at 2015-06-22 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2015-06-22, presumably until 2015-07-06, with intended 3 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-06 08:30:00, ended at 2015-07-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n\n### Condition\n- Edema\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-06 08:48:26, ended at 2015-07-06 11:59:46\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-21 00:00:00, ended at 2015-07-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on the integumentary system on the extremities, anterior trunk and perineum; not otherwise specified\n\n### Condition\n- Breast signs and symptoms\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2015-07-21, presumably until 2015-07-21\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-07-21, presumably until 2015-07-21\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-07-21, presumably until 2015-07-21\n- midazolam 1 MG/ML Injectable Solution, started on 2015-07-21, presumably until 2015-07-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-07-21 00:00:00, ended at 2015-07-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-07-21, presumably until 2015-07-21\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2015-07-21, presumably until 2015-07-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-21 06:43:00, ended at 2015-07-21 11:29:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 115 (milligram per deciliter)\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Local excision of lesion of breast\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Excision of cyst, fibroadenoma, or other benign or malignant tumor, aberrant breast tissue, duct lesion, nipple or areolar lesion (except 19300), open, male or female, 1 or more lesions\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Polyneuropathy due to diabetes mellitus\n- Mammary duct ectasia\n- Hyperlipidemia\n- Fibrosclerosis of breast\n- Asthma\n- Disorder of nervous system due to diabetes mellitus\n- Breast signs and symptoms\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-07-21, presumably until 2015-07-21\n- promethazine hydrochloride 25 MG Oral Tablet, started on 2015-06-28, presumably until 2015-11-16, with intended 0 refill(s)\n- ondansetron 8 MG Disintegrating Oral Tablet, started on 2015-07-02, presumably until 2017-12-04, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-30 11:49:52, ended at 2015-07-30 14:44:26\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mammary duct ectasia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-16 13:15:41, ended at 2015-11-16 18:41:50\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, started on 2015-11-11, presumably until 2016-02-10, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-16 14:10:00, ended at 2015-11-16 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-24 13:04:00, ended at 2016-01-24 13:04:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Discharge from nipple\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-24 13:05:00, ended at 2016-01-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited\n\n### Condition\n- Mammary duct ectasia of left breast\n- Discharge from nipple\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-25 13:53:44, ended at 2016-01-25 14:21:40\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute cystitis\n- Mixed urinary incontinence\n- Primary diagnosis: Overactive bladder\n- Retention of urine\n\n### Drug\n- phenazopyridine hydrochloride 200 MG Oral Tablet, through Oral route, started on 2016-01-25, presumably until 2016-02-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (Dysuria)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-25 14:29:22, ended at 2016-01-25 15:51:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-02-06 00:00:00, ended at 2016-02-06 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oxybutynin chloride 5 MG Oral Tablet, started on 2016-02-07, presumably until 2016-08-17, with intended 1 refill(s). Instructions: TAKE 3 TABLETS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-10 10:28:55, ended at 2016-02-10 11:32:38\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mixed urinary incontinence\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-11-23, presumably until 2015-11-23, with intended 0 refill(s). Instructions: take 1 Tablet (40 mg total) by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-15 10:25:00, ended at 2016-02-15 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-14 10:05:19, ended at 2016-03-14 11:07:31\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy (separate procedure)\n\n### Condition\n- Overactive bladder\n- Mixed urinary incontinence\n- Retention of urine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-27 12:52:39, ended at 2016-03-27 13:50:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Primary diagnosis: Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-03 12:57:13, ended at 2016-04-03 13:46:25\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-10 13:06:27, ended at 2016-04-10 13:29:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-12 00:00:00, ended at 2016-04-12 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oxybutynin chloride 5 MG Oral Tablet, started on 2016-04-12, presumably until 2016-04-12, with intended 0 refill(s). Instructions: TAKE 3 TABLETS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-19 13:30:00, ended at 2016-04-19 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and/or with contrast material(s); bilateral\n\n### Condition\n- Pain of breast\n- Menopause present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-24 12:46:14, ended at 2016-04-24 13:40:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-01 13:10:38, ended at 2016-05-01 13:40:36\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-08 13:20:59, ended at 2016-05-08 14:02:43\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-15 12:46:27, ended at 2016-05-15 14:04:01\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-29 12:31:45, ended at 2016-05-29 13:19:17\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-15 11:01:37, ended at 2016-06-15 11:35:57\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-19 11:10:22, ended at 2016-06-19 11:58:53\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-26 11:00:25, ended at 2016-06-26 11:52:33\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-03 10:54:03, ended at 2016-07-03 11:48:19\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-08-17 10:15:28, ended at 2016-08-17 10:35:20\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Overactive bladder\n- Mixed urinary incontinence\n\n### Drug\n- 24 HR oxybutynin chloride 15 MG Extended Release Oral Tablet, through Oral route, started on 2016-08-17, presumably until 2016-09-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-24 10:03:04, ended at 2016-08-24 10:48:24\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Primary diagnosis: Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-14 00:00:00, ended at 2016-09-14 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR oxybutynin chloride 15 MG Extended Release Oral Tablet, started on 2016-09-14, presumably until 2016-10-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-16 00:00:00, ended at 2016-09-16 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR oxybutynin chloride 15 MG Extended Release Oral Tablet, started on 2016-09-19, presumably until 2016-09-19, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-05 10:34:39, ended at 2016-10-05 11:34:20\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-16 00:00:00, ended at 2016-10-16 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR oxybutynin chloride 15 MG Extended Release Oral Tablet, started on 2016-10-16, presumably until 2016-11-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-08 11:00:16, ended at 2016-11-08 11:52:09\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-12-21 10:04:34, ended at 2014-12-21 11:15:46\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging\n\n### Condition\n- Atrophic vulva\n- Primary diagnosis: Low compliance bladder\n- Mixed urinary incontinence\n- Incomplete emptying of bladder\n\n### Drug\n- topiramate 100 MG Oral Tablet, through Oral route, presumably until 2017-12-04, with intended 0 refill(s). Instructions: take  by mouth 2 times a day.\n- estrogens, conjugated (USP) 0.625 MG/ML Vaginal Cream, through Vaginal route, started on 2014-12-21, presumably until 2017-05-18, with intended 0 refill(s). Instructions: insert 0.5 g into the vagina every 7 days.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2015-05-11, with intended 0 refill(s). Instructions: by Nasal route.\n- aripiprazole 20 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 0.75 Tablets (15 mg total) by mouth\n- simvastatin 20 MG Oral Tablet, through Oral route, presumably until 2017-02-06, with intended 0 refill(s). Instructions: take 20 mg by mouth every bedtime.\n- lisinopril 2.5 MG Oral Tablet, through Oral route, presumably until 2015-07-06, with intended 0 refill(s). Instructions: take 2.5 mg by mouth daily.\n- citalopram 20 MG Oral Tablet, through Oral route, presumably until 2015-07-06, with intended 0 refill(s). Instructions: take  by mouth.\n- amlodipine 2.5 MG Oral Tablet, through Oral route, presumably until 2015-11-16, with intended 0 refill(s). Instructions: take 2.5 mg by mouth daily.\n- citalopram 40 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take  by mouth.\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2019-04-29, with intended 0 refill(s). Instructions: take 81 mg by mouth daily.\n- sitagliptin 100 MG Oral Tablet, through Oral route, presumably until 2022-07-20, with intended 0 refill(s). Instructions: take by mouth every morning with breakfast \n- tolterodine tartrate 1 MG Oral Tablet, through Oral route, started on 2014-12-21, presumably until 2015-02-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-17 00:00:00, ended at 2015-02-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Trauma and postoperative pulmonary insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-22 09:15:49, ended at 2015-02-22 09:51:29\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low compliance bladder\n\n### Drug\n- 24 HR tolterodine tartrate 4 MG Extended Release Oral Capsule, through Oral route, started on 2015-02-22, presumably until 2015-04-15, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-25 14:04:00, ended at 2015-03-25 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 11 - 20 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-29 10:36:44, ended at 2015-03-29 11:47:58\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low compliance bladder\n\n### Drug\n- solifenacin succinate 10 MG Oral Tablet, through Oral route, started on 2015-03-29, presumably until 2015-04-05, with intended 0 refill(s). Instructions: take 5 mg by mouth daily.\n- levofloxacin 500 MG Oral Tablet, through Oral route, presumably until 2015-05-11, with intended 0 refill(s). Instructions: take 500 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-30 10:00:00, ended at 2015-03-30 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] in Arterial blood: 41.6 (millimeter mercury column)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.31 (millimole per liter)\n- Oxygen [Partial pressure] in Arterial blood: 91.4 (millimeter mercury column)\n- Base excess in Arterial blood by calculation: -1.1 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 145 (milligram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 23.5 (millimole per liter)\n\n### Procedure\n- Arterial puncture, withdrawal of blood for diagnosis\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Trauma and postoperative pulmonary insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-30 11:02:16, ended at 2015-03-30 13:07:44\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n- Primary diagnosis: Cough\n- Gastroesophageal reflux disease\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2015-04-01, presumably until 2015-05-31, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-02 00:00:00, ended at 2015-04-02 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- solifenacin succinate 10 MG Oral Tablet, through Oral route, started on 2015-04-05, presumably until 2015-04-15, with intended 0 refill(s). Instructions: take 10 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-06 00:00:00, ended at 2015-04-06 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR oxybutynin chloride 15 MG Extended Release Oral Tablet, through Oral route, started on 2015-04-08, presumably until 2015-04-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-14 00:00:00, ended at 2015-04-14 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oxybutynin chloride 5 MG Oral Tablet, through Oral route, started on 2015-04-19, presumably until 2015-06-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-23 07:43:00, ended at 2015-04-23 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, soft tissue neck; without contrast material\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-23 07:43:00, ended at 2015-04-23 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Lung field abnormal\n- Cough\n- Diaphragmatic hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-11 08:07:03, ended at 2015-05-11 09:32:54\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal breathing\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-05-11, presumably until 2017-12-04, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-31 00:00:00, ended at 2015-05-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2015-06-08, presumably until 2015-06-22, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-15 00:00:00, ended at 2015-06-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Solitary cyst of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-15 10:07:09, ended at 2015-06-15 14:03:16\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.748\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast signs and symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-18 00:00:00, ended at 2015-06-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Primary diagnosis: Breast signs and symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-21 00:00:00, ended at 2015-06-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oxybutynin chloride 5 MG Oral Tablet, started on 2015-06-21, presumably until 2016-02-06, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-22 00:00:00, ended at 2015-06-22 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-22 00:00:00, ended at 2015-06-22 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2015-06-22, presumably until 2015-07-06, with intended 3 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-06 08:30:00, ended at 2015-07-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n\n### Condition\n- Edema\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-06 08:48:26, ended at 2015-07-06 11:59:46\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-21 00:00:00, ended at 2015-07-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on the integumentary system on the extremities, anterior trunk and perineum; not otherwise specified\n\n### Condition\n- Breast signs and symptoms\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2015-07-21, presumably until 2015-07-21\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-07-21, presumably until 2015-07-21\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-07-21, presumably until 2015-07-21\n- midazolam 1 MG/ML Injectable Solution, started on 2015-07-21, presumably until 2015-07-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-07-21 00:00:00, ended at 2015-07-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-07-21, presumably until 2015-07-21\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2015-07-21, presumably until 2015-07-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-21 06:43:00, ended at 2015-07-21 11:29:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 115 (milligram per deciliter)\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Local excision of lesion of breast\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Excision of cyst, fibroadenoma, or other benign or malignant tumor, aberrant breast tissue, duct lesion, nipple or areolar lesion (except 19300), open, male or female, 1 or more lesions\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Polyneuropathy due to diabetes mellitus\n- Mammary duct ectasia\n- Hyperlipidemia\n- Fibrosclerosis of breast\n- Asthma\n- Disorder of nervous system due to diabetes mellitus\n- Breast signs and symptoms\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-07-21, presumably until 2015-07-21\n- promethazine hydrochloride 25 MG Oral Tablet, started on 2015-06-28, presumably until 2015-11-16, with intended 0 refill(s)\n- ondansetron 8 MG Disintegrating Oral Tablet, started on 2015-07-02, presumably until 2017-12-04, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-30 11:49:52, ended at 2015-07-30 14:44:26\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mammary duct ectasia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-16 13:15:41, ended at 2015-11-16 18:41:50\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, started on 2015-11-11, presumably until 2016-02-10, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-16 14:10:00, ended at 2015-11-16 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-24 13:04:00, ended at 2016-01-24 13:04:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Discharge from nipple\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-24 13:05:00, ended at 2016-01-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited\n\n### Condition\n- Mammary duct ectasia of left breast\n- Discharge from nipple\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-25 13:53:44, ended at 2016-01-25 14:21:40\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute cystitis\n- Mixed urinary incontinence\n- Primary diagnosis: Overactive bladder\n- Retention of urine\n\n### Drug\n- phenazopyridine hydrochloride 200 MG Oral Tablet, through Oral route, started on 2016-01-25, presumably until 2016-02-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (Dysuria)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-25 14:29:22, ended at 2016-01-25 15:51:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-02-06 00:00:00, ended at 2016-02-06 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oxybutynin chloride 5 MG Oral Tablet, started on 2016-02-07, presumably until 2016-08-17, with intended 1 refill(s). Instructions: TAKE 3 TABLETS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-10 10:28:55, ended at 2016-02-10 11:32:38\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mixed urinary incontinence\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-11-23, presumably until 2015-11-23, with intended 0 refill(s). Instructions: take 1 Tablet (40 mg total) by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-15 10:25:00, ended at 2016-02-15 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-14 10:05:19, ended at 2016-03-14 11:07:31\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy (separate procedure)\n\n### Condition\n- Overactive bladder\n- Mixed urinary incontinence\n- Retention of urine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-27 12:52:39, ended at 2016-03-27 13:50:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Primary diagnosis: Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-03 12:57:13, ended at 2016-04-03 13:46:25\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-10 13:06:27, ended at 2016-04-10 13:29:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-12 00:00:00, ended at 2016-04-12 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oxybutynin chloride 5 MG Oral Tablet, started on 2016-04-12, presumably until 2016-04-12, with intended 0 refill(s). Instructions: TAKE 3 TABLETS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-19 13:30:00, ended at 2016-04-19 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and/or with contrast material(s); bilateral\n\n### Condition\n- Pain of breast\n- Menopause present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-24 12:46:14, ended at 2016-04-24 13:40:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-01 13:10:38, ended at 2016-05-01 13:40:36\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-08 13:20:59, ended at 2016-05-08 14:02:43\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-15 12:46:27, ended at 2016-05-15 14:04:01\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-29 12:31:45, ended at 2016-05-29 13:19:17\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-15 11:01:37, ended at 2016-06-15 11:35:57\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-19 11:10:22, ended at 2016-06-19 11:58:53\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-26 11:00:25, ended at 2016-06-26 11:52:33\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-03 10:54:03, ended at 2016-07-03 11:48:19\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-08-17 10:15:28, ended at 2016-08-17 10:35:20\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Overactive bladder\n- Mixed urinary incontinence\n\n### Drug\n- 24 HR oxybutynin chloride 15 MG Extended Release Oral Tablet, through Oral route, started on 2016-08-17, presumably until 2016-09-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-24 10:03:04, ended at 2016-08-24 10:48:24\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Primary diagnosis: Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-14 00:00:00, ended at 2016-09-14 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR oxybutynin chloride 15 MG Extended Release Oral Tablet, started on 2016-09-14, presumably until 2016-10-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-16 00:00:00, ended at 2016-09-16 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR oxybutynin chloride 15 MG Extended Release Oral Tablet, started on 2016-09-19, presumably until 2016-09-19, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-05 10:34:39, ended at 2016-10-05 11:34:20\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-16 00:00:00, ended at 2016-10-16 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR oxybutynin chloride 15 MG Extended Release Oral Tablet, started on 2016-10-16, presumably until 2016-11-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-08 11:00:16, ended at 2016-11-08 11:52:09\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, includes programming\n\n### Condition\n- Overactive bladder\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of ischemic_stroke means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "b04985ebc3270745dcd7093ca416f6c584f748c17853a07ca3fdce5c8e2b6a60", "prompt_hash": "23afd310fa1e84d116a29d12ebda55b3f5e2bc3625b060dad3931fec9e4e6706", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 6, "doc": {"person_id": 115970933, "visit_occurrence_id": 135704990, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2019-04-11 00:00:00", "visit_end_datetime": "2019-04-11 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-11 00:00:00, ended at 2019-04-11 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2019-04-11, presumably until 2020-04-10, with intended 1 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n", "approximate_token_count": 124, "patient_first_visit_date": "2017-05-22 00:00:00", "patient_last_visit_date": "2021-09-29 08:20:32", "end_obs_date": "2020-04-10", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 16, "cumulated_visit_num": 16, "cumulated_approximate_token_count": 9681, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-22 00:00:00, ended at 2017-05-22 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-24 07:34:18, ended at 2017-05-24 08:38:15\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.039\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- atorvastatin 80 MG Oral Tablet, through Oral route, presumably until 2017-07-05, with intended 0 refill(s). Instructions: take 80 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-23 10:22:00, ended at 2017-06-23 23:59:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Cardiomegaly\n- Abnormal findings on diagnostic imaging of lung\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-06-26 00:00:00, ended at 2017-06-26 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Anesthesia for direct coronary artery bypass grafting; with pump oxygenator\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Essential hypertension\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- cefazolin 1000 MG Injection, started on 2017-06-26, presumably until 2017-06-26\n- 50 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-06-26, presumably until 2017-06-26\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2017-06-26, presumably until 2017-06-26\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 6-aminocaproic acid 250 MG/ML Injectable Solution, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- midazolam 1 MG/ML Injectable Solution, started on 2017-06-26, presumably until 2017-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-06-26 00:00:00, ended at 2017-06-26 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 2 ML papaverine hydrochloride 30 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-06-26 06:05:00, ended at 2017-07-05 12:15:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Blood by calculation: 6 (millimole per liter)\n- Lactate [Moles/volume] in Blood: 9.1 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 87 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.0 (millimole per liter)\n- Body height: 5' 5\" (inch (US))\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 40.9 (millimeter mercury column)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Oxygen [Partial pressure] in Arterial blood: 356.0 (millimeter mercury column)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 31.7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.70 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.9 (percent)\n- Lactate [Moles/volume] in Serum or Plasma: 9.1 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 7.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.82 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.86 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 91 (millimeter mercury column)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.9 (nanogram per milliliter)\n- Prothrombin time (PT): 20.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Base excess in Arterial blood by calculation: 7.1 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.28 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.41 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.5 (percent)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.27 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.4 (percent)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Carbon dioxide [Partial pressure] in Arterial blood: 48.1 (millimeter mercury column)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 368 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.9 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 53.0 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n\n### Procedure\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Radiologic examination, chest; single view, frontal\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Performance of Cardiac Output, Continuous\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Restoration of Cardiac Rhythm, Single\n- Bypass Coronary Artery, One Artery from Aorta with Autologous Venous Tissue, Open Approach\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Controlled ventilation procedure and therapy, initiation and management\n- Collection of venous blood by venipuncture\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Bypass Coronary Artery, One Artery from Left Internal Mammary, Open Approach\n- Splitting of blood or blood products, each unit\n- Excision of Lower Vein, Percutaneous Endoscopic Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Atrial fibrillation\n- Chronic kidney disease stage 2\n- Leukocytosis\n- Rheumatic disease of heart valve\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Blood coagulation disorder\n- Pleural effusion\n- Type 2 diabetes mellitus\n- Ventricular premature complex\n- Benign prostatic hyperplasia\n- Postoperative state\n- Acute on chronic systolic heart failure\n- Acute posthemorrhagic anemia\n- Congestive heart failure\n- Generalized ischemic myocardial dysfunction\n- Unstable angina co-occurrent and due to coronary arteriosclerosis\n- Electrocardiogram abnormal\n- Cardiomegaly\n- Disorders of both mitral and tricuspid valves\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Acidosis\n- Chronic pulmonary edema\n- Aortocoronary bypass graft present\n- Atelectasis\n- Complication due to diabetes mellitus\n- Secondary pulmonary hypertension\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-08-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily For one month\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-30\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-06-28, presumably until 2017-07-05\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-27\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-06-26, presumably until 2017-06-29\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2017-07-01, presumably until 2018-05-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily For two weeks then stop\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-04\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-05\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2018-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-05, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed for Pain\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-06-27, presumably until 2017-06-30\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2017-06-26, presumably until 2017-06-27\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-06-27, presumably until 2017-09-27, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed for Constipation\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-27, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily For two weeks then stop\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2017-09-27, with intended 0 refill(s). Instructions: take 3 Tabs by mouth 2 times a day before meals 10mg in AM, 5mg in PM.\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-06-27, presumably until 2017-07-05\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-27\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-07-01, presumably until 2017-07-03\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-06-26, presumably until 2017-06-29\n- ferrous sulfate 140 MG Extended Release Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-05\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-06-27, presumably until 2017-07-05\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2017-06-29, presumably until 2017-07-01\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2017-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2017-07-01, presumably until 2017-07-04\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2017-06-28, presumably until 2017-07-05\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-06-27, presumably until 2017-07-03\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-06-30, presumably until 2017-07-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-06-28, presumably until 2017-06-28\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-07-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-07-01, presumably until 2017-07-05\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-06-27, presumably until 2017-07-03\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2017-06-28, presumably until 2017-06-29\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-06-27, presumably until 2017-07-02\n- magnesium oxide 400 MG Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2018-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily For two weeks then stop\n- glucagon (rDNA) 1 MG Injection, started on 2017-07-05, presumably until 2017-07-05, with intended 0 refill(s). Instructions: 1 Kit by Injection route One Time\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2017-07-05, presumably until 2018-05-11, with intended 0 refill(s). Instructions: inject 30 Units subcutaneous (under the skin) every bedtime\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-06-27, presumably until 2017-07-27, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2017-06-28, presumably until 2017-06-30\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2017-06-27, presumably until 2017-07-04\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-05\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-06-27, presumably until 2017-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2017-06-28, presumably until 2018-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-07 00:00:00, ended at 2017-08-07 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- First degree atrioventricular block\n- Electrocardiogram abnormal\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Conduction disorder of the heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-07 07:49:00, ended at 2017-08-07 09:59:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 35.0 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Cardiomyopathy\n- Heart failure\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-07 08:37:36, ended at 2017-08-07 10:14:29\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-08-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day Una pastilla dos veces al dia\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals Una pastilla dos veces al dia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-05-07 21:26:00, ended at 2018-05-11 19:09:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.6 (percent)\n- Homocysteine [Moles/volume] in Serum or Plasma: 11.0 (micromole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.752 (nanogram per milliliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 234 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: 0.23 (unit per milliliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 67.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 162 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 179 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Base excess in Blood by calculation: 1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.63 (thousand per microliter)\n- Prothrombin time (PT): 16.7 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 53 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 84.6 (second)\n- Acetaminophen [Presence] in Urine: <2.0 (microgram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.6 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.37 (micro-international unit per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 464 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 9.0 (milligram per liter)\n- Glucose [Mass/volume] in Blood: 85 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 4717 (picogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Radiologic examination, chest; single view\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; more than 30 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Radiologic examination, chest; 2 views\n- Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or \n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Ultrasound, abdominal, real time with image documentation; complete\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, ven\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; complete study\n\n### Condition\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Gastroesophageal reflux disease without esophagitis\n- Generalized ischemic myocardial dysfunction\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Type 2 diabetes mellitus\n- Primary diagnosis: Acute non-ST segment elevation myocardial infarction\n- Atelectasis\n- Disorder of bilirubin metabolism\n- Abnormal findings on diagnostic imaging of lung\n- Anemia of chronic disease\n- Abdominal pain\n- Aortocoronary bypass graft present\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic congestive heart failure\n- Chronic kidney disease stage 2\n- Electrocardiogram abnormal\n- Conduction disorder of the heart\n- Hyperglycemia due to type 2 diabetes mellitus\n- Abnormal results of cardiovascular function studies\n- Cardiomyopathy\n- Bradycardia\n- Cardiomegaly\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Epigastric pain\n- Pulmonary hypertension due to left heart disease\n- Acute ischemic heart disease\n- Chronic systolic heart failure\n- Disorder of biliary tract\n- Essential hypertension\n- Hyperlipidemia\n- Myocardial infarction due to demand ischemia\n- Old myocardial infarction\n\n### Drug\n- ticagrelor 90 MG Oral Tablet, through Oral route, started on 2018-05-07, presumably until 2018-05-07\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-05-07, presumably until 2018-05-09\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2018-05-07, presumably until 2018-05-07\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2018-05-09, presumably until 2018-05-10\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-05-11\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-05-08, presumably until 2018-05-08\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-05-11\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-05-10\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2018-05-08, presumably until 2018-05-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-05-08, presumably until 2018-05-09\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-05-11, presumably until 2019-05-11, with intended 0 refill(s). Instructions: inject 22 Units subcutaneous (under the skin) every bedtime Pt takes 22 units at night\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2018-05-08, presumably until 2018-05-08\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-05-07, presumably until 2018-05-09\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-05-11\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-05-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-05-09 00:00:00, ended at 2018-05-09 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-05-09, presumably until 2018-05-09\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2018-05-09, presumably until 2018-05-09\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-05-09, presumably until 2018-05-09\n- midazolam 1 MG/ML Injectable Solution, started on 2018-05-09, presumably until 2018-05-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-23 10:51:00, ended at 2018-05-23 11:09:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Chronic congestive heart failure\n- Chronic systolic heart failure\n- Cerebral infarction\n- Gastroesophageal reflux disease without esophagitis\n- Acute non-ST segment elevation myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-23 11:10:00, ended at 2018-05-23 23:59:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 374 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 187 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.95 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Chronic congestive heart failure\n- Acute non-ST segment elevation myocardial infarction\n- Chronic systolic heart failure\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-29 14:22:00, ended at 2018-08-29 23:59:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 28.4 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Heart failure\n- Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-13 11:07:00, ended at 2018-09-13 23:59:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-11 00:00:00, ended at 2019-04-11 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2019-04-11, presumably until 2020-04-10, with intended 1 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-22 00:00:00, ended at 2017-05-22 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-24 07:34:18, ended at 2017-05-24 08:38:15\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.039\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- atorvastatin 80 MG Oral Tablet, through Oral route, presumably until 2017-07-05, with intended 0 refill(s). Instructions: take 80 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-23 10:22:00, ended at 2017-06-23 23:59:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Cardiomegaly\n- Abnormal findings on diagnostic imaging of lung\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-06-26 00:00:00, ended at 2017-06-26 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Anesthesia for direct coronary artery bypass grafting; with pump oxygenator\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Essential hypertension\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- cefazolin 1000 MG Injection, started on 2017-06-26, presumably until 2017-06-26\n- 50 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-06-26, presumably until 2017-06-26\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2017-06-26, presumably until 2017-06-26\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 6-aminocaproic acid 250 MG/ML Injectable Solution, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- midazolam 1 MG/ML Injectable Solution, started on 2017-06-26, presumably until 2017-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-06-26 00:00:00, ended at 2017-06-26 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 2 ML papaverine hydrochloride 30 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-06-26 06:05:00, ended at 2017-07-05 12:15:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Blood by calculation: 6 (millimole per liter)\n- Lactate [Moles/volume] in Blood: 9.1 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 87 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.0 (millimole per liter)\n- Body height: 5' 5\" (inch (US))\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 40.9 (millimeter mercury column)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Oxygen [Partial pressure] in Arterial blood: 356.0 (millimeter mercury column)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 31.7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.70 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.9 (percent)\n- Lactate [Moles/volume] in Serum or Plasma: 9.1 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 7.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.82 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.86 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 91 (millimeter mercury column)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.9 (nanogram per milliliter)\n- Prothrombin time (PT): 20.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Base excess in Arterial blood by calculation: 7.1 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.28 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.41 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.5 (percent)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.27 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.4 (percent)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Carbon dioxide [Partial pressure] in Arterial blood: 48.1 (millimeter mercury column)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 368 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.9 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 53.0 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n\n### Procedure\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Radiologic examination, chest; single view, frontal\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Performance of Cardiac Output, Continuous\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Restoration of Cardiac Rhythm, Single\n- Bypass Coronary Artery, One Artery from Aorta with Autologous Venous Tissue, Open Approach\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Controlled ventilation procedure and therapy, initiation and management\n- Collection of venous blood by venipuncture\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Bypass Coronary Artery, One Artery from Left Internal Mammary, Open Approach\n- Splitting of blood or blood products, each unit\n- Excision of Lower Vein, Percutaneous Endoscopic Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Atrial fibrillation\n- Chronic kidney disease stage 2\n- Leukocytosis\n- Rheumatic disease of heart valve\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Blood coagulation disorder\n- Pleural effusion\n- Type 2 diabetes mellitus\n- Ventricular premature complex\n- Benign prostatic hyperplasia\n- Postoperative state\n- Acute on chronic systolic heart failure\n- Acute posthemorrhagic anemia\n- Congestive heart failure\n- Generalized ischemic myocardial dysfunction\n- Unstable angina co-occurrent and due to coronary arteriosclerosis\n- Electrocardiogram abnormal\n- Cardiomegaly\n- Disorders of both mitral and tricuspid valves\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Acidosis\n- Chronic pulmonary edema\n- Aortocoronary bypass graft present\n- Atelectasis\n- Complication due to diabetes mellitus\n- Secondary pulmonary hypertension\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-08-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily For one month\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-30\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-06-28, presumably until 2017-07-05\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-27\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-06-26, presumably until 2017-06-29\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2017-07-01, presumably until 2018-05-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily For two weeks then stop\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-04\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-05\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2018-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-05, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed for Pain\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-06-27, presumably until 2017-06-30\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2017-06-26, presumably until 2017-06-27\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-06-27, presumably until 2017-09-27, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed for Constipation\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-27, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily For two weeks then stop\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2017-09-27, with intended 0 refill(s). Instructions: take 3 Tabs by mouth 2 times a day before meals 10mg in AM, 5mg in PM.\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-06-27, presumably until 2017-07-05\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-27\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-07-01, presumably until 2017-07-03\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-06-26, presumably until 2017-06-29\n- ferrous sulfate 140 MG Extended Release Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-05\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-06-27, presumably until 2017-07-05\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2017-06-29, presumably until 2017-07-01\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2017-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2017-07-01, presumably until 2017-07-04\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2017-06-28, presumably until 2017-07-05\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-06-27, presumably until 2017-07-03\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-06-30, presumably until 2017-07-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-06-28, presumably until 2017-06-28\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-07-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-07-01, presumably until 2017-07-05\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-06-27, presumably until 2017-07-03\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2017-06-28, presumably until 2017-06-29\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-06-27, presumably until 2017-07-02\n- magnesium oxide 400 MG Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2018-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily For two weeks then stop\n- glucagon (rDNA) 1 MG Injection, started on 2017-07-05, presumably until 2017-07-05, with intended 0 refill(s). Instructions: 1 Kit by Injection route One Time\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2017-07-05, presumably until 2018-05-11, with intended 0 refill(s). Instructions: inject 30 Units subcutaneous (under the skin) every bedtime\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-06-27, presumably until 2017-07-27, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2017-06-28, presumably until 2017-06-30\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2017-06-27, presumably until 2017-07-04\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2017-06-30, presumably until 2017-07-05\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-06-27, presumably until 2017-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2017-06-28, presumably until 2018-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-26\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-06-26, presumably until 2017-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-07 00:00:00, ended at 2017-08-07 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- First degree atrioventricular block\n- Electrocardiogram abnormal\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Conduction disorder of the heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-07 07:49:00, ended at 2017-08-07 09:59:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 35.0 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Cardiomyopathy\n- Heart failure\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-07 08:37:36, ended at 2017-08-07 10:14:29\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-08-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day Una pastilla dos veces al dia\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals Una pastilla dos veces al dia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-05-07 21:26:00, ended at 2018-05-11 19:09:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.6 (percent)\n- Homocysteine [Moles/volume] in Serum or Plasma: 11.0 (micromole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.752 (nanogram per milliliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 234 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: 0.23 (unit per milliliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 67.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 162 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 179 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Base excess in Blood by calculation: 1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.63 (thousand per microliter)\n- Prothrombin time (PT): 16.7 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 53 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 84.6 (second)\n- Acetaminophen [Presence] in Urine: <2.0 (microgram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.6 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.37 (micro-international unit per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 464 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 9.0 (milligram per liter)\n- Glucose [Mass/volume] in Blood: 85 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 4717 (picogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Radiologic examination, chest; single view\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; more than 30 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Radiologic examination, chest; 2 views\n- Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or \n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Ultrasound, abdominal, real time with image documentation; complete\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, ven\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; complete study\n\n### Condition\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Gastroesophageal reflux disease without esophagitis\n- Generalized ischemic myocardial dysfunction\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Type 2 diabetes mellitus\n- Primary diagnosis: Acute non-ST segment elevation myocardial infarction\n- Atelectasis\n- Disorder of bilirubin metabolism\n- Abnormal findings on diagnostic imaging of lung\n- Anemia of chronic disease\n- Abdominal pain\n- Aortocoronary bypass graft present\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic congestive heart failure\n- Chronic kidney disease stage 2\n- Electrocardiogram abnormal\n- Conduction disorder of the heart\n- Hyperglycemia due to type 2 diabetes mellitus\n- Abnormal results of cardiovascular function studies\n- Cardiomyopathy\n- Bradycardia\n- Cardiomegaly\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Epigastric pain\n- Pulmonary hypertension due to left heart disease\n- Acute ischemic heart disease\n- Chronic systolic heart failure\n- Disorder of biliary tract\n- Essential hypertension\n- Hyperlipidemia\n- Myocardial infarction due to demand ischemia\n- Old myocardial infarction\n\n### Drug\n- ticagrelor 90 MG Oral Tablet, through Oral route, started on 2018-05-07, presumably until 2018-05-07\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-05-07, presumably until 2018-05-09\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2018-05-07, presumably until 2018-05-07\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2018-05-09, presumably until 2018-05-10\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-05-11\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-05-08, presumably until 2018-05-08\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-05-11\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-05-10\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2018-05-08, presumably until 2018-05-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-05-08, presumably until 2018-05-09\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-05-11, presumably until 2019-05-11, with intended 0 refill(s). Instructions: inject 22 Units subcutaneous (under the skin) every bedtime Pt takes 22 units at night\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2018-05-08, presumably until 2018-05-08\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-05-07, presumably until 2018-05-09\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-05-11\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2018-05-08, presumably until 2018-05-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-05-09 00:00:00, ended at 2018-05-09 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-05-09, presumably until 2018-05-09\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2018-05-09, presumably until 2018-05-09\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-05-09, presumably until 2018-05-09\n- midazolam 1 MG/ML Injectable Solution, started on 2018-05-09, presumably until 2018-05-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-23 10:51:00, ended at 2018-05-23 11:09:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n\n### Condition\n- Chronic congestive heart failure\n- Chronic systolic heart failure\n- Cerebral infarction\n- Gastroesophageal reflux disease without esophagitis\n- Acute non-ST segment elevation myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-23 11:10:00, ended at 2018-05-23 23:59:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 374 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 187 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.95 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Chronic congestive heart failure\n- Acute non-ST segment elevation myocardial infarction\n- Chronic systolic heart failure\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-29 14:22:00, ended at 2018-08-29 23:59:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 28.4 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Heart failure\n- Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-13 11:07:00, ended at 2018-09-13 23:59:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-11 00:00:00, ended at 2019-04-11 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2019-04-11, presumably until 2020-04-10, with intended 1 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of ischemic_stroke means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "f758aa5518f49ac5e9ba02d2eae99128bbf6fbc5dede07fd5f9ceae4ec84d13c", "prompt_hash": "7e11aa52285fa60091aa532431f231f7acb48b80715a7f321e80693997af1d63", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 7, "doc": {"person_id": 115971959, "visit_occurrence_id": 194439755, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2021-12-22 14:48:15", "visit_end_datetime": "2021-12-22 15:12:34", "visit_length_in_hours": 0.4052777777777778, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2021-12-22 14:48:15, ended at 2021-12-22 15:12:34\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 85, "patient_first_visit_date": "2014-05-03 00:00:00", "patient_last_visit_date": "2023-01-25 15:00:40", "end_obs_date": "2022-12-22", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 1, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 1, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 1, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 222, "cumulated_visit_num": 222, "cumulated_approximate_token_count": 41559, "visit_cumulated": "## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-03 00:00:00, ended at 2014-05-03 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2014-05-03, presumably until 2017-02-22, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY DAY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-25 10:53:28, ended at 2017-04-25 12:21:06\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 722.9 (microgram per milliliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 371 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 6.2 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 6 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 33 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 6.0 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Body height: 5' 7\" (inch (US))\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 1131.3 (milligram per gram of creatinine)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 123 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.87 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 63.9 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart murmur\n- Pain in right foot\n- Cataract\n- Pure hypercholesterolemia\n- Glaucoma\n- Nicotine dependence\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2017-02-03, presumably until 2017-06-19, with intended 5 refill(s). Instructions: take 25 mg by mouth daily\n- dexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension, started on 2017-03-17, presumably until 2017-04-25, with intended 0 refill(s). Instructions: ADMINISTER 1-2 DROPS INTO THE LEFT EYE EVERY 4 (FOUR) HOURS FOR 7 DAYS. AVOID IN LACTATION.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-28 00:00:00, ended at 2017-05-28 00:00:00\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.65 ML varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection, through Subcutaneous route, started on 2017-05-31, presumably until 2017-05-31, with intended 0 refill(s). Instructions: inject 0.65 mL subcutaneous (under the skin) One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-14 10:24:38, ended at 2017-06-14 12:43:44\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Acute renal failure syndrome\n- Raised prostate specific antigen\n- Hyperkalemia\n\n### Drug\n- nepafenac 3 MG/ML Ophthalmic Suspension, started on 2017-06-10, presumably until 2017-09-23, with intended 1 refill(s). Instructions: INSTILL 1 DROP INTO LEFT EYE ONCE A DAY\n- moxifloxacin 5 MG/ML Ophthalmic Solution, started on 2017-06-10, presumably until 2017-06-14, with intended 1 refill(s). Instructions: INSTILL 1 DROP INTO LEFT EYE FOUR TIMES A DAY\n- difluprednate 0.5 MG/ML Ophthalmic Suspension, started on 2017-06-10, presumably until 2017-09-23, with intended 1 refill(s). Instructions: APPLY 1 DROP INTO LEFT EYE FOUR TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-18 00:00:00, ended at 2017-06-18 00:00:00\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.2 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Ureteric stone\n- Acute renal failure syndrome\n\n### Drug\n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, started on 2017-06-19, presumably until 2017-08-02, with intended 0 refill(s). Instructions: take 1,600 mg by mouth 3 times a day\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-06-19, presumably until 2017-07-01, with intended 0 refill(s). Instructions: take 5 mg by mouth daily Take 2 tabs by mouth daily\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-06-19, presumably until 2017-07-22, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-28 08:44:05, ended at 2017-06-28 10:25:07\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma by Electrophoresis: 3.9 (gram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.84 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis: 0.7 (gram per deciliter)\n- Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis: 1.0 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis: 0.7 (gram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: 0-10 (per high power field)\n- Lambda light chains.free [Mass/volume] in Serum or Plasma: 43.0 (milligram per liter)\n- MCV [Entitic volume] by Automated count: 97 (femtoliter)\n- Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis: 0.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis: Not Observed (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Kappa light chains [Mass/volume] in Serum or Plasma: 62.4 (milligram per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Acute renal failure syndrome\n- Chronic kidney disease due to hypertension\n- Essential hypertension\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-01 08:56:43, ended at 2017-07-01 09:34:27\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Pure hypercholesterolemia\n- Acute renal failure syndrome\n- Essential hypertension\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic kidney disease stage 4\n- Hyperkalemia\n- Type 2 diabetes mellitus without complication\n- Ureteric stone\n- Type 2 diabetes mellitus\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2017-07-01, presumably until 2018-07-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2017-07-01, presumably until 2018-07-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-15 00:00:00, ended at 2017-07-15 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-22 00:00:00, ended at 2017-07-22 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sevelamer carbonate 800 MG Oral Tablet, started on 2017-07-23, presumably until 2017-08-02, with intended 6 refill(s). Instructions: TAKE 2 TABLETS BY MOUTH 3 TIMES A DAY WITH MEALS\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2017-07-23, presumably until 2017-10-31, with intended 6 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AFTER MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-02 11:18:16, ended at 2017-08-02 11:58:22\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Urate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Kidney stone\n- Primary diagnosis: Acute renal failure syndrome\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2017-08-02, presumably until 2018-01-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-07-17, presumably until 2018-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-16 00:00:00, ended at 2017-09-16 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.78 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 81 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 18 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Essential hypertension\n- Type 2 diabetes mellitus\n- Pure hypercholesterolemia\n- Chronic kidney disease stage 4\n- Primary diagnosis: Kidney stone\n\n### Drug\n- potassium citrate 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-09-06, presumably until 2018-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-23 08:48:51, ended at 2017-09-23 10:30:27\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.3 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 354 (picogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18 (percent)\n- Body height: 5' 7\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Chronic kidney disease stage 4\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Dependence on enabling machine or device\n- Obstructive sleep apnea syndrome\n- Renal disorder due to type 2 diabetes mellitus\n- Malaise\n- Pure hypercholesterolemia\n- Fatigue\n- Type 2 diabetes mellitus without complication\n- Type 2 diabetes mellitus\n\n### Drug\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, started on 2017-09-13, presumably until 2022-10-10, with intended 0 refill(s). Instructions: RIHNSE 1/2 TEASPOON BY MOUTH AFTER ORAL HYGEINE ROUTINE TWICE A DAY NO RINSING AFTERWARDS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-30 00:00:00, ended at 2017-09-30 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.19 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-10-31 00:00:00, ended at 2017-10-31 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2017-10-31, presumably until 2018-11-19, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AFTER MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-11 00:00:00, ended at 2017-11-11 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.51 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-15 08:29:15, ended at 2017-11-15 08:59:47\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 15.7 (nanogram per milliliter)\n- Body height: 5' 7\" (inch (US))\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 145 (picogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.84 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 260 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney stone\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Chronic kidney disease stage 4\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-26 10:35:00, ended at 2017-11-26 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Disorder of kidney and/or ureter\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-17 00:00:00, ended at 2017-12-17 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2017-12-17, presumably until 2017-12-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-25 09:12:37, ended at 2017-12-25 10:06:37\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71 (percent)\n- Body height: 5' 7\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 28 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.5 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 99 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 251 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 4\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Renal disorder due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Herpes zoster without complication\n- Nicotine dependence\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-17 08:19:42, ended at 2018-01-17 10:33:12\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 59 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.5 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 5.7 (millimole per liter)\n- Body height: 5' 7\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Protein [Mass/volume] in Urine: 415.9 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 11-30 (per high power field)\n- Protein/Creatinine [Mass Ratio] in Urine: 6350 (milligram per gram of creatinine)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.63 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 4\n- Essential hypertension\n- Vitamin D deficiency\n- Kidney stone\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- chlorthalidone 25 MG Oral Tablet, through Oral route, started on 2018-01-17, presumably until 2019-01-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-01-17, presumably until 2018-12-05, with intended 3 refill(s). Instructions: take 1 Cap by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-02-04 00:00:00, ended at 2018-02-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium citrate 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-02-04, presumably until 2018-05-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-28 00:00:00, ended at 2018-03-28 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 1 MG Oral Tablet, started on 2018-03-28, presumably until 2018-04-07, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-28 00:00:00, ended at 2018-03-28 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Protein/Creatinine [Mass Ratio] in Urine: 4714 (milligram per gram of creatinine)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.7 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Protein [Mass/volume] in Urine: 352.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.18 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-04-01 00:00:00, ended at 2018-04-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-04 13:46:43, ended at 2018-04-04 15:09:33\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 109 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 28 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.76 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 74 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 190 (microgram per deciliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 127 (picogram per milliliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 146 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 264 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 40.1 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 17 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Chronic kidney disease stage 5\n- Chronic kidney disease\n- Vitamin D deficiency\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n- Anemia in chronic kidney disease\n\n### Drug\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2018-07-15, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2019-04-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-07 10:06:27, ended at 2018-04-07 10:56:46\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.2 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Primary diagnosis: Post-herpetic neuritis\n- Essential hypertension\n- Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- glimepiride 1 MG Oral Tablet, through Oral route, started on 2018-04-07, presumably until 2019-04-03, with intended 3 refill(s). Instructions: take 0.5 mg by mouth as needed \n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2018-04-07, presumably until 2018-07-29, with intended 3 refill(s). Instructions: apply 3 Patches to skin daily\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2018-04-07, presumably until 2018-06-24, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n- triamcinolone acetonide 1 MG/ML Topical Cream, started on 2018-04-07, presumably until 2019-04-25, with intended 3 refill(s). Instructions: Apply BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-05 00:00:00, ended at 2018-05-05 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2018-05-06, presumably until 2018-05-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-08 00:00:00, ended at 2018-05-08 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.76 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 56.1 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.78 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 11-30 (per high power field)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 3399 (milligram per gram of creatinine)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 280 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Protein [Mass/volume] in Urine: 275.6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease stage 4\n- Renal disorder due to type 2 diabetes mellitus\n- Kidney stone\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-08 00:00:00, ended at 2018-05-08 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2018-05-09, presumably until 2018-05-09, with intended 0 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-13 00:00:00, ended at 2018-05-13 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.29 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-15 00:00:00, ended at 2018-05-15 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.66 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-16 00:00:00, ended at 2018-05-16 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2018-05-16, presumably until 2018-10-12, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-23 09:22:43, ended at 2018-05-23 16:08:02\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Essential hypertension\n- Primary diagnosis: Chronic kidney disease stage 5\n- Melena\n\n### Drug\n- 1 ML darbepoetin alfa 0.06 MG/ML Injection, through Subcutaneous route, started on 2018-05-23, presumably until 2019-02-04, with intended 3 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 4 weeks\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-25 00:00:00, ended at 2018-05-25 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.82 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69 (percent)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-26 00:00:00, ended at 2018-05-26 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-27 14:15:17, ended at 2018-05-27 16:55:43\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Gastrointestinal hemorrhage\n- Pure hypercholesterolemia\n- Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2018-06-02, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-02 00:00:00, ended at 2018-06-02 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Platelets [#/volume] in Blood by Automated count: 171 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.59 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 104 (femtoliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-02 13:40:26, ended at 2018-06-02 15:55:28\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic duodenal ulcer with hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-06-02, presumably until 2018-11-17, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-03 00:00:00, ended at 2018-06-03 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, started on 2018-06-03, presumably until 2018-08-01, with intended 0 refill(s). Instructions: Take 2L by mouth night before and 2L morning of procedure. Stop fluids 4hr before procedure. Instructions are forwarded to patient.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-06 00:00:00, ended at 2018-06-06 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-09 00:00:00, ended at 2018-06-09 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-13 00:00:00, ended at 2018-06-13 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-16 00:00:00, ended at 2018-06-16 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-20 00:00:00, ended at 2018-06-20 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-23 00:00:00, ended at 2018-06-23 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- doxazosin 4 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-09-24, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-01 08:54:00, ended at 2018-07-01 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n\n### Condition\n- Chronic kidney disease stage 4\n- Chronic kidney disease due to type 2 diabetes mellitus\n- End-stage renal disease\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-01 08:58:14, ended at 2018-07-01 15:00:26\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease stage 4\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-09 00:00:00, ended at 2018-07-09 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2018-07-11, presumably until 2019-06-29, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-09 10:03:56, ended at 2018-07-09 11:09:14\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Chronic kidney disease stage 4\n- Essential hypertension\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, presumably until 2018-07-11, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- atorvastatin 40 MG Oral Tablet, through Oral route, presumably until 2018-07-21, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-15 09:50:13, ended at 2018-07-15 10:46:19\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 138 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 214 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 73 (microgram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Body height: 5' 7.008\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 25 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.83 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 197 (picogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 287 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperparathyroidism due to renal insufficiency\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n- Anemia in chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- epoetin alfa 20000 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-07-15, presumably until 2018-08-01, with intended 3 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2018-07-15, presumably until 2019-08-04, with intended 3 refill(s). Instructions: take 1.5 Tabs by mouth daily\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2018-07-15, presumably until 2019-04-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2018-07-15, presumably until 2019-03-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-21 00:00:00, ended at 2018-07-21 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2018-07-21, presumably until 2019-07-14, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-07-29 00:00:00, ended at 2018-07-29 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2018-07-29, presumably until 2018-07-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-29 11:25:00, ended at 2018-07-29 14:15:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 100 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Colonoscopy, flexible; with biopsy, single or multiple\n- Excision of Descending Colon, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Excision of Transverse Colon, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Hemorrhoids\n- Non-rheumatic aortic sclerosis\n- End-stage renal disease\n- Type 2 diabetes mellitus\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Anemia\n- Hyperlipidemia\n- Obstructive sleep apnea syndrome\n- Benign neoplasm of descending colon\n- Gout\n- Hypertensive renal failure\n- Benign neoplasm of transverse colon\n- Diverticulosis of large intestine without diverticulitis\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-01 08:38:33, ended at 2018-08-01 09:22:48\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic kidney disease stage 5\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-01 09:14:17, ended at 2018-08-01 10:47:53\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-07 09:01:20, ended at 2018-08-07 10:01:36\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Otalgia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-08-11 00:00:00, ended at 2018-08-11 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2018-08-11, presumably until 2018-08-11\n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2018-08-11, presumably until 2018-08-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-11 00:00:00, ended at 2018-08-11 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 30 ML mepivacaine hydrochloride 15 MG/ML Injection, started on 2018-08-11, presumably until 2018-08-11\n- midazolam 1 MG/ML Injectable Solution, started on 2018-08-11, presumably until 2018-08-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-11 00:00:00, ended at 2018-08-11 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for vascular shunt, or shunt revision, any type (eg, dialysis)\n\n### Condition\n- Chronic kidney disease stage 5\n- Sleep apnea\n- Hypertensive renal failure\n- Kidney stone\n- Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2018-08-11, presumably until 2018-08-11\n- cefazolin 1000 MG Injection, started on 2018-08-11, presumably until 2018-08-11\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-08-11, presumably until 2018-08-11\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-08-11, presumably until 2018-08-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-08-11, presumably until 2018-08-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-11 06:05:00, ended at 2018-08-11 12:54:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 116 (milligram per deciliter)\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Bypass Right Radial Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach\n- Arteriovenous anastomosis, open; direct, any site (eg, Cimino type) (separate procedure)\n\n### Condition\n- End-stage renal disease\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Kidney stone\n- Type 2 diabetes mellitus without complication\n- Hearing loss\n- Heart murmur\n- Non-rheumatic aortic sclerosis\n- Type 2 diabetes mellitus\n- Chronic kidney disease stage 5\n- Glaucoma\n- Hypertensive renal failure\n- Obstructive sleep apnea syndrome\n- Renal disorder due to type 2 diabetes mellitus\n- Gout\n- Hyperlipidemia\n- Anemia\n\n### Drug\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-08-11, presumably until 2018-08-11\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-08-11, presumably until 2018-08-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-12 00:00:00, ended at 2018-08-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-08-12, presumably until 2018-11-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-13 09:47:50, ended at 2018-08-13 11:32:39\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Chronic kidney disease stage 5\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-26 11:10:48, ended at 2018-08-26 11:41:12\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease stage 5\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-15 00:00:00, ended at 2018-09-15 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 6.34 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 176 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 84 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.6 (milligram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 250 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 26 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 327 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 233 (picogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Essential hypertension\n- Hyperparathyroidism due to renal insufficiency\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-18 00:00:00, ended at 2018-09-18 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-24 12:35:00, ended at 2018-09-24 14:06:21\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary gout\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Hyperparathyroidism due to renal insufficiency\n- Chronic kidney disease stage 5\n- Essential hypertension\n- Type 2 diabetes mellitus\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-24 12:35:41, ended at 2018-09-24 14:06:06\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperparathyroidism due to renal insufficiency\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n- Essential hypertension\n- Primary gout\n- Anemia in chronic kidney disease\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- doxazosin 8 MG Oral Tablet, through Oral route, started on 2018-09-24, presumably until 2019-09-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-25 00:00:00, ended at 2018-09-25 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- doxazosin 4 MG Oral Tablet, started on 2018-09-25, presumably until 2018-09-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-25 12:12:00, ended at 2018-09-25 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)\n\n### Condition\n- Acute renal failure syndrome\n- End-stage renal disease\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-25 12:12:52, ended at 2018-09-25 16:12:10\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease\n- Primary diagnosis: Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-06 00:00:00, ended at 2018-10-06 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-10 00:00:00, ended at 2018-10-10 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Protein [Mass/volume] in Urine: 192.1 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 99.1 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 1938 (milligram per gram of creatinine)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: 0-10 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 11-30 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.74 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-10 00:00:00, ended at 2018-10-10 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.90 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-12 00:00:00, ended at 2018-10-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, started on 2018-10-13, presumably until 2018-12-17, with intended 3 refill(s). Instructions: TAKE 2 TABLETS BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-20 00:00:00, ended at 2018-10-20 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic duodenal ulcer with hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2018-10-23, presumably until 2018-10-23, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-17 09:14:51, ended at 2018-11-17 12:01:18\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n- Anemia in chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 5\n- Primary diagnosis: Type 2 diabetes mellitus\n- Essential hypertension\n\n### Drug\n- hydroxyzine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-11-17, presumably until 2019-03-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-19 00:00:00, ended at 2018-11-19 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2018-11-19, presumably until 2019-11-16, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH DAILY AFTER A MEAL.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-20 00:00:00, ended at 2018-11-20 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Anemia in chronic kidney disease\n\n### Drug\n- 1 ML darbepoetin alfa 0.06 MG/ML Injection, through Subcutaneous route, started on 2018-11-20, presumably until 2019-11-20, with intended 6 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 4 weeks\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-05 00:00:00, ended at 2018-12-05 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-12-05, presumably until 2019-07-23, with intended 3 refill(s). Instructions: TAKE 1 CAP BY MOUTH EVERY 7 DAYS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-17 00:00:00, ended at 2018-12-17 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2018-12-17, presumably until 2019-06-26, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-17 00:00:00, ended at 2018-12-17 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-12-23 00:00:00, ended at 2018-12-23 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-03 00:00:00, ended at 2019-01-03 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- chlorthalidone 25 MG Oral Tablet, through Oral route, started on 2019-01-06, presumably until 2019-12-24, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-07 14:02:04, ended at 2019-01-07 15:42:05\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Hyperparathyroidism due to renal insufficiency\n- Essential hypertension\n- Chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2019-01-07, with intended 0 refill(s). Instructions: take 800 mg by mouth 3 times a day 2 tablets\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-04 00:00:00, ended at 2019-02-04 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n- Anemia in chronic kidney disease\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- 1 ML darbepoetin alfa 0.06 MG/ML Injection, through Subcutaneous route, started on 2019-02-04, presumably until 2019-02-12, with intended 12 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 4 weeks\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-04 00:00:00, ended at 2019-02-04 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 333 (microgram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.66 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 302 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 9 (percent)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.15 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 31 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 231 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 70 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-06 00:00:00, ended at 2019-02-06 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-12 00:00:00, ended at 2019-02-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Type 2 diabetes mellitus\n- Chronic kidney disease stage 5\n- Chronic kidney disease due to type 2 diabetes mellitus\n\n### Drug\n- 1 ML darbepoetin alfa 0.06 MG/ML Injection, through Subcutaneous route, started on 2019-02-12, presumably until 2019-02-18, with intended 12 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 4 weeks\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-17 00:00:00, ended at 2019-02-17 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.32 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.2 (percent)\n- Mitogen stimulated gamma interferon [Units/volume] in Blood: >10.00 (international unit per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 237 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 46 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 22 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 74 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Gamma interferon background [Units/volume] in Blood by Immunoassay: 0.02 (international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 7.6 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 333 (microgram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.13 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 259 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] in Blood: 0.02 (international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Anemia in chronic kidney disease\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Primary diagnosis: End-stage renal disease\n- Type 2 diabetes mellitus\n\n### Drug\n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-02-18, presumably until 2019-06-26, with intended 6 refill(s). Instructions: inject 0.5 mL (100 mcg total) subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-27 10:54:00, ended at 2019-02-27 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-11 00:00:00, ended at 2019-03-11 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic kidney disease stage 5\n- Type 2 diabetes mellitus\n\n### Drug\n- hydroxyzine hydrochloride 10 MG Oral Tablet, started on 2019-03-11, presumably until 2019-05-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES A DAY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-19 00:00:00, ended at 2019-03-19 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 294 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 104 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.31 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 10 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.60 (million per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 165 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 204 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.0 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 266 (microgram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 28 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-26 00:00:00, ended at 2019-03-26 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 224 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 41 (microgram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.41 (milligram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 312 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 271 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 13 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-01 00:00:00, ended at 2019-04-01 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.14 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 321 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 46 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 275 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 252 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 14 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-03 07:43:27, ended at 2019-04-03 08:23:02\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Essential hypertension\n- Primary diagnosis: Chronic kidney disease stage 5\n- Constipation\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2019-04-03, presumably until 2019-04-28, with intended 6 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 3 times a day as needed For high blood pressure (systolic BP >160)\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-04-03, presumably until 2019-04-07, with intended 3 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 2 times a day 2 tablets\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2019-04-03, presumably until 2019-08-20, with intended 3 refill(s). Instructions: take 2 Tabs (1,600 mg total) by mouth 3 times a day with meals\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2019-04-03, presumably until 2020-04-02, with intended 3 refill(s). Instructions: take 17 g by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-07 00:00:00, ended at 2019-04-07 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Constipation\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-04-07, presumably until 2020-06-02, with intended 3 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-08 00:00:00, ended at 2019-04-08 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Glaucoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-15 00:00:00, ended at 2019-04-15 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 72 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 328 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 256 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 22 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 140 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.57 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-17 00:00:00, ended at 2019-04-17 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2019-04-17, presumably until 2019-07-03, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-17 00:00:00, ended at 2019-04-17 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 1 MG Oral Tablet, started on 2019-04-17, presumably until 2020-06-02, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-25 00:00:00, ended at 2019-04-25 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- triamcinolone acetonide 1 MG/ML Topical Cream, started on 2019-04-28, presumably until 2022-10-10, with intended 2 refill(s). Instructions: APPLY TO AFFECTED AREA TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-28 00:00:00, ended at 2019-04-28 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2019-04-28, presumably until 2019-06-26, with intended 3 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 3 times a day as needed For high blood pressure (systolic BP >160)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 287 (microgram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.83 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 85 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 202 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 30 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 149 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-05-18 00:00:00, ended at 2019-05-18 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-18 00:00:00, ended at 2019-05-18 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 25 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 87 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 256 (microgram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 168 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.29 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-25 13:23:54, ended at 2019-05-25 15:43:39\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Body height: 5' 7\" (inch (US))\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Asthenia\n- Primary diagnosis: Fatigue\n- Renal disorder due to type 2 diabetes mellitus\n- Primary diagnosis: Malaise\n- Glaucoma\n- Essential hypertension\n- Non-rheumatic aortic sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-29 00:00:00, ended at 2019-05-29 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-29 07:42:51, ended at 2019-05-29 09:38:36\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 5\n- Hyperparathyroidism due to renal insufficiency\n- Anemia in chronic kidney disease\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-01 00:00:00, ended at 2019-06-01 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 5\n- Anemia in chronic kidney disease\n- Essential hypertension\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-01 00:00:00, ended at 2019-06-01 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Gamma interferon background [Units/volume] in Blood by Immunoassay: 0.02 (international unit per milliliter)\n- Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] in Blood: 0.02 (international unit per milliliter)\n- Mitogen stimulated gamma interferon [Units/volume] in Blood: >10.00 (international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-01 00:00:00, ended at 2019-06-01 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hepatitis B virus surface Ab [Units/volume] in Serum: <3.1 (milli-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-01 00:00:00, ended at 2019-06-01 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 5\n- End-stage renal disease\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-15 00:00:00, ended at 2019-06-15 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-06-15, presumably until 2020-06-14, with intended 3 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-26 10:47:13, ended at 2019-06-26 12:15:53\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution, through Intraocular route, presumably until 2020-06-09, with intended 0 refill(s). Instructions: by Ophthalmic route\n- brimonidine tartrate 1.5 MG/ML Ophthalmic Solution, presumably until 2020-10-28, with intended 0 refill(s). Instructions: 1 Drop 2 times a day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-29 00:00:00, ended at 2019-06-29 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2019-06-30, presumably until 2019-10-09, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-14 00:00:00, ended at 2019-07-14 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2019-07-14, presumably until 2020-08-10, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-04 00:00:00, ended at 2019-08-04 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n- Essential hypertension\n\n### Drug\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2019-08-04, presumably until 2020-06-02, with intended 3 refill(s). Instructions: TAKE 1.5 TABS BY MOUTH DAILY\n- torsemide 20 MG Oral Tablet, started on 2019-08-04, presumably until 2019-10-09, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-10 00:00:00, ended at 2019-08-10 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dependence on enabling machine or device\n- Primary diagnosis: Obstructive sleep apnea syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-18 14:41:57, ended at 2019-09-18 16:39:37\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Sprain of upper extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-22 00:00:00, ended at 2019-09-22 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-16 00:00:00, ended at 2019-11-16 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, started on 2019-11-17, presumably until 2019-11-17, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY 7 DAYS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-16 00:00:00, ended at 2019-11-16 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2019-11-16, presumably until 2020-12-08, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH DAILY AFTER A MEAL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-17 00:00:00, ended at 2019-11-17 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2019-11-17, presumably until 2019-11-19, with intended 3 refill(s). Instructions: take 1 Tab (2.5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-20 00:00:00, ended at 2019-12-20 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, started on 2019-12-21, presumably until 2019-12-21, with intended 11 refill(s). Instructions: TAKE 2 TABLETS BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- chlorthalidone 25 MG Oral Tablet, started on 2019-12-24, presumably until 2020-05-13, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-11 11:12:30, ended at 2020-01-11 15:08:51\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Polyneuropathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-13 00:00:00, ended at 2020-01-13 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, started on 2020-01-13, presumably until 2020-01-13, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY 7 DAYS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-08 00:00:00, ended at 2020-03-08 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-08 00:00:00, ended at 2020-03-08 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-14 00:00:00, ended at 2020-03-14 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lesion of median nerve\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-20 00:00:00, ended at 2020-03-20 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, started on 2020-03-21, presumably until 2020-03-21, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY 7 DAYS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-24 00:00:00, ended at 2020-03-24 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Melena\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-25 10:46:55, ended at 2020-03-25 11:06:18\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-08 10:35:04, ended at 2020-04-08 11:06:59\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-20 00:00:00, ended at 2020-04-20 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- hydrocortisone 0.005 MG/MG Topical Ointment, started on 2020-04-20, presumably until 2021-04-20, with intended 0 refill(s). Instructions: Apply a small amount to right forearm rash twice a day until resolved.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-25 00:00:00, ended at 2020-04-25 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transient cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-04-27 00:00:00, ended at 2020-04-27 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-04-27, presumably until 2020-04-27\n- iodixanol, through Intravenous route, started on 2020-04-27, presumably until 2020-04-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2020-04-27, presumably until 2020-04-27\n- midazolam 1 MG/ML Injectable Solution, started on 2020-04-27, presumably until 2020-04-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-27 05:50:00, ended at 2020-04-27 11:15:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 38 (percent)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 89 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n- Potassium [Moles/volume] in Blood: 4.6 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 12.9 (gram per deciliter)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Introduction of needle(s) and/or catheter(s), dialysis circuit, with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis \n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Stenosis due to any device, implant AND/OR graft\n- Aphasia\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n- Anemia in chronic kidney disease\n- Pure hypercholesterolemia\n- End-stage renal disease\n- Hypertensive renal failure\n- Inflammatory dermatosis\n- Glaucoma\n- Primary diagnosis: Chronic kidney disease stage 5\n- Transient cerebral ischemia\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2020-04-29, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-28 14:21:09, ended at 2020-04-28 14:48:23\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebrovascular disease\n- Dysphasia\n- Slurred speech\n- Disorientated\n- Primary diagnosis: Transient cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-29 00:00:00, ended at 2020-04-29 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transient cerebral ischemia\n- Slurred speech\n- Dysphasia\n- Spontaneous subarachnoid hemorrhage\n- Melena\n- Disorientated\n- Cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-06 09:03:50, ended at 2020-05-06 09:26:39\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution, through Intraocular route, presumably until 2022-02-16, with intended 0 refill(s). Instructions: by Ophthalmic route \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2020-06-02, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-13 00:00:00, ended at 2020-05-13 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral ischemia\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2020-05-06, presumably until 2020-06-02, with intended 0 refill(s). Instructions: On non-dialysis days; does not take if bp is less than 140\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysphasia\n- Primary diagnosis: Slurred speech\n- Transient cerebral ischemia\n- Cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-23 00:00:00, ended at 2020-05-23 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.62 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.5 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n- Disorder of upper gastrointestinal tract\n- Acute gastric ulcer without hemorrhage AND without perforation\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2020-05-23, presumably until 2020-07-01, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysarthria\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-31 00:00:00, ended at 2020-05-31 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebrovascular disease\n- Dysphasia\n- Primary diagnosis: Slurred speech\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-02 15:06:33, ended at 2020-06-02 15:59:23\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Constipation\n- Cerebrovascular disease\n- Primary diagnosis: Cerebral infarction\n- Gastric ulcer without hemorrhage AND without perforation\n- Dysphasia\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2020-06-02, presumably until 2020-06-09, with intended 0 refill(s). Instructions: One tablet only On non-dialysis days; does not take if bp is less than 140\n- glimepiride 1 MG Oral Tablet, through Oral route, started on 2020-06-02, presumably until 2020-07-01, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth daily As needed if blood sugar is greater than 150\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2020-06-02, presumably until 2021-05-29, with intended 0 refill(s). Instructions: take 1 Cap (250 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-09 13:22:06, ended at 2020-06-09 13:56:53\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hypertensive renal failure\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2020-06-09, presumably until 2020-10-28, with intended 3 refill(s). Instructions: On dialysis days, take after dialysis\n- dorzolamide 20 MG/ML Ophthalmic Solution, started on 2020-06-08, presumably until 2020-12-21, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-16 00:00:00, ended at 2020-06-16 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2020-06-16, presumably until 2021-01-20, with intended 1 refill(s). Instructions: take 1 Tab (75 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-21 14:16:25, ended at 2020-06-21 15:08:47\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-29 00:00:00, ended at 2020-06-29 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-01 15:50:44, ended at 2020-07-01 16:29:19\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebrovascular disease\n- Primary diagnosis: Cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-04 07:45:00, ended at 2020-07-04 23:59:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-06 00:00:00, ended at 2020-07-06 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, through Oral route, started on 2020-07-06, presumably until 2020-08-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-06 00:00:00, ended at 2020-07-06 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2020-07-19, presumably until 2020-08-26, with intended 0 refill(s). Instructions: take 1 Amper (30 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-11 15:13:48, ended at 2020-07-11 15:40:54\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transient cerebral ischemia\n- Chronic kidney disease stage 5\n- Essential hypertension\n- Primary diagnosis: Cerebral infarction\n- Dysphasia\n- Type 2 diabetes mellitus without complication\n- Anemia\n- Gastric ulcer without hemorrhage AND without perforation\n- Slurred speech\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-15 00:00:00, ended at 2020-07-15 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Aphasia as late effect of cerebrovascular disease\n- Primary diagnosis: Cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 08:46:19, ended at 2020-07-29 09:16:52\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-04 00:00:00, ended at 2020-08-04 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-10 00:00:00, ended at 2020-08-10 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-08-10, presumably until 2021-08-31, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-18 15:50:00, ended at 2020-08-18 23:59:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n- Magnetic resonance angiography, head; without contrast material(s)\n\n### Condition\n- Cerebrovascular disease\n- Aphasia as late effect of cerebrovascular disease\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-19 13:19:17, ended at 2020-08-19 13:47:55\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-20 00:00:00, ended at 2020-08-20 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2020-08-26, presumably until 2020-09-18, with intended 0 refill(s). Instructions: TAKE 1 CAP (30 MG TOTAL) BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-31 00:00:00, ended at 2020-08-31 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-02 15:19:26, ended at 2020-09-02 16:06:36\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-23 00:00:00, ended at 2020-09-23 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, started on 2020-09-23, presumably until 2020-09-23, with intended 1 refill(s). Instructions: TAKE 1 CAP (30 MG TOTAL) BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-23 13:19:24, ended at 2020-09-23 13:49:26\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- torsemide 100 MG Oral Tablet, through Oral route, started on 2020-10-28, presumably until 2020-10-28, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n\n### Drug\n- allopurinol 100 MG Oral Tablet, started on 2020-10-28, presumably until 2021-10-09, with intended 3 refill(s). Instructions: TAKE 1 AND 1/2 TABLETS BY MOUTH DAILY\n- torsemide 100 MG Oral Tablet, started on 2020-10-28, presumably until 2021-10-09, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-28 13:22:06, ended at 2020-10-28 13:46:11\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n- Essential hypertension\n- Primary diagnosis: End-stage renal disease\n- Hypertensive renal failure\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2020-10-28, presumably until 2021-06-21, with intended 3 refill(s). Instructions: 50 mg daily Mon/Wed/Fri/Sun and 37.5mg daily on Tue/Thur/Sat after dialysis\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2020-10-28, presumably until 2021-11-26, with intended 3 refill(s). Instructions: take 4 Tabs (3,200 mg total) by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-29 00:00:00, ended at 2020-11-29 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n- Pruritic rash\n\n### Drug\n- hydroxyzine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2020-11-29, presumably until 2021-11-29, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth 3 times a day as needed for Itching\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-02 13:24:07, ended at 2020-12-02 13:42:54\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-06 00:00:00, ended at 2020-12-06 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2020-12-08, presumably until 2021-11-21, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH DAILY AFTER A MEAL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-21 15:07:55, ended at 2020-12-21 15:43:35\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Cerebral infarction\n- Chronic kidney disease stage 5\n- Dysphasia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-23 14:56:23, ended at 2020-12-23 15:15:08\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 15:49:21, ended at 2021-01-06 16:20:31\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-18 00:00:00, ended at 2021-01-18 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 1 MG Oral Tablet, through Oral route, started on 2021-01-18, presumably until 2021-04-17, with intended 3 refill(s). Instructions: take 0.5 Tabs (0.5 mg total) by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-18 00:00:00, ended at 2021-01-18 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-19 00:00:00, ended at 2021-01-19 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2021-02-02, presumably until 2021-02-02, with intended 1 refill(s). Instructions: take 1 Tab (75 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-20 00:00:00, ended at 2021-01-20 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2021-01-20, presumably until 2022-01-30, with intended 2 refill(s). Instructions: take 1 Tab (75 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-08 00:00:00, ended at 2021-02-08 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Anemia in chronic kidney disease\n- Primary diagnosis: Anemia\n- Iron deficiency anemia due to blood loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-09 00:00:00, ended at 2021-02-09 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, through Oral route, started on 2021-02-09, presumably until 2021-03-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-02-14 12:41:39, ended at 2021-02-14 14:25:34\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.598\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebral infarction\n- Primary diagnosis: Anemia in chronic kidney disease\n- Gastrointestinal hemorrhage\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-14 14:06:00, ended at 2021-02-14 23:59:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, abdomen; 1 view\n\n### Condition\n- Cerebral infarction\n- Chronic kidney disease stage 5\n- Constipation\n- Anemia in chronic kidney disease\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-20 13:32:20, ended at 2021-02-20 14:03:46\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebral infarction\n- Essential hypertension\n- Chronic kidney disease stage 5\n- Iron deficiency anemia due to blood loss\n- Primary diagnosis: Gastrointestinal hemorrhage\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-03-03 10:49:32, ended at 2021-03-03 11:15:36\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-21 00:00:00, ended at 2021-03-21 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, started on 2021-03-21, presumably until 2021-04-24, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-31 00:00:00, ended at 2021-03-31 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2021-03-31, presumably until 2022-03-31, with intended 11 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-31 00:00:00, ended at 2021-03-31 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2021-03-31, presumably until 2021-03-31, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-03-31 10:47:16, ended at 2021-03-31 11:05:09\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-03-31 13:49:57, ended at 2021-03-31 14:44:28\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-14 00:00:00, ended at 2021-04-14 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; not otherwise specified\n\n### Condition\n- Essential hypertension\n- Anemia\n- Diverticulosis of small intestine\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2021-04-14, presumably until 2021-04-14\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2021-04-14, presumably until 2021-04-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2021-04-14, presumably until 2021-04-14\n- 2 ML alfentanil 0.5 MG/ML Injection, started on 2021-04-14, presumably until 2021-04-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2021-04-14 00:00:00, ended at 2021-04-14 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Small intestinal endoscopy, enteroscopy beyond second portion of duodenum, including ileum; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-14 10:11:00, ended at 2021-04-14 13:26:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 4.2 (milliequivalent per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 93 (milligram per deciliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 27.9 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 28.6 (milliequivalent per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n\n### Procedure\n- Small intestinal endoscopy, enteroscopy beyond second portion of duodenum, including ileum; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia in chronic kidney disease\n- End-stage renal disease\n- Diverticulosis of small intestine\n- Non-rheumatic aortic sclerosis\n- Hyperlipidemia\n- Type 2 diabetes mellitus\n- Gout\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Hypertensive renal failure\n- Obstructive sleep apnea syndrome\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-15 00:00:00, ended at 2021-04-15 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, started on 2021-04-24, presumably until 2021-07-27, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-16 00:00:00, ended at 2021-04-16 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 1 MG Oral Tablet, through Oral route, started on 2021-04-17, presumably until 2021-06-16, with intended 2 refill(s). Instructions: TAKE 0.5 TABS (0.5 MG TOTAL) BY MOUTH EVERY MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-21 10:48:15, ended at 2021-04-21 11:12:33\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-27 00:00:00, ended at 2021-04-27 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vancomycin 125 MG Oral Capsule, started on 2021-04-24, presumably until 2021-05-22, with intended 0 refill(s). Instructions: EVERY 6 HOURS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-28 00:00:00, ended at 2021-04-28 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2021-04-28, presumably until 2021-05-29, with intended 3 refill(s). Instructions: take 1 Capsule (30 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-05-29 15:45:56, ended at 2021-05-29 16:55:46\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Iron deficiency anemia due to blood loss\n- Chronic kidney disease stage 5\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n- Type 2 diabetes mellitus without complication\n- Cerebral infarction\n- Transient cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-05-30 12:47:58, ended at 2021-05-30 13:19:10\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-15 00:00:00, ended at 2021-06-15 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-15 00:00:00, ended at 2021-06-15 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease\n- Primary diagnosis: Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-06-15 00:00:00, ended at 2021-06-15 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 1 MG Oral Tablet, started on 2021-06-16, presumably until 2021-11-21, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-16 00:00:00, ended at 2021-06-16 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-19 00:00:00, ended at 2021-06-19 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Iron deficiency anemia due to blood loss\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-07-18 07:46:15, ended at 2021-07-18 08:03:21\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n- Essential hypertension\n- Hypertensive renal failure\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2021-07-18, presumably until 2021-09-06, with intended 3 refill(s). Instructions: take 2 Tablets (50 mg total) by mouth daily Take after dialysis on MWF.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-07-27 00:00:00, ended at 2021-07-27 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, started on 2021-07-27, presumably until 2021-12-01, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-08-22 08:15:56, ended at 2021-08-22 08:51:17\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Primary diagnosis: Iron deficiency anemia due to blood loss\n- Cerebral infarction\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-08-22 10:00:44, ended at 2021-08-22 10:35:20\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-08-30 00:00:00, ended at 2021-08-30 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2021-08-31, presumably until 2022-08-26, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-09-19 00:00:00, ended at 2021-09-19 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-09-19, presumably until 2021-09-19, with intended 3 refill(s). Instructions: take 1 Tablet (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-09-19 09:18:03, ended at 2021-09-19 09:48:09\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-10-07 00:00:00, ended at 2021-10-07 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n\n### Drug\n- allopurinol 100 MG Oral Tablet, started on 2021-10-09, presumably until 2022-07-09, with intended 3 refill(s). Instructions: TAKE 1 AND 1/2 TABLETS DAILY BY MOUTH\n- torsemide 100 MG Oral Tablet, started on 2021-10-09, presumably until 2022-08-07, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-10-20 14:46:32, ended at 2021-10-20 15:04:54\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n- Hyperparathyroidism due to renal insufficiency\n- Pruritic rash\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-17 15:47:01, ended at 2021-11-17 16:27:49\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-21 00:00:00, ended at 2021-11-21 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2021-11-21, presumably until 2022-12-28, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH DAILY AFTER A MEAL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-21 09:16:19, ended at 2021-11-21 10:02:43\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- End-stage renal disease\n- Cerebral infarction\n- Shoulder joint pain\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2021-11-30, presumably until 2022-01-19, with intended 0 refill(s). Instructions: take 12.5 mg by mouth daily \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-26 00:00:00, ended at 2021-11-26 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperparathyroidism due to renal insufficiency\n- End-stage renal disease\n\n### Drug\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2021-11-27, presumably until 2022-08-07, with intended 12 refill(s). Instructions: TAKE 4 TABS (3,200 MG TOTAL) BY MOUTH 3 TIMES A DAY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-27 00:00:00, ended at 2021-11-27 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in toe\n- Primary diagnosis: Onychomycosis due to dermatophyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-12-01 00:00:00, ended at 2021-12-01 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, through Oral route, started on 2021-12-01, presumably until 2022-03-18, with intended 0 refill(s). Instructions: take 1 Tablet by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-12-22 14:48:15, ended at 2021-12-22 15:12:34\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-03 00:00:00, ended at 2014-05-03 00:00:00\nThe patient in this visit was 66 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2014-05-03, presumably until 2017-02-22, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY DAY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-25 10:53:28, ended at 2017-04-25 12:21:06\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 722.9 (microgram per milliliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 371 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 6.2 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 6 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 33 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 6.0 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Body height: 5' 7\" (inch (US))\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 1131.3 (milligram per gram of creatinine)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 123 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.87 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 63.9 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart murmur\n- Pain in right foot\n- Cataract\n- Pure hypercholesterolemia\n- Glaucoma\n- Nicotine dependence\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2017-02-03, presumably until 2017-06-19, with intended 5 refill(s). Instructions: take 25 mg by mouth daily\n- dexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension, started on 2017-03-17, presumably until 2017-04-25, with intended 0 refill(s). Instructions: ADMINISTER 1-2 DROPS INTO THE LEFT EYE EVERY 4 (FOUR) HOURS FOR 7 DAYS. AVOID IN LACTATION.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-28 00:00:00, ended at 2017-05-28 00:00:00\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.65 ML varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection, through Subcutaneous route, started on 2017-05-31, presumably until 2017-05-31, with intended 0 refill(s). Instructions: inject 0.65 mL subcutaneous (under the skin) One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-14 10:24:38, ended at 2017-06-14 12:43:44\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Acute renal failure syndrome\n- Raised prostate specific antigen\n- Hyperkalemia\n\n### Drug\n- nepafenac 3 MG/ML Ophthalmic Suspension, started on 2017-06-10, presumably until 2017-09-23, with intended 1 refill(s). Instructions: INSTILL 1 DROP INTO LEFT EYE ONCE A DAY\n- moxifloxacin 5 MG/ML Ophthalmic Solution, started on 2017-06-10, presumably until 2017-06-14, with intended 1 refill(s). Instructions: INSTILL 1 DROP INTO LEFT EYE FOUR TIMES A DAY\n- difluprednate 0.5 MG/ML Ophthalmic Suspension, started on 2017-06-10, presumably until 2017-09-23, with intended 1 refill(s). Instructions: APPLY 1 DROP INTO LEFT EYE FOUR TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-18 00:00:00, ended at 2017-06-18 00:00:00\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.2 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Ureteric stone\n- Acute renal failure syndrome\n\n### Drug\n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, started on 2017-06-19, presumably until 2017-08-02, with intended 0 refill(s). Instructions: take 1,600 mg by mouth 3 times a day\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-06-19, presumably until 2017-07-01, with intended 0 refill(s). Instructions: take 5 mg by mouth daily Take 2 tabs by mouth daily\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-06-19, presumably until 2017-07-22, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-28 08:44:05, ended at 2017-06-28 10:25:07\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma by Electrophoresis: 3.9 (gram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.84 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis: 0.7 (gram per deciliter)\n- Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis: 1.0 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis: 0.7 (gram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: 0-10 (per high power field)\n- Lambda light chains.free [Mass/volume] in Serum or Plasma: 43.0 (milligram per liter)\n- MCV [Entitic volume] by Automated count: 97 (femtoliter)\n- Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis: 0.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis: Not Observed (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Kappa light chains [Mass/volume] in Serum or Plasma: 62.4 (milligram per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Acute renal failure syndrome\n- Chronic kidney disease due to hypertension\n- Essential hypertension\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-01 08:56:43, ended at 2017-07-01 09:34:27\nThe patient in this visit was 69 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Pure hypercholesterolemia\n- Acute renal failure syndrome\n- Essential hypertension\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic kidney disease stage 4\n- Hyperkalemia\n- Type 2 diabetes mellitus without complication\n- Ureteric stone\n- Type 2 diabetes mellitus\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2017-07-01, presumably until 2018-07-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2017-07-01, presumably until 2018-07-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-15 00:00:00, ended at 2017-07-15 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-22 00:00:00, ended at 2017-07-22 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sevelamer carbonate 800 MG Oral Tablet, started on 2017-07-23, presumably until 2017-08-02, with intended 6 refill(s). Instructions: TAKE 2 TABLETS BY MOUTH 3 TIMES A DAY WITH MEALS\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2017-07-23, presumably until 2017-10-31, with intended 6 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AFTER MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-02 11:18:16, ended at 2017-08-02 11:58:22\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Urate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Kidney stone\n- Primary diagnosis: Acute renal failure syndrome\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2017-08-02, presumably until 2018-01-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-07-17, presumably until 2018-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-16 00:00:00, ended at 2017-09-16 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.78 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 81 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 18 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Essential hypertension\n- Type 2 diabetes mellitus\n- Pure hypercholesterolemia\n- Chronic kidney disease stage 4\n- Primary diagnosis: Kidney stone\n\n### Drug\n- potassium citrate 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-09-06, presumably until 2018-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-23 08:48:51, ended at 2017-09-23 10:30:27\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.3 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 354 (picogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18 (percent)\n- Body height: 5' 7\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Chronic kidney disease stage 4\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Dependence on enabling machine or device\n- Obstructive sleep apnea syndrome\n- Renal disorder due to type 2 diabetes mellitus\n- Malaise\n- Pure hypercholesterolemia\n- Fatigue\n- Type 2 diabetes mellitus without complication\n- Type 2 diabetes mellitus\n\n### Drug\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, started on 2017-09-13, presumably until 2022-10-10, with intended 0 refill(s). Instructions: RIHNSE 1/2 TEASPOON BY MOUTH AFTER ORAL HYGEINE ROUTINE TWICE A DAY NO RINSING AFTERWARDS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-30 00:00:00, ended at 2017-09-30 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.19 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-10-31 00:00:00, ended at 2017-10-31 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2017-10-31, presumably until 2018-11-19, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AFTER MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-11 00:00:00, ended at 2017-11-11 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.51 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-15 08:29:15, ended at 2017-11-15 08:59:47\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 15.7 (nanogram per milliliter)\n- Body height: 5' 7\" (inch (US))\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 145 (picogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.84 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 260 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney stone\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Chronic kidney disease stage 4\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-26 10:35:00, ended at 2017-11-26 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Disorder of kidney and/or ureter\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-17 00:00:00, ended at 2017-12-17 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2017-12-17, presumably until 2017-12-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-25 09:12:37, ended at 2017-12-25 10:06:37\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71 (percent)\n- Body height: 5' 7\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 28 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.5 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 99 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 251 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 4\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Renal disorder due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Herpes zoster without complication\n- Nicotine dependence\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-17 08:19:42, ended at 2018-01-17 10:33:12\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 59 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.5 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 5.7 (millimole per liter)\n- Body height: 5' 7\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Protein [Mass/volume] in Urine: 415.9 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 11-30 (per high power field)\n- Protein/Creatinine [Mass Ratio] in Urine: 6350 (milligram per gram of creatinine)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.63 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 4\n- Essential hypertension\n- Vitamin D deficiency\n- Kidney stone\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- chlorthalidone 25 MG Oral Tablet, through Oral route, started on 2018-01-17, presumably until 2019-01-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-01-17, presumably until 2018-12-05, with intended 3 refill(s). Instructions: take 1 Cap by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-02-04 00:00:00, ended at 2018-02-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium citrate 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-02-04, presumably until 2018-05-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-28 00:00:00, ended at 2018-03-28 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 1 MG Oral Tablet, started on 2018-03-28, presumably until 2018-04-07, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-28 00:00:00, ended at 2018-03-28 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Protein/Creatinine [Mass Ratio] in Urine: 4714 (milligram per gram of creatinine)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.7 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Protein [Mass/volume] in Urine: 352.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.18 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-04-01 00:00:00, ended at 2018-04-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-04 13:46:43, ended at 2018-04-04 15:09:33\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 109 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 28 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.76 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 74 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 190 (microgram per deciliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 127 (picogram per milliliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 146 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 264 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 40.1 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 17 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Chronic kidney disease stage 5\n- Chronic kidney disease\n- Vitamin D deficiency\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n- Anemia in chronic kidney disease\n\n### Drug\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2018-07-15, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2019-04-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-07 10:06:27, ended at 2018-04-07 10:56:46\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.2 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Primary diagnosis: Post-herpetic neuritis\n- Essential hypertension\n- Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- glimepiride 1 MG Oral Tablet, through Oral route, started on 2018-04-07, presumably until 2019-04-03, with intended 3 refill(s). Instructions: take 0.5 mg by mouth as needed \n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2018-04-07, presumably until 2018-07-29, with intended 3 refill(s). Instructions: apply 3 Patches to skin daily\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2018-04-07, presumably until 2018-06-24, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n- triamcinolone acetonide 1 MG/ML Topical Cream, started on 2018-04-07, presumably until 2019-04-25, with intended 3 refill(s). Instructions: Apply BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-05 00:00:00, ended at 2018-05-05 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2018-05-06, presumably until 2018-05-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-08 00:00:00, ended at 2018-05-08 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.76 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 56.1 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.78 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 11-30 (per high power field)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 3399 (milligram per gram of creatinine)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 280 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Protein [Mass/volume] in Urine: 275.6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease stage 4\n- Renal disorder due to type 2 diabetes mellitus\n- Kidney stone\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-08 00:00:00, ended at 2018-05-08 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, started on 2018-05-09, presumably until 2018-05-09, with intended 0 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-13 00:00:00, ended at 2018-05-13 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.29 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-15 00:00:00, ended at 2018-05-15 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.66 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-16 00:00:00, ended at 2018-05-16 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2018-05-16, presumably until 2018-10-12, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-23 09:22:43, ended at 2018-05-23 16:08:02\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Essential hypertension\n- Primary diagnosis: Chronic kidney disease stage 5\n- Melena\n\n### Drug\n- 1 ML darbepoetin alfa 0.06 MG/ML Injection, through Subcutaneous route, started on 2018-05-23, presumably until 2019-02-04, with intended 3 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 4 weeks\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-25 00:00:00, ended at 2018-05-25 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.82 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69 (percent)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-26 00:00:00, ended at 2018-05-26 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-27 14:15:17, ended at 2018-05-27 16:55:43\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Gastrointestinal hemorrhage\n- Pure hypercholesterolemia\n- Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2018-06-02, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-02 00:00:00, ended at 2018-06-02 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Platelets [#/volume] in Blood by Automated count: 171 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.59 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 104 (femtoliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-02 13:40:26, ended at 2018-06-02 15:55:28\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic duodenal ulcer with hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-06-02, presumably until 2018-11-17, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-03 00:00:00, ended at 2018-06-03 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, started on 2018-06-03, presumably until 2018-08-01, with intended 0 refill(s). Instructions: Take 2L by mouth night before and 2L morning of procedure. Stop fluids 4hr before procedure. Instructions are forwarded to patient.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-06 00:00:00, ended at 2018-06-06 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-09 00:00:00, ended at 2018-06-09 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-13 00:00:00, ended at 2018-06-13 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-16 00:00:00, ended at 2018-06-16 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-20 00:00:00, ended at 2018-06-20 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-23 00:00:00, ended at 2018-06-23 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrointestinal hemorrhage\n\n### Drug\n- doxazosin 4 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-09-24, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-01 08:54:00, ended at 2018-07-01 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n\n### Condition\n- Chronic kidney disease stage 4\n- Chronic kidney disease due to type 2 diabetes mellitus\n- End-stage renal disease\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-01 08:58:14, ended at 2018-07-01 15:00:26\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease stage 4\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-09 00:00:00, ended at 2018-07-09 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2018-07-11, presumably until 2019-06-29, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-09 10:03:56, ended at 2018-07-09 11:09:14\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Chronic kidney disease stage 4\n- Essential hypertension\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, presumably until 2018-07-11, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- atorvastatin 40 MG Oral Tablet, through Oral route, presumably until 2018-07-21, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-15 09:50:13, ended at 2018-07-15 10:46:19\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 138 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 214 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 73 (microgram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Body height: 5' 7.008\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 25 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.83 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 197 (picogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 287 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperparathyroidism due to renal insufficiency\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n- Anemia in chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- epoetin alfa 20000 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-07-15, presumably until 2018-08-01, with intended 3 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2018-07-15, presumably until 2019-08-04, with intended 3 refill(s). Instructions: take 1.5 Tabs by mouth daily\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2018-07-15, presumably until 2019-04-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2018-07-15, presumably until 2019-03-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-21 00:00:00, ended at 2018-07-21 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2018-07-21, presumably until 2019-07-14, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-07-29 00:00:00, ended at 2018-07-29 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2018-07-29, presumably until 2018-07-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-29 11:25:00, ended at 2018-07-29 14:15:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 100 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Colonoscopy, flexible; with biopsy, single or multiple\n- Excision of Descending Colon, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Excision of Transverse Colon, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Hemorrhoids\n- Non-rheumatic aortic sclerosis\n- End-stage renal disease\n- Type 2 diabetes mellitus\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Anemia\n- Hyperlipidemia\n- Obstructive sleep apnea syndrome\n- Benign neoplasm of descending colon\n- Gout\n- Hypertensive renal failure\n- Benign neoplasm of transverse colon\n- Diverticulosis of large intestine without diverticulitis\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-01 08:38:33, ended at 2018-08-01 09:22:48\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic kidney disease stage 5\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-01 09:14:17, ended at 2018-08-01 10:47:53\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-07 09:01:20, ended at 2018-08-07 10:01:36\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Otalgia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-08-11 00:00:00, ended at 2018-08-11 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2018-08-11, presumably until 2018-08-11\n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2018-08-11, presumably until 2018-08-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-11 00:00:00, ended at 2018-08-11 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 30 ML mepivacaine hydrochloride 15 MG/ML Injection, started on 2018-08-11, presumably until 2018-08-11\n- midazolam 1 MG/ML Injectable Solution, started on 2018-08-11, presumably until 2018-08-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-11 00:00:00, ended at 2018-08-11 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for vascular shunt, or shunt revision, any type (eg, dialysis)\n\n### Condition\n- Chronic kidney disease stage 5\n- Sleep apnea\n- Hypertensive renal failure\n- Kidney stone\n- Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2018-08-11, presumably until 2018-08-11\n- cefazolin 1000 MG Injection, started on 2018-08-11, presumably until 2018-08-11\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-08-11, presumably until 2018-08-11\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-08-11, presumably until 2018-08-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-08-11, presumably until 2018-08-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-11 06:05:00, ended at 2018-08-11 12:54:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 116 (milligram per deciliter)\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Bypass Right Radial Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach\n- Arteriovenous anastomosis, open; direct, any site (eg, Cimino type) (separate procedure)\n\n### Condition\n- End-stage renal disease\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Kidney stone\n- Type 2 diabetes mellitus without complication\n- Hearing loss\n- Heart murmur\n- Non-rheumatic aortic sclerosis\n- Type 2 diabetes mellitus\n- Chronic kidney disease stage 5\n- Glaucoma\n- Hypertensive renal failure\n- Obstructive sleep apnea syndrome\n- Renal disorder due to type 2 diabetes mellitus\n- Gout\n- Hyperlipidemia\n- Anemia\n\n### Drug\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-08-11, presumably until 2018-08-11\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-08-11, presumably until 2018-08-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-12 00:00:00, ended at 2018-08-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-08-12, presumably until 2018-11-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-13 09:47:50, ended at 2018-08-13 11:32:39\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Chronic kidney disease stage 5\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-26 11:10:48, ended at 2018-08-26 11:41:12\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease stage 5\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-15 00:00:00, ended at 2018-09-15 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 6.34 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 176 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 84 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.6 (milligram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 250 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 26 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 327 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 233 (picogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Essential hypertension\n- Hyperparathyroidism due to renal insufficiency\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-18 00:00:00, ended at 2018-09-18 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-24 12:35:00, ended at 2018-09-24 14:06:21\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary gout\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Hyperparathyroidism due to renal insufficiency\n- Chronic kidney disease stage 5\n- Essential hypertension\n- Type 2 diabetes mellitus\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-24 12:35:41, ended at 2018-09-24 14:06:06\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperparathyroidism due to renal insufficiency\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n- Essential hypertension\n- Primary gout\n- Anemia in chronic kidney disease\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- doxazosin 8 MG Oral Tablet, through Oral route, started on 2018-09-24, presumably until 2019-09-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-25 00:00:00, ended at 2018-09-25 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- doxazosin 4 MG Oral Tablet, started on 2018-09-25, presumably until 2018-09-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-25 12:12:00, ended at 2018-09-25 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)\n\n### Condition\n- Acute renal failure syndrome\n- End-stage renal disease\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-25 12:12:52, ended at 2018-09-25 16:12:10\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease\n- Primary diagnosis: Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-06 00:00:00, ended at 2018-10-06 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-10 00:00:00, ended at 2018-10-10 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Protein [Mass/volume] in Urine: 192.1 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 99.1 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 1938 (milligram per gram of creatinine)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: 0-10 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 11-30 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.74 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-10 00:00:00, ended at 2018-10-10 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.90 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-12 00:00:00, ended at 2018-10-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, started on 2018-10-13, presumably until 2018-12-17, with intended 3 refill(s). Instructions: TAKE 2 TABLETS BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-20 00:00:00, ended at 2018-10-20 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic duodenal ulcer with hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2018-10-23, presumably until 2018-10-23, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-17 09:14:51, ended at 2018-11-17 12:01:18\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n- Anemia in chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 5\n- Primary diagnosis: Type 2 diabetes mellitus\n- Essential hypertension\n\n### Drug\n- hydroxyzine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-11-17, presumably until 2019-03-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-19 00:00:00, ended at 2018-11-19 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2018-11-19, presumably until 2019-11-16, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH DAILY AFTER A MEAL.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-20 00:00:00, ended at 2018-11-20 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Anemia in chronic kidney disease\n\n### Drug\n- 1 ML darbepoetin alfa 0.06 MG/ML Injection, through Subcutaneous route, started on 2018-11-20, presumably until 2019-11-20, with intended 6 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 4 weeks\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-05 00:00:00, ended at 2018-12-05 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-12-05, presumably until 2019-07-23, with intended 3 refill(s). Instructions: TAKE 1 CAP BY MOUTH EVERY 7 DAYS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-17 00:00:00, ended at 2018-12-17 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2018-12-17, presumably until 2019-06-26, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-17 00:00:00, ended at 2018-12-17 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-12-23 00:00:00, ended at 2018-12-23 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-03 00:00:00, ended at 2019-01-03 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- chlorthalidone 25 MG Oral Tablet, through Oral route, started on 2019-01-06, presumably until 2019-12-24, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-07 14:02:04, ended at 2019-01-07 15:42:05\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Hyperparathyroidism due to renal insufficiency\n- Essential hypertension\n- Chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2019-01-07, with intended 0 refill(s). Instructions: take 800 mg by mouth 3 times a day 2 tablets\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-04 00:00:00, ended at 2019-02-04 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n- Anemia in chronic kidney disease\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- 1 ML darbepoetin alfa 0.06 MG/ML Injection, through Subcutaneous route, started on 2019-02-04, presumably until 2019-02-12, with intended 12 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 4 weeks\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-04 00:00:00, ended at 2019-02-04 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 333 (microgram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.66 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 302 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 9 (percent)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.15 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 31 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 231 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 70 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-06 00:00:00, ended at 2019-02-06 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-12 00:00:00, ended at 2019-02-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Type 2 diabetes mellitus\n- Chronic kidney disease stage 5\n- Chronic kidney disease due to type 2 diabetes mellitus\n\n### Drug\n- 1 ML darbepoetin alfa 0.06 MG/ML Injection, through Subcutaneous route, started on 2019-02-12, presumably until 2019-02-18, with intended 12 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 4 weeks\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-17 00:00:00, ended at 2019-02-17 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.32 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.2 (percent)\n- Mitogen stimulated gamma interferon [Units/volume] in Blood: >10.00 (international unit per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 237 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 46 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 22 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 74 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Gamma interferon background [Units/volume] in Blood by Immunoassay: 0.02 (international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 7.6 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 333 (microgram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.13 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 259 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] in Blood: 0.02 (international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Anemia in chronic kidney disease\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Primary diagnosis: End-stage renal disease\n- Type 2 diabetes mellitus\n\n### Drug\n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-02-18, presumably until 2019-06-26, with intended 6 refill(s). Instructions: inject 0.5 mL (100 mcg total) subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-27 10:54:00, ended at 2019-02-27 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-11 00:00:00, ended at 2019-03-11 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic kidney disease stage 5\n- Type 2 diabetes mellitus\n\n### Drug\n- hydroxyzine hydrochloride 10 MG Oral Tablet, started on 2019-03-11, presumably until 2019-05-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES A DAY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-19 00:00:00, ended at 2019-03-19 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 294 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 104 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.31 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 10 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.60 (million per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 165 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 204 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.0 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 266 (microgram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 28 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-26 00:00:00, ended at 2019-03-26 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 224 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 41 (microgram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.41 (milligram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 312 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 271 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 13 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-01 00:00:00, ended at 2019-04-01 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.14 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 321 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 46 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 275 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 252 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 14 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-03 07:43:27, ended at 2019-04-03 08:23:02\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Essential hypertension\n- Primary diagnosis: Chronic kidney disease stage 5\n- Constipation\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2019-04-03, presumably until 2019-04-28, with intended 6 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 3 times a day as needed For high blood pressure (systolic BP >160)\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-04-03, presumably until 2019-04-07, with intended 3 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 2 times a day 2 tablets\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2019-04-03, presumably until 2019-08-20, with intended 3 refill(s). Instructions: take 2 Tabs (1,600 mg total) by mouth 3 times a day with meals\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2019-04-03, presumably until 2020-04-02, with intended 3 refill(s). Instructions: take 17 g by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-07 00:00:00, ended at 2019-04-07 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Constipation\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-04-07, presumably until 2020-06-02, with intended 3 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-08 00:00:00, ended at 2019-04-08 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Glaucoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-15 00:00:00, ended at 2019-04-15 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 72 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 328 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 256 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 22 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 140 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.57 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-17 00:00:00, ended at 2019-04-17 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2019-04-17, presumably until 2019-07-03, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-17 00:00:00, ended at 2019-04-17 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 1 MG Oral Tablet, started on 2019-04-17, presumably until 2020-06-02, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-25 00:00:00, ended at 2019-04-25 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- triamcinolone acetonide 1 MG/ML Topical Cream, started on 2019-04-28, presumably until 2022-10-10, with intended 2 refill(s). Instructions: APPLY TO AFFECTED AREA TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-28 00:00:00, ended at 2019-04-28 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2019-04-28, presumably until 2019-06-26, with intended 3 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 3 times a day as needed For high blood pressure (systolic BP >160)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 287 (microgram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.83 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 85 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 202 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 30 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 149 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-05-18 00:00:00, ended at 2019-05-18 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-18 00:00:00, ended at 2019-05-18 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 25 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 87 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 256 (microgram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 96 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 168 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.29 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-25 13:23:54, ended at 2019-05-25 15:43:39\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Body height: 5' 7\" (inch (US))\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Asthenia\n- Primary diagnosis: Fatigue\n- Renal disorder due to type 2 diabetes mellitus\n- Primary diagnosis: Malaise\n- Glaucoma\n- Essential hypertension\n- Non-rheumatic aortic sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-29 00:00:00, ended at 2019-05-29 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-29 07:42:51, ended at 2019-05-29 09:38:36\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 5\n- Hyperparathyroidism due to renal insufficiency\n- Anemia in chronic kidney disease\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-01 00:00:00, ended at 2019-06-01 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 5\n- Anemia in chronic kidney disease\n- Essential hypertension\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-01 00:00:00, ended at 2019-06-01 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Gamma interferon background [Units/volume] in Blood by Immunoassay: 0.02 (international unit per milliliter)\n- Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] in Blood: 0.02 (international unit per milliliter)\n- Mitogen stimulated gamma interferon [Units/volume] in Blood: >10.00 (international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-01 00:00:00, ended at 2019-06-01 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hepatitis B virus surface Ab [Units/volume] in Serum: <3.1 (milli-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-01 00:00:00, ended at 2019-06-01 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 5\n- End-stage renal disease\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-15 00:00:00, ended at 2019-06-15 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-06-15, presumably until 2020-06-14, with intended 3 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-26 10:47:13, ended at 2019-06-26 12:15:53\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution, through Intraocular route, presumably until 2020-06-09, with intended 0 refill(s). Instructions: by Ophthalmic route\n- brimonidine tartrate 1.5 MG/ML Ophthalmic Solution, presumably until 2020-10-28, with intended 0 refill(s). Instructions: 1 Drop 2 times a day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-29 00:00:00, ended at 2019-06-29 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2019-06-30, presumably until 2019-10-09, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-14 00:00:00, ended at 2019-07-14 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2019-07-14, presumably until 2020-08-10, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-04 00:00:00, ended at 2019-08-04 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n- Essential hypertension\n\n### Drug\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2019-08-04, presumably until 2020-06-02, with intended 3 refill(s). Instructions: TAKE 1.5 TABS BY MOUTH DAILY\n- torsemide 20 MG Oral Tablet, started on 2019-08-04, presumably until 2019-10-09, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-10 00:00:00, ended at 2019-08-10 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dependence on enabling machine or device\n- Primary diagnosis: Obstructive sleep apnea syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-18 14:41:57, ended at 2019-09-18 16:39:37\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Sprain of upper extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-22 00:00:00, ended at 2019-09-22 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-16 00:00:00, ended at 2019-11-16 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, started on 2019-11-17, presumably until 2019-11-17, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY 7 DAYS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-16 00:00:00, ended at 2019-11-16 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2019-11-16, presumably until 2020-12-08, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH DAILY AFTER A MEAL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-17 00:00:00, ended at 2019-11-17 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2019-11-17, presumably until 2019-11-19, with intended 3 refill(s). Instructions: take 1 Tab (2.5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-20 00:00:00, ended at 2019-12-20 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, started on 2019-12-21, presumably until 2019-12-21, with intended 11 refill(s). Instructions: TAKE 2 TABLETS BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- chlorthalidone 25 MG Oral Tablet, started on 2019-12-24, presumably until 2020-05-13, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-11 11:12:30, ended at 2020-01-11 15:08:51\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Polyneuropathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-13 00:00:00, ended at 2020-01-13 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, started on 2020-01-13, presumably until 2020-01-13, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY 7 DAYS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-08 00:00:00, ended at 2020-03-08 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-08 00:00:00, ended at 2020-03-08 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-14 00:00:00, ended at 2020-03-14 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lesion of median nerve\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-20 00:00:00, ended at 2020-03-20 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, started on 2020-03-21, presumably until 2020-03-21, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY 7 DAYS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-24 00:00:00, ended at 2020-03-24 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Melena\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-25 10:46:55, ended at 2020-03-25 11:06:18\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-08 10:35:04, ended at 2020-04-08 11:06:59\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-20 00:00:00, ended at 2020-04-20 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- hydrocortisone 0.005 MG/MG Topical Ointment, started on 2020-04-20, presumably until 2021-04-20, with intended 0 refill(s). Instructions: Apply a small amount to right forearm rash twice a day until resolved.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-25 00:00:00, ended at 2020-04-25 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transient cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-04-27 00:00:00, ended at 2020-04-27 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-04-27, presumably until 2020-04-27\n- iodixanol, through Intravenous route, started on 2020-04-27, presumably until 2020-04-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2020-04-27, presumably until 2020-04-27\n- midazolam 1 MG/ML Injectable Solution, started on 2020-04-27, presumably until 2020-04-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-27 05:50:00, ended at 2020-04-27 11:15:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 38 (percent)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 89 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n- Potassium [Moles/volume] in Blood: 4.6 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 12.9 (gram per deciliter)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Introduction of needle(s) and/or catheter(s), dialysis circuit, with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis \n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Stenosis due to any device, implant AND/OR graft\n- Aphasia\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n- Anemia in chronic kidney disease\n- Pure hypercholesterolemia\n- End-stage renal disease\n- Hypertensive renal failure\n- Inflammatory dermatosis\n- Glaucoma\n- Primary diagnosis: Chronic kidney disease stage 5\n- Transient cerebral ischemia\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2020-04-29, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-28 14:21:09, ended at 2020-04-28 14:48:23\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebrovascular disease\n- Dysphasia\n- Slurred speech\n- Disorientated\n- Primary diagnosis: Transient cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-29 00:00:00, ended at 2020-04-29 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transient cerebral ischemia\n- Slurred speech\n- Dysphasia\n- Spontaneous subarachnoid hemorrhage\n- Melena\n- Disorientated\n- Cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-06 09:03:50, ended at 2020-05-06 09:26:39\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution, through Intraocular route, presumably until 2022-02-16, with intended 0 refill(s). Instructions: by Ophthalmic route \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2020-06-02, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-13 00:00:00, ended at 2020-05-13 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral ischemia\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2020-05-06, presumably until 2020-06-02, with intended 0 refill(s). Instructions: On non-dialysis days; does not take if bp is less than 140\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysphasia\n- Primary diagnosis: Slurred speech\n- Transient cerebral ischemia\n- Cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-23 00:00:00, ended at 2020-05-23 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.62 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.5 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n- Disorder of upper gastrointestinal tract\n- Acute gastric ulcer without hemorrhage AND without perforation\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2020-05-23, presumably until 2020-07-01, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysarthria\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-31 00:00:00, ended at 2020-05-31 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebrovascular disease\n- Dysphasia\n- Primary diagnosis: Slurred speech\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-02 15:06:33, ended at 2020-06-02 15:59:23\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Constipation\n- Cerebrovascular disease\n- Primary diagnosis: Cerebral infarction\n- Gastric ulcer without hemorrhage AND without perforation\n- Dysphasia\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2020-06-02, presumably until 2020-06-09, with intended 0 refill(s). Instructions: One tablet only On non-dialysis days; does not take if bp is less than 140\n- glimepiride 1 MG Oral Tablet, through Oral route, started on 2020-06-02, presumably until 2020-07-01, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth daily As needed if blood sugar is greater than 150\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2020-06-02, presumably until 2021-05-29, with intended 0 refill(s). Instructions: take 1 Cap (250 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-09 13:22:06, ended at 2020-06-09 13:56:53\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hypertensive renal failure\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2020-06-09, presumably until 2020-10-28, with intended 3 refill(s). Instructions: On dialysis days, take after dialysis\n- dorzolamide 20 MG/ML Ophthalmic Solution, started on 2020-06-08, presumably until 2020-12-21, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-16 00:00:00, ended at 2020-06-16 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2020-06-16, presumably until 2021-01-20, with intended 1 refill(s). Instructions: take 1 Tab (75 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-21 14:16:25, ended at 2020-06-21 15:08:47\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-29 00:00:00, ended at 2020-06-29 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-01 15:50:44, ended at 2020-07-01 16:29:19\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebrovascular disease\n- Primary diagnosis: Cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-04 07:45:00, ended at 2020-07-04 23:59:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-06 00:00:00, ended at 2020-07-06 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, through Oral route, started on 2020-07-06, presumably until 2020-08-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-06 00:00:00, ended at 2020-07-06 00:00:00\nThe patient in this visit was 72 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2020-07-19, presumably until 2020-08-26, with intended 0 refill(s). Instructions: take 1 Amper (30 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-11 15:13:48, ended at 2020-07-11 15:40:54\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transient cerebral ischemia\n- Chronic kidney disease stage 5\n- Essential hypertension\n- Primary diagnosis: Cerebral infarction\n- Dysphasia\n- Type 2 diabetes mellitus without complication\n- Anemia\n- Gastric ulcer without hemorrhage AND without perforation\n- Slurred speech\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-15 00:00:00, ended at 2020-07-15 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Aphasia as late effect of cerebrovascular disease\n- Primary diagnosis: Cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 08:46:19, ended at 2020-07-29 09:16:52\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-04 00:00:00, ended at 2020-08-04 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-10 00:00:00, ended at 2020-08-10 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-08-10, presumably until 2021-08-31, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-18 15:50:00, ended at 2020-08-18 23:59:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n- Magnetic resonance angiography, head; without contrast material(s)\n\n### Condition\n- Cerebrovascular disease\n- Aphasia as late effect of cerebrovascular disease\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-19 13:19:17, ended at 2020-08-19 13:47:55\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-20 00:00:00, ended at 2020-08-20 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2020-08-26, presumably until 2020-09-18, with intended 0 refill(s). Instructions: TAKE 1 CAP (30 MG TOTAL) BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-31 00:00:00, ended at 2020-08-31 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-02 15:19:26, ended at 2020-09-02 16:06:36\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-23 00:00:00, ended at 2020-09-23 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, started on 2020-09-23, presumably until 2020-09-23, with intended 1 refill(s). Instructions: TAKE 1 CAP (30 MG TOTAL) BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-23 13:19:24, ended at 2020-09-23 13:49:26\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- torsemide 100 MG Oral Tablet, through Oral route, started on 2020-10-28, presumably until 2020-10-28, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n\n### Drug\n- allopurinol 100 MG Oral Tablet, started on 2020-10-28, presumably until 2021-10-09, with intended 3 refill(s). Instructions: TAKE 1 AND 1/2 TABLETS BY MOUTH DAILY\n- torsemide 100 MG Oral Tablet, started on 2020-10-28, presumably until 2021-10-09, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-28 13:22:06, ended at 2020-10-28 13:46:11\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n- Essential hypertension\n- Primary diagnosis: End-stage renal disease\n- Hypertensive renal failure\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2020-10-28, presumably until 2021-06-21, with intended 3 refill(s). Instructions: 50 mg daily Mon/Wed/Fri/Sun and 37.5mg daily on Tue/Thur/Sat after dialysis\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2020-10-28, presumably until 2021-11-26, with intended 3 refill(s). Instructions: take 4 Tabs (3,200 mg total) by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-29 00:00:00, ended at 2020-11-29 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n- Pruritic rash\n\n### Drug\n- hydroxyzine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2020-11-29, presumably until 2021-11-29, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth 3 times a day as needed for Itching\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-02 13:24:07, ended at 2020-12-02 13:42:54\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-06 00:00:00, ended at 2020-12-06 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2020-12-08, presumably until 2021-11-21, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH DAILY AFTER A MEAL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-21 15:07:55, ended at 2020-12-21 15:43:35\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Cerebral infarction\n- Chronic kidney disease stage 5\n- Dysphasia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-23 14:56:23, ended at 2020-12-23 15:15:08\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 15:49:21, ended at 2021-01-06 16:20:31\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-18 00:00:00, ended at 2021-01-18 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 1 MG Oral Tablet, through Oral route, started on 2021-01-18, presumably until 2021-04-17, with intended 3 refill(s). Instructions: take 0.5 Tabs (0.5 mg total) by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-18 00:00:00, ended at 2021-01-18 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-19 00:00:00, ended at 2021-01-19 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2021-02-02, presumably until 2021-02-02, with intended 1 refill(s). Instructions: take 1 Tab (75 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-20 00:00:00, ended at 2021-01-20 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2021-01-20, presumably until 2022-01-30, with intended 2 refill(s). Instructions: take 1 Tab (75 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-08 00:00:00, ended at 2021-02-08 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Anemia in chronic kidney disease\n- Primary diagnosis: Anemia\n- Iron deficiency anemia due to blood loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-09 00:00:00, ended at 2021-02-09 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, through Oral route, started on 2021-02-09, presumably until 2021-03-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-02-14 12:41:39, ended at 2021-02-14 14:25:34\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.598\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebral infarction\n- Primary diagnosis: Anemia in chronic kidney disease\n- Gastrointestinal hemorrhage\n- Primary diagnosis: Chronic kidney disease stage 5\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-14 14:06:00, ended at 2021-02-14 23:59:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, abdomen; 1 view\n\n### Condition\n- Cerebral infarction\n- Chronic kidney disease stage 5\n- Constipation\n- Anemia in chronic kidney disease\n- Gastrointestinal hemorrhage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-20 13:32:20, ended at 2021-02-20 14:03:46\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebral infarction\n- Essential hypertension\n- Chronic kidney disease stage 5\n- Iron deficiency anemia due to blood loss\n- Primary diagnosis: Gastrointestinal hemorrhage\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-03-03 10:49:32, ended at 2021-03-03 11:15:36\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-21 00:00:00, ended at 2021-03-21 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, started on 2021-03-21, presumably until 2021-04-24, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-31 00:00:00, ended at 2021-03-31 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2021-03-31, presumably until 2022-03-31, with intended 11 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-03-31 00:00:00, ended at 2021-03-31 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2021-03-31, presumably until 2021-03-31, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-03-31 10:47:16, ended at 2021-03-31 11:05:09\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-03-31 13:49:57, ended at 2021-03-31 14:44:28\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-14 00:00:00, ended at 2021-04-14 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; not otherwise specified\n\n### Condition\n- Essential hypertension\n- Anemia\n- Diverticulosis of small intestine\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2021-04-14, presumably until 2021-04-14\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2021-04-14, presumably until 2021-04-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2021-04-14, presumably until 2021-04-14\n- 2 ML alfentanil 0.5 MG/ML Injection, started on 2021-04-14, presumably until 2021-04-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2021-04-14 00:00:00, ended at 2021-04-14 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Small intestinal endoscopy, enteroscopy beyond second portion of duodenum, including ileum; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-14 10:11:00, ended at 2021-04-14 13:26:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 4.2 (milliequivalent per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 93 (milligram per deciliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 27.9 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 28.6 (milliequivalent per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n\n### Procedure\n- Small intestinal endoscopy, enteroscopy beyond second portion of duodenum, including ileum; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia in chronic kidney disease\n- End-stage renal disease\n- Diverticulosis of small intestine\n- Non-rheumatic aortic sclerosis\n- Hyperlipidemia\n- Type 2 diabetes mellitus\n- Gout\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Hypertensive renal failure\n- Obstructive sleep apnea syndrome\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-15 00:00:00, ended at 2021-04-15 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, started on 2021-04-24, presumably until 2021-07-27, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-16 00:00:00, ended at 2021-04-16 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 1 MG Oral Tablet, through Oral route, started on 2021-04-17, presumably until 2021-06-16, with intended 2 refill(s). Instructions: TAKE 0.5 TABS (0.5 MG TOTAL) BY MOUTH EVERY MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-21 10:48:15, ended at 2021-04-21 11:12:33\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-27 00:00:00, ended at 2021-04-27 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vancomycin 125 MG Oral Capsule, started on 2021-04-24, presumably until 2021-05-22, with intended 0 refill(s). Instructions: EVERY 6 HOURS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-28 00:00:00, ended at 2021-04-28 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2021-04-28, presumably until 2021-05-29, with intended 3 refill(s). Instructions: take 1 Capsule (30 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-05-29 15:45:56, ended at 2021-05-29 16:55:46\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Iron deficiency anemia due to blood loss\n- Chronic kidney disease stage 5\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n- Type 2 diabetes mellitus without complication\n- Cerebral infarction\n- Transient cerebral ischemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-05-30 12:47:58, ended at 2021-05-30 13:19:10\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-15 00:00:00, ended at 2021-06-15 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-15 00:00:00, ended at 2021-06-15 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease\n- Primary diagnosis: Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-06-15 00:00:00, ended at 2021-06-15 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- glimepiride 1 MG Oral Tablet, started on 2021-06-16, presumably until 2021-11-21, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-16 00:00:00, ended at 2021-06-16 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-19 00:00:00, ended at 2021-06-19 00:00:00\nThe patient in this visit was 73 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Iron deficiency anemia due to blood loss\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-07-18 07:46:15, ended at 2021-07-18 08:03:21\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n- Essential hypertension\n- Hypertensive renal failure\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2021-07-18, presumably until 2021-09-06, with intended 3 refill(s). Instructions: take 2 Tablets (50 mg total) by mouth daily Take after dialysis on MWF.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-07-27 00:00:00, ended at 2021-07-27 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, started on 2021-07-27, presumably until 2021-12-01, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-08-22 08:15:56, ended at 2021-08-22 08:51:17\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5\n- Primary diagnosis: Iron deficiency anemia due to blood loss\n- Cerebral infarction\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-08-22 10:00:44, ended at 2021-08-22 10:35:20\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-08-30 00:00:00, ended at 2021-08-30 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2021-08-31, presumably until 2022-08-26, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-09-19 00:00:00, ended at 2021-09-19 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-09-19, presumably until 2021-09-19, with intended 3 refill(s). Instructions: take 1 Tablet (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-09-19 09:18:03, ended at 2021-09-19 09:48:09\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-10-07 00:00:00, ended at 2021-10-07 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease\n\n### Drug\n- allopurinol 100 MG Oral Tablet, started on 2021-10-09, presumably until 2022-07-09, with intended 3 refill(s). Instructions: TAKE 1 AND 1/2 TABLETS DAILY BY MOUTH\n- torsemide 100 MG Oral Tablet, started on 2021-10-09, presumably until 2022-08-07, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-10-20 14:46:32, ended at 2021-10-20 15:04:54\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n- Hyperparathyroidism due to renal insufficiency\n- Pruritic rash\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-17 15:47:01, ended at 2021-11-17 16:27:49\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-21 00:00:00, ended at 2021-11-21 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2021-11-21, presumably until 2022-12-28, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH DAILY AFTER A MEAL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-21 09:16:19, ended at 2021-11-21 10:02:43\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- End-stage renal disease\n- Cerebral infarction\n- Shoulder joint pain\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2021-11-30, presumably until 2022-01-19, with intended 0 refill(s). Instructions: take 12.5 mg by mouth daily \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-26 00:00:00, ended at 2021-11-26 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperparathyroidism due to renal insufficiency\n- End-stage renal disease\n\n### Drug\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2021-11-27, presumably until 2022-08-07, with intended 12 refill(s). Instructions: TAKE 4 TABS (3,200 MG TOTAL) BY MOUTH 3 TIMES A DAY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-27 00:00:00, ended at 2021-11-27 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in toe\n- Primary diagnosis: Onychomycosis due to dermatophyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-12-01 00:00:00, ended at 2021-12-01 00:00:00\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexlansoprazole 60 MG Delayed Release Oral Capsule, through Oral route, started on 2021-12-01, presumably until 2022-03-18, with intended 0 refill(s). Instructions: take 1 Tablet by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-12-22 14:48:15, ended at 2021-12-22 15:12:34\nThe patient in this visit was 74 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of ischemic_stroke means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "5c463d1c1b90d61d08b0e26145f96e2efa0529100a94a726b289b41e96dab928", "prompt_hash": "1f05dc322cfd7d7a897749d0058c0087ad29fad2ea66c65e14cd41dc8668de93", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 1.0, "f1_gu_yn": [1, 1], "recall_gu_yn": [1, 1]}
{"doc_id": 8, "doc": {"person_id": 115973247, "visit_occurrence_id": 138130634, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2019-07-03 16:35:37", "visit_end_datetime": "2019-07-03 17:56:46", "visit_length_in_hours": 1.3525, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-03 16:35:37, ended at 2019-07-03 17:56:46\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n", "approximate_token_count": 102, "patient_first_visit_date": "2014-05-24 18:47:00", "patient_last_visit_date": "2023-01-11 08:18:00", "end_obs_date": "2020-07-02", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 46, "cumulated_visit_num": 46, "cumulated_approximate_token_count": 43120, "visit_cumulated": "## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 18:47:00, ended at 2014-06-01 18:22:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 56 (milligram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 945 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: <0.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 22.3 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.23 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 20 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 72 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 8.4 (microgram per deciliter)\n- Erythrocyte sedimentation rate: 18 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 203 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 428 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 6.11 (milli-international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 369 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: <8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 22 (nanogram per milliliter)\n- Lactate [Moles/volume] in Blood: 2.8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- MCH [Entitic mass] by Automated count: 26.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 9.97 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Left ventricular Ejection fraction: 42 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.66 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.0 (percent)\n- Prothrombin time (PT): 14.4 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n\n### Procedure\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Hospital discharge day management; 30 minutes or less\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Occupational therapy evaluation\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography, cervical spine; without contrast material\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n- Radiologic examination, pelvis; 1 or 2 views\n- Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours\n- Gastric emptying imaging study (eg, solid, liquid, or both)\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Lumbar puncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Computed tomography, head or brain; without contrast material\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Headache\n- Chronic pain syndrome\n- Contusion of head and/or neck\n- Disorder of function of stomach\n- Disorder of nervous system due to diabetes mellitus\n- Anxiety state\n- Cardiac arrhythmia\n- Gastroparesis syndrome\n- Iron deficiency anemia\n- Cystitis\n- Primary diagnosis: Abdominal pain\n- Congenital deformity of hip joint\n- Functional disorder of intestine\n- Neck pain\n- Persistent vomiting\n- Chronic pain\n- Right upper quadrant pain\n- Abnormal findings on diagnostic imaging of skull and head\n- Atelectasis\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Disorder of cardiovascular system\n- Induced psychotic disorder\n- Malnutrition (calorie)\n- Chest pain\n- Essential hypertension\n- Injury of trunk\n- Vomiting\n- Generalized hyperhidrosis\n- Vitamin B deficiency\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-25, presumably until 2014-05-30\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-06-01\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2014-05-26, presumably until 2018-05-10, with intended 0 refill(s). Instructions: take 6 mL by mouth 3 times a day.\n- methylprednisolone 40 MG Injection, started on 2014-05-27, presumably until 2014-05-28\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2014-02-28, presumably until 2014-06-01. Instructions: take 1 Tab by mouth as needed.\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-25, presumably until 2014-06-01\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2014-05-29, presumably until 2014-05-29\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-05-25, presumably until 2015-06-01, with intended 0 refill(s). Instructions: 40 mg by Intravenous route daily.\n- dicyclomine hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2014-06-01, presumably until 2018-05-10, with intended 0 refill(s). Instructions: take 5 mL by mouth 4 times a day.\n- thiamine hydrochloride 100 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-30, presumably until 2014-06-01\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2014-04-27, presumably until 2014-06-01. Instructions: take 1 Tab by mouth 4 times a day. With meals\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-28, presumably until 2014-05-28\n- aztreonam 1000 MG Injection, started on 2014-05-29, presumably until 2014-05-31\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-05-25, presumably until 2015-06-01, with intended 0 refill(s). Instructions: inject 0-8 Units subcutaneous (under the skin) 4 times a day before meals and bedtime.\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2014-04-16, presumably until 2014-06-01. Instructions: take 1 Tab by mouth as needed.\n- 168 HR clonidine 0.00417 MG/HR Transdermal System, through Transdermal route, started on 2014-05-28, presumably until 2014-05-30\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-26, presumably until 2014-06-01\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2014-02-28, presumably until 2014-06-01. Instructions: take 1 Tab by mouth 3 times a day as needed.\n- omeprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2014-04-27, presumably until 2014-06-01. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2015-06-01, with intended 0 refill(s). Instructions: 4 mL by Intravenous route every 6 hours.\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-06-01, presumably until 2014-06-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, presumably until 2014-06-01. Instructions: take 25 mg by mouth as needed.\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-05-29, presumably until 2014-05-31\n- verapamil hydrochloride 40 MG Oral Tablet, through Oral route, started on 2014-06-01, presumably until 2015-06-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-26\n- bethanechol chloride 5 MG Oral Tablet, through Oral route, started on 2014-05-29, presumably until 2014-05-29\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2014-05-30, presumably until 2014-05-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-30 14:00:00, ended at 2014-05-30 23:59:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Acute cerebrovascular insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-05-10 00:00:00, ended at 2018-05-10 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.45 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 33 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 21 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 29.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.02 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.22 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: 1.13 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 489 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 136 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.8 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Procalcitonin [Mass/volume] in Serum or Plasma: <0.10 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- MCH [Entitic mass] by Automated count: 15.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 9.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Base excess in Blood by calculation: 3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 10.3 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Prothrombin time (PT): 13.5 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 403 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Blood: 258 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.1 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCV [Entitic volume] by Automated count: 54.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 33 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 285 (milligram per deciliter)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-05-10 08:54:00, ended at 2018-05-15 12:41:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Base excess in Blood by calculation: 3 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Prothrombin time (PT): 13.5 (second)\n- Volume of 24 hour Urine: 1253 (milliliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCH [Entitic mass] by Automated count: 16.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: 1.13 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 122 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 403 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Blood: 282 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Normetanephrine Free [Moles/volume] in Serum or Plasma: 0.63 (nanomole per liter)\n- Sodium [Moles/volume] in Blood: 136 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 21.1 (microgram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.2 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 21 (microgram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 506 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 2.3 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.8 (second)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: <8 (nanogram per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 5 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.66 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 10.3 (nanogram per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: <0.10 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.75 (micro-international unit per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 5.22 (million per microliter)\n- MCV [Entitic volume] by Automated count: 54.8 (femtoliter)\n- Metanephrine Free [Moles/volume] in Serum or Plasma: <0.20 (nanomole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 9.2 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Collection duration of Specimen: 24 (hour)\n- Erythrocyte sedimentation rate: 33 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 285 (milligram per deciliter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 163 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 33 (percent)\n- MCHC [Mass/volume] by Automated count: 29.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.02 (thousand per microliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, chest; single view\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Computed tomography, head or brain; without contrast material\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Radiologic examination, abdomen; 1 view\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography, abdomen and pelvis; without contrast material\n\n### Condition\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Body pale\n- Nausea and vomiting\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Abdominal distension, gaseous\n- Anxiety disorder\n- Essential hypertension\n- Gastroparesis syndrome\n- Cyclical vomiting syndrome\n- Dependence on wheelchair\n- Hypertensive emergency\n- Leukocytosis\n- Opioid-induced organic mental disorder\n- Type 2 diabetes mellitus\n- Drowsy\n- Generalized anxiety disorder\n- Hypertensive urgency\n- Primary diagnosis: Chest pain\n- Diabetic ketoacidosis without coma\n- Electrocardiogram abnormal\n- Tachycardia\n- Eruption\n- Hyperosmolarity\n- Obesity\n- Hyperglycemia due to type 2 diabetes mellitus\n- Iron deficiency anemia\n- Refractory migraine\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-05-13, presumably until 2018-05-13\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2018-05-15, presumably until 2018-06-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2018-05-10, presumably until 2018-05-15\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-05-14, presumably until 2018-10-05, with intended 0 refill(s). Instructions: take 40 mg by mouth every morning\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-05-10, presumably until 2018-05-15\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2018-05-13, presumably until 2018-05-13\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Film, through Sublingual route, presumably until 2019-02-01, with intended 0 refill(s). Instructions: place 18 mg under the tongue and let dissolve every morning Patient receives in clinic. \n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-05-14, presumably until 2018-05-14\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2018-05-13, presumably until 2018-05-13\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2018-05-10, presumably until 2018-05-10\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2018-05-10, presumably until 2018-05-13\n- cetirizine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-05-13, presumably until 2018-05-15\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-05-14, presumably until 2018-06-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-05-10, presumably until 2018-05-15\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, presumably until 2018-05-15, with intended 0 refill(s). Instructions: take 50 mg by mouth 2 times a day\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-05-10, presumably until 2018-05-11\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2018-05-10, presumably until 2018-05-10\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-05-11, presumably until 2018-05-14\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-05-10, presumably until 2018-05-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-05-10, presumably until 2018-05-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-05-10, presumably until 2018-05-12\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-05-12, presumably until 2018-05-15\n- 200 ML nicardipine hydrochloride 0.2 MG/ML Injection, through Intravenous route, started on 2018-05-13, presumably until 2018-05-14\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2018-05-11, presumably until 2018-05-12\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2018-05-10, presumably until 2018-05-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-12 00:00:00, ended at 2018-06-12 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-06-24 00:00:00, ended at 2018-06-24 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 29.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 325 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 24.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 137 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.89 (million per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: <0.10 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.76 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.0 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 0.9 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- MCV [Entitic volume] by Automated count: 66.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Prothrombin time (PT): 13.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.88 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Base excess in Blood by calculation: 1 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 443 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 20.92 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 181 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 513 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-06-24 09:28:00, ended at 2018-06-27 14:25:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 0.9 (nanogram per milliliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 443 (microgram of fibrinogen equivalent unit per milliliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Procalcitonin [Mass/volume] in Serum or Plasma: <0.10 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Blood: 278 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 325 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 7.6 (micromole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 24.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Volume of 24 hour Urine: 1006 (milliliter)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 11.1 (milligram per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.3 (percent)\n- Thyroxine (T4) [Mass/volume] in Serum or Plasma: 10.3 (microgram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 20.6 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 68.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Collection duration of Urine: 24 (hour)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.88 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 97 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 22 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Left ventricular Ejection fraction: 39.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.1 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Glucagon [Mass/volume] in Serum or Plasma: 24 (picogram per milliliter)\n- MCH [Entitic mass] by Automated count: 21.5 (picogram)\n- Thyrotropin [Units/volume] in Serum or Plasma: 11.10 (micro-international unit per milliliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.0 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 137 (unit per liter)\n- Base excess in Blood by calculation: 1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.89 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 21.5 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 877 (picogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 513 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.4 (gram per deciliter)\n- Prothrombin time (PT): 13.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 20.92 (thousand per microliter)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Radiologic examination, chest; single view\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Radiologic examination, abdomen; 1 view\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Hospital discharge day management; 30 minutes or less\n- Radiologic examination, chest; 2 views\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Fecal impaction\n- Precordial pain\n- Acute systolic heart failure\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Tietze's disease\n- Cardiomyopathy\n- Dyspnea\n- Leukocytosis\n- Disorder of digestive system\n- Essential hypertension\n- Acquired absence of organ\n- Conduction disorder of the heart\n- Congestive heart failure\n- Hyperglycemia due to type 2 diabetes mellitus\n- Monoplegia of nondominant lower limb as a late effect of cerebrovascular accident\n- Chronic systolic heart failure\n- Cyclical vomiting syndrome\n- Hypertensive heart failure\n- Iron deficiency anemia\n- Primary diagnosis: Nausea and vomiting\n- Tachycardia\n- Chronic congestive heart failure\n- Dependence on wheelchair\n- Electrocardiogram abnormal\n- Gastroparesis syndrome\n- Acquired hypothyroidism\n- Fever\n- Obesity\n- Opioid abuse\n- Refractory migraine\n- Type 2 diabetes mellitus\n- Chest pain\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-06-25, presumably until 2018-06-27\n- lorazepam 0.5 MG Oral Tablet, through Sublingual route, started on 2018-06-27, presumably until 2018-07-04, with intended 0 refill(s). Instructions: place 1 Tab under the tongue and let dissolve every 4 hours as needed\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-24, presumably until 2018-06-27\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2018-06-26, presumably until 2018-06-27\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-06-24\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-06-24\n- sodium chloride 9 MG/ML Injection, started on 2018-06-24, presumably until 2018-06-24\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-06-26\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-06-26, presumably until 2018-06-27\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-06-24\n- ertapenem 1000 MG Injection, started on 2018-06-24, presumably until 2018-06-24\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2018-06-27, presumably until 2019-06-27, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed For constipation\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-06-28, presumably until 2019-06-28, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-07-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-06-25, presumably until 2019-01-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2018-06-27, presumably until 2019-01-12, with intended 0 refill(s). Instructions: take 500 mg by mouth daily\n- labetalol hydrochloride 200 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-06-25\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-06-24, presumably until 2018-09-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 6 hours as needed (For nausea)\n- capsaicin 0.25 MG/ML Topical Cream, through Topical route, started on 2018-06-27, presumably until 2018-09-07, with intended 0 refill(s). Instructions: by Topical route 3 times a day\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-06-25, presumably until 2018-06-27\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2018-06-24, presumably until 2018-06-24\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2018-06-24, presumably until 2018-06-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-06-29 00:00:00, ended at 2018-06-29 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 433 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Blood: 228 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 68.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 9.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.63 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 21.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.08 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.92 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 136 (unit per liter)\n- Globulin [Mass/volume] in Serum: 5.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 28.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-06-29 19:14:00, ended at 2018-07-04 13:41:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 136 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- MCV [Entitic volume] by Automated count: 68.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 21.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 296 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.08 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 433 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 28.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 51 - 100 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n\n### Procedure\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; single view\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Computed tomography, abdomen; without contrast material\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Hospital discharge day management; 30 minutes or less\n- Radiologic examination, abdomen; 1 view\n\n### Condition\n- Alkalosis\n- Chronic congestive heart failure\n- Chronic systolic heart failure\n- Anemia\n- Disorder of bladder\n- Gastroparesis syndrome\n- Nausea and vomiting\n- Tachycardia\n- Urinary tract infectious disease\n- Hypomagnesemia\n- Opioid dependence\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Electrocardiogram abnormal\n- Tietze's disease\n- Chest pain\n- Dyspnea\n- Steatosis of liver\n- Primary diagnosis: Cyclical vomiting syndrome\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Acute renal failure syndrome\n- Infection due to enterococcus\n- Primary diagnosis: Refractory migraine\n- Abdominal pain\n- Hypertensive heart failure\n- Low blood pressure\n\n### Drug\n- granisetron 1 MG Oral Tablet, through Oral route, started on 2018-07-04, presumably until 2018-08-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed for Nausea\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-07-02, presumably until 2018-07-04\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-06-30, presumably until 2018-07-03\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-06-30, presumably until 2018-07-04\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-29, presumably until 2018-07-04\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2018-06-30, presumably until 2018-06-30\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-06-30, presumably until 2018-07-04\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2018-06-30, presumably until 2018-07-03\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-07-01, presumably until 2018-07-04\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-07-03, presumably until 2018-07-03\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2018-06-30, presumably until 2018-07-02\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-06-29, presumably until 2018-06-30\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-06-30, presumably until 2018-07-04\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-06-29, presumably until 2018-06-29\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-06-30, presumably until 2018-07-04\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-06-30, presumably until 2018-07-04\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-07-02, presumably until 2018-07-02\n- 0.5 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-07-02, presumably until 2018-07-02\n- melatonin 3 MG Disintegrating Oral Tablet, through Oral route, started on 2018-06-30, presumably until 2018-06-30\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2018-06-30, presumably until 2018-06-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-08-15 00:00:00, ended at 2018-08-15 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 257 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 210 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 459 (thousand per microliter)\n- Base excess in Blood by calculation: 5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.51 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.32 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- MCV [Entitic volume] by Automated count: 69.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 16.46 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-08-15 07:53:00, ended at 2018-08-17 15:01:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.5 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 210 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 257 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.0 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Base excess in Blood by calculation: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 16.46 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 459 (thousand per microliter)\n- Body height: 5' 2.008\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lactate [Moles/volume] in Blood: 2.7 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.32 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 21.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 70.3 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; 30 minutes or less\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Computed tomography, head or brain; without contrast material\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Radiologic examination, chest; single view\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Electrocardiogram abnormal\n- Gastroparesis syndrome\n- Hypertensive heart failure\n- Obesity\n- Musculoskeletal finding\n- Chronic congestive heart failure\n- Chronic systolic heart failure\n- Primary diagnosis: Nausea and vomiting\n- Disorder of soft tissue\n- Dizziness and giddiness\n- Epigastric pain\n- Hypertensive urgency\n- Monoplegia of nondominant lower limb as a late effect of cerebrovascular accident\n- Tachycardia\n- Abnormal heart beat\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Chest pain\n- Dependence on wheelchair\n- Disorder of intestine\n- Dyspnea\n- Hypertensive emergency\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-08-15, presumably until 2018-08-17\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-08-15, presumably until 2018-08-17\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2018-08-15, presumably until 2018-08-15\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-08-15, presumably until 2018-08-15\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-08-15, presumably until 2018-08-17\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-08-15, presumably until 2018-08-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-08-15, presumably until 2018-08-17\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-08-15, presumably until 2018-08-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-09-02 00:00:00, ended at 2018-09-02 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 14.8 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 13.24 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.57 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.27 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.03 (micro-international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.0 (picogram)\n- MCV [Entitic volume] by Automated count: 69.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 452 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 257 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-09-02 09:28:00, ended at 2018-09-02 13:56:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 69.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 257 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.24 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.57 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.27 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- MCH [Entitic mass] by Automated count: 22.0 (picogram)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.03 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 452 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, chest; single view\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Tachycardia\n- Cerebral artery occlusion\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Chest pain\n- Electrocardiogram abnormal\n- Vomiting\n- Essential hypertension\n- Gastroparesis syndrome\n- Opioid abuse\n- Shoulder joint pain\n- Anemia\n- Palpitations\n- Cardiomegaly\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-09-02, presumably until 2018-09-02\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-09-02, presumably until 2018-09-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-09-05 00:00:00, ended at 2018-09-05 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 233 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 22.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Acetaminophen [Presence] in Urine: <2.0 (microgram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 344 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 777 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 402 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 318 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.37 (million per microliter)\n- Glucose [Mass/volume] in Blood: 212 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.65 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- MCV [Entitic volume] by Automated count: 68.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.96 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-09-05 14:38:00, ended at 2018-09-07 16:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Acetaminophen [Presence] in Urine: <2.0 (microgram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 69.7 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 318 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 402 (thousand per microliter)\n- Protein S actual/normal in Platelet poor plasma by Coagulation assay: 99 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 777 (microgram of fibrinogen equivalent unit per milliliter)\n- MCH [Entitic mass] by Automated count: 22.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Protein C actual/normal in Platelet poor plasma by Coagulation assay: 99 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 344 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 334 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 212 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.4 (micromole per liter)\n- Left ventricular Ejection fraction: 46.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.37 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.96 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.75 (milligram per deciliter)\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view\n- Hospital discharge day management; 30 minutes or less\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- Ultrasound, abdominal, real time with image documentation; complete\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Collection of venous blood by venipuncture\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Chronic congestive heart failure\n- Essential hypertension\n- Gastroparesis syndrome\n- Complication due to diabetes mellitus\n- Dehydration\n- Dependence on wheelchair\n- Dyspnea\n- Pain in right lower limb\n- Electrocardiogram abnormal\n- Heart failure\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Chest pain\n- Chronic systolic heart failure\n- Localized edema\n- Primary diagnosis: Nausea and vomiting\n- Secondary hypertension\n- Steatosis of liver\n- Hypertensive heart failure\n- Opioid abuse\n- Blood chemistry abnormal\n- Anemia\n- Large liver\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Tachycardia\n\n### Drug\n- capsaicin 0.75 MG/ML Topical Cream, through Topical route, started on 2018-09-06, presumably until 2018-09-06\n- granisetron 1 MG Oral Tablet, through Oral route, started on 2018-09-07, presumably until 2018-09-07\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-09-05, presumably until 2018-09-05\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-09-07, presumably until 2018-10-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- hydroxyzine hydrochloride 50 MG/ML Injectable Solution, through Intramuscular route, started on 2018-09-05, presumably until 2018-09-05\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-09-06, presumably until 2018-10-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (nausea)\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2018-09-07, presumably until 2018-09-07\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-09-06, presumably until 2018-09-06\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-09-05, presumably until 2018-09-05\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-09-06, presumably until 2018-09-07\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-09-05, presumably until 2018-09-05\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-09-06, presumably until 2019-09-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 6 hours as needed (For nausea)\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-09-06, presumably until 2018-09-07\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2018-09-05, presumably until 2018-09-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.50 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 21.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 67.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 471 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte sedimentation rate: 27 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 380 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 21 - 50 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.44 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 231 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.48 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 13.99 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-09-21 11:25:00, ended at 2018-10-05 19:55:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 21 - 50 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.44 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Glucose [Mass/volume] in Blood: 341 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 391 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.1 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum: 2 (beta-2 GPI IgG Ab unit)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 68.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 513 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Lactate [Moles/volume] in Blood: 3.3 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 380 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- MCH [Entitic mass] by Automated count: 22.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.99 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.68 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte sedimentation rate: 27 (millimeter per hour)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 327 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.48 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.7 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n\n### Procedure\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Radiologic examination, abdomen; 1 view\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Excision of Abdomen Skin, External Approach, Diagnostic\n- Hospital discharge day management; more than 30 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Radiologic examination, chest; single view\n- Collection of venous blood by venipuncture\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Introduction of Nutritional Substance into Central Vein, Percutaneous Approach\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Introduction of Nutritional Substance into Peripheral Vein, Percutaneous Approach\n\n### Condition\n- Anemia of chronic disease\n- Electrocardiogram abnormal\n- Inflammatory dermatosis\n- Long QT syndrome\n- Nausea and vomiting\n- Chronic congestive heart failure\n- Disorder of artery\n- Dyspnea\n- Chest pain\n- Eruption\n- Vomiting\n- Acidosis\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Constipation\n- Disorder of skin and/or subcutaneous tissue\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hypertensive urgency\n- Monoplegia of nondominant lower limb as a late effect of cerebrovascular accident\n- Subcorneal pustular dermatosis\n- Cardiomegaly\n- Hypertensive emergency\n- Hypertensive heart failure\n- Left bundle branch block\n- Non-infectious systemic inflammatory response syndrome without acute organ failure\n- Body pale\n- Chronic systolic heart failure\n- Dependence on wheelchair\n- Primary diagnosis: Essential hypertension\n- Gastroparesis syndrome\n- Type 2 diabetes mellitus\n- Leukocytosis\n- Tachycardia\n\n### Drug\n- capsaicin 0.75 MG/ML Topical Cream, through Topical route, started on 2018-09-21, presumably until 2018-09-25, with intended 0 refill(s). Instructions: 1 Tube by Topical route 3 times a day as needed To painful area.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2018-09-25, presumably until 2018-09-26\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2018-09-24, presumably until 2018-10-04\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-09-21, presumably until 2018-10-04\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-10-05, presumably until 2018-11-23, with intended 3 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 2 times a day\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-10-05, presumably until 2018-10-31, with intended 2 refill(s). Instructions: take 0.5 Tabs by mouth every morning\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-09-21, presumably until 2018-10-04\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-10-05, presumably until 2019-02-01, with intended 5 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 2 times a day\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-09-21\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-10-04, presumably until 2018-10-05\n- 20 ML chloroprocaine hydrochloride 20 MG/ML Injection, started on 2018-09-29, presumably until 2018-09-29\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2018-09-21, presumably until 2018-09-25\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2018-09-21, presumably until 2018-09-25\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-10-03, presumably until 2018-10-05, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 2 times a day\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-09-21, presumably until 2018-09-23\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-10-03, presumably until 2019-10-04, with intended 9 refill(s). Instructions: inject 1-10 Units subcutaneous (under the skin) as needed (glucose control q snack)\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2018-09-27, presumably until 2018-10-04\n- 168 HR clonidine 0.00417 MG/HR Transdermal System, through Transdermal route, started on 2018-09-25, presumably until 2018-09-25\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-11-23, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-09-21\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-09-22, presumably until 2018-10-01\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-09-21, presumably until 2018-10-01\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2018-09-23, presumably until 2018-09-25\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-09-21, presumably until 2018-09-21\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-09-21, presumably until 2018-09-23\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-10-04, presumably until 2018-10-05\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-09-22, presumably until 2018-10-05\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-09-29, presumably until 2018-09-30\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2018-09-25, presumably until 2018-09-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-19 00:00:00, ended at 2018-10-19 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.55 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.3 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 435 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 911 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 259 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.55 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.4 (picogram)\n- MCV [Entitic volume] by Automated count: 67.4 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-19 07:24:00, ended at 2018-10-19 16:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 259 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.4 (picogram)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 911 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 75 (picogram per milliliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.55 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.55 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 67.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 435 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Pulmonary ventilation (eg, aerosol or gas) and perfusion imaging\n- Radiologic examination, chest; 2 views\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Tachycardia\n- Nausea and vomiting\n- Chronic systolic heart failure\n- Abdominal pain\n- Primary diagnosis: Gastroparesis syndrome\n- Hyperglycemia due to type 2 diabetes mellitus\n- Anemia\n- Chest pain\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Hypo-osmolality and or hyponatremia\n- Type 2 diabetes mellitus\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-10-19, presumably until 2018-10-19\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-10-19, presumably until 2018-10-19\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-10-19, presumably until 2018-12-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-10-19, presumably until 2018-10-19\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2018-10-19, presumably until 2018-10-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-25 00:00:00, ended at 2018-10-25 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 20.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.17 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 233 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 398 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.90 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- MCV [Entitic volume] by Automated count: 66.5 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 32 (percent)\n- Sodium [Moles/volume] in Blood: 136 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-25 13:23:00, ended at 2018-10-25 17:38:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.90 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 32 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.17 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 136 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 233 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 20.6 (picogram)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 66.5 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 398 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Chronic congestive heart failure\n- Dizziness and giddiness\n- Chronic systolic heart failure\n- Gastroparesis syndrome\n- Hypertensive heart failure\n- Primary diagnosis: Nausea and vomiting\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Headache\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Chest pain\n- Long QT syndrome\n- Dyspnea\n- Electrocardiogram abnormal\n- Tachycardia\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-10-25, presumably until 2018-10-25\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-10-25, presumably until 2018-10-25\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2018-10-25, presumably until 2018-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-27 00:00:00, ended at 2018-10-27 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.08 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 20.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 117 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.40 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 740 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 256 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 66.3 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 332 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.80 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-10-27 06:10:00, ended at 2018-10-31 17:38:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 92 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 740 (microgram of fibrinogen equivalent unit per milliliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 67.5 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.1 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.2 (percent)\n- Body height: 5' 2\" (inch (US))\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.80 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 21.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.08 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 256 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 117 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 336 (thousand per microliter)\n\n### Procedure\n- Pulmonary ventilation (eg, aerosol or gas) and perfusion imaging\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Hospital discharge day management; 30 minutes or less\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Anemia of chronic disease\n- Anxiety disorder\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Hypertensive heart failure\n- Tachycardia\n- Dyspnea\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Localized edema\n- Monoplegia of nondominant lower limb as a late effect of cerebrovascular accident\n- Nausea and vomiting\n- Acquired absence of organ\n- Chronic pain\n- Dependence on wheelchair\n- Heartburn\n- Morbid obesity\n- Type 2 diabetes mellitus\n- Chronic systolic heart failure\n- Hypomagnesemia\n- Subcorneal pustular dermatosis\n- Abnormal findings on diagnostic imaging of lung\n- Chronic congestive heart failure\n- Disorder of digestive system\n- Primary diagnosis: Chest pain\n- Coag./bleeding tests abnormal\n- Gastroesophageal reflux disease without esophagitis\n- Gastroparesis syndrome\n- Non-infectious systemic inflammatory response syndrome without acute organ failure\n\n### Drug\n- granisetron 1 MG Oral Tablet, through Oral route, started on 2018-10-28, presumably until 2018-11-06, with intended 5 refill(s). Instructions: take 1 Tab by mouth daily as needed for Nausea\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-10-27, presumably until 2018-10-29\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-10-31, presumably until 2019-02-01, with intended 4 refill(s). Instructions: take 0.5 Tabs by mouth every morning\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-10-27, presumably until 2018-10-30\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2018-10-29, presumably until 2018-10-30\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2018-10-27, presumably until 2018-10-31\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2018-10-27, presumably until 2018-10-31\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-10-31, presumably until 2018-10-31\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-10-27, presumably until 2018-10-30\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2018-10-29, presumably until 2018-10-30\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2018-10-29, presumably until 2018-10-29\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-10-28, presumably until 2018-10-30\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-10-27, presumably until 2018-10-28\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-10-31, presumably until 2018-10-31\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-10-27, presumably until 2018-10-31\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2018-10-30, presumably until 2018-10-30\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2018-10-27, presumably until 2018-10-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-06 07:59:30, ended at 2018-11-06 09:18:32\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Dependence on wheelchair\n- Iron deficiency anemia due to blood loss\n- Primary diagnosis: Gastroparesis syndrome\n- Opioid-induced organic mental disorder\n- Chronic systolic heart failure\n- Nausea and vomiting\n- Vitamin D deficiency\n- Chronic congestive heart failure\n\n### Drug\n- granisetron 1 MG Oral Tablet, through Oral route, started on 2018-11-06, presumably until 2018-12-19, with intended 5 refill(s). Instructions: take 1 Tab by mouth daily as needed for Nausea\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2018-11-06, presumably until 2019-02-01, with intended 12 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-23 13:42:50, ended at 2018-11-23 14:55:38\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea and vomiting\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Body pale\n- Chronic congestive heart failure\n- Primary diagnosis: Arteritis\n- Anemia\n- Chronic systolic heart failure\n- Opioid-induced organic mental disorder\n\n### Drug\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-11-23, presumably until 2019-01-12, with intended 3 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-11 00:00:00, ended at 2018-12-11 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.50 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.24 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 295 (milligram per deciliter)\n- Prothrombin time (PT): 13.0 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 420 (microgram of fibrinogen equivalent unit per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.63 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- MCV [Entitic volume] by Automated count: 61.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 375 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 18.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.8 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-12-11 11:06:00, ended at 2018-12-19 11:25:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Iron [Mass/volume] in Serum or Plasma: 24 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 15.92 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.64 (milligram per deciliter)\n- Left ventricular Ejection fraction: 45.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Blood: 317 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 309 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 61.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.9 (second)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 420 (microgram of fibrinogen equivalent unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 97 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 399 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.66 (micro-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 18.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.51 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 72 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 162 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Body height: 5' 2\" (inch (US))\n- Ferritin [Mass/volume] in Serum or Plasma: 14.8 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.30 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.36 (million per microliter)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Hospital discharge day management; more than 30 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Esophagogastroduodenoscopy, flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Inspection of Upper Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n- Radiologic examination, chest; 2 views\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Collection of venous blood by venipuncture\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Chronic diastolic heart failure\n- Type 2 diabetes mellitus\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Disorder of artery\n- Megaloblastic anemia due to folate deficiency\n- Nausea and vomiting\n- Opioid dependence\n- Organic mental disorder\n- Asthenia\n- Chest pain\n- Electrocardiogram abnormal\n- Hip pain\n- Chronic systolic heart failure\n- Cyclical vomiting syndrome\n- Dyspnea\n- Epigastric pain\n- Essential hypertension\n- Obesity\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hypertensive emergency\n- Acquired absence of organ\n- Chronic congestive heart failure\n- Congenital anomaly of lower limb\n- Hypertensive heart failure\n- Migraine\n- Monoplegia of nondominant lower limb as a late effect of cerebrovascular accident\n- Primary diagnosis: Tachycardia\n- Disorder of digestive system\n- Gastroparesis syndrome\n- Hypo-osmolality and or hyponatremia\n- Iron deficiency anemia\n- Iron deficiency anemia due to blood loss\n- Old myocardial infarction\n- Opioid-induced organic mental disorder\n- Acidosis\n- Body pale\n- Dependence on wheelchair\n- Precordial pain\n- Chronic pain\n- Congestive heart failure\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2018-12-14, presumably until 2018-12-16\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2018-12-12, presumably until 2018-12-12\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-12-11, presumably until 2018-12-15\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-12-18, presumably until 2018-12-19\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-12-17, presumably until 2018-12-17\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-12-11, presumably until 2018-12-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-12-17, presumably until 2018-12-19\n- hydroxyzine hydrochloride 50 MG/ML Injectable Solution, through Intramuscular route, started on 2018-12-15, presumably until 2018-12-15\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2018-12-12, presumably until 2018-12-17\n- 168 HR clonidine 0.00833 MG/HR Transdermal System, through Transdermal route, started on 2018-12-15, presumably until 2019-02-01, with intended 0 refill(s). Instructions: apply 1 Patch to skin every 7 days\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2018-12-11, presumably until 2018-12-11\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-12-18, presumably until 2019-01-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2018-12-15, presumably until 2018-12-15\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-12-12, presumably until 2018-12-19\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-12-11, presumably until 2018-12-15\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-12-11, presumably until 2018-12-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-12-18, presumably until 2018-12-19\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-12-12, presumably until 2018-12-13\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-12-11, presumably until 2018-12-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-12-12, presumably until 2018-12-13\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2018-12-11, presumably until 2018-12-11\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-12-12, presumably until 2018-12-19\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2018-12-11, presumably until 2018-12-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-12-12 00:00:00, ended at 2018-12-12 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Esophagogastroduodenoscopy, flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-12-12 00:00:00, ended at 2018-12-12 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; not otherwise specified\n\n### Condition\n- Chest pain\n- Dyspnea\n- Epigastric pain\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Nausea and vomiting\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2018-12-12, presumably until 2018-12-12\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-12-12, presumably until 2018-12-12\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-12-12, presumably until 2018-12-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-12-12, presumably until 2018-12-12\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2018-12-12, presumably until 2018-12-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-12 13:06:47, ended at 2019-01-12 14:23:14\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroparesis syndrome\n- Nausea and vomiting\n- Chest pain\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, started on 2019-01-12, presumably until 2019-02-01, with intended 3 refill(s). Instructions: Use 18 units every morning and 15 units every night.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-01-12, presumably until 2019-02-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2019-01-12, presumably until 2019-02-28, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2019-01-12, presumably until 2019-02-01, with intended 12 refill(s). Instructions: take 1,000 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-01 00:00:00, ended at 2019-02-01 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 64.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 150 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 28.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Glucose [Mass/volume] in Blood: 361 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 18.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 10.29 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.47 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.47 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 351 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 355 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-01 11:22:00, ended at 2019-02-02 09:53:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 18.5 (picogram)\n- MCV [Entitic volume] by Automated count: 64.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.29 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 150 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 351 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.47 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.47 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 355 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 361 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.1 (percent)\n- MCHC [Mass/volume] by Automated count: 28.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; without contrast material\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Computed tomography, maxillofacial area; without contrast material\n- Radiologic examination, chest; 2 views\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Computed tomography, cervical spine; without contrast material\n- Hospital discharge day management; 30 minutes or less\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Primary diagnosis: Neck pain\n- Anesthesia of skin\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Chronic congestive heart failure\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Dental caries\n- Headache\n- Gastroparesis syndrome\n- Hypertensive heart failure\n- Chronic systolic heart failure\n- Dependence on wheelchair\n- Periodontal disease\n- Dizziness and giddiness\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film, through Sublingual route, presumably until 2019-02-01, with intended 0 refill(s). Instructions: place under the tongue and let dissolve\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2019-03-29, with intended 0 refill(s). Instructions: take 40 mg by mouth every morning\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2019-02-01, presumably until 2019-02-01\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-02-01, presumably until 2019-02-01\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, presumably until 2019-07-31, with intended 0 refill(s). Instructions: place 1 Tab under the tongue and let dissolve every morning Total 18mg daily. Daily dose given in pain clinic.\n- buprenorphine 8 MG Sublingual Tablet, through Sublingual route, presumably until 2019-02-01, with intended 0 refill(s). Instructions: place 16 mg under the tongue and let dissolve every morning Total 18mg daily. Administered in pain clinic.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-02-01, presumably until 2019-02-02\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2019-02-02, presumably until 2019-02-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- buprenorphine 2 MG Sublingual Tablet, through Sublingual route, presumably until 2019-02-01, with intended 0 refill(s). Instructions: place 2 mg under the tongue and let dissolve every morning Total 18mg daily. Administered in pain clinic.\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2021-07-08, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, presumably until 2019-03-29, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) 2 times a day before meals\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2020-01-31, with intended 0 refill(s). Instructions: inject 0-12 Units subcutaneous (under the skin) 3 times a day before meals Per sliding scale for BS > 150\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2019-02-01, presumably until 2019-02-02\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, presumably until 2019-10-01, with intended 0 refill(s). Instructions: Take 1000mg in the AM and 500mg in the PM\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2019-02-01, presumably until 2019-02-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-02-02, presumably until 2019-02-02\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2019-02-02, presumably until 2019-07-31, with intended 0 refill(s). Instructions: place 2 Tabs under the tongue and let dissolve every morning Total 18mg daily. Daily dose given in pain clinic.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-02 00:00:00, ended at 2019-02-02 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-06-06, presumably until 2019-06-06, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-05 13:30:17, ended at 2019-02-05 14:56:54\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroparesis syndrome\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-02-05, presumably until 2019-02-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-28 16:13:43, ended at 2019-02-28 17:01:48\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroparesis syndrome\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-02-28, presumably until 2019-03-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2019-02-28, presumably until 2020-02-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2019-02-28, presumably until 2019-05-16, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-15 00:00:00, ended at 2019-03-15 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-03-21, presumably until 2019-07-31, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-29 13:24:37, ended at 2019-03-29 14:34:35\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic congestive heart failure\n- Dependence on wheelchair\n- Gastroparesis syndrome\n- Essential hypertension\n- Chronic systolic heart failure\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- empagliflozin 10 MG Oral Tablet, through Oral route, started on 2019-03-29, presumably until 2019-06-26, with intended 5 refill(s). Instructions: take 10 mg by mouth every day\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2019-03-29, presumably until 2020-08-15, with intended 12 refill(s). Instructions: take 1 Tab (40 mg total) by mouth every morning\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-03-29, presumably until 2019-06-26, with intended 5 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-03-29, presumably until 2019-06-26, with intended 5 refill(s). Instructions: Inject 35 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-10 14:40:58, ended at 2019-04-10 16:34:03\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 434 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-12 00:00:00, ended at 2019-04-12 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus\n- Body pale\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-13 00:00:00, ended at 2019-04-13 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperosmolarity\n- Primary diagnosis: Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-16 00:00:00, ended at 2019-05-16 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 6.25 MG Oral Tablet, started on 2019-05-16, presumably until 2019-07-31, with intended 11 refill(s). Instructions: TAKE 2 TABLETS BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-26 00:00:00, ended at 2019-06-26 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-06-27, presumably until 2019-06-27, with intended 5 refill(s). Instructions: Inject 35 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-26 15:00:16, ended at 2019-06-26 16:23:25\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic systolic heart failure\n- Primary diagnosis: Complication due to diabetes mellitus\n- Chronic congestive heart failure\n- Acute systolic heart failure\n- Primary diagnosis: Type 2 diabetes mellitus\n- Disorder of artery\n- Secondary hypertension\n- Congestive heart failure\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2019-06-26, presumably until 2019-07-31, with intended 0 refill(s). Instructions: take 0.5 Tabs (12.5 mg total) by mouth daily\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-06-26, presumably until 2021-07-08, with intended 5 refill(s). Instructions: take 1.5 Tabs (7.5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-28 00:00:00, ended at 2019-06-28 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-03 16:21:50, ended at 2019-07-03 16:32:23\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Tachycardia\n- Disorder of artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-03 16:35:37, ended at 2019-07-03 17:56:46\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-05-24 18:47:00, ended at 2014-06-01 18:22:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 56 (milligram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 945 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: <0.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 22.3 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.23 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 20 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 72 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 8.4 (microgram per deciliter)\n- Erythrocyte sedimentation rate: 18 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 203 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 428 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 6.11 (milli-international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 369 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: <8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 22 (nanogram per milliliter)\n- Lactate [Moles/volume] in Blood: 2.8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- MCH [Entitic mass] by Automated count: 26.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 9.97 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Left ventricular Ejection fraction: 42 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.66 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.0 (percent)\n- Prothrombin time (PT): 14.4 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n\n### Procedure\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Hospital discharge day management; 30 minutes or less\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Occupational therapy evaluation\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography, cervical spine; without contrast material\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n- Radiologic examination, pelvis; 1 or 2 views\n- Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours\n- Gastric emptying imaging study (eg, solid, liquid, or both)\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Lumbar puncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Computed tomography, head or brain; without contrast material\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Headache\n- Chronic pain syndrome\n- Contusion of head and/or neck\n- Disorder of function of stomach\n- Disorder of nervous system due to diabetes mellitus\n- Anxiety state\n- Cardiac arrhythmia\n- Gastroparesis syndrome\n- Iron deficiency anemia\n- Cystitis\n- Primary diagnosis: Abdominal pain\n- Congenital deformity of hip joint\n- Functional disorder of intestine\n- Neck pain\n- Persistent vomiting\n- Chronic pain\n- Right upper quadrant pain\n- Abnormal findings on diagnostic imaging of skull and head\n- Atelectasis\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Disorder of cardiovascular system\n- Induced psychotic disorder\n- Malnutrition (calorie)\n- Chest pain\n- Essential hypertension\n- Injury of trunk\n- Vomiting\n- Generalized hyperhidrosis\n- Vitamin B deficiency\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2014-05-24\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-25, presumably until 2014-05-30\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2014-05-24, presumably until 2014-06-01\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2014-05-26, presumably until 2018-05-10, with intended 0 refill(s). Instructions: take 6 mL by mouth 3 times a day.\n- methylprednisolone 40 MG Injection, started on 2014-05-27, presumably until 2014-05-28\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2014-02-28, presumably until 2014-06-01. Instructions: take 1 Tab by mouth as needed.\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-25, presumably until 2014-06-01\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2014-05-29, presumably until 2014-05-29\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-05-25, presumably until 2015-06-01, with intended 0 refill(s). Instructions: 40 mg by Intravenous route daily.\n- dicyclomine hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2014-06-01, presumably until 2018-05-10, with intended 0 refill(s). Instructions: take 5 mL by mouth 4 times a day.\n- thiamine hydrochloride 100 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-30, presumably until 2014-06-01\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2014-04-27, presumably until 2014-06-01. Instructions: take 1 Tab by mouth 4 times a day. With meals\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2014-05-28, presumably until 2014-05-28\n- aztreonam 1000 MG Injection, started on 2014-05-29, presumably until 2014-05-31\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-05-25, presumably until 2015-06-01, with intended 0 refill(s). Instructions: inject 0-8 Units subcutaneous (under the skin) 4 times a day before meals and bedtime.\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2014-04-16, presumably until 2014-06-01. Instructions: take 1 Tab by mouth as needed.\n- 168 HR clonidine 0.00417 MG/HR Transdermal System, through Transdermal route, started on 2014-05-28, presumably until 2014-05-30\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-26, presumably until 2014-06-01\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2014-02-28, presumably until 2014-06-01. Instructions: take 1 Tab by mouth 3 times a day as needed.\n- omeprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2014-04-27, presumably until 2014-06-01. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, through Intravenous route, started on 2014-05-24, presumably until 2015-06-01, with intended 0 refill(s). Instructions: 4 mL by Intravenous route every 6 hours.\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-06-01, presumably until 2014-06-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, presumably until 2014-06-01. Instructions: take 25 mg by mouth as needed.\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-05-29, presumably until 2014-05-31\n- verapamil hydrochloride 40 MG Oral Tablet, through Oral route, started on 2014-06-01, presumably until 2015-06-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2014-05-24, presumably until 2014-05-26\n- bethanechol chloride 5 MG Oral Tablet, through Oral route, started on 2014-05-29, presumably until 2014-05-29\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2014-05-30, presumably until 2014-05-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-30 14:00:00, ended at 2014-05-30 23:59:00\nThe patient in this visit was 31 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Acute cerebrovascular insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-05-10 00:00:00, ended at 2018-05-10 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.45 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 33 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 21 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 29.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.02 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.22 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: 1.13 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 489 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 136 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.8 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Procalcitonin [Mass/volume] in Serum or Plasma: <0.10 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- MCH [Entitic mass] by Automated count: 15.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 9.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Base excess in Blood by calculation: 3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 10.3 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Prothrombin time (PT): 13.5 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 403 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Blood: 258 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.1 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCV [Entitic volume] by Automated count: 54.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 33 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 285 (milligram per deciliter)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-05-10 08:54:00, ended at 2018-05-15 12:41:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Base excess in Blood by calculation: 3 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Prothrombin time (PT): 13.5 (second)\n- Volume of 24 hour Urine: 1253 (milliliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCH [Entitic mass] by Automated count: 16.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: 1.13 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 122 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 403 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Blood: 282 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Normetanephrine Free [Moles/volume] in Serum or Plasma: 0.63 (nanomole per liter)\n- Sodium [Moles/volume] in Blood: 136 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 21.1 (microgram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.2 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 21 (microgram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 506 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 2.3 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.8 (second)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: <8 (nanogram per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 5 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.66 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 10.3 (nanogram per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: <0.10 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.75 (micro-international unit per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 5.22 (million per microliter)\n- MCV [Entitic volume] by Automated count: 54.8 (femtoliter)\n- Metanephrine Free [Moles/volume] in Serum or Plasma: <0.20 (nanomole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 9.2 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Collection duration of Specimen: 24 (hour)\n- Erythrocyte sedimentation rate: 33 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 285 (milligram per deciliter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 163 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 33 (percent)\n- MCHC [Mass/volume] by Automated count: 29.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.02 (thousand per microliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, chest; single view\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Computed tomography, head or brain; without contrast material\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Radiologic examination, abdomen; 1 view\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography, abdomen and pelvis; without contrast material\n\n### Condition\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Body pale\n- Nausea and vomiting\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Abdominal distension, gaseous\n- Anxiety disorder\n- Essential hypertension\n- Gastroparesis syndrome\n- Cyclical vomiting syndrome\n- Dependence on wheelchair\n- Hypertensive emergency\n- Leukocytosis\n- Opioid-induced organic mental disorder\n- Type 2 diabetes mellitus\n- Drowsy\n- Generalized anxiety disorder\n- Hypertensive urgency\n- Primary diagnosis: Chest pain\n- Diabetic ketoacidosis without coma\n- Electrocardiogram abnormal\n- Tachycardia\n- Eruption\n- Hyperosmolarity\n- Obesity\n- Hyperglycemia due to type 2 diabetes mellitus\n- Iron deficiency anemia\n- Refractory migraine\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2018-05-13, presumably until 2018-05-13\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2018-05-15, presumably until 2018-06-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2018-05-10, presumably until 2018-05-15\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-05-14, presumably until 2018-10-05, with intended 0 refill(s). Instructions: take 40 mg by mouth every morning\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-05-10, presumably until 2018-05-15\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2018-05-13, presumably until 2018-05-13\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Film, through Sublingual route, presumably until 2019-02-01, with intended 0 refill(s). Instructions: place 18 mg under the tongue and let dissolve every morning Patient receives in clinic. \n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-05-14, presumably until 2018-05-14\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2018-05-13, presumably until 2018-05-13\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2018-05-10, presumably until 2018-05-10\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2018-05-10, presumably until 2018-05-13\n- cetirizine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-05-13, presumably until 2018-05-15\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-05-14, presumably until 2018-06-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-05-10, presumably until 2018-05-15\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, presumably until 2018-05-15, with intended 0 refill(s). Instructions: take 50 mg by mouth 2 times a day\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-05-10, presumably until 2018-05-11\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2018-05-10, presumably until 2018-05-10\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-05-11, presumably until 2018-05-14\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-05-10, presumably until 2018-05-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-05-10, presumably until 2018-05-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-05-10, presumably until 2018-05-12\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-05-12, presumably until 2018-05-15\n- 200 ML nicardipine hydrochloride 0.2 MG/ML Injection, through Intravenous route, started on 2018-05-13, presumably until 2018-05-14\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2018-05-11, presumably until 2018-05-12\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2018-05-10, presumably until 2018-05-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-12 00:00:00, ended at 2018-06-12 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-06-24 00:00:00, ended at 2018-06-24 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 29.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 325 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 24.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 137 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.89 (million per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: <0.10 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.76 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.0 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 0.9 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- MCV [Entitic volume] by Automated count: 66.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Prothrombin time (PT): 13.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.88 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Base excess in Blood by calculation: 1 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 443 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 20.92 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 181 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 513 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-06-24 09:28:00, ended at 2018-06-27 14:25:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 0.9 (nanogram per milliliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 443 (microgram of fibrinogen equivalent unit per milliliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Procalcitonin [Mass/volume] in Serum or Plasma: <0.10 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Blood: 278 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 325 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 7.6 (micromole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 24.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Volume of 24 hour Urine: 1006 (milliliter)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 11.1 (milligram per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.3 (percent)\n- Thyroxine (T4) [Mass/volume] in Serum or Plasma: 10.3 (microgram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 20.6 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 68.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Collection duration of Urine: 24 (hour)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.88 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 97 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 22 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Left ventricular Ejection fraction: 39.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.1 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Glucagon [Mass/volume] in Serum or Plasma: 24 (picogram per milliliter)\n- MCH [Entitic mass] by Automated count: 21.5 (picogram)\n- Thyrotropin [Units/volume] in Serum or Plasma: 11.10 (micro-international unit per milliliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.0 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 137 (unit per liter)\n- Base excess in Blood by calculation: 1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.89 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 21.5 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 877 (picogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 513 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.4 (gram per deciliter)\n- Prothrombin time (PT): 13.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 20.92 (thousand per microliter)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Radiologic examination, chest; single view\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Radiologic examination, abdomen; 1 view\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Hospital discharge day management; 30 minutes or less\n- Radiologic examination, chest; 2 views\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Fecal impaction\n- Precordial pain\n- Acute systolic heart failure\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Tietze's disease\n- Cardiomyopathy\n- Dyspnea\n- Leukocytosis\n- Disorder of digestive system\n- Essential hypertension\n- Acquired absence of organ\n- Conduction disorder of the heart\n- Congestive heart failure\n- Hyperglycemia due to type 2 diabetes mellitus\n- Monoplegia of nondominant lower limb as a late effect of cerebrovascular accident\n- Chronic systolic heart failure\n- Cyclical vomiting syndrome\n- Hypertensive heart failure\n- Iron deficiency anemia\n- Primary diagnosis: Nausea and vomiting\n- Tachycardia\n- Chronic congestive heart failure\n- Dependence on wheelchair\n- Electrocardiogram abnormal\n- Gastroparesis syndrome\n- Acquired hypothyroidism\n- Fever\n- Obesity\n- Opioid abuse\n- Refractory migraine\n- Type 2 diabetes mellitus\n- Chest pain\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-06-25, presumably until 2018-06-27\n- lorazepam 0.5 MG Oral Tablet, through Sublingual route, started on 2018-06-27, presumably until 2018-07-04, with intended 0 refill(s). Instructions: place 1 Tab under the tongue and let dissolve every 4 hours as needed\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-24, presumably until 2018-06-27\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2018-06-26, presumably until 2018-06-27\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-06-24\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-06-24\n- sodium chloride 9 MG/ML Injection, started on 2018-06-24, presumably until 2018-06-24\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-06-26\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-06-26, presumably until 2018-06-27\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-06-24\n- ertapenem 1000 MG Injection, started on 2018-06-24, presumably until 2018-06-24\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2018-06-27, presumably until 2019-06-27, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed For constipation\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-06-28, presumably until 2019-06-28, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-07-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-06-25, presumably until 2019-01-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2018-06-27, presumably until 2019-01-12, with intended 0 refill(s). Instructions: take 500 mg by mouth daily\n- labetalol hydrochloride 200 MG Oral Tablet, through Oral route, started on 2018-06-24, presumably until 2018-06-25\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-06-24, presumably until 2018-09-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 6 hours as needed (For nausea)\n- capsaicin 0.25 MG/ML Topical Cream, through Topical route, started on 2018-06-27, presumably until 2018-09-07, with intended 0 refill(s). Instructions: by Topical route 3 times a day\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-06-25, presumably until 2018-06-27\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2018-06-24, presumably until 2018-06-24\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2018-06-24, presumably until 2018-06-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-06-29 00:00:00, ended at 2018-06-29 00:00:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 433 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Blood: 228 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 68.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 9.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.63 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 21.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.08 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.92 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 136 (unit per liter)\n- Globulin [Mass/volume] in Serum: 5.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 28.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-06-29 19:14:00, ended at 2018-07-04 13:41:00\nThe patient in this visit was 35 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 136 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- MCV [Entitic volume] by Automated count: 68.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 21.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 296 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.08 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 433 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 28.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 51 - 100 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n\n### Procedure\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; single view\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Computed tomography, abdomen; without contrast material\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Hospital discharge day management; 30 minutes or less\n- Radiologic examination, abdomen; 1 view\n\n### Condition\n- Alkalosis\n- Chronic congestive heart failure\n- Chronic systolic heart failure\n- Anemia\n- Disorder of bladder\n- Gastroparesis syndrome\n- Nausea and vomiting\n- Tachycardia\n- Urinary tract infectious disease\n- Hypomagnesemia\n- Opioid dependence\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Electrocardiogram abnormal\n- Tietze's disease\n- Chest pain\n- Dyspnea\n- Steatosis of liver\n- Primary diagnosis: Cyclical vomiting syndrome\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Acute renal failure syndrome\n- Infection due to enterococcus\n- Primary diagnosis: Refractory migraine\n- Abdominal pain\n- Hypertensive heart failure\n- Low blood pressure\n\n### Drug\n- granisetron 1 MG Oral Tablet, through Oral route, started on 2018-07-04, presumably until 2018-08-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed for Nausea\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-07-02, presumably until 2018-07-04\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-06-30, presumably until 2018-07-03\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-06-30, presumably until 2018-07-04\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-29, presumably until 2018-07-04\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2018-06-30, presumably until 2018-06-30\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-06-30, presumably until 2018-07-04\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2018-06-30, presumably until 2018-07-03\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-07-01, presumably until 2018-07-04\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-07-03, presumably until 2018-07-03\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2018-06-30, presumably until 2018-07-02\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-06-29, presumably until 2018-06-30\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-06-30, presumably until 2018-07-04\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-06-29, presumably until 2018-06-29\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-06-30, presumably until 2018-07-04\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-06-30, presumably until 2018-07-04\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-07-02, presumably until 2018-07-02\n- 0.5 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-07-02, presumably until 2018-07-02\n- melatonin 3 MG Disintegrating Oral Tablet, through Oral route, started on 2018-06-30, presumably until 2018-06-30\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2018-06-30, presumably until 2018-06-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-08-15 00:00:00, ended at 2018-08-15 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 257 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 210 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 459 (thousand per microliter)\n- Base excess in Blood by calculation: 5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.51 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.32 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- MCV [Entitic volume] by Automated count: 69.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 16.46 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-08-15 07:53:00, ended at 2018-08-17 15:01:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.5 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 210 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 257 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.0 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Base excess in Blood by calculation: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 16.46 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 459 (thousand per microliter)\n- Body height: 5' 2.008\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lactate [Moles/volume] in Blood: 2.7 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.32 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 21.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 70.3 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; 30 minutes or less\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Computed tomography, head or brain; without contrast material\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Radiologic examination, chest; single view\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Electrocardiogram abnormal\n- Gastroparesis syndrome\n- Hypertensive heart failure\n- Obesity\n- Musculoskeletal finding\n- Chronic congestive heart failure\n- Chronic systolic heart failure\n- Primary diagnosis: Nausea and vomiting\n- Disorder of soft tissue\n- Dizziness and giddiness\n- Epigastric pain\n- Hypertensive urgency\n- Monoplegia of nondominant lower limb as a late effect of cerebrovascular accident\n- Tachycardia\n- Abnormal heart beat\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Chest pain\n- Dependence on wheelchair\n- Disorder of intestine\n- Dyspnea\n- Hypertensive emergency\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-08-15, presumably until 2018-08-17\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-08-15, presumably until 2018-08-17\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2018-08-15, presumably until 2018-08-15\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-08-15, presumably until 2018-08-15\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-08-15, presumably until 2018-08-17\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-08-15, presumably until 2018-08-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-08-15, presumably until 2018-08-17\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-08-15, presumably until 2018-08-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-09-02 00:00:00, ended at 2018-09-02 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 14.8 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 13.24 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.57 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.27 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.03 (micro-international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.0 (picogram)\n- MCV [Entitic volume] by Automated count: 69.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 452 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 257 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-09-02 09:28:00, ended at 2018-09-02 13:56:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 69.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 257 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.24 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.57 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.27 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- MCH [Entitic mass] by Automated count: 22.0 (picogram)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.03 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 452 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, chest; single view\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Tachycardia\n- Cerebral artery occlusion\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Chest pain\n- Electrocardiogram abnormal\n- Vomiting\n- Essential hypertension\n- Gastroparesis syndrome\n- Opioid abuse\n- Shoulder joint pain\n- Anemia\n- Palpitations\n- Cardiomegaly\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-09-02, presumably until 2018-09-02\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-09-02, presumably until 2018-09-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-09-05 00:00:00, ended at 2018-09-05 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 233 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 22.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Acetaminophen [Presence] in Urine: <2.0 (microgram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 344 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 777 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 402 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 318 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.37 (million per microliter)\n- Glucose [Mass/volume] in Blood: 212 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.65 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- MCV [Entitic volume] by Automated count: 68.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.96 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-09-05 14:38:00, ended at 2018-09-07 16:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Acetaminophen [Presence] in Urine: <2.0 (microgram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 69.7 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 318 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 402 (thousand per microliter)\n- Protein S actual/normal in Platelet poor plasma by Coagulation assay: 99 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 777 (microgram of fibrinogen equivalent unit per milliliter)\n- MCH [Entitic mass] by Automated count: 22.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Protein C actual/normal in Platelet poor plasma by Coagulation assay: 99 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 344 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 334 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 212 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.4 (micromole per liter)\n- Left ventricular Ejection fraction: 46.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.37 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.96 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.75 (milligram per deciliter)\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view\n- Hospital discharge day management; 30 minutes or less\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- Ultrasound, abdominal, real time with image documentation; complete\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Collection of venous blood by venipuncture\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Chronic congestive heart failure\n- Essential hypertension\n- Gastroparesis syndrome\n- Complication due to diabetes mellitus\n- Dehydration\n- Dependence on wheelchair\n- Dyspnea\n- Pain in right lower limb\n- Electrocardiogram abnormal\n- Heart failure\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Chest pain\n- Chronic systolic heart failure\n- Localized edema\n- Primary diagnosis: Nausea and vomiting\n- Secondary hypertension\n- Steatosis of liver\n- Hypertensive heart failure\n- Opioid abuse\n- Blood chemistry abnormal\n- Anemia\n- Large liver\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Tachycardia\n\n### Drug\n- capsaicin 0.75 MG/ML Topical Cream, through Topical route, started on 2018-09-06, presumably until 2018-09-06\n- granisetron 1 MG Oral Tablet, through Oral route, started on 2018-09-07, presumably until 2018-09-07\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-09-05, presumably until 2018-09-05\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2018-09-07, presumably until 2018-10-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- hydroxyzine hydrochloride 50 MG/ML Injectable Solution, through Intramuscular route, started on 2018-09-05, presumably until 2018-09-05\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-09-06, presumably until 2018-10-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (nausea)\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2018-09-07, presumably until 2018-09-07\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-09-06, presumably until 2018-09-06\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-09-05, presumably until 2018-09-05\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-09-06, presumably until 2018-09-07\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-09-05, presumably until 2018-09-05\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-09-06, presumably until 2019-09-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 6 hours as needed (For nausea)\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-09-06, presumably until 2018-09-07\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2018-09-05, presumably until 2018-09-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.50 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 21.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 67.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 471 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte sedimentation rate: 27 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 380 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 21 - 50 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.44 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 231 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.48 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 13.99 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-09-21 11:25:00, ended at 2018-10-05 19:55:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 21 - 50 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.44 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Glucose [Mass/volume] in Blood: 341 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 391 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.1 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum: 2 (beta-2 GPI IgG Ab unit)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 68.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 513 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 9.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Lactate [Moles/volume] in Blood: 3.3 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 380 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- MCH [Entitic mass] by Automated count: 22.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.99 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.68 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte sedimentation rate: 27 (millimeter per hour)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 327 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.48 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.7 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n\n### Procedure\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Radiologic examination, abdomen; 1 view\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Excision of Abdomen Skin, External Approach, Diagnostic\n- Hospital discharge day management; more than 30 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Radiologic examination, chest; single view\n- Collection of venous blood by venipuncture\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Introduction of Nutritional Substance into Central Vein, Percutaneous Approach\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Introduction of Nutritional Substance into Peripheral Vein, Percutaneous Approach\n\n### Condition\n- Anemia of chronic disease\n- Electrocardiogram abnormal\n- Inflammatory dermatosis\n- Long QT syndrome\n- Nausea and vomiting\n- Chronic congestive heart failure\n- Disorder of artery\n- Dyspnea\n- Chest pain\n- Eruption\n- Vomiting\n- Acidosis\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Constipation\n- Disorder of skin and/or subcutaneous tissue\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hypertensive urgency\n- Monoplegia of nondominant lower limb as a late effect of cerebrovascular accident\n- Subcorneal pustular dermatosis\n- Cardiomegaly\n- Hypertensive emergency\n- Hypertensive heart failure\n- Left bundle branch block\n- Non-infectious systemic inflammatory response syndrome without acute organ failure\n- Body pale\n- Chronic systolic heart failure\n- Dependence on wheelchair\n- Primary diagnosis: Essential hypertension\n- Gastroparesis syndrome\n- Type 2 diabetes mellitus\n- Leukocytosis\n- Tachycardia\n\n### Drug\n- capsaicin 0.75 MG/ML Topical Cream, through Topical route, started on 2018-09-21, presumably until 2018-09-25, with intended 0 refill(s). Instructions: 1 Tube by Topical route 3 times a day as needed To painful area.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2018-09-25, presumably until 2018-09-26\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2018-09-24, presumably until 2018-10-04\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-09-21, presumably until 2018-10-04\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-10-05, presumably until 2018-11-23, with intended 3 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 2 times a day\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-10-05, presumably until 2018-10-31, with intended 2 refill(s). Instructions: take 0.5 Tabs by mouth every morning\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-09-21, presumably until 2018-10-04\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-10-05, presumably until 2019-02-01, with intended 5 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 2 times a day\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-09-21\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-10-04, presumably until 2018-10-05\n- 20 ML chloroprocaine hydrochloride 20 MG/ML Injection, started on 2018-09-29, presumably until 2018-09-29\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2018-09-21, presumably until 2018-09-25\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2018-09-21, presumably until 2018-09-25\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-10-03, presumably until 2018-10-05, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 2 times a day\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-09-21, presumably until 2018-09-23\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-10-03, presumably until 2019-10-04, with intended 9 refill(s). Instructions: inject 1-10 Units subcutaneous (under the skin) as needed (glucose control q snack)\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2018-09-27, presumably until 2018-10-04\n- 168 HR clonidine 0.00417 MG/HR Transdermal System, through Transdermal route, started on 2018-09-25, presumably until 2018-09-25\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-11-23, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-09-21\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-09-22, presumably until 2018-10-01\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-09-21, presumably until 2018-10-01\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2018-09-23, presumably until 2018-09-25\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-09-21, presumably until 2018-09-21\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-09-21, presumably until 2018-09-23\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-10-04, presumably until 2018-10-05\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-09-22, presumably until 2018-10-05\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-09-29, presumably until 2018-09-30\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2018-09-25, presumably until 2018-09-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-19 00:00:00, ended at 2018-10-19 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.55 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.3 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 435 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 911 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 259 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.55 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.4 (picogram)\n- MCV [Entitic volume] by Automated count: 67.4 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-19 07:24:00, ended at 2018-10-19 16:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 259 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.4 (picogram)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 911 (microgram of fibrinogen equivalent unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 75 (picogram per milliliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.55 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.55 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 67.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 435 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Pulmonary ventilation (eg, aerosol or gas) and perfusion imaging\n- Radiologic examination, chest; 2 views\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Tachycardia\n- Nausea and vomiting\n- Chronic systolic heart failure\n- Abdominal pain\n- Primary diagnosis: Gastroparesis syndrome\n- Hyperglycemia due to type 2 diabetes mellitus\n- Anemia\n- Chest pain\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Hypo-osmolality and or hyponatremia\n- Type 2 diabetes mellitus\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-10-19, presumably until 2018-10-19\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-10-19, presumably until 2018-10-19\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-10-19, presumably until 2018-12-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-10-19, presumably until 2018-10-19\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2018-10-19, presumably until 2018-10-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-25 00:00:00, ended at 2018-10-25 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 20.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.17 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 233 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 398 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.90 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- MCV [Entitic volume] by Automated count: 66.5 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 32 (percent)\n- Sodium [Moles/volume] in Blood: 136 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-25 13:23:00, ended at 2018-10-25 17:38:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.90 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.49 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 32 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.17 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 136 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 233 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 20.6 (picogram)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 66.5 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 398 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Chronic congestive heart failure\n- Dizziness and giddiness\n- Chronic systolic heart failure\n- Gastroparesis syndrome\n- Hypertensive heart failure\n- Primary diagnosis: Nausea and vomiting\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Headache\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Chest pain\n- Long QT syndrome\n- Dyspnea\n- Electrocardiogram abnormal\n- Tachycardia\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-10-25, presumably until 2018-10-25\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-10-25, presumably until 2018-10-25\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2018-10-25, presumably until 2018-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-27 00:00:00, ended at 2018-10-27 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.08 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 20.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 117 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.40 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 740 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 256 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 66.3 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 332 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.80 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-10-27 06:10:00, ended at 2018-10-31 17:38:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 92 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 740 (microgram of fibrinogen equivalent unit per milliliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 67.5 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.1 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.2 (percent)\n- Body height: 5' 2\" (inch (US))\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.80 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 21.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.08 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 256 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 117 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 336 (thousand per microliter)\n\n### Procedure\n- Pulmonary ventilation (eg, aerosol or gas) and perfusion imaging\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Hospital discharge day management; 30 minutes or less\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Anemia of chronic disease\n- Anxiety disorder\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Hypertensive heart failure\n- Tachycardia\n- Dyspnea\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Localized edema\n- Monoplegia of nondominant lower limb as a late effect of cerebrovascular accident\n- Nausea and vomiting\n- Acquired absence of organ\n- Chronic pain\n- Dependence on wheelchair\n- Heartburn\n- Morbid obesity\n- Type 2 diabetes mellitus\n- Chronic systolic heart failure\n- Hypomagnesemia\n- Subcorneal pustular dermatosis\n- Abnormal findings on diagnostic imaging of lung\n- Chronic congestive heart failure\n- Disorder of digestive system\n- Primary diagnosis: Chest pain\n- Coag./bleeding tests abnormal\n- Gastroesophageal reflux disease without esophagitis\n- Gastroparesis syndrome\n- Non-infectious systemic inflammatory response syndrome without acute organ failure\n\n### Drug\n- granisetron 1 MG Oral Tablet, through Oral route, started on 2018-10-28, presumably until 2018-11-06, with intended 5 refill(s). Instructions: take 1 Tab by mouth daily as needed for Nausea\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-10-27, presumably until 2018-10-29\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-10-31, presumably until 2019-02-01, with intended 4 refill(s). Instructions: take 0.5 Tabs by mouth every morning\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-10-27, presumably until 2018-10-30\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2018-10-29, presumably until 2018-10-30\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2018-10-27, presumably until 2018-10-31\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2018-10-27, presumably until 2018-10-31\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-10-31, presumably until 2018-10-31\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-10-27, presumably until 2018-10-30\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2018-10-29, presumably until 2018-10-30\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2018-10-29, presumably until 2018-10-29\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-10-28, presumably until 2018-10-30\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-10-27, presumably until 2018-10-28\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-10-31, presumably until 2018-10-31\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-10-27, presumably until 2018-10-31\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2018-10-30, presumably until 2018-10-30\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2018-10-27, presumably until 2018-10-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-06 07:59:30, ended at 2018-11-06 09:18:32\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Dependence on wheelchair\n- Iron deficiency anemia due to blood loss\n- Primary diagnosis: Gastroparesis syndrome\n- Opioid-induced organic mental disorder\n- Chronic systolic heart failure\n- Nausea and vomiting\n- Vitamin D deficiency\n- Chronic congestive heart failure\n\n### Drug\n- granisetron 1 MG Oral Tablet, through Oral route, started on 2018-11-06, presumably until 2018-12-19, with intended 5 refill(s). Instructions: take 1 Tab by mouth daily as needed for Nausea\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2018-11-06, presumably until 2019-02-01, with intended 12 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-23 13:42:50, ended at 2018-11-23 14:55:38\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea and vomiting\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Body pale\n- Chronic congestive heart failure\n- Primary diagnosis: Arteritis\n- Anemia\n- Chronic systolic heart failure\n- Opioid-induced organic mental disorder\n\n### Drug\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-11-23, presumably until 2019-01-12, with intended 3 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-11 00:00:00, ended at 2018-12-11 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.50 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.24 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 295 (milligram per deciliter)\n- Prothrombin time (PT): 13.0 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 420 (microgram of fibrinogen equivalent unit per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.63 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- MCV [Entitic volume] by Automated count: 61.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 375 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 18.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.8 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-12-11 11:06:00, ended at 2018-12-19 11:25:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Iron [Mass/volume] in Serum or Plasma: 24 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 15.92 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.64 (milligram per deciliter)\n- Left ventricular Ejection fraction: 45.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Blood: 317 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 309 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 61.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.9 (second)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 420 (microgram of fibrinogen equivalent unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 97 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 399 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.66 (micro-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 18.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.51 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 72 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 162 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Body height: 5' 2\" (inch (US))\n- Ferritin [Mass/volume] in Serum or Plasma: 14.8 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.30 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.36 (million per microliter)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Hospital discharge day management; more than 30 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Esophagogastroduodenoscopy, flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Inspection of Upper Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n- Radiologic examination, chest; 2 views\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Collection of venous blood by venipuncture\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Chronic diastolic heart failure\n- Type 2 diabetes mellitus\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Disorder of artery\n- Megaloblastic anemia due to folate deficiency\n- Nausea and vomiting\n- Opioid dependence\n- Organic mental disorder\n- Asthenia\n- Chest pain\n- Electrocardiogram abnormal\n- Hip pain\n- Chronic systolic heart failure\n- Cyclical vomiting syndrome\n- Dyspnea\n- Epigastric pain\n- Essential hypertension\n- Obesity\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hypertensive emergency\n- Acquired absence of organ\n- Chronic congestive heart failure\n- Congenital anomaly of lower limb\n- Hypertensive heart failure\n- Migraine\n- Monoplegia of nondominant lower limb as a late effect of cerebrovascular accident\n- Primary diagnosis: Tachycardia\n- Disorder of digestive system\n- Gastroparesis syndrome\n- Hypo-osmolality and or hyponatremia\n- Iron deficiency anemia\n- Iron deficiency anemia due to blood loss\n- Old myocardial infarction\n- Opioid-induced organic mental disorder\n- Acidosis\n- Body pale\n- Dependence on wheelchair\n- Precordial pain\n- Chronic pain\n- Congestive heart failure\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2018-12-14, presumably until 2018-12-16\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2018-12-12, presumably until 2018-12-12\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-12-11, presumably until 2018-12-15\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2018-12-18, presumably until 2018-12-19\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-12-17, presumably until 2018-12-17\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-12-11, presumably until 2018-12-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-12-17, presumably until 2018-12-19\n- hydroxyzine hydrochloride 50 MG/ML Injectable Solution, through Intramuscular route, started on 2018-12-15, presumably until 2018-12-15\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2018-12-12, presumably until 2018-12-17\n- 168 HR clonidine 0.00833 MG/HR Transdermal System, through Transdermal route, started on 2018-12-15, presumably until 2019-02-01, with intended 0 refill(s). Instructions: apply 1 Patch to skin every 7 days\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2018-12-11, presumably until 2018-12-11\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2018-12-18, presumably until 2019-01-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2018-12-15, presumably until 2018-12-15\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-12-12, presumably until 2018-12-19\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-12-11, presumably until 2018-12-15\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-12-11, presumably until 2018-12-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-12-18, presumably until 2018-12-19\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-12-12, presumably until 2018-12-13\n- 1 ML granisetron 1 MG/ML Injection, through Intravenous route, started on 2018-12-11, presumably until 2018-12-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-12-12, presumably until 2018-12-13\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2018-12-11, presumably until 2018-12-11\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2018-12-12, presumably until 2018-12-19\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2018-12-11, presumably until 2018-12-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-12-12 00:00:00, ended at 2018-12-12 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Esophagogastroduodenoscopy, flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-12-12 00:00:00, ended at 2018-12-12 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; not otherwise specified\n\n### Condition\n- Chest pain\n- Dyspnea\n- Epigastric pain\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Nausea and vomiting\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2018-12-12, presumably until 2018-12-12\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2018-12-12, presumably until 2018-12-12\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-12-12, presumably until 2018-12-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-12-12, presumably until 2018-12-12\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2018-12-12, presumably until 2018-12-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-12 13:06:47, ended at 2019-01-12 14:23:14\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroparesis syndrome\n- Nausea and vomiting\n- Chest pain\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, started on 2019-01-12, presumably until 2019-02-01, with intended 3 refill(s). Instructions: Use 18 units every morning and 15 units every night.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-01-12, presumably until 2019-02-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2019-01-12, presumably until 2019-02-28, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2019-01-12, presumably until 2019-02-01, with intended 12 refill(s). Instructions: take 1,000 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-01 00:00:00, ended at 2019-02-01 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 64.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 150 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 28.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Glucose [Mass/volume] in Blood: 361 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 18.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 10.29 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.47 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.47 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 351 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 355 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-01 11:22:00, ended at 2019-02-02 09:53:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 18.5 (picogram)\n- MCV [Entitic volume] by Automated count: 64.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.29 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 150 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 351 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.47 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.47 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.10 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 355 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 361 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.1 (percent)\n- MCHC [Mass/volume] by Automated count: 28.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; without contrast material\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Computed tomography, maxillofacial area; without contrast material\n- Radiologic examination, chest; 2 views\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Computed tomography, cervical spine; without contrast material\n- Hospital discharge day management; 30 minutes or less\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Primary diagnosis: Neck pain\n- Anesthesia of skin\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Chronic congestive heart failure\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Dental caries\n- Headache\n- Gastroparesis syndrome\n- Hypertensive heart failure\n- Chronic systolic heart failure\n- Dependence on wheelchair\n- Periodontal disease\n- Dizziness and giddiness\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film, through Sublingual route, presumably until 2019-02-01, with intended 0 refill(s). Instructions: place under the tongue and let dissolve\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2019-03-29, with intended 0 refill(s). Instructions: take 40 mg by mouth every morning\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2019-02-01, presumably until 2019-02-01\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-02-01, presumably until 2019-02-01\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, presumably until 2019-07-31, with intended 0 refill(s). Instructions: place 1 Tab under the tongue and let dissolve every morning Total 18mg daily. Daily dose given in pain clinic.\n- buprenorphine 8 MG Sublingual Tablet, through Sublingual route, presumably until 2019-02-01, with intended 0 refill(s). Instructions: place 16 mg under the tongue and let dissolve every morning Total 18mg daily. Administered in pain clinic.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-02-01, presumably until 2019-02-02\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2019-02-02, presumably until 2019-02-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- buprenorphine 2 MG Sublingual Tablet, through Sublingual route, presumably until 2019-02-01, with intended 0 refill(s). Instructions: place 2 mg under the tongue and let dissolve every morning Total 18mg daily. Administered in pain clinic.\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2021-07-08, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, presumably until 2019-03-29, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) 2 times a day before meals\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2020-01-31, with intended 0 refill(s). Instructions: inject 0-12 Units subcutaneous (under the skin) 3 times a day before meals Per sliding scale for BS > 150\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2019-02-01, presumably until 2019-02-02\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, presumably until 2019-10-01, with intended 0 refill(s). Instructions: Take 1000mg in the AM and 500mg in the PM\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2019-02-01, presumably until 2019-02-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-02-02, presumably until 2019-02-02\n- buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet, through Sublingual route, started on 2019-02-02, presumably until 2019-07-31, with intended 0 refill(s). Instructions: place 2 Tabs under the tongue and let dissolve every morning Total 18mg daily. Daily dose given in pain clinic.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-02 00:00:00, ended at 2019-02-02 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-06-06, presumably until 2019-06-06, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-05 13:30:17, ended at 2019-02-05 14:56:54\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroparesis syndrome\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-02-05, presumably until 2019-02-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-28 16:13:43, ended at 2019-02-28 17:01:48\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroparesis syndrome\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-02-28, presumably until 2019-03-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2019-02-28, presumably until 2020-02-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2019-02-28, presumably until 2019-05-16, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-15 00:00:00, ended at 2019-03-15 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-03-21, presumably until 2019-07-31, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-29 13:24:37, ended at 2019-03-29 14:34:35\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic congestive heart failure\n- Dependence on wheelchair\n- Gastroparesis syndrome\n- Essential hypertension\n- Chronic systolic heart failure\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- empagliflozin 10 MG Oral Tablet, through Oral route, started on 2019-03-29, presumably until 2019-06-26, with intended 5 refill(s). Instructions: take 10 mg by mouth every day\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2019-03-29, presumably until 2020-08-15, with intended 12 refill(s). Instructions: take 1 Tab (40 mg total) by mouth every morning\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-03-29, presumably until 2019-06-26, with intended 5 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-03-29, presumably until 2019-06-26, with intended 5 refill(s). Instructions: Inject 35 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-10 14:40:58, ended at 2019-04-10 16:34:03\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 434 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-12 00:00:00, ended at 2019-04-12 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus\n- Body pale\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-13 00:00:00, ended at 2019-04-13 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperosmolarity\n- Primary diagnosis: Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-16 00:00:00, ended at 2019-05-16 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 6.25 MG Oral Tablet, started on 2019-05-16, presumably until 2019-07-31, with intended 11 refill(s). Instructions: TAKE 2 TABLETS BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-26 00:00:00, ended at 2019-06-26 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-06-27, presumably until 2019-06-27, with intended 5 refill(s). Instructions: Inject 35 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-26 15:00:16, ended at 2019-06-26 16:23:25\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic systolic heart failure\n- Primary diagnosis: Complication due to diabetes mellitus\n- Chronic congestive heart failure\n- Acute systolic heart failure\n- Primary diagnosis: Type 2 diabetes mellitus\n- Disorder of artery\n- Secondary hypertension\n- Congestive heart failure\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2019-06-26, presumably until 2019-07-31, with intended 0 refill(s). Instructions: take 0.5 Tabs (12.5 mg total) by mouth daily\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-06-26, presumably until 2021-07-08, with intended 5 refill(s). Instructions: take 1.5 Tabs (7.5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-28 00:00:00, ended at 2019-06-28 00:00:00\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-03 16:21:50, ended at 2019-07-03 16:32:23\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Tachycardia\n- Disorder of artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-03 16:35:37, ended at 2019-07-03 17:56:46\nThe patient in this visit was 36 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of ischemic_stroke means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "6c1eaaacab1f917a1c43a59aa97372a1b481aaaad90dd9a4c73ad8bb4fd8b9ef", "prompt_hash": "82ee44ab973dfa3ec1b72f6e030134e1af823e03282ced91c1d889a4ccb0dab0", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 9, "doc": {"person_id": 115971341, "visit_occurrence_id": 179786590, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2021-06-03 09:29:25", "visit_end_datetime": "2021-06-03 10:54:36", "visit_length_in_hours": 1.4197222222222223, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2021-06-03 09:29:25, ended at 2021-06-03 10:54:36\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 101, "patient_first_visit_date": "2014-03-10 00:00:00", "patient_last_visit_date": "2023-02-03 00:00:00", "end_obs_date": "2022-06-03", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 1, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 516, "cumulated_visit_num": 516, "cumulated_approximate_token_count": 145378, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-10 00:00:00, ended at 2014-03-10 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 22 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-10 17:37:00, ended at 2014-03-29 17:22:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Blood by calculation: 2.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 379 (unit per liter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.12 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: N/A (millimeter mercury column)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.71 (milli-international unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Base deficit in Blood: N/A (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.7 (percent)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 350 (thousand per microliter)\n- Prothrombin time (PT): 29.2 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 4.0 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- Left ventricular Ejection fraction: 2.4EF(MOD-sp4) (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.9 (percent)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.58 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 72 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: N/A (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 394 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 291 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 77.6 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Body height: 5' 2.008\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: N/A (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 97 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.39 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.97 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: N/A (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Computed tomography, thorax, diagnostic; without contrast material\n- Occupational therapy evaluation\n- Other cystoscopy\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Physical therapy evaluation\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Computed tomography, head or brain; without contrast material\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Cardiac pacemaker procedure\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; subsequent\n- Nonoperative removal of heart assist system\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Implantation of heart assist system\n- Radiologic examination, chest; single view, frontal\n- Controlled ventilation procedure and therapy, initiation and management\n- Packed blood cell transfusion\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Insertion of catheter into artery\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Collection of venous blood by venipuncture\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Aphasia\n- Chronic total occlusion of coronary artery\n- Disorder of muscle\n- Electrocardiogram abnormal\n- Urinary tract infectious disease\n- Acute bronchitis\n- Acute myocardial infarction of inferior wall\n- Atelectasis\n- Atrial flutter\n- Diabetes mellitus without complication\n- Disorder of artery\n- Acute upper respiratory infection\n- Diabetic - poor control\n- Heart failure\n- Hyperlipidemia\n- Transient cerebral ischemia\n- Chronic ischemic heart disease\n- Coronary atherosclerosis\n- Neoplasm of uncertain behavior of bladder\n- Peripheral vascular disease\n- Primary cardiomyopathy\n- Pulmonary congestion and hypostasis\n- Disorder of carotid artery\n- Long QT syndrome\n- Viral pneumonia\n- Acidosis\n- Acute on chronic systolic heart failure\n- Primary diagnosis: Cardiogenic shock\n- Cerebrovascular disease\n- Respiratory insufficiency\n- Thoracic spondylosis without myelopathy\n- Acquired deformity of thoracic structure\n- Acute myocardial infarction\n- Acute myocardial infarction of lateral wall\n- Acute posthemorrhagic anemia\n- Acute subendocardial infarction\n- Congestive heart failure\n- Cough\n- Lung field abnormal\n- Osteoarthritis\n- Pleural effusion\n- Cardiomegaly\n- Coronary arteriosclerosis\n- Frank hematuria\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2014-03-22, presumably until 2014-03-24\n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2014-03-11, presumably until 2014-03-16\n- sildenafil 20 MG Oral Tablet, through Oral route, started on 2014-03-17, presumably until 2014-03-22\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-17\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2014-03-10, presumably until 2014-03-21\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-03-12, presumably until 2014-03-16\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-03-10, presumably until 2014-04-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-27\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2014-03-17, presumably until 2014-03-26\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2014-03-22, presumably until 2014-03-29\n- 24 HR ferrous sulfate 142 MG Extended Release Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-24\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2014-03-29, presumably until 2014-09-08, with intended 5 refill(s). Instructions: inject 0-12 Units subcutaneous (under the skin) 4 times a day before meals and bedtime.\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2014-03-11, presumably until 2014-03-11\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2014-03-14, presumably until 2014-03-16\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-03-16, presumably until 2014-06-29, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed.\n- candesartan cilexetil 4 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 4 mg by mouth daily.\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2014-03-17, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n- dipyridamole 75 MG Oral Tablet, through Oral route, started on 2014-03-28, presumably until 2014-04-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-22\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-03-10, presumably until 2014-03-10\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-04-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-29\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-03-10, presumably until 2014-05-10, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-04-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2014-03-22, presumably until 2014-04-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- ascorbic acid 1000 MG Oral Tablet, through Oral route, presumably until 2014-03-29. Instructions: take 1,000 mg by mouth every bedtime.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 5 mg by mouth 2 times a day.\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2014-03-13, presumably until 2014-03-24\n- 10 ML furosemide 10 MG/ML Injection, started on 2014-03-17, presumably until 2014-03-20\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2014-03-19, presumably until 2014-03-24\n- metformin hydrochloride 1000 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-06-19, with intended 3 refill(s). Instructions: take 1,000 mg by mouth 2 times a day.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-03-10, presumably until 2014-05-10, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime.\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-19\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-08-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-03-10, presumably until 2014-03-29\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-03-15, presumably until 2014-03-16\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-21\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 20 mg by mouth every bedtime.\n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-28\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-03-21, presumably until 2014-03-25\n- cefepime 2000 MG Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-18\n- bumetanide 0.5 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 0.5 mg by mouth daily.\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 3.125 mg by mouth daily.\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-19\n- digoxin 0.125 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 0.125 mg by mouth daily.\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 25 mg by mouth daily.\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2014-03-29, presumably until 2014-09-08, with intended 5 refill(s). Instructions: inject 35 Units subcutaneous (under the skin) daily in the evening.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-03-16, presumably until 2014-03-27\n- warfarin sodium 2 MG Oral Tablet, started on 2014-03-29, presumably until 2014-04-04, with intended 3 refill(s). Instructions: Take 3.5 mg PO daily or as directed\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2014-03-17, presumably until 2014-03-20\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-18\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2014-03-12, presumably until 2014-03-27\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-22\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2014-03-11, presumably until 2014-03-16\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-03-23, presumably until 2014-04-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day before meals.\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2014-03-21, presumably until 2014-03-21\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-03-24, presumably until 2014-03-28\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-03-28, presumably until 2014-08-07, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-18\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-03-11, presumably until 2014-03-11\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-04-04, with intended 3 refill(s). Instructions: Take 3.5 mg PO daily or as directed\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-03-17, presumably until 2014-03-25\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2014-03-21, presumably until 2014-03-29\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-28\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2014-03-16, presumably until 2014-03-16\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-29. Instructions: take 81 mg by mouth daily.\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2014-03-16, presumably until 2015-03-29, with intended 0 refill(s). Instructions: take 4 Tabs by mouth as needed.\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-03-11, presumably until 2014-03-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-16 00:00:00, ended at 2014-03-16 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n\n### Condition\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Coronary atherosclerosis\n- Heart failure\n\n### Drug\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2014-03-16, presumably until 2014-03-16\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-03-16, presumably until 2014-03-16\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- cefepime 2000 MG Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 6-aminocaproic acid 250 MG/ML Injectable Solution, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- midazolam 1 MG/ML Injectable Solution, started on 2014-03-16, presumably until 2014-03-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-03-16 00:00:00, ended at 2014-03-16 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifampin 600 MG Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2014-03-16, presumably until 2014-03-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-30 00:00:00, ended at 2014-03-30 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute on chronic systolic heart failure\n- Acute myocardial infarction\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-31 00:00:00, ended at 2014-03-31 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Acute myocardial infarction of anterior wall\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Electrocardiogram abnormal\n- Acute myocardial infarction\n- Acute myocardial infarction of inferior wall\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-31 11:58:00, ended at 2014-03-31 15:23:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.31 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.66 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 321 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.1 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 360 (thousand per microliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prothrombin time (PT): 17.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-31 15:24:00, ended at 2014-04-04 16:24:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.93 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.14 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 323 (unit per liter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 202 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 393 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: N/A (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Prothrombin time (PT): 21.4 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Body height: 5' 1\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n\n### Procedure\n- Prophylactic administration of vaccine against other diseases\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Computed tomography, head or brain; without contrast material\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cardiogenic shock\n- Congestive heart failure\n- Bleeding from nose\n- Disorder of function of stomach\n- Allergic disposition\n- Benign hypertensive renal disease with renal failure\n- Coag./bleeding tests abnormal\n- Disorder of carotid artery\n- Transient cerebral ischemia\n- Acute posthemorrhagic anemia\n- Acute subendocardial infarction\n- Cerebrovascular disease\n- Constipation\n- Chronic ischemic heart disease\n- Malaise\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Chronic kidney disease stage 2\n- Coronary arteriosclerosis\n- Gastrointestinal hemorrhage\n- Acute myocardial infarction\n- Chronic combined systolic and diastolic heart failure\n- Paroxysmal ventricular tachycardia\n\n### Drug\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2014-04-03, presumably until 2014-04-03\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-04-04, presumably until 2014-04-28, with intended 4 refill(s). Instructions: take 5 mg by mouth daily.\n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2014-04-02, presumably until 2015-04-04, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-04-01, presumably until 2014-07-31, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-04-03, presumably until 2014-04-04\n- dipyridamole 50 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-06, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 3 times a day.\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2014-04-01, presumably until 2014-04-04\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-04-02, presumably until 2014-04-02\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2014-04-03, presumably until 2014-04-04\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-01\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-03\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-03-31, presumably until 2014-04-04\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-03\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2014-04-04, presumably until 2014-04-04\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-04-01, presumably until 2014-04-04\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-04-03, presumably until 2014-04-06, with intended 2 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours.\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2014-04-03, presumably until 2014-04-03\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- ondansetron 4 MG Oral Film, through Oral route, started on 2014-04-04, presumably until 2014-05-10, with intended 1 refill(s). Instructions: take 4 mg by mouth 3 times a day as needed (before meals).\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-04-02, presumably until 2014-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2014-04-05 16:29:00, ended at 2014-04-05 17:57:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.73 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.55 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 366 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 71.1 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Prothrombin time (PT): 23.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Old myocardial infarction\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Bleeding from nose\n\n### Drug\n- oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray, through Nasal route, started on 2014-04-05, presumably until 2014-04-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-06 00:00:00, ended at 2014-04-06 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Chronic ischemic heart disease\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-06 08:08:55, ended at 2014-04-06 09:25:51\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- dipyridamole 75 MG Oral Tablet, started on 2014-04-06, presumably until 2014-04-07, with intended 3 refill(s). Instructions: Take 1 tab three times per day.\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2014-04-06, presumably until 2014-04-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ondansetron 4 MG Oral Tablet, started on 2014-03-29, presumably until 2014-05-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-06 09:39:00, ended at 2014-04-06 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.61 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 348 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Prothrombin time (PT): 22.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 222 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-07 10:09:00, ended at 2014-04-07 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.50 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 372 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.73 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 229 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.34 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Prothrombin time (PT): 21.8 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-07 10:38:01, ended at 2014-04-07 12:17:04\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Chronic ischemic heart disease\n- Electrocardiogram abnormal\n- Acute myocardial infarction of inferior wall\n- Acute on chronic systolic heart failure\n- Acute myocardial infarction\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Congestive heart failure\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-04-07, presumably until 2014-05-10, with intended 1 refill(s). Instructions: take 0.5 Tabs by mouth daily.\n- dipyridamole 50 MG Oral Tablet, started on 2014-04-07, presumably until 2014-06-15, with intended 3 refill(s). Instructions: Take 2 tab three times per day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-10 11:07:00, ended at 2014-04-10 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 340 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 227 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.76 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.88 (thousand per microliter)\n- Prothrombin time (PT): 25.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.2 (percent)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-14 11:04:00, ended at 2014-04-14 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 229 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.50 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.4 (percent)\n- Prothrombin time (PT): 25.9 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.73 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.1 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.00 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 319 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-14 11:24:45, ended at 2014-04-14 13:44:57\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n\n### Condition\n- Electrocardiogram abnormal\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Atrial fibrillation\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-20 14:26:00, ended at 2014-04-20 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.9 (percent)\n- MCV [Entitic volume] by Automated count: 92.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Prothrombin time (PT): 22.0 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.69 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 246 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.60 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 278 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-28 00:00:00, ended at 2014-04-28 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2014-04-28, presumably until 2014-06-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-28 13:08:00, ended at 2014-04-28 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Prothrombin time (PT): 19.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 241 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.54 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 233 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-28 13:27:31, ended at 2014-04-28 16:02:49\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n\n### Condition\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n\n### Drug\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-04-28, presumably until 2014-05-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2014-04-28, presumably until 2014-05-10, with intended 0 refill(s). Instructions: take 2 Caps by mouth One Time. Take 1 g of amoxicillin 30 minutes prior to the dental cleaning.\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-04-28, presumably until 2014-05-10, with intended 0 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-10 12:56:00, ended at 2014-05-10 13:55:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.99 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 186 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 223 (unit per liter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.3 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.28 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.6 (percent)\n- Prothrombin time (PT): 23.3 (second)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-10 13:56:00, ended at 2014-05-10 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Cardiomyopathy associated with another disorder\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 15:27:58, ended at 2014-05-10 17:12:01\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Electrocardiogram abnormal\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Old myocardial infarction\n- Acute myocardial infarction\n- Congestive heart failure\n\n### Drug\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-05-10, presumably until 2014-07-26, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily in the evening.\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-05-10, presumably until 2014-06-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-05-10, presumably until 2014-05-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-19 09:23:17, ended at 2014-05-19 10:23:19\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Transient cerebral ischemia\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-26 13:58:00, ended at 2014-05-26 14:14:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 19 (milligram per gram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.10 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.64 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.3 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Prothrombin time (PT): 24.6 (second)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 205 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 7 (milligram per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-26 14:56:18, ended at 2014-05-26 16:25:46\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Acute myocardial infarction\n- Congestive heart failure\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Electrocardiogram abnormal\n- Chronic ischemic heart disease\n\n### Drug\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-05-26, presumably until 2014-06-15, with intended 1 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-09 14:02:21, ended at 2014-06-09 15:49:36\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Congestive heart failure\n- Electrocardiogram abnormal\n- Acute myocardial infarction\n- Chronic ischemic heart disease\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-06-09, presumably until 2014-06-15, with intended 1 refill(s). Instructions: take 0.5 Tabs by mouth daily.\n- ondansetron 4 MG Oral Film, through Oral route, presumably until 2014-08-03. Instructions: take 4 mg by mouth 3 times a day as needed (Nausea).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2014-06-10 11:52:00, ended at 2014-06-15 15:56:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 32 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: 1.24 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 44 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: N/A (second)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 59 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Body height: 5' 1\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 19.9 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 376 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.7 (femtoliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.05 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 10.9 (micromole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.9 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Prothrombin time (PT): 26.4 (second)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 276 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomography, head or brain; without contrast material\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Cerebral perfusion analysis using computed tomography with contrast administration, including post-processing of parametric maps with determination of cerebral blood flow, cerebral blood volume, and mean transit time\n- Radiologic examination, chest; single view, frontal\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of extracranial arteries; complete bilateral study\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; 30 minutes or less\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Coag./bleeding tests abnormal\n- Old myocardial infarction\n- Umbilical hernia\n- Acute on chronic systolic heart failure\n- Solitary nodule of lung\n- Transient cerebral ischemia\n- Cardiomegaly\n- Electrocardiogram abnormal\n- Essential hypertension\n- Heart disease\n- Cerebrovascular disease\n- Disorder of brain\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Anemia\n- Aphasia\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n- Coronary arteriosclerosis\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Congestive heart failure\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-15\n- warfarin sodium 10 MG Oral Tablet, through Oral route, started on 2014-06-12, presumably until 2014-06-12\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-06-15, presumably until 2015-06-15, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily in the evening.\n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2014-06-13, presumably until 2014-06-14\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-06-14, presumably until 2014-06-15\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-06-13, presumably until 2014-06-15\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-13\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-06-10, presumably until 2014-06-13\n- dipyridamole 50 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-11\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-06-12, presumably until 2014-06-14\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-15\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2014-06-14, presumably until 2014-06-15\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-11\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-06-12, presumably until 2014-06-14\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-06-11, presumably until 2014-06-15\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-06-12, presumably until 2014-06-12\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-09-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-15\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2014-06-13, presumably until 2014-06-13\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-06-11, presumably until 2014-06-14\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-15\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-14\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2014-06-11, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-15 09:00:00, ended at 2014-06-15 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-19 00:00:00, ended at 2014-06-19 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, through Oral route, started on 2014-06-19, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-19 00:00:00, ended at 2014-06-19 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-20 00:00:00, ended at 2014-06-20 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-20 12:42:00, ended at 2014-06-20 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Unlisted diagnostic radiographic procedure\n- Screening mammography, bilateral (2-view study of each breast)\n\n### Condition\n- Postmenopausal state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-23 00:00:00, ended at 2014-06-23 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-29 07:45:00, ended at 2014-06-29 11:10:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Colonoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n- Colonoscopy\n\n### Condition\n- Old myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Primary cardiomyopathy\n\n### Drug\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-06-29, presumably until 2014-06-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-06-29, presumably until 2014-06-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-30 07:38:00, ended at 2014-06-30 09:49:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-30 09:50:00, ended at 2014-06-30 11:41:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Acute myocardial infarction\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-30 11:42:00, ended at 2014-06-30 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 204 (thousand per microliter)\n- Prothrombin time (PT): 28.7 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 206 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.73 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Acute myocardial infarction\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-30 15:05:43, ended at 2014-06-30 15:05:54\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Electrocardiogram abnormal\n- Acute on chronic systolic heart failure\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Chronic ischemic heart disease\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-07 00:00:00, ended at 2014-07-07 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-07 12:00:00, ended at 2014-07-07 15:52:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-07 15:53:00, ended at 2014-07-07 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-14 14:37:00, ended at 2014-07-14 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Prothrombin time (PT): 26.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.36 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 193 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.79 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-14 15:23:22, ended at 2014-07-14 16:23:39\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n\n### Condition\n- Acute myocardial infarction of inferior wall\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Old myocardial infarction\n- Chronic ischemic heart disease\n- Electrocardiogram abnormal\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-20 08:01:00, ended at 2014-07-20 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 23.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-24 00:00:00, ended at 2014-07-24 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 5 MG Oral Tablet, started on 2014-07-24, presumably until 2014-07-24, with intended 3 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY IN THE EVENING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-26 00:00:00, ended at 2014-07-26 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-07-26, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily in the evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-31 00:00:00, ended at 2014-07-31 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2014-07-31, presumably until 2014-09-08, with intended 4 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-03 14:23:44, ended at 2014-08-03 15:57:30\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aphasia as late effect of cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-08-07 00:00:00, ended at 2014-08-07 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-08-07, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-11 13:45:00, ended at 2014-08-11 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.30 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 87.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.8 (percent)\n- Prothrombin time (PT): 30.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.64 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 223 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-11 14:36:29, ended at 2014-08-11 16:15:21\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n\n### Condition\n- Acute myocardial infarction\n- Old myocardial infarction\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-08-21 00:00:00, ended at 2014-08-21 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2014-08-21, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-08-23 21:51:00, ended at 2014-09-08 16:44:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- CD19 cells [#/volume] in Blood: 206 (per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Body height: 5' 1\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 79.2 (millimeter mercury column)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.8 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 27.8 (millimole per liter)\n- CD19 cells/100 cells in Blood: 85 (percent)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.55 (thousand per microliter)\n- Oxygen [Partial pressure] in Blood: 75 (millimeter mercury column)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 24 (nanogram per milliliter)\n- Base excess in Blood by calculation: 3.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood: 10 (per microliter)\n- Carbon dioxide [Partial pressure] in Blood: 33.0 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: >300.0 (second)\n- Left ventricular Ejection fraction: 64.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- CD3 cells [#/volume] in Blood: 19 (per microliter)\n- CD3 cells/100 cells in Blood: 8 (percent)\n- CD3+CD4+ (T4 helper) cells [#/volume] in Blood: 7 (per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Prothrombin time (PT): 29.1 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.55 (milli-international unit per liter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 416 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 152 (millimole per liter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 24 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 120 (millimole per liter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n\n### Procedure\n- Insertion of pleural tube drain\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Noninvasive ventilation\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; subsequent\n- Transplantation of heart\n- Radiologic examination, chest; single view, frontal\n- Collection of venous blood by venipuncture\n- Operative external blood circulation\n- Biopsy of heart\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Duplex scan of extracranial arteries; complete bilateral study\n- Occupational therapy evaluation\n- Transfusion of other serum\n- Splitting of blood or blood products, each unit\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Removal of external heart assist system(s) or device(s)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Endomyocardial biopsy\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Insertion of catheter into artery\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Controlled ventilation procedure and therapy, initiation and management\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n\n### Condition\n- Acidosis\n- Cardiomegaly\n- Coronary arteriosclerosis\n- Pleural effusion\n- Pneumothorax\n- Secondary diabetes mellitus\n- Acute systolic heart failure\n- Atrial flutter\n- Disorder of carotid artery\n- Electrocardiogram abnormal\n- Late effects of cerebrovascular disease\n- Old myocardial infarction\n- Weakness of face muscles\n- Abnormal glucose level\n- Atrial fibrillation\n- Cardiac arrhythmia\n- Vitamin D deficiency\n- Dysphonia\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Acute posthemorrhagic anemia\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n- Lung field abnormal\n- Urinary tract infectious disease\n- Atelectasis\n- Dysarthria as late effects of cerebrovascular disease\n- Effect of exposure to physical force\n- Injury involving multiple body regions\n- Abnormal breathing\n- Congestive heart failure\n- Bacterial infection due to Klebsiella pneumoniae\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Chronic ischemic heart disease\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2014-08-25, presumably until 2014-08-25\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2014-08-30, presumably until 2014-11-07, with intended 2 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2014-09-05, presumably until 2014-09-08, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 8 hours.\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2014-08-28, presumably until 2014-08-28\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2014-08-30, presumably until 2015-04-13, with intended 11 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-08-27, presumably until 2014-10-19, with intended 11 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-30\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-09-05, presumably until 2014-09-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2014-08-25, presumably until 2014-08-27\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2014-09-01, presumably until 2014-09-29, with intended 3 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) 2 times a day. Or as directed.\n- 50 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-25\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2014-08-25, presumably until 2014-09-01\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2014-09-06, presumably until 2015-07-09, with intended 11 refill(s). Instructions: take 10 mL by mouth every morning with breakfast.\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-09-05, presumably until 2014-11-07, with intended 1 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n- ganciclovir 500 MG Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-26\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-08-24, presumably until 2014-08-24\n- magnesium chloride 535 MG Delayed Release Oral Tablet, through Oral route, started on 2014-09-03, presumably until 2014-09-08\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2014-08-24, presumably until 2014-08-24\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2014-09-01, presumably until 2015-02-09, with intended 3 refill(s). Instructions: inject 12 Units subcutaneous (under the skin) 3 times a day before meals. Additionally, inject 0-12 Units subcutaneously 4 times a day before meals and bedtime per sliding scale.\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2014-09-03, presumably until 2014-09-03\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-29\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2014-08-30, presumably until 2014-09-21, with intended 11 refill(s). Instructions: take 2 capsules by mouth 2 times a day. Or as directed.\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-09-01, presumably until 2014-11-07, with intended 2 refill(s). Instructions: take 1 tablet by mouth 2 times a day. Or as directed.\n- amphotericin B 50 MG Injection, started on 2014-08-25, presumably until 2014-09-08\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2014-09-04, presumably until 2014-09-05\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2014-08-27, presumably until 2015-09-01, with intended 11 refill(s). Instructions: take 1 lozenge by mouth 3 times a day.\n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-28\n- dabigatran etexilate 75 MG Oral Capsule, through Oral route, started on 2014-09-07, presumably until 2014-09-08\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-08-25, presumably until 2014-10-26, with intended 11 refill(s). Instructions: take 1 capsule by mouth 2 times a day as needed.\n- lidocaine 70 MG / tetracaine 70 MG Medicated Patch, through Topical route, started on 2014-08-31, presumably until 2014-08-31\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-09-07\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2014-08-26, presumably until 2014-09-08\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2014-09-08, presumably until 2015-09-08, with intended 3 refill(s). Instructions: take 1 tablet by mouth daily.\n- 10 ML furosemide 10 MG/ML Injection, started on 2014-08-24, presumably until 2014-09-02\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-09-02\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2014-08-27, presumably until 2015-07-09, with intended 11 refill(s). Instructions: take 1 tablet by mouth daily in the evening.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-08-25, presumably until 2014-08-28\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2014-09-01, presumably until 2014-09-21, with intended 2 refill(s). Instructions: take 1 tablet by mouth 2 times a day. Or as directed.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-08-26, presumably until 2014-09-08\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-08-26, presumably until 2014-09-01\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-29\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-08-25, presumably until 2014-08-25\n- amiodarone hydrochloride 50 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-29, presumably until 2014-08-29\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-08-24, presumably until 2014-08-24\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-08-27, presumably until 2014-08-27\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2014-08-25, presumably until 2014-11-07, with intended 11 refill(s). Instructions: take 1 capsule by mouth 2 times a day. Or as directed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-25, presumably until 2014-09-08\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-31\n- dabigatran etexilate 150 MG Oral Capsule, through Oral route, started on 2014-09-07, presumably until 2014-10-17, with intended 1 refill(s). Instructions: take 1 capsule by mouth 2 times a day.\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2014-08-29, presumably until 2014-08-29\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2014-09-02, presumably until 2014-09-02\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2014-09-02, presumably until 2014-09-05\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2014-08-25, presumably until 2014-09-07, with intended 11 refill(s). Instructions: take 1 tablet by mouth daily.\n- mupirocin 0.02 MG/MG Topical Ointment, through Topical route, started on 2014-09-01, presumably until 2014-09-08\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2014-08-27, presumably until 2014-09-03\n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2014-08-26, presumably until 2014-10-02, with intended 2 refill(s). Instructions: Take 200 mg (20 mL) by mouth every morning and 100 mg (10 mL) every evening on an empty stomach.\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-09-08, presumably until 2015-02-09, with intended 11 refill(s). Instructions: take 2 tablets by mouth Every Day.\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2014-09-01, presumably until 2015-09-01, with intended 11 refill(s). Instructions: take 1 tablet by mouth 2 times a day with meals.\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-09-03\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-08-27, presumably until 2014-09-03\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2014-09-01, presumably until 2014-09-01\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-08-23, presumably until 2014-08-23\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2014-08-26, presumably until 2014-09-08, with intended 0 refill(s). Instructions: take 1 tablet by mouth 2 times a day. Or as directed.\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2014-08-27, presumably until 2015-02-09, with intended 6 refill(s). Instructions: take 2 tablets by mouth daily. Or as directed.\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2014-08-29, presumably until 2014-10-17, with intended 11 refill(s). Instructions: take 2 tablets by mouth 2 times a day. Or as directed.\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2014-08-28, presumably until 2020-05-08, with intended 11 refill(s). Instructions: take 1 tablet by mouth every morning with breakfast.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-08-25, presumably until 2014-08-26\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2014-09-08, presumably until 2014-09-21, with intended 0 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2014-08-25, presumably until 2014-08-25\n- methylprednisolone 125 MG Injection, started on 2014-08-25, presumably until 2014-08-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-08-24 00:00:00, ended at 2014-08-24 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2014-08-24, presumably until 2014-08-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-08-24 00:00:00, ended at 2014-08-24 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Anesthesia for heart transplant or heart/lung transplant\n\n### Condition\n- Chronic ischemic heart disease\n- Transplanted heart present\n- Heart failure\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- anti-inhibitor coagulant complex 1 UNT Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2014-08-24, presumably until 2014-08-24\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 6-aminocaproic acid 250 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- midazolam 1 MG/ML Injectable Solution, started on 2014-08-24, presumably until 2014-08-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-08 00:00:00, ended at 2014-09-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2014-09-26, presumably until 2014-09-28, with intended 11 refill(s). Instructions: take 1 packet by mouth daily.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2014-09-22, presumably until 2014-09-29, with intended 11 refill(s). Instructions: take 0.5 tablets by mouth Every Day. Or as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-11 08:46:00, ended at 2014-09-11 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.75 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 277 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 12.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 332 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-11 09:42:26, ended at 2014-09-11 11:19:29\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-12 11:09:00, ended at 2014-09-12 12:38:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n\n### Condition\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-12 13:06:38, ended at 2014-09-12 13:25:01\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n- Effect of exposure to physical force\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-13 00:00:00, ended at 2014-09-13 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-14 07:30:00, ended at 2014-09-14 07:30:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Long-term drug therapy\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-14 07:31:00, ended at 2014-09-14 07:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 25.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 98.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.29 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 12.8 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.64 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 218 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Congestive heart failure\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-14 08:00:00, ended at 2014-09-14 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 1.6EF(MOD-sp4) (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-14 08:50:21, ended at 2014-09-14 15:04:02\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Primary diagnosis: Transplanted heart present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-21 00:00:00, ended at 2014-09-21 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 65.9 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-21 07:58:00, ended at 2014-09-21 08:47:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: N/A (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 215 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 25.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.94 (thousand per microliter)\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Acute on chronic systolic heart failure\n- Atrial fibrillation\n- Chronic ischemic heart disease\n- Essential hypertension\n- Late effect of medical and surgical care complication\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Congestive heart failure\n- Effect of exposure to physical force\n- Disorder affecting transplanted structure\n- Transplanted heart present\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-21 09:03:46, ended at 2014-09-21 16:30:51\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Electrocardiogram abnormal\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-21 10:00:00, ended at 2014-09-21 12:37:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-21 12:38:00, ended at 2014-09-21 13:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Effect of exposure to physical force\n- Primary diagnosis: Transplanted heart present\n- Acute myocardial infarction\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-09-21, presumably until 2014-09-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-21 14:00:00, ended at 2014-09-21 17:19:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n\n### Condition\n- Lung field abnormal\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-21 17:20:00, ended at 2014-09-21 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-25 00:00:00, ended at 2014-09-25 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-25 08:10:00, ended at 2014-09-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.02 (million per microliter)\n- MCV [Entitic volume] by Automated count: 99.5 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 13.1 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.35 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Effect of exposure to physical force\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-27 00:00:00, ended at 2014-09-27 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-28 07:10:00, ended at 2014-09-28 07:28:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 23.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.84 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 10.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Effect of exposure to physical force\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-28 07:29:00, ended at 2014-09-28 08:45:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-28 09:01:25, ended at 2014-09-28 11:03:29\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n- Essential hypertension\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-09-28, presumably until 2014-12-18, with intended 11 refill(s). Instructions: take 1 tablet by mouth daily. DISPENSE TABLETS PLEASE!\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-28 11:00:00, ended at 2014-09-28 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 62.2 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-28 11:54:29, ended at 2014-09-28 12:05:25\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Lung field abnormal\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-29 00:00:00, ended at 2014-09-29 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-29 15:58:34, ended at 2014-09-29 17:04:42\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Abnormal involuntary movement\n- Hyperlipidemia\n\n### Drug\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2014-11-07, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) Evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-02 07:46:00, ended at 2014-10-02 10:53:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.32 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.72 (milli-international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 191 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 14.0 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Effect of exposure to physical force\n- Type 2 diabetes mellitus without complication\n- Abnormal involuntary movement\n- Acute myocardial infarction\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-02 08:28:18, ended at 2014-10-02 10:48:57\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- itraconazole 10 MG/ML Oral Solution, started on 2014-10-02, presumably until 2014-11-23, with intended 2 refill(s). Instructions: Take 200 mg (20 mL) by mouth every morning and 100 mg (10 mL) every evening on an empty stomach.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-10-04 00:00:00, ended at 2014-10-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-04 08:14:00, ended at 2014-10-04 22:56:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 139 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood: 46 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.5 (picogram)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Body height: 5' 1\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Lactate [Moles/volume] in Blood: 1.2 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Coronary arteriography using two catheters\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Endomyocardial biopsy\n- Collection of venous blood by venipuncture\n- Intravascular imaging of coronary vessels\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n\n### Condition\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2014-10-04, presumably until 2014-10-04\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2014-10-04, presumably until 2014-10-04\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-10-04, presumably until 2014-10-04\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-10-04, presumably until 2014-10-04\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-10-04, presumably until 2014-10-04\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2014-10-04, presumably until 2014-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-05 08:37:00, ended at 2014-10-05 10:24:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.83 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 14.7 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Effect of exposure to physical force\n- Acute on chronic systolic heart failure\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-05 08:59:15, ended at 2014-10-05 10:23:05\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal breathing\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-05 10:25:00, ended at 2014-10-05 11:14:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 63.2 (percent)\n\n### Procedure\n- Long-term drug therapy\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-05 11:15:00, ended at 2014-10-05 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2014-10-08 12:05:00, ended at 2014-10-08 16:21:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 7.67 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Prothrombin time (PT): 15.0 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 161 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Hemorrhage of rectum and anus\n- Atrial fibrillation\n- Gastrointestinal hemorrhage\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Allergic disposition\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-09 07:55:00, ended at 2014-10-09 11:13:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 21.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.98 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.9 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.69 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-09 11:14:00, ended at 2014-10-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-10-09, presumably until 2014-10-09\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-10-09, presumably until 2014-10-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-16 08:11:00, ended at 2014-10-16 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.5 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 14.3 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 3.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 87 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-16 08:45:08, ended at 2014-10-16 10:32:48\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Immune defect\n- Primary diagnosis: Transplanted heart present\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-10-17 00:00:00, ended at 2014-10-17 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Nausea\n- Diarrhea\n- Leukocytosis\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-10-17, presumably until 2014-12-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2014-10-17, presumably until 2014-11-07, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-19 07:45:00, ended at 2014-10-19 08:39:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.97 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 41 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Tacrolimus [Mass/volume] in Blood: 18.3 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 265 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.07 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Biopsy of heart\n- Echocardiography\n\n### Condition\n- Acute on chronic systolic heart failure\n- Mechanical complication due to heart valve prosthesis\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Nausea\n- Acute myocardial infarction\n- Disorder of diaphragm\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-19 10:35:00, ended at 2014-10-19 11:49:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 59.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-19 11:50:00, ended at 2014-10-19 12:12:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Nausea\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-19 12:13:00, ended at 2014-10-19 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-10-19, presumably until 2014-10-19\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-10-19, presumably until 2014-10-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-26 08:40:00, ended at 2014-10-26 08:54:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 13.23 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 209 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 15.8 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 91 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n- Effect of exposure to physical force\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Diarrhea\n- Nausea\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-26 08:55:00, ended at 2014-10-26 11:46:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-26 09:14:28, ended at 2014-10-26 11:37:22\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Essential hypertension\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-26 11:47:00, ended at 2014-10-26 12:18:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-26 12:19:00, ended at 2014-10-26 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Leukocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2014-10-27 09:54:00, ended at 2014-11-07 18:35:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 100 (percent)\n- Platelets [#/volume] in Blood by Automated count: 381 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Base excess in Blood by calculation: 6.0 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 16.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 48 (percent)\n- Lactate [Moles/volume] in Blood: 1.8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 38.3 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.51 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCV [Entitic volume] by Automated count: 97.4 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Body height: 5' 1\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 276 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.91 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 129 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 4.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 28.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 214 (millimeter mercury column)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Collection of venous blood by venipuncture\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Computed tomography, thorax, diagnostic; without contrast material\n- Arterial puncture, withdrawal of blood for diagnosis\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Central venous catheter placement with guidance\n\n### Condition\n- Acute on chronic systolic heart failure\n- Pressure ulcer of buttock\n- Primary diagnosis: Sepsis\n- Urinary tract infectious disease\n- Chronic ischemic heart disease\n- Essential hypertension\n- Hypervolemia\n- Muscle atrophy\n- Pressure ulcer stage 2\n- Sepsis due to Gram negative bacteria\n- Congestive heart failure\n- Disorder of diaphragm\n- Effect of exposure to physical force\n- Immune defect\n- Type 2 diabetes mellitus without complication\n- Acute posthemorrhagic anemia\n- Hypo-osmolality and or hyponatremia\n- Hypoxemia\n- Late effect of medical and surgical care complication\n- Lung field abnormal\n- Pressure ulcer\n- Acute myocardial infarction\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder affecting transplanted structure\n- Hyperlipidemia\n- Atrial fibrillation\n- Diarrhea\n- Malaise\n- Pneumothorax\n- Senility\n- Bacteremia\n- Bronchitis\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Dysphonia\n- Hyperkalemia\n- Transplanted heart present\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-11-07\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2014-11-03, presumably until 2015-05-24, with intended 11 refill(s). Instructions: take 3 Tabs by mouth daily in the evening.\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2014-10-28, presumably until 2014-11-07\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-11-06, presumably until 2015-11-07, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take 2 tablets by mouth in the morning and 1 tablet by mouth in the afternoon.\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2014-11-02, presumably until 2014-11-06\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-10-28\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-11-05\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-10-28, presumably until 2014-10-28\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2014-10-27, presumably until 2014-11-07\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2014-11-06, presumably until 2014-11-07\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2014-10-28, presumably until 2014-12-13, with intended 1 refill(s). Instructions: take 8 Tabs by mouth 2 times a day.\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2014-10-28, presumably until 2014-11-07\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2014-11-01, presumably until 2014-12-18, with intended 3 refill(s). Instructions: by Topical route as needed (at time of buttock dressing change).\n- 10 ML furosemide 10 MG/ML Injection, started on 2014-11-04, presumably until 2014-11-05\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-11-06\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-10-27, presumably until 2014-11-07\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2014-10-28, presumably until 2014-11-07\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-10-27, presumably until 2014-11-07\n- clotrimazole 10 MG/ML Topical Solution, through Topical route, started on 2014-10-27, presumably until 2014-11-06\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-10-28, presumably until 2014-11-03\n- cefepime 2000 MG Injection, through Intravenous route, started on 2014-10-27, presumably until 2014-10-29\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2014-10-29, presumably until 2014-11-20, with intended 11 refill(s). Instructions: Take 0.5 mg in the morning and 1 mg in the evening. Or as directed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-10-27, presumably until 2014-11-05\n- ceftriaxone 2000 MG Injection, through Intravenous route, started on 2014-11-07, presumably until 2014-11-23, with intended 0 refill(s). Instructions: 2 g by Intravenous route daily in the evening.\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2014-10-27, presumably until 2014-10-28\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-11-04, presumably until 2014-11-06\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-10-27, presumably until 2015-05-24, with intended 0 refill(s). Instructions: inject 18 Units subcutaneous (under the skin) Evening.\n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2014-10-27, presumably until 2014-11-07\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-11-07\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-10-27, presumably until 2014-11-07\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2014-10-28, presumably until 2014-11-06\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2014-10-28, presumably until 2014-11-07\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-11-07, with intended 11 refill(s). Instructions: take 2 Tabs by mouth Every Day. Take a total of 720 mg by mouth in the morning ( 2 tablets)\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2014-10-30, presumably until 2014-10-30\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-10-30, presumably until 2014-10-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-07 00:00:00, ended at 2014-11-07 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dabigatran etexilate 150 MG Oral Capsule, started on 2014-11-07, presumably until 2014-11-07, with intended 10 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-13 08:07:00, ended at 2014-11-13 09:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.20 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.4 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 214 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Erythrocyte sedimentation rate: 17 (millimeter per hour)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.34 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Diarrhea\n- Effect of exposure to physical force\n- Leukocytosis\n- Nausea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-13 09:10:15, ended at 2014-11-13 10:23:33\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Effect of exposure to physical force\n- Immune defect\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-13 10:00:00, ended at 2014-11-13 11:18:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 61.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Diarrhea\n- Leukocytosis\n- Nausea\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-13 11:19:00, ended at 2014-11-13 13:13:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Transplanted heart present\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-15 15:00:00, ended at 2014-11-15 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Effect of exposure to physical force\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-11-15, presumably until 2014-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-16 00:00:00, ended at 2014-11-16 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- furosemide 20 MG Oral Tablet, started on 2014-11-29, presumably until 2014-12-29, with intended 11 refill(s). Instructions: Take 2 tablets by mouth in the morning and 1 tablet by mouth in the afternoon.\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2014-11-20, presumably until 2014-12-19, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- tacrolimus 0.5 MG Oral Capsule, started on 2014-11-20, presumably until 2014-12-28, with intended 11 refill(s). Instructions: Take a total of 1.5 mg in the evening. Fax 999-999-9999\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-17 10:05:00, ended at 2014-11-17 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Leukocytosis\n- Diarrhea\n- Nausea\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-23 07:45:00, ended at 2014-11-23 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 226 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.6 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-23 08:20:46, ended at 2014-11-23 09:53:07\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-29 00:00:00, ended at 2014-11-29 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-30 07:48:00, ended at 2014-11-30 08:06:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 167 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- MCV [Entitic volume] by Automated count: 100.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.73 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.59 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 45 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Effect of exposure to physical force\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-30 08:07:00, ended at 2014-11-30 10:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Endomyocardial biopsy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n- Late effect of medical and surgical care complication\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-30 11:17:00, ended at 2014-11-30 11:58:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 62.4 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-30 11:59:00, ended at 2014-11-30 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-05 10:49:00, ended at 2014-12-05 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.75 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 29.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 192 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-13 00:00:00, ended at 2014-12-13 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal glucose level\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2014-12-13, presumably until 2015-02-09, with intended 3 refill(s). Instructions: take 8 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-15 00:00:00, ended at 2014-12-15 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-15 09:53:00, ended at 2014-12-15 09:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 244 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 45 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.44 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Acute myocardial infarction\n- Effect of exposure to physical force\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-15 10:00:00, ended at 2014-12-15 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-12-15, presumably until 2014-12-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-12-18 08:59:20, ended at 2014-12-18 10:01:13\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Essential hypertension\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-18 10:06:00, ended at 2014-12-18 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.10 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Effect of exposure to physical force\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-19 00:00:00, ended at 2014-12-19 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2014-12-19, presumably until 2015-02-09, with intended 11 refill(s). Instructions: 1 Spray by Nasal route daily. 1 spray each nare daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2014-12-19, presumably until 2015-02-09, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2014-12-19, presumably until 2014-12-29, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-12-20 12:39:07, ended at 2014-12-20 13:41:22\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-27 00:00:00, ended at 2014-12-27 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-28 09:05:00, ended at 2014-12-28 09:26:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 202 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 327 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.32 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <15 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-28 09:27:00, ended at 2014-12-28 12:29:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.5 (percent)\n\n### Procedure\n- Long-term drug therapy\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-28 12:30:00, ended at 2014-12-28 14:16:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Endomyocardial biopsy\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n- Essential hypertension\n- Lung field abnormal\n- Asthenia\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-29 00:00:00, ended at 2014-12-29 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-12-29, presumably until 2015-02-09, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. Fax 999-999-9999 with any questions.\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2014-12-29, presumably until 2015-02-13, with intended 11 refill(s). Instructions: take 0.5 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-01 11:18:00, ended at 2015-01-01 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.81 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n- Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-23 00:00:00, ended at 2015-01-23 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-31 00:00:00, ended at 2015-01-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-01 00:00:00, ended at 2015-02-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-01 07:26:00, ended at 2015-02-01 07:26:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 11.0 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 222 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Congestive heart failure\n- Effect of exposure to physical force\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-01 07:27:00, ended at 2015-02-01 07:50:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-01 07:51:00, ended at 2015-02-01 10:09:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-01 08:35:30, ended at 2015-02-01 09:41:12\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-01 10:10:00, ended at 2015-02-01 11:12:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-01 11:13:00, ended at 2015-02-01 15:05:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-02-08 17:47:00, ended at 2015-02-13 19:22:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 18.9 (microgram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <15 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n- Lactate [Moles/volume] in Blood: 1.5 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Left ventricular Ejection fraction: 59.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.04 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.77 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.7 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Ultrasound, abdominal, real time with image documentation; complete\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Collection of venous blood by venipuncture\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Cachexia\n- Chronic kidney disease stage 2\n- Dehydration\n- Acute on chronic systolic heart failure\n- Cough\n- Electrocardiogram abnormal\n- Sepsis due to Streptococcus\n- Transplanted heart present\n- Atrial fibrillation\n- Allergic disposition\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Urinary tract infectious disease\n- Anemia\n- Chronic ischemic heart disease\n- Effect of exposure to physical force\n- Primary diagnosis: Nausea and vomiting\n- Acute posthemorrhagic anemia\n- Dysphonia\n- Essential hypertension\n- Sepsis\n- Type 2 diabetes mellitus without complication\n- Acute renal failure syndrome\n- Congestive heart failure\n- Hypogammaglobulinemia\n- Immune defect\n- Pneumothorax\n- Disorder of diaphragm\n- Hypervolemia\n- Severe protein-calorie malnutrition (Gomez: less than 60 percent of standard weight)\n- Acute myocardial infarction\n- Large liver\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2015-02-09, presumably until 2015-02-10\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-02-13, presumably until 2015-05-16, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every morning.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-02-13, presumably until 2015-02-28, with intended 11 refill(s). Instructions: 1 Spray by Nasal route daily.\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2015-02-08, presumably until 2015-02-11\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2015-02-09, presumably until 2015-02-13\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-02-08, presumably until 2015-05-24, with intended 0 refill(s). Instructions: take 2 mg by mouth 2 times a day.\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-02-08, presumably until 2015-02-12\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-02-11, presumably until 2015-02-13\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2015-02-08, presumably until 2015-02-13\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2015-02-10, presumably until 2015-02-13\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2015-02-08, presumably until 2015-03-28, with intended 0 refill(s). Instructions: take 4 mg by mouth 2 times a day.\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2015-02-08, presumably until 2015-02-12\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-02-09, presumably until 2015-02-22, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 3 times a day with meals. Inject additional 1unit for every 30 >130 BS.\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2015-02-13, presumably until 2015-02-20, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-02-12, presumably until 2016-02-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2015-02-11, presumably until 2015-12-24, with intended 0 refill(s). Instructions: take 3 Caps by mouth daily in the evening.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-02-08, presumably until 2015-02-13\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-02-08, presumably until 2015-02-08\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-04-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2015-02-08, presumably until 2015-02-11\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-03-28, with intended 1 refill(s). Instructions: take 450 mg by mouth 2 times a day.\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-16 00:00:00, ended at 2015-02-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-19 00:00:00, ended at 2015-02-19 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2015-02-20, presumably until 2015-04-12, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day before meals. For nausea. About 30 minutes prior to meals.Fax 999-999-9999.\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2015-02-20, presumably until 2015-12-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- estradiol 0.1 MG/ML Vaginal Cream, through Vaginal route, started on 2015-02-20, presumably until 2016-02-20, with intended 11 refill(s). Instructions: insert 2 g into the vagina daily.\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2015-02-20, presumably until 2015-08-29, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-19 08:50:00, ended at 2015-02-19 11:18:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Effect of exposure to physical force\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-19 09:32:08, ended at 2015-02-19 11:07:48\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Pure hypercholesterolemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-19 11:19:00, ended at 2015-02-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-02-22 00:00:00, ended at 2015-02-22 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2015-02-22, presumably until 2015-05-24, with intended 10 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 3 times a day with meals. Inject additional 1unit for every 30 >130 BS.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-28 10:02:46, ended at 2015-02-28 10:52:52\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted heart present\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-07 00:00:00, ended at 2015-03-07 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-08 08:53:00, ended at 2015-03-08 09:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.15 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Acute myocardial infarction\n- Effect of exposure to physical force\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-08 09:16:00, ended at 2015-03-08 12:04:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 31.6mlEF(MOD-bp) (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-08 09:57:44, ended at 2015-03-08 11:57:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-08 12:05:00, ended at 2015-03-08 12:25:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-08 12:27:00, ended at 2015-03-08 13:22:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Radiologic examination, hip, unilateral; 1 view\n\n### Condition\n- Joint pain of pelvic region\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-08 13:23:00, ended at 2015-03-08 14:56:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy of heart\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n- Nausea\n- Transplanted heart present\n- Disorder of kidney and/or ureter\n- Effect of exposure to physical force\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-12 00:00:00, ended at 2015-03-12 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2015-03-12, presumably until 2015-04-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-13 12:46:53, ended at 2015-03-13 15:04:08\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-14 00:00:00, ended at 2015-03-14 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-03-14, presumably until 2015-04-12, with intended 1 refill(s). Instructions: take 1 Cap by mouth as directed. Take 1 tablet 1 to 2 hrs prior to CT scan. May repeat x1.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-19 13:52:00, ended at 2015-03-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-28 00:00:00, ended at 2015-03-28 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2015-03-28, presumably until 2015-04-16, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-03-28, presumably until 2015-10-16, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-06 07:36:00, ended at 2015-04-06 10:16:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 104 (milligram per deciliter)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopic excision or destruction of lesion or tissue of stomach\n\n### Condition\n- Allergic disposition\n- Atrial fibrillation\n- Benign neoplasm of stomach\n- Gastritis\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Nausea and vomiting\n- Transplanted heart present\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2015-04-06, presumably until 2015-04-06\n- midazolam 1 MG/ML Injectable Solution, started on 2015-04-06, presumably until 2015-04-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-11 00:00:00, ended at 2015-04-11 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-11 00:00:00, ended at 2015-04-11 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-12 08:59:00, ended at 2015-04-12 08:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-12 09:00:00, ended at 2015-04-12 09:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 4.3 (microgram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n\n### Procedure\n- Long-term drug therapy\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-12 09:43:00, ended at 2015-04-12 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 1.6EF(MOD-sp4) (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-12 10:36:14, ended at 2015-04-12 12:23:36\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Essential hypertension\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-13 00:00:00, ended at 2015-04-13 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2015-04-13, presumably until 2016-02-12, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-15 00:00:00, ended at 2015-04-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2015-04-15, presumably until 2015-04-15, with intended 3 refill(s). Instructions: TAKE 2 TABLETS ORALLY TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-16 00:00:00, ended at 2015-04-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Urine finding\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2015-04-16, presumably until 2015-09-12, with intended 11 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-16 20:24:00, ended at 2015-04-16 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n- Urine finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-17 00:00:00, ended at 2015-04-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-04-17, presumably until 2015-05-24, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-17 00:00:00, ended at 2015-04-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-09 10:16:00, ended at 2015-05-09 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-09 10:40:49, ended at 2015-05-09 11:39:12\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Hyperlipidemia\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-05-15 00:00:00, ended at 2015-05-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-15 11:22:01, ended at 2015-05-15 12:45:14\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Urinary tract infectious disease\n- Bacterial infection due to Klebsiella pneumoniae\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-05-16 00:00:00, ended at 2015-05-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-05-16, presumably until 2015-08-15, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-17 07:43:00, ended at 2015-05-17 07:44:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.53 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 230 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Effect of exposure to physical force\n- Type 2 diabetes mellitus without complication\n- Anemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-17 07:45:00, ended at 2015-05-17 07:47:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-17 07:48:00, ended at 2015-05-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 2.8 (microgram per milliliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.9 (nanogram per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-17 08:14:01, ended at 2015-05-17 10:04:58\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2015-05-23 13:28:00, ended at 2015-05-24 14:08:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 190 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 215 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 244 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Tacrolimus [Mass/volume] in Blood: 8.4 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 3.1 (microgram per milliliter)\n- Base excess in Blood by calculation: 1 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.39 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 97.7 (femtoliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.3 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Acute on chronic systolic heart failure\n- Disorder of eye due to diabetes mellitus\n- Bacterial infection due to Klebsiella pneumoniae\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Dysphonia\n- Cardiac arrhythmia\n- Congestive heart failure\n- Effect of exposure to physical force\n- Essential hypertension\n- Vomiting\n- Acute posthemorrhagic anemia\n- Hyperlipidemia\n- Nausea and vomiting\n- Nonproliferative retinopathy due to diabetes mellitus\n- Old myocardial infarction\n- Primary diagnosis: Urinary tract infectious disease\n- Pneumothorax\n- Transplanted heart present\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Immune defect\n- Sepsis\n- Acute myocardial infarction\n- Atrial fibrillation\n- Electrocardiogram abnormal\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-10-16, with intended 1 refill(s). Instructions: take 3 Tabs by mouth every 12 hours at 10am and 10pm\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-05-24\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-05-24, presumably until 2015-05-24\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2015-05-24, presumably until 2015-10-16, with intended 10 refill(s). Instructions: 6-8 Units by Injection route 3 times a day inject 10 Units subcutaneous (under the skin) 3 times a day with meals. Inject additional 1unit for every 30 >130 BS.\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-05-23, presumably until 2016-02-05, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily in the morning\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-05-24\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-05-23\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-05-23, presumably until 2015-05-23\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2015-05-23, presumably until 2015-05-23\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-05-23, presumably until 2015-05-23\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-05-23, presumably until 2016-02-05, with intended 0 refill(s). Instructions: inject 16 Units subcutaneous (under the skin) Evening\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-05-24\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-05-23\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-08-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-31 07:58:00, ended at 2015-05-31 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 4.7 (microgram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n- Bacterial infection due to Klebsiella pneumoniae\n- Transplanted heart present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-07 09:44:00, ended at 2015-06-07 09:45:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Effect of exposure to physical force\n- Type 2 diabetes mellitus without complication\n- Urinary tract infectious disease\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-07 09:46:00, ended at 2015-06-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 5.0 (microgram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 8.6 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n\n### Procedure\n- Long-term drug therapy\n- Collection of venous blood by venipuncture\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n- Urinary tract infectious disease\n- Type 2 diabetes mellitus without complication\n- Bacterial infection due to Klebsiella pneumoniae\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-13 00:00:00, ended at 2015-06-13 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-06-14 00:00:00, ended at 2015-06-14 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-08-15, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-14 08:19:00, ended at 2015-06-14 11:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 64.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-14 11:01:00, ended at 2015-06-14 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Bacterial infection due to Klebsiella pneumoniae\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-15 00:00:00, ended at 2015-06-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-06-15, presumably until 2015-06-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days DO NOT take with AUGMENTIN. Fax 999-999-9999. Complete this course for 14 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-15 00:00:00, ended at 2015-06-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2015-06-15, presumably until 2015-10-16, with intended 11 refill(s). Instructions: take 1 Tab by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-22 09:12:00, ended at 2015-06-22 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-09 00:00:00, ended at 2015-07-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-07-09, presumably until 2015-09-12, with intended 11 refill(s). Instructions: take 10 mL by mouth every morning with breakfast ICD 9: 996.83; Fax: 999-999-9999\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2015-07-09, presumably until 2015-09-03, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-14 08:20:05, ended at 2015-08-14 09:11:09\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Immune defect\n- Primary diagnosis: Urinary tract infectious disease\n- Bacterial infection due to Klebsiella pneumoniae\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-15 00:00:00, ended at 2015-08-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-15 09:15:00, ended at 2015-08-15 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 2.1 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-15 10:09:16, ended at 2015-08-15 10:44:56\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disorder due to diabetes mellitus\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-24 00:00:00, ended at 2015-08-24 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 08:52:00, ended at 2015-08-29 09:12:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.6 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 228 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.3 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 0.3 (milligram per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.6 (nanogram per milliliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.9 (ratio)\n- Homocysteine [Moles/volume] in Serum or Plasma: 13.1 (micromole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 133 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.69 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 27.9 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.26 (micro-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 09:13:00, ended at 2015-08-29 09:54:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 09:55:00, ended at 2015-08-29 13:35:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.8 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-29 10:37:19, ended at 2015-08-29 13:27:06\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary hypertension\n- Pure hypercholesterolemia\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-30 08:11:00, ended at 2015-08-30 16:25:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 30 (percent)\n- INR in Blood by Coagulation assay: 1.2 (ratio)\n- Potassium [Moles/volume] in Blood: 4.7 (millimole per liter)\n- Body height: 5' 1\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.2 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 137 (millimole per liter)\n\n### Procedure\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of blood specimen from a completely implantable venous access device\n- Intravascular imaging of coronary vessels\n- Coronary arteriography using single catheter\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Chronic kidney disease\n- Allergic disposition\n- Primary diagnosis: Postprocedural state finding\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-08-30, presumably until 2015-08-30\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-30, presumably until 2015-08-30\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2015-08-30, presumably until 2015-08-30\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2015-08-30, presumably until 2015-08-30\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-08-30, presumably until 2015-08-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-08-30, presumably until 2015-08-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-03 00:00:00, ended at 2015-09-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2015-09-03, presumably until 2015-09-14, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-12 08:10:32, ended at 2015-09-12 09:02:30\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Hyperlipidemia\n- Primary diagnosis: Kidney disease\n- Transplanted heart present\n- Essential hypertension\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2015-09-12, presumably until 2015-12-01, with intended 2 refill(s). Instructions: take 500 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-14 00:00:00, ended at 2015-09-14 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2015-09-14, presumably until 2016-04-15, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-18 00:00:00, ended at 2015-09-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-18 00:00:00, ended at 2015-09-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercalcemia\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-25 00:00:00, ended at 2015-09-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-09-26, presumably until 2015-10-16, with intended 5 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-27 00:00:00, ended at 2015-09-27 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- repaglinide 0.5 MG Oral Tablet, through Oral route, started on 2015-09-28, presumably until 2015-11-23, with intended 1 refill(s). Instructions: take 0.5 mg by mouth 2 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-16 00:00:00, ended at 2015-10-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2015-10-16, presumably until 2015-12-25, with intended 11 refill(s). Instructions: take 3 Tabs by mouth every 12 hours at 10am and 10pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-16 09:31:18, ended at 2015-10-16 10:17:17\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Primary diagnosis: Urinary tract infectious disease\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n- Immune defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-18 00:00:00, ended at 2015-10-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2015-10-18, presumably until 2016-10-18, with intended 1 refill(s). Instructions: take 4 Caps by mouth Every Day Take within 1hr of dental procedures\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-30 00:00:00, ended at 2015-10-30 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cefpodoxime 200 MG Oral Tablet, through Oral route, started on 2015-11-01, presumably until 2015-11-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-13 09:02:20, ended at 2015-11-13 10:07:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Fatigue\n- Malaise\n- Primary diagnosis: Urinary tract infectious disease\n- Transplanted heart present\n- Stomatitis\n- Disorder due to infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-13 10:16:00, ended at 2015-11-13 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n- Disorder due to infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-11-14 00:00:00, ended at 2015-11-14 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Stomatitis\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2015-11-14, presumably until 2015-11-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth 3 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-16 00:00:00, ended at 2015-11-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cytomegalovirus infection\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-17 00:00:00, ended at 2015-11-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cytomegalovirus infection\n- Transplanted heart present\n\n### Drug\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-11-17, presumably until 2015-12-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day for 30 days Please get specific dosing instructions including duration from your doctor.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-17 00:00:00, ended at 2015-11-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Transplanted heart present\n- Bacterial infection due to Klebsiella pneumoniae\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-17 11:37:00, ended at 2015-11-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.64 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 3.75 (log international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 5666 (international unit per milliliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cytomegalovirus infection\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Urinary tract infectious disease\n- Disorder due to infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-19 00:00:00, ended at 2015-11-19 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Cytomegalovirus infection\n- Neutropenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-21 10:46:00, ended at 2015-11-21 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder of immune function\n- Cytomegalovirus infection\n- Transplanted heart present\n- Disorder due to infection\n- Type 2 diabetes mellitus without complication\n- Hypercalcemia\n- Neutropenia\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-22 00:00:00, ended at 2015-11-22 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.29 (micro-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-23 00:00:00, ended at 2015-11-23 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n- repaglinide 0.5 MG Oral Tablet, started on 2015-11-26, presumably until 2016-02-18, with intended 10 refill(s). Instructions: TAKE 0.5 MG BY MOUTH 2 TIMES A DAY BEFORE MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-28 00:00:00, ended at 2015-11-28 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Cytomegalovirus infection\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-30 00:00:00, ended at 2015-11-30 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 20 MG Oral Tablet, started on 2015-12-19, presumably until 2015-12-19, with intended 3 refill(s). Instructions: TAKE 2 TABLETS ORALLY EVERY MORNING AND 1 TAB IN THE AFTERNOON\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-01 00:00:00, ended at 2015-12-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2015-12-05, presumably until 2016-02-18, with intended 6 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-04 00:00:00, ended at 2015-12-04 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, started on 2015-12-04, presumably until 2016-02-05, with intended 10 refill(s). Instructions: TAKE A TOTAL OF 1.5 MG IN THE EVENING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-10 00:00:00, ended at 2015-12-10 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-17 08:24:00, ended at 2015-12-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.63 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 164 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.67 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 6.7 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Urinary tract infectious disease\n- Disorder of immune function\n- Bacterial infection due to Klebsiella pneumoniae\n- Transplanted heart present\n- Disorder of transplanted heart\n- Cytomegalovirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-20 00:00:00, ended at 2015-12-20 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-21 00:00:00, ended at 2015-12-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 07:56:00, ended at 2015-12-24 10:14:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 59.9 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-24 08:49:59, ended at 2015-12-24 10:05:35\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, presumably until 2017-10-28, with intended 0 refill(s). Instructions: take by mouth 2 times a day Takes 2 tabs in the Am and 3 tabs in the pm\n- valganciclovir 450 MG Oral Tablet, through Oral route, presumably until 2016-02-05, with intended 0 refill(s). Instructions: take 450 mg by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 10:15:00, ended at 2015-12-24 10:34:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of immune function\n- Urinary tract infectious disease\n- Bacterial infection due to Klebsiella pneumoniae\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 10:35:00, ended at 2015-12-24 11:32:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 11:33:00, ended at 2015-12-24 12:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Endomyocardial biopsy\n\n### Condition\n- Late effect of complications of procedure\n- Transplanted heart present\n- Cardiac transplant rejection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-12-25 00:00:00, ended at 2015-12-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2015-12-25, presumably until 2016-02-12, with intended 11 refill(s). Instructions: take 2 Tabs by mouth every 12 hours at 10am and 10pm\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2015-12-25, presumably until 2016-03-28, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-26 00:00:00, ended at 2015-12-26 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-12-26, presumably until 2016-03-28, with intended 7 refill(s). Instructions: take 1-2 Caps by mouth 2 times a day Taking a total of 2mg in AM, 1.5mg in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-24 00:00:00, ended at 2016-01-24 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2016-01-24, presumably until 2016-06-05, with intended 3 refill(s). Instructions: inject 14 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-05 09:19:51, ended at 2016-02-05 10:02:23\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cytomegalovirus infection\n- Transplanted heart present\n- Urinary tract infectious disease\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-02-11 00:00:00, ended at 2016-02-11 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2016-02-11, presumably until 2016-03-05, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2016-02-11, presumably until 2016-03-05, with intended 3 refill(s). Instructions: TAKE 2 TABLETS TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Transplanted heart present\n- Type 2 diabetes mellitus\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2016-02-12, presumably until 2017-01-26, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every 12 hours at 10am and 10pm\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2016-02-12, presumably until 2016-02-14, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-02-13 00:00:00, ended at 2016-02-13 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2016-02-18, presumably until 2016-03-10, with intended 0 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY DAY, additional refills at next appt\n- repaglinide 0.5 MG Oral Tablet, started on 2016-02-18, presumably until 2016-03-05, with intended 0 refill(s). Instructions: TAKE 0.5 MG BY MOUTH 2 TIMES A DAY BEFORE MEALS, additional refills at next appt\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-14 00:00:00, ended at 2016-02-14 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2016-02-14, presumably until 2016-02-18, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-18 00:00:00, ended at 2016-02-18 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Primary diagnosis: Disorder of transplanted heart\n- Hyperglycemia due to type 2 diabetes mellitus\n- Transplanted heart present\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2016-02-18, presumably until 2016-12-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day Fax 999-999-9999 with questions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-05 10:01:02, ended at 2016-03-05 11:08:53\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- repaglinide 0.5 MG Oral Tablet, started on 2016-03-05, presumably until 2017-01-29, with intended 3 refill(s). Instructions: TAKE 0.5 MG BY MOUTH 2 TIMES A DAY BEFORE MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-07 07:45:05, ended at 2016-03-07 09:58:04\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 18 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n- Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-10 00:00:00, ended at 2016-03-10 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2016-03-13, presumably until 2016-08-17, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-12 00:00:00, ended at 2016-03-12 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-28 00:00:00, ended at 2016-03-28 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-03-28, presumably until 2016-04-25, with intended 3 refill(s). Instructions: take 1-2 Caps by mouth 2 times a day Taking a total of 2mg in AM, 1.5mg in PM\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2016-03-28, presumably until 2017-02-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2016-03-28, presumably until 2016-04-25, with intended 3 refill(s). Instructions: take 1 Cap by mouth PM Total dose of 2mg AM, 1.5mg PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-15 00:00:00, ended at 2016-04-15 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2016-04-15, presumably until 2017-02-18, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-24 00:00:00, ended at 2016-04-24 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-24 10:08:00, ended at 2016-04-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.45 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 190 (thousand per microliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.58 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 117 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.3 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Transplanted heart present\n- Disorder of transplanted heart\n- Illness\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-04-25 00:00:00, ended at 2016-04-25 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-04-25, presumably until 2017-01-26, with intended 3 refill(s). Instructions: take 2 Caps by mouth 2 times a day Taking a total of 2mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-02 00:00:00, ended at 2016-05-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-05 07:48:00, ended at 2016-05-05 11:06:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 59.6 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-05 11:07:00, ended at 2016-05-05 14:02:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.9 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.16 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.48 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n\n### Procedure\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Collection of venous blood by venipuncture\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Essential hypertension\n- Transplanted heart present\n- Disorder of immune function\n- Type 2 diabetes mellitus without complication\n- Disorder of transplanted heart\n- Bacterial infection due to Klebsiella pneumoniae\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-05 14:34:00, ended at 2016-05-05 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-09 00:00:00, ended at 2016-05-09 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-13 10:33:05, ended at 2016-05-13 11:08:22\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n- Transplanted heart present\n- Cytomegalovirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-27 00:00:00, ended at 2016-05-27 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-29 00:00:00, ended at 2016-05-29 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of respiratory system\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-05 00:00:00, ended at 2016-06-05 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2016-06-05, presumably until 2017-06-10, with intended 3 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) Evening Fax 999-999-9999, DM type II, s/p heart transplant.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-24 00:00:00, ended at 2016-06-24 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-30 10:22:43, ended at 2016-06-30 11:55:11\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .984\" (inch (US))\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion)\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n\n### Condition\n- Disorder of immune function\n- Primary diagnosis: Actinic keratosis\n- Benign neoplasm of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-17 00:00:00, ended at 2016-08-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2016-08-19, presumably until 2016-09-05, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-05 12:07:00, ended at 2016-09-05 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Complication due to diabetes mellitus\n- Cytomegalovirus infection\n- Disorder of immune function\n- Essential hypertension\n- Disorder of respiratory system\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Urinary tract infectious disease\n- Hyperlipidemia\n- Bacterial infection due to Klebsiella pneumoniae\n- Obesity\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-05 13:02:51, ended at 2016-09-05 13:54:33\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Creatinine [Mass/volume] in Urine: 54.50 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 16 (milligram per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Complication due to diabetes mellitus\n- Essential hypertension\n- Obesity\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2016-09-05, presumably until 2016-12-10, with intended 3 refill(s). Instructions: take 1,000 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-19 00:00:00, ended at 2016-09-19 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- acetylcysteine 600 MG Oral Capsule, through Oral route, started on 2016-09-19, presumably until 2016-09-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day Take 1 cap 12hrs before test, 1 cap before test, 1 cap 12hrs after test, 1 cap 24hrs after test\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-19 00:00:00, ended at 2016-09-19 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Fatigue\n- Disorder of transplanted heart\n- Type 2 diabetes mellitus\n- Pure hypercholesterolemia\n- Complication due to diabetes mellitus\n- Transplanted heart present\n\n### Drug\n- acetylcysteine 600 MG Oral Capsule, through Oral route, started on 2016-09-19, presumably until 2016-09-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day Take 1 cap 12hrs before test, 1 cap before test, 1 cap 12hrs after test, 1 cap 24hrs after test\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-23 09:23:00, ended at 2016-09-23 09:51:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 13.7 (micromole per liter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 33.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.21 (micro-international unit per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.38 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 98 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 0.6 (milligram per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 13.7 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.4 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 890 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 177 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.5 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of immune function\n- Disorder of transplanted heart\n- Urinary tract infectious disease\n- Transplanted heart present\n- Pure hypercholesterolemia\n- Type 2 diabetes mellitus\n- Complication due to diabetes mellitus\n- Bacterial infection due to Klebsiella pneumoniae\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-23 09:52:00, ended at 2016-09-23 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-23 10:27:00, ended at 2016-09-23 10:35:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 61.1 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Type 2 diabetes mellitus\n- Dyspnea\n- Fatigue\n- Complication due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-23 12:03:31, ended at 2016-09-23 13:36:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 136 (picogram per milliliter)\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Dyspnea\n- Type 2 diabetes mellitus\n- Pure hypercholesterolemia\n- Fatigue\n- Complication due to diabetes mellitus\n- Transplanted heart present\n\n### Drug\n- estradiol 0.1 MG/ML Vaginal Cream, through Vaginal route, presumably until 2017-10-05, with intended 0 refill(s). Instructions: insert 1 Application into the vagina every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-24 06:50:00, ended at 2016-09-24 12:43:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 167 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Collection of venous blood by venipuncture\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Ultrasonography of Single Coronary Artery, Intravascular\n- Endomyocardial biopsy\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n\n### Condition\n- Generalized ischemic myocardial dysfunction\n- Essential hypertension\n- Heart failure\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Transplanted heart present\n- Cardiac transplant rejection\n- Late effect of complications of procedure\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2016-09-24, presumably until 2016-09-24\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-09-24, presumably until 2016-09-24\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2016-09-24\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2016-09-24\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-09-24, presumably until 2016-09-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-09-24, presumably until 2016-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-22 13:07:32, ended at 2016-10-22 14:25:05\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized ischemic myocardial dysfunction\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-10-28 00:00:00, ended at 2016-10-28 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-18 10:09:15, ended at 2016-11-18 10:50:39\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-28 10:04:00, ended at 2016-11-28 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computer-aided detection (computer algorithm analysis of digital image data for lesion detection) with further review for interpretation, with or without digitization of film radiographic images; screening mammography (List separately in addition to code \n- Screening digital breast tomosynthesis, bilateral (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-10 09:02:31, ended at 2016-12-10 09:31:35\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Obesity\n- Complication due to diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2016-12-10, presumably until 2018-01-06, with intended 4 refill(s). Instructions: take 1,500 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-10 09:38:00, ended at 2016-12-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-30 00:00:00, ended at 2016-12-30 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Hyperglycemia due to type 2 diabetes mellitus\n- Transplanted heart present\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, started on 2016-12-31, presumably until 2017-04-07, with intended 2 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-23 00:00:00, ended at 2017-01-23 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-01-26 00:00:00, ended at 2017-01-26 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-26 09:38:00, ended at 2017-01-26 12:16:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 10.1 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.25 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.10 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 128 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cytomegalovirus infection\n- Disorder of transplanted heart\n- Transplanted heart present\n- Bacterial infection due to Klebsiella pneumoniae\n- Urinary tract infectious disease\n- Complication due to diabetes mellitus\n- Disorder of immune function\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-26 10:17:42, ended at 2017-01-26 12:03:22\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2017-01-26, presumably until 2017-12-24, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every 12 hours at 10am and 10pm\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2017-01-26, presumably until 2017-09-01, with intended 3 refill(s). Instructions: take 2 Caps by mouth 2 times a day Taking a total of 2mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-26 12:17:00, ended at 2017-01-26 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-01-27 00:00:00, ended at 2017-01-27 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-01-28 00:00:00, ended at 2017-01-28 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- repaglinide 1 MG Oral Tablet, through Oral route, started on 2017-01-29, presumably until 2018-03-03, with intended 3 refill(s). Instructions: take 1 mg by mouth 2 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-30 09:55:00, ended at 2017-01-30 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 59.4 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-08 00:00:00, ended at 2017-02-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- lisinopril 5 MG Oral Tablet, started on 2017-02-11, presumably until 2017-11-08, with intended 2 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-10 00:00:00, ended at 2017-02-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, started on 2017-02-10, presumably until 2017-02-10, with intended 2 refill(s). Instructions: TAKE 1 TABLET DAILY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-11 16:04:34, ended at 2017-02-11 16:36:19\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute upper respiratory infection\n- Otitis media\n\n### Drug\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2017-02-11, presumably until 2017-03-20, with intended 0 refill(s). Instructions: take 5 mL by mouth 3 times a day as needed\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2017-02-11, presumably until 2017-02-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-18 00:00:00, ended at 2017-02-18 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2017-02-18, presumably until 2018-02-18, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-03 00:00:00, ended at 2017-03-03 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2017-03-03, presumably until 2017-09-01, with intended 3 refill(s). Instructions: TAKE 2 TABLETS ORALLY TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-09 00:00:00, ended at 2017-03-09 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-03-20 00:00:00, ended at 2017-03-20 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Osmolality of Urine: 406 (milliosmole per kilogram)\n- Sodium/Creatinine [Molar ratio] in Urine: 64 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 70.77 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypo-osmolality and or hyponatremia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-20 10:40:00, ended at 2017-03-20 11:22:55\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Type 2 diabetes mellitus\n- Obesity\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-20 11:28:00, ended at 2017-03-20 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Creatinine [Mass/volume] in Urine: 73.60 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.13 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Hypo-osmolality and or hyponatremia\n- Obesity\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Urinary tract infectious disease\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-03-24 00:00:00, ended at 2017-03-24 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-25 00:00:00, ended at 2017-03-25 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-25 12:52:59, ended at 2017-03-25 14:34:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left lower limb\n- Pain in right lower limb\n- Primary diagnosis: Peripheral vascular disorder due to diabetes mellitus\n- Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-25 12:53:00, ended at 2017-03-25 13:04:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in left lower limb\n- Peripheral vascular disorder due to diabetes mellitus\n- Arthralgia of the ankle and/or foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-03 09:43:00, ended at 2017-04-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-07 00:00:00, ended at 2017-04-07 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-07, presumably until 2018-06-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day Please provide 3 month supply as prescribed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-08 14:24:28, ended at 2017-04-08 14:55:28\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arteriosclerotic vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-08 13:25:56, ended at 2017-05-08 15:09:50\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 18 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Type 2 diabetes mellitus\n- Primary diagnosis: Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-02 09:54:03, ended at 2017-06-02 10:44:25\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .98\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-10 00:00:00, ended at 2017-06-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2017-06-10, presumably until 2018-06-15, with intended 4 refill(s). Instructions: inject 17 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 09:37:34, ended at 2017-06-24 10:32:57\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .748\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-24 10:41:00, ended at 2017-06-24 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 732 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Triglyceride [Moles/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 103 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.3 (ratio)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Obesity\n- Type 2 diabetes mellitus\n- Bacterial infection due to Klebsiella pneumoniae\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Transplanted heart present\n- Urinary tract infectious disease\n- Disorder of immune function\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Disorder of transplanted heart\n- Electrocardiogram abnormal\n- Transplanted heart present\n- Primary diagnosis: Pure hyperglyceridemia\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-31 00:00:00, ended at 2017-08-31 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-01 00:00:00, ended at 2017-09-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-01 09:24:00, ended at 2017-09-01 10:14:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.26 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 89.1 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 15.6 (micromole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 256 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 1.2 (milligram per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 105 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.1 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.55 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 29.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 11.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Transplanted heart present\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder of transplanted heart\n- Pure hyperglyceridemia\n- Disorder of immune function\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-01 10:15:00, ended at 2017-09-01 10:56:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-01 10:57:00, ended at 2017-09-01 10:57:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 66.2 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Transplanted heart present\n- Disorder of transplanted heart\n- Pure hyperglyceridemia\n- Disorder of immune function\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-01 12:50:39, ended at 2017-09-01 14:33:15\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- diphenhydramine hydrochloride 50 MG Oral Capsule, started on 2017-09-01, presumably until 2017-10-28, with intended 0 refill(s). Instructions: Take 50mg in morning prior to angiogram.\n- tacrolimus 1 MG Oral Capsule, started on 2017-09-01, presumably until 2018-05-19, with intended 3 refill(s). Instructions: Taking a 1.5mg in the morning and 2mg in the evening\n- tacrolimus 0.5 MG Oral Capsule, started on 2017-09-01, presumably until 2018-05-19, with intended 3 refill(s). Instructions: Take 1.5mg in the morning and 2mg in the evening.\n- prednisone 20 MG Oral Tablet, started on 2017-09-01, presumably until 2017-10-28, with intended 0 refill(s). Instructions: Take 60mg evening prior to angiogram and 60mg in morning prior to angiogram.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-02 06:11:00, ended at 2017-09-02 14:34:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 283 (milligram per deciliter)\n\n### Procedure\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Collection of blood specimen from a completely implantable venous access device\n- Collection of venous blood by venipuncture\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Ultrasonography of Single Coronary Artery, Intravascular\n\n### Condition\n- Hyperlipidemia\n- Transplanted heart present\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2017-09-02, presumably until 2017-09-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2017-09-02, presumably until 2017-09-02\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2017-09-02, presumably until 2017-09-02\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2017-09-02, presumably until 2017-09-02\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2017-09-02, presumably until 2017-09-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-09-02, presumably until 2017-09-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-18 09:58:00, ended at 2017-09-18 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 9.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-05 12:43:45, ended at 2017-10-05 14:36:37\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Menopause present\n- Primary diagnosis: Hypomagnesemia\n- Breast lump\n- Tetany\n- Transplanted heart present\n- Tremor\n\n### Drug\n- estradiol 0.1 MG/ML Vaginal Cream, through Vaginal route, started on 2017-10-05, presumably until 2019-05-09, with intended 2 refill(s). Instructions: insert 1 g into the vagina 2 times a week\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-13 13:04:00, ended at 2017-10-13 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited\n\n### Condition\n- Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-13 13:04:00, ended at 2017-10-13 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-21 14:09:00, ended at 2017-10-21 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Menopause present\n- Disorder of bone\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-28 00:00:00, ended at 2017-10-28 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-28 00:00:00, ended at 2017-10-28 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-10-28, presumably until 2017-11-02, with intended 12 refill(s). Instructions: take 2 Tabs by mouth 2 times a day Clarify-- patient should take 2 tabs in the am and 3 tabs in the pm for 5 total tabs per day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-28 09:26:37, ended at 2017-10-28 10:25:32\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .236\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal level of blood mineral\n- Obesity\n- Essential hypertension\n- Hyperlipidemia\n- Primary diagnosis: Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-28 10:33:00, ended at 2017-10-28 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 56 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 28 (picogram per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 56 (nanogram per milliliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Obesity\n- Hyperlipidemia\n- Type 2 diabetes mellitus\n- Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Tetany\n- Transplanted heart present\n- Abnormal level of blood mineral\n- Urinary tract infectious disease\n- Hyperglycemia due to type 2 diabetes mellitus\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder of immune function\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-02 00:00:00, ended at 2017-11-02 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2017-11-02, presumably until 2017-11-05, with intended 12 refill(s). Instructions: Patient should take 2 tabs in the am and 3 tabs in the pm for 5 total tabs per day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-05 00:00:00, ended at 2017-11-05 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2017-11-05, presumably until 2019-01-02, with intended 12 refill(s). Instructions: Patient should take 2 tabs in the am and 3 tabs in the pm for 5 total tabs per day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-08 00:00:00, ended at 2017-11-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- lisinopril 5 MG Oral Tablet, started on 2017-11-10, presumably until 2018-11-06, with intended 3 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-24 00:00:00, ended at 2017-12-24 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, started on 2017-12-24, presumably until 2018-11-05, with intended 3 refill(s). Instructions: TAKE 2 TABLETS EVERY 12 HOURS AT 10 A.M. AND 10 P.M.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-06 00:00:00, ended at 2018-01-06 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-01-07, presumably until 2019-04-03, with intended 4 refill(s). Instructions: TAKE 3 TABLETS (1500 MG) DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-14 00:00:00, ended at 2018-01-14 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-14 18:08:35, ended at 2018-01-14 18:45:53\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cough\n- Primary diagnosis: Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-15 00:00:00, ended at 2018-01-15 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-15 14:40:00, ended at 2018-01-15 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Fever\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-18 00:00:00, ended at 2018-01-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-19 00:00:00, ended at 2018-01-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-01-29 00:00:00, ended at 2018-01-29 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.4 (ratio)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 108 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypo-osmolality and or hyponatremia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-29 09:00:03, ended at 2018-01-29 10:03:20\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Tremor\n- Urinary tract infectious disease\n- Essential hypertension\n- Hypo-osmolality and or hyponatremia\n- Transplanted heart present\n- Obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-29 12:05:44, ended at 2018-01-29 13:10:18\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.91 (micro-international unit per milliliter)\n- Body height: 5' .276\" (inch (US))\n- Osmolality of Serum or Plasma: 287 (milliosmole per kilogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Essential hypertension\n- Hyperlipidemia\n- Hypo-osmolality and or hyponatremia\n- Obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-19 00:00:00, ended at 2018-02-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-22 08:54:00, ended at 2018-02-22 09:55:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.84 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.9 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Osmolality of Urine: 441 (milliosmole per kilogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 129 (millimole per liter)\n- Sodium/Creatinine [Molar ratio] in Urine: 39 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.56 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder of transplanted heart\n- Hyperglycemia due to type 2 diabetes mellitus\n- Transplanted heart present\n- Type 2 diabetes mellitus\n- Urinary tract infectious disease\n- Disorder of immune function\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Hypo-osmolality and or hyponatremia\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-22 09:56:00, ended at 2018-02-22 12:04:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 61.0 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Pure hypercholesterolemia\n- Hypomagnesemia\n- Urinary tract infectious disease\n- Fatigue\n- Transplanted heart present\n- Complication due to diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Hypo-osmolality and or hyponatremia\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder of immune function\n- Essential hypertension\n- Hypercalcemia\n- Type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-22 11:00:59, ended at 2018-02-22 11:50:15\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-22 12:05:00, ended at 2018-02-22 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-23 00:00:00, ended at 2018-02-23 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cortisol [Mass/volume] in Serum or Plasma: 9.0 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercalcemia\n- Primary diagnosis: Hypo-osmolality and or hyponatremia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-02-23 00:00:00, ended at 2018-02-23 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2018-02-23, presumably until 2018-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-03 00:00:00, ended at 2018-03-03 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- repaglinide 1 MG Oral Tablet, started on 2018-03-04, presumably until 2020-01-23, with intended 3 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY BEFORE MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-07 10:59:00, ended at 2018-04-07 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 45 (nanogram per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 45 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 38 (picogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Parathyrin related protein [Moles/volume] in Serum or Plasma: 0.7 (picomole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypercalcemia\n- Hyperglycemia due to type 2 diabetes mellitus\n- Disorder of immune function\n- Type 2 diabetes mellitus\n- Bacterial infection due to Klebsiella pneumoniae\n- Hypo-osmolality and or hyponatremia\n- Transplanted heart present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-09 00:00:00, ended at 2018-04-09 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-17 08:49:08, ended at 2018-05-17 10:20:42\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 17 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Primary diagnosis: Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-19 00:00:00, ended at 2018-05-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-05-19, presumably until 2018-09-30, with intended 3 refill(s). Instructions: Taking a 1.5mg in the morning and 2mg in the evening\n- tacrolimus 0.5 MG Oral Capsule, started on 2018-05-19, presumably until 2018-09-30, with intended 3 refill(s). Instructions: Take 1.5mg in the morning and 2mg in the evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-28 09:45:38, ended at 2018-05-28 10:23:53\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .394\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Transplanted heart present\n- Essential hypertension\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-28 10:27:00, ended at 2018-05-28 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 7 (milligram per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 27 (milligram per gram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 25.80 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 840 (picogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.95 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Obesity\n- Urinary tract infectious disease\n- Essential hypertension\n- Disorder of immune function\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-02 10:12:42, ended at 2018-06-02 11:39:23\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n\n### Condition\n- Intertrigo\n- Seborrheic dermatitis\n- Primary diagnosis: Actinic keratosis\n- Benign neoplasm of skin\n- Disorder of lip\n\n### Drug\n- hydrocortisone 0.025 MG/MG Topical Ointment, started on 2018-06-02, presumably until 2019-06-02, with intended 3 refill(s). Instructions: Apply topically to affected area twice daily as directed.\n- ketoconazole 20 MG/ML Topical Cream, started on 2018-06-02, presumably until 2019-05-15, with intended 3 refill(s). Instructions: Apply topically to affected area(s) twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-06 00:00:00, ended at 2018-06-06 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, started on 2018-06-07, presumably until 2019-06-05, with intended 3 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-08 10:12:36, ended at 2018-06-08 11:11:57\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-15 00:00:00, ended at 2018-06-15 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Disorder of transplanted heart\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-06-15, presumably until 2019-05-15, with intended 4 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-25 08:42:59, ended at 2018-06-25 16:07:12\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .394\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of immune function\n- Hyperlipidemia\n- Cerebral infarction\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Essential hypertension\n- Transplanted heart present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-20 09:16:17, ended at 2018-08-20 10:26:40\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .394\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-03 11:08:27, ended at 2018-09-03 11:44:13\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Essential hypertension\n- Obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-23 00:00:00, ended at 2018-09-23 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n- Blood glucose abnormal\n- Transplanted heart present\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-23 12:36:29, ended at 2018-09-23 13:59:29\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized ischemic myocardial dysfunction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-27 08:28:00, ended at 2018-09-27 09:14:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.0 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.8 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.19 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 41.88 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.31 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.71 (micro-international unit per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 122 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.51 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 214 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.6 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.68 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Blood glucose abnormal\n- Disorder of eye due to type 2 diabetes mellitus\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Fatigue\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-27 09:15:00, ended at 2018-09-27 09:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Blood glucose abnormal\n- Pure hypercholesterolemia\n- Fatigue\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-27 10:00:00, ended at 2018-09-27 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 72.9 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n- Blood glucose abnormal\n- Fatigue\n- Disorder of eye due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-27 10:47:59, ended at 2018-09-27 13:03:38\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Blood glucose abnormal\n- Fatigue\n- Pure hypercholesterolemia\n- Electrocardiogram abnormal\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- loratadine 10 MG Oral Tablet, through Oral route, started on 2018-09-27, presumably until 2018-09-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth One Time Take one tablet by mouth one hour before your procedure\n- prednisone 50 MG Oral Tablet, through Oral route, presumably until 2019-05-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed Take one tablet by mouth 13 hours, 7 hours, then one hour before your heart procedure,\n- diphenhydramine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2018-09-27, presumably until 2018-09-27, with intended 0 refill(s). Instructions: take 2 Tabs by mouth One Time Take 2 Tabs by mouth once before your heart catheterization procedure.\n- atorvastatin 40 MG Oral Tablet, through Oral route, presumably until 2018-09-30, with intended 11 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-09-28 00:00:00, ended at 2018-09-28 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-09-28, presumably until 2018-09-28\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-09-28, presumably until 2018-09-28\n- midazolam 1 MG/ML Injectable Solution, started on 2018-09-28, presumably until 2018-09-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-28 08:22:00, ended at 2018-09-28 18:25:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 243 (milligram per deciliter)\n- INR in Blood by Coagulation assay: 0.9 (ratio)\n\n### Procedure\n- Ultrasonography of Single Coronary Artery, Intravascular\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Collection of blood specimen from a completely implantable venous access device\n- Collection of venous blood by venipuncture\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Generalized ischemic myocardial dysfunction\n- Hypertensive heart failure\n- Type 2 diabetes mellitus without complication\n- Disorder of transplanted heart\n- Hyperlipidemia\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-09-28, presumably until 2018-09-28\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2018-09-28, presumably until 2018-09-28\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2018-09-28, presumably until 2018-09-28\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2018-09-28, presumably until 2018-09-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-09-28, presumably until 2018-09-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-30 00:00:00, ended at 2018-09-30 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-09-30, presumably until 2018-10-05, with intended 3 refill(s). Instructions: Taking a 1.5mg BID; Fax: 999-999-9999, Z94.1\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, presumably until 2018-10-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth every bedtime\n- tacrolimus 0.5 MG Oral Capsule, started on 2018-09-30, presumably until 2018-10-13, with intended 3 refill(s). Instructions: Take 1.5mg BID; Fax: 999-999-9999; Z94.1\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-01 00:00:00, ended at 2018-10-01 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Pure hypercholesterolemia\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-10-01, presumably until 2019-08-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-05 00:00:00, ended at 2018-10-05 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-10-05, presumably until 2018-10-13, with intended 3 refill(s). Instructions: Taking a 1.5mg BID; Fax: 999-999-9999, Z94.1\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-13 00:00:00, ended at 2018-10-13 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-10-13, presumably until 2019-05-09, with intended 3 refill(s). Instructions: Total dose 1.5mg BID; Fax: 999-999-9999, Z94.1\n- tacrolimus 0.5 MG Oral Capsule, started on 2018-10-13, presumably until 2019-05-09, with intended 3 refill(s). Instructions: Take 1.5mg BID; Fax: 999-999-9999; Z94.1\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-15 10:45:12, ended at 2018-10-15 13:25:51\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-19 13:28:58, ended at 2018-10-19 13:29:08\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized ischemic myocardial dysfunction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-27 00:00:00, ended at 2018-10-27 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-05 00:00:00, ended at 2018-11-05 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, started on 2018-11-05, presumably until 2019-09-07, with intended 3 refill(s). Instructions: TAKE 2 TABLETS EVERY 12 HOURS AT 10 A.M. AND 10 P.M.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-06 00:00:00, ended at 2018-11-06 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- lisinopril 5 MG Oral Tablet, started on 2018-11-08, presumably until 2019-01-28, with intended 3 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-31 10:47:55, ended at 2018-12-31 11:23:16\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.024\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Hyperlipidemia\n- Primary diagnosis: Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-31 11:28:00, ended at 2018-12-31 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.7 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Obesity\n- Hyperlipidemia\n- Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Transplanted heart present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-02 00:00:00, ended at 2019-01-02 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2019-01-02, presumably until 2019-02-10, with intended 3 refill(s). Instructions: PATIENT SHOULD TAKE 2 TABS IN THE AM AND 3 TABS IN THE PM FOR 5 TOTAL TABS PER DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-03 00:00:00, ended at 2019-01-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Hypercalcemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-01-17 16:49:00, ended at 2019-01-18 16:16:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Potassium [Moles/volume] in 24 hour Urine: 33.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 32 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 59 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 119.31 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.87 (million per microliter)\n- Glucose [Mass/volume] in Blood: 196 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.48 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.99 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 127 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.3 (nanogram per milliliter)\n- Chloride [Moles/volume] in Urine: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n\n### Procedure\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordinat\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Radiologic examination, chest; 2 views\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Conjunctivitis\n- Hypo-osmolality and or hyponatremia\n- Transplanted heart present\n- Acute conjunctivitis\n- Fatigue\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Anemia\n- Chronic kidney disease stage 2\n- Dyspnea\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Bronchitis\n- Type 2 diabetes mellitus\n- Atrial fibrillation\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Cough\n- Edema\n- Hyperlipidemia\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Primary diagnosis: Pneumonia\n- Pure hypercholesterolemia\n\n### Drug\n- guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2019-01-18, presumably until 2019-05-15, with intended 2 refill(s). Instructions: take 10 mL by mouth every 4 hours as needed\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-01-17, presumably until 2019-01-18\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2019-01-18, presumably until 2019-01-23, with intended 0 refill(s). Instructions: take 2 Caps by mouth 3 times a day for 5 days Begin on same day as azithromycin\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2019-01-17, presumably until 2019-01-18\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-01-17, presumably until 2019-01-17\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-01-17, presumably until 2019-01-17\n- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2019-01-18, presumably until 2019-01-18\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-01-17, presumably until 2019-01-18\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2019-01-18, presumably until 2019-01-18\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2019-01-18, presumably until 2019-01-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 3 days Begin on same day as amoxicillin\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-01-18, presumably until 2019-01-18\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2019-01-17, presumably until 2019-01-18\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2019-01-17, presumably until 2019-01-18\n- 120 ACTUAT albuterol 0.1 MG/ACTUAT / ipratropium bromide 0.02 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2019-01-18, presumably until 2019-04-11, with intended 0 refill(s). Instructions: 1 Puff by Inhalation route 4 times a day as needed (wheezing cough)\n- polymyxin B 10000 UNT/ML / trimethoprim 1 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-01-18, presumably until 2019-01-23, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day Stop after five days of use.\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2019-01-17, presumably until 2019-01-17\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-01-17, presumably until 2019-01-17\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2019-01-18, presumably until 2019-01-18\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-01-18, presumably until 2019-01-18\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2019-01-17, presumably until 2019-01-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-28 10:19:49, ended at 2019-01-28 11:30:15\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.02\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Pneumonia\n- Essential hypertension\n- Disorder of eye due to type 2 diabetes mellitus\n- Disorder of immune function\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-01-28, presumably until 2019-04-11, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2019-01-28, presumably until 2019-04-11, with intended 3 refill(s). Instructions: take 1 Quan by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-31 09:53:48, ended at 2019-01-31 10:35:43\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tremor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-10 00:00:00, ended at 2019-02-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2019-02-10, presumably until 2019-04-12, with intended 12 refill(s). Instructions: Take 2 tablets orally in the monring and 3 tablets in the evening for 5 total tabs per day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Complication due to diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2019-04-05, presumably until 2020-06-14, with intended 4 refill(s). Instructions: Take 500 mg (1 tab) at lunch, take 1000 mg (2 tabs) at dinner.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-08 00:00:00, ended at 2019-04-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-11 09:52:00, ended at 2019-04-11 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 46.7 (picogram per milliliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 68 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 46 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.6 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.42 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 10.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 46 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.65 (thousand per microliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 227 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Essential hypertension\n- Hypercalcemia\n- Hyperlipidemia\n- Disorder of eye due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-11 10:47:27, ended at 2019-04-11 11:57:22\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n- Essential hypertension\n\n### Drug\n- lisinopril 5 MG Oral Tablet, through Oral route, presumably until 2019-04-12, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-12 00:00:00, ended at 2019-04-12 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2019-04-12, presumably until 2019-06-11, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2019-04-12, presumably until 2020-05-08, with intended 3 refill(s). Instructions: take 2 Tabs (266 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-15 00:00:00, ended at 2019-04-15 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tachycardia\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-18 00:00:00, ended at 2019-04-18 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-22 00:00:00, ended at 2019-04-22 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 7.4 (microgram per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-22 00:00:00, ended at 2019-04-22 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-25 00:00:00, ended at 2019-04-25 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-02 00:00:00, ended at 2019-05-02 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 10:13:10, ended at 2019-05-04 11:03:38\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.024\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Primary diagnosis: Type 2 diabetes mellitus\n- Essential hypertension\n- Hyperlipidemia\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Hypercalcemia\n\n### Drug\n- 3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector, through Subcutaneous route, started on 2019-05-04, presumably until 2019-06-11, with intended 3 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) every day Replaces Lantus\n- telmisartan 20 MG Oral Tablet, through Oral route, started on 2019-05-04, presumably until 2019-05-15, with intended 3 refill(s). Instructions: take 20 mg by mouth daily Replaces lisinopril.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-04 11:07:00, ended at 2019-05-04 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted heart present\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Obesity\n- Hypercalcemia\n- Type 2 diabetes mellitus\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-06 00:00:00, ended at 2019-05-06 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-09 00:00:00, ended at 2019-05-09 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-09 14:05:49, ended at 2019-05-09 15:17:04\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Essential hypertension\n- Disorder of transplanted heart\n- Disorder of immune function\n- Hyperlipidemia\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2019-05-09, presumably until 2019-10-05, with intended 3 refill(s). Instructions: 1 mg in morning and 1.5 mg in the evening\n- estradiol 0.1 MG/ML Vaginal Cream, through Vaginal route, started on 2019-05-09, presumably until 2021-12-11, with intended 12 refill(s). Instructions: insert 1 g into the vagina 2 times a week\n- tacrolimus 0.5 MG Oral Capsule, started on 2019-05-09, presumably until 2019-10-05, with intended 3 refill(s). Instructions: 1 mg in morning and 1.5 mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-11 00:00:00, ended at 2019-05-11 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, started on 2019-05-11, presumably until 2019-08-10, with intended 0 refill(s). Instructions: Take 2L by mouth night before and 2L morning of procedure. Stop fluids 4hr before procedure. Instructions are forwarded to patient.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 11:01:00, ended at 2019-05-13 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Screening digital breast tomosynthesis, bilateral (List separately in addition to code for primary procedure)\n- Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-16 00:00:00, ended at 2019-05-16 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-19 14:17:02, ended at 2019-05-19 15:38:45\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Primary diagnosis: Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Nuclear senile cataract\n- Regular astigmatism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-20 00:00:00, ended at 2019-05-20 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-23 00:00:00, ended at 2019-05-23 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-25 00:00:00, ended at 2019-05-25 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-05-26 00:00:00, ended at 2019-05-26 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-06-11, presumably until 2020-05-28, with intended 4 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-30 00:00:00, ended at 2019-05-30 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-03 00:00:00, ended at 2019-06-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-05 00:00:00, ended at 2019-06-05 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, started on 2019-06-06, presumably until 2020-03-22, with intended 3 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-06 00:00:00, ended at 2019-06-06 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-10 00:00:00, ended at 2019-06-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-13 00:00:00, ended at 2019-06-13 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-14 10:07:49, ended at 2019-06-14 10:36:48\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-17 00:00:00, ended at 2019-06-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-20 00:00:00, ended at 2019-06-20 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-07 11:36:10, ended at 2019-07-07 12:53:46\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Verruca vulgaris\n- Epidermoid cyst of skin\n- Primary diagnosis: Intertrigo\n\n### Drug\n- ketoconazole 20 MG/ML Topical Cream, started on 2019-07-07, presumably until 2020-06-10, with intended 3 refill(s). Instructions: Apply topically to affected area(s) twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2019-07-26, presumably until 2019-07-26\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2019-07-26, presumably until 2019-07-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-26 09:25:00, ended at 2019-07-26 12:43:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 133 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Inspection of Lower Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n\n### Condition\n- Hemorrhoids\n- Obesity\n- Transplanted heart present\n- Congestive heart failure\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Hypertensive heart failure\n- Acute on chronic systolic heart failure\n\n### Drug\n- amoxicillin 500 MG Oral Capsule, started on 2019-05-14, presumably until 2021-06-03, with intended 0 refill(s). Instructions: TAKE 4 CAPS BY MOUTH 1 HOUR BEFORE PROCEDURE\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-10 10:05:14, ended at 2019-08-10 11:00:49\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.024\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Hypercalcemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-10 11:06:00, ended at 2019-08-10 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 57.2 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Hypercalcemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-27 00:00:00, ended at 2019-08-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-08-29, presumably until 2019-11-04, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-07 00:00:00, ended at 2019-09-07 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-07, presumably until 2020-05-08, with intended 3 refill(s). Instructions: take 2 Tabs (360 mg total) by mouth every 12 hours at 10am and 10pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2019-09-21, presumably until 2019-09-21, with intended 4 refill(s). Instructions: Take 500 mg (1 tab) at lunch, take 1000 mg (2 tabs) at dinner.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-21 00:00:00, ended at 2019-09-21 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-21 00:00:00, ended at 2019-09-21 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- telmisartan 20 MG Oral Tablet, through Oral route, started on 2019-09-21, presumably until 2019-10-05, with intended 3 refill(s). Instructions: take 1 Tab (20 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Hyperlipidemia\n- Transplanted heart present\n- Fatigue\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-23 08:34:00, ended at 2019-09-24 18:15:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Base excess in Blood by calculation: -3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 13.3 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.56 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.4 (percent)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Blood: 176 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.95 (thousand per microliter)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.12 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.46 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.5 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; limited\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Ultrasound, chest (includes mediastinum), real time with image documentation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordinat\n\n### Condition\n- Cardiomegaly\n- Disorder of immune function\n- Disorder of transplanted heart\n- Electrocardiogram abnormal\n- Transplanted heart present\n- Primary diagnosis: Acute pyelonephritis\n- Atrial fibrillation\n- Urinary tract infectious disease\n- Abdominal pain\n- Acute on chronic systolic heart failure\n- Hyperlipidemia\n- Hypertensive heart failure\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Pure hypercholesterolemia\n- Congestive heart failure\n- Nausea and vomiting\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-09-24\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2019-09-23, presumably until 2019-09-24\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-09-23\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2019-09-23, presumably until 2019-09-23\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2019-09-23, presumably until 2019-09-23\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-10-05, with intended 0 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed (nausea or vomiting)\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-09-23, presumably until 2019-09-24, with intended 0 refill(s). Instructions: take 2 Caps (500 mg total) by mouth 2 times a day for 7 days\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2019-09-24, presumably until 2019-09-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-09-23, presumably until 2019-09-24\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-09-24, presumably until 2019-09-24\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-09-24\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-09-24\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-24, presumably until 2019-09-24\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-24, presumably until 2019-09-24\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-09-24, presumably until 2019-10-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-09-25 16:03:00, ended at 2019-10-05 16:31:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.88 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Prothrombin time (PT): 14.2 (second)\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.27 (micro-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Left ventricular Ejection fraction: 73.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.0 (percent)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.22 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.98 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Base excess in Blood by calculation: -4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.52 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.6 (second)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Body height: 5' 1\" (inch (US))\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 443 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 257 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.027 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 15.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Excision of Stomach, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Radiologic examination, chest; 2 views\n- Radiologic examination, abdomen; 1 view\n\n### Condition\n- Abdominal pain\n- Chronic vascular insufficiency of intestine\n- Gastric polyp\n- Disorder of transplanted heart\n- Ischemia of kidney\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Nausea and vomiting\n- Acute ST segment elevation myocardial infarction\n- Electrocardiogram abnormal\n- Transplanted heart present\n- Vomiting\n- Cough\n- Disorder of upper gastrointestinal tract\n- Old myocardial infarction\n- Essential hypertension\n- Tubulointerstitial nephritis\n- Constipation\n- Disorder of immune function\n- Fever\n- Gastritis\n- Hypovolemia\n- Acute renal failure syndrome\n- Atrial fibrillation\n- Disorder of brain\n- Acute pyelonephritis\n- Diabetes mellitus without complication\n- Hyperlipidemia\n- Right lower quadrant pain\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-09-30, presumably until 2019-10-01\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2019-09-29, presumably until 2019-09-30\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2019-09-29, presumably until 2019-09-29\n- glycerin 995 MG/ML Topical Solution, through Topical route, started on 2019-09-29, presumably until 2019-09-30\n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2019-10-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-09-25, presumably until 2019-09-25\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-09-27, presumably until 2019-09-30\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-09-26\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2019-10-01, presumably until 2019-10-04\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-05, presumably until 2019-10-05\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-10-01, presumably until 2019-10-01\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2019-10-04\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2019-09-29, presumably until 2019-09-30\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2019-09-27, presumably until 2019-10-04\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2019-09-26, presumably until 2020-02-09, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2019-09-25, presumably until 2019-09-25\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-10-04, presumably until 2019-10-04\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2019-09-28, presumably until 2019-11-03, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day as needed for Constipation\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2019-09-27, presumably until 2019-10-01\n- gadobenate, through Intravenous route, started on 2019-09-28, presumably until 2019-09-28\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2020-05-04, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily as needed (constipation)\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2019-09-28, presumably until 2020-10-04, with intended 0 refill(s). Instructions: take 1 Packet (17 g total) by mouth daily as needed (constipation)\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-10-05, presumably until 2020-05-04, with intended 0 refill(s). Instructions: take 2 Tabs (8 mg total) by mouth every 8 hours as needed (nausea or vomiting)\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2019-09-26, presumably until 2020-02-09, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-09-25, presumably until 2019-09-30\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-10-03, presumably until 2019-10-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-09-27, presumably until 2019-10-04\n- sucralfate 100 MG/ML Oral Suspension, through Oral route, started on 2019-09-29, presumably until 2020-05-04, with intended 0 refill(s). Instructions: take 10 mL (1 g total) by mouth 4 times a day before meals and bedtime\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-09-26, presumably until 2019-10-04\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-10-05\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2019-09-27, presumably until 2019-09-30\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-10-04\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2019-09-29, presumably until 2019-09-30\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-10-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2019-09-25, presumably until 2019-10-02\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2019-09-30, presumably until 2019-10-05\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-10-05\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-09-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-09-29 00:00:00, ended at 2019-09-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2019-09-29 00:00:00, ended at 2019-09-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; not otherwise specified\n\n### Condition\n- Disorder of upper gastrointestinal tract\n- Nausea and vomiting\n- Morbid obesity\n- Gastric polyp\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-09-29, presumably until 2019-09-29\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2019-09-29, presumably until 2019-09-29\n- midazolam 1 MG/ML Injectable Solution, started on 2019-09-29, presumably until 2019-09-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-05 00:00:00, ended at 2019-10-05 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.3 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.23 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 48 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 14 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1776 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2467 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 470 (cells per microliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 5.3 (microgram per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-16 00:00:00, ended at 2019-10-16 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-17 14:52:32, ended at 2019-10-17 16:02:10\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 10.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.11 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of eye due to type 2 diabetes mellitus\n- Primary diagnosis: Nausea and vomiting\n- Constipation\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-03 08:47:00, ended at 2019-11-03 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 75 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.32 (micro-international unit per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 67 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.4 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.6 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.54 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.94 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Fatigue\n- Transplanted heart present\n- Abnormal urine\n- Diabetes mellitus without complication\n- Essential hypertension\n- Disorder of immune function\n- Disorder of transplanted heart\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-03 09:38:01, ended at 2019-11-03 11:29:39\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Disorder of immune function\n- Essential hypertension\n- Abnormal urine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-04 00:00:00, ended at 2019-11-04 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-11-04, presumably until 2020-05-08, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-07 00:00:00, ended at 2019-11-07 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysuria\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2019-11-07, presumably until 2019-11-14, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-17 12:52:51, ended at 2019-11-17 13:51:38\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-18 14:31:00, ended at 2019-11-18 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 65.3 (percent)\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n\n### Condition\n- Disorder of transplanted heart\n- Rheumatic tricuspid valve regurgitation\n- Cardiomegaly\n- Tachycardia\n\n### Drug\n- 250 ML dobutamine 1 MG/ML Injection, through Intravenous route, started on 2019-11-18, presumably until 2019-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-29 09:44:12, ended at 2019-11-29 10:26:48\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of immune function\n- Essential hypertension\n- Hyperlipidemia\n- Diarrhea\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n\n### Drug\n- telmisartan 20 MG Oral Tablet, through Oral route, presumably until 2020-03-27, with intended 0 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 14:17:37, ended at 2019-12-21 14:57:27\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .236\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea and vomiting\n- Constipation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-23 00:00:00, ended at 2020-01-23 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- repaglinide 1 MG Oral Tablet, through Oral route, started on 2020-01-23, presumably until 2020-05-04, with intended 1 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 2 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-30 11:03:04, ended at 2020-01-30 11:48:15\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tremor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-08 10:20:55, ended at 2020-02-08 10:58:12\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.22\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 49.59 (milligram per deciliter)\n- Calcium [Mass/volume] in Urine: 11.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Obesity\n- Hypercalcemia\n- Transplanted heart present\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-08 11:03:00, ended at 2020-02-08 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 15 (milligram per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 44 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 44 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Urine: 49.50 (milligram per deciliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 46.6 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 30 (milligram per gram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Disorder of eye due to type 2 diabetes mellitus\n- Hypercalcemia\n- Hyperlipidemia\n- Transplanted heart present\n- Obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-09 00:00:00, ended at 2020-02-09 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2020-02-09, presumably until 2020-12-17, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n- tacrolimus 0.5 MG Oral Capsule, started on 2020-02-09, presumably until 2020-12-17, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-09 00:00:00, ended at 2020-02-09 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperparathyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-22 00:00:00, ended at 2020-03-22 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastro-esophageal reflux disease with esophagitis\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-03-22, presumably until 2021-02-22, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-26 00:00:00, ended at 2020-03-26 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-03-27 12:55:08, ended at 2020-03-27 14:35:54\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Essential tremor\n- Essential hypertension\n- Disorder of immune function\n- Transplanted heart present\n\n### Drug\n- telmisartan 40 MG Oral Tablet, through Oral route, started on 2020-03-27, presumably until 2020-06-25, with intended 12 refill(s). Instructions: take 40 mg by mouth daily Note dose change\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-04 00:00:00, ended at 2020-05-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- repaglinide 1 MG Oral Tablet, through Oral route, started on 2020-05-04, presumably until 2021-01-25, with intended 3 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 2 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-07 00:00:00, ended at 2020-05-07 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-08 00:00:00, ended at 2020-05-08 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2021-01-24, with intended 3 refill(s). Instructions: take 2 Tabs (360 mg total) by mouth every 12 hours at 10am and 10pm\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2020-05-08, with intended 3 refill(s). Instructions: take 1 Tab (1,000 Units total) by mouth every day\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2020-05-08, with intended 3 refill(s). Instructions: take 2 Tabs (266 mg total) by mouth 2 times a day\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2021-02-02, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2020-05-08, with intended 11 refill(s). Instructions: take 1 Tab (81 mg total) by mouth every morning with breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-22 00:00:00, ended at 2020-05-22 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-23 00:00:00, ended at 2020-05-23 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-28 00:00:00, ended at 2020-05-28 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-06-05, presumably until 2021-01-25, with intended 4 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-04 00:00:00, ended at 2020-06-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Disorder of transplanted heart\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-06-05, presumably until 2020-06-05, with intended 3 refill(s). Instructions: INJECT 20 UNITS UNDER THE SKIN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-04 00:00:00, ended at 2020-06-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-06-05, presumably until 2020-06-05, with intended 4 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-08 00:00:00, ended at 2020-06-08 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Obesity\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Essential hypertension\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-10 00:00:00, ended at 2020-06-10 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ketoconazole 20 MG/ML Topical Cream, started on 2020-06-12, presumably until 2020-09-28, with intended 3 refill(s). Instructions: Apply topically to affected area(s) twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-14 00:00:00, ended at 2020-06-14 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2020-06-21, presumably until 2021-01-25, with intended 4 refill(s). Instructions: Take 500 mg (1 tab) at lunch, take 1000 mg (2 tabs) at dinner.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-15 09:28:00, ended at 2020-06-15 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed\n- Screening digital breast tomosynthesis, bilateral (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-21 00:00:00, ended at 2020-06-21 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2020-06-21, presumably until 2020-06-21, with intended 4 refill(s). Instructions: Take 500 mg (1 tab) at lunch, take 1000 mg (2 tabs) at dinner.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-15 00:00:00, ended at 2020-07-15 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- repaglinide 1 MG Oral Tablet, through Oral route, started on 2020-07-27, presumably until 2020-07-27, with intended 1 refill(s). Instructions: TAKE 1 TAB (1 MG TOTAL) BY MOUTH 2 TIMES A DAY BEFORE MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-21 00:00:00, ended at 2020-09-21 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-21 10:32:41, ended at 2020-09-21 10:54:12\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Obesity\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperlipidemia\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-09-28 10:12:07, ended at 2020-09-28 10:43:06\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .276\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intertrigo\n- Transplant present\n\n### Drug\n- ketoconazole 20 MG/ML Topical Cream, started on 2020-09-28, presumably until 2021-10-04, with intended 3 refill(s). Instructions: Apply topically to affected area(s) twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-05 00:00:00, ended at 2020-10-05 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-22 00:00:00, ended at 2020-11-22 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 81 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.2 (ratio)\n- Triglyceride [Moles/volume] in Serum or Plasma: 159 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Blood glucose abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-29 00:00:00, ended at 2020-11-29 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Finding of frequency of urination\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-29 07:30:00, ended at 2020-11-29 07:37:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.11 (milligram per milligram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 4.0 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Creatinine [Mass/volume] in Urine: 37.24 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Blood glucose abnormal\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-29 07:38:00, ended at 2020-11-29 11:34:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 63.7 (percent)\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n\n### Condition\n- Transplanted heart present\n- Abnormal urine\n- Pure hypercholesterolemia\n- Blood glucose abnormal\n- Cardiomegaly\n- Dilatation of aorta\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- 250 ML dobutamine 1 MG/ML Injection, through Intravenous route, started on 2020-11-29, presumably until 2020-11-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-11-29 09:39:11, ended at 2020-11-29 11:24:13\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Transplanted heart present\n- Pure hypercholesterolemia\n- Blood glucose abnormal\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-29 11:35:00, ended at 2020-11-29 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Blood glucose abnormal\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-30 00:00:00, ended at 2020-11-30 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal urine\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- telmisartan 80 MG Oral Tablet, through Oral route, started on 2020-11-30, presumably until 2021-01-24, with intended 11 refill(s). Instructions: take 80 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-17 00:00:00, ended at 2020-12-17 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, started on 2020-12-17, presumably until 2021-02-28, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-17 00:00:00, ended at 2020-12-17 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2020-12-17, presumably until 2021-02-28, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE EVERY EVENING (TOTAL DOSE IS 0.5 MG IN THE MORNING AND 1 MG IN THE EVENING)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-21 00:00:00, ended at 2020-12-21 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, started on 2020-12-21, presumably until 2020-12-21, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE EVERY MORNING (TOTAL DOSE IS 0.5 MG IN THE MORNING AND 1 MG IN THE EVENING)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-24 00:00:00, ended at 2021-01-24 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- telmisartan 80 MG Oral Tablet, through Oral route, started on 2021-01-24, presumably until 2021-02-07, with intended 3 refill(s). Instructions: take 80 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-24 00:00:00, ended at 2021-01-24 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2021-01-25, presumably until 2021-04-08, with intended 3 refill(s). Instructions: take 2 Tabs (360 mg total) by mouth every 12 hours at 10am and 10pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-25 10:46:33, ended at 2021-01-25 11:13:21\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercalcemia\n- Hyperglycemia due to type 2 diabetes mellitus\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Complication due to diabetes mellitus\n- Disorder of transplanted heart\n- Primary diagnosis: Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2021-01-25, presumably until 2022-01-03, with intended 11 refill(s). Instructions: inject 22 Units subcutaneous (under the skin) Evening Injecting 22 units subcutaneous, Evening\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2021-01-25, presumably until 2022-01-03, with intended 3 refill(s). Instructions: take 1,000 mg by mouth 2 times a day\n- repaglinide 1 MG Oral Tablet, through Oral route, started on 2021-01-25, presumably until 2022-01-03, with intended 3 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 2 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-02 00:00:00, ended at 2021-02-02 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-02-06, presumably until 2022-01-28, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-06 00:00:00, ended at 2021-02-06 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- telmisartan 80 MG Oral Tablet, through Oral route, started on 2021-02-07, presumably until 2021-04-26, with intended 3 refill(s). Instructions: take 40 mg by mouth daily Pt decreased to 40mg daily on 1/21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-21 00:00:00, ended at 2021-02-21 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, started on 2021-02-21, presumably until 2021-02-21, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-21 00:00:00, ended at 2021-02-21 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Gastro-esophageal reflux disease with esophagitis\n- Transplanted heart present\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2021-02-22, presumably until 2021-02-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-25 00:00:00, ended at 2021-02-25 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n- Gastro-esophageal reflux disease with esophagitis\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2021-02-25, presumably until 2022-02-06, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-27 00:00:00, ended at 2021-02-27 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2021-02-27, presumably until 2021-02-27, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE EVERY EVENING (TOTAL DOSE IS 0.5 MG IN THE MORNING AND 1 MG IN THE EVENING)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-28 00:00:00, ended at 2021-02-28 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2021-02-28, presumably until 2021-03-04, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE EVERY EVENING (TOTAL DOSE IS 0.5 MG IN THE MORNING AND 1 MG IN THE EVENING)\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2021-02-28, presumably until 2021-07-29, with intended 3 refill(s). Instructions: take 1 Drew (0.5 mg total) by mouth AM 0.5 mg in morning and 1 mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-04 00:00:00, ended at 2021-03-04 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2021-03-04, presumably until 2021-07-29, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE EVERY EVENING (TOTAL DOSE IS 0.5 MG IN THE MORNING AND 1 MG IN THE EVENING)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-08 00:00:00, ended at 2021-04-08 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2021-04-08, presumably until 2021-04-16, with intended 3 refill(s). Instructions: take 2 Tabs (360 mg total) by mouth every 12 hours at 10am and 10pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-16 00:00:00, ended at 2021-04-16 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2021-04-16, presumably until 2021-12-17, with intended 3 refill(s). Instructions: take 2 Tabs (360 mg total) by mouth every 12 hours at 10am and 10pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-26 10:31:50, ended at 2021-04-26 11:20:27\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperlipidemia\n- Transplanted heart present\n- Essential hypertension\n- Disorder of transplanted heart\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Obesity\n\n### Drug\n- telmisartan 80 MG Oral Tablet, through Oral route, started on 2021-04-26, presumably until 2022-01-06, with intended 3 refill(s). Instructions: take 80 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-31 00:00:00, ended at 2021-05-31 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-03 09:29:25, ended at 2021-06-03 10:54:36\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-10 00:00:00, ended at 2014-03-10 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 22 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-10 17:37:00, ended at 2014-03-29 17:22:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Blood by calculation: 2.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 379 (unit per liter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.12 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: N/A (millimeter mercury column)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.71 (milli-international unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Base deficit in Blood: N/A (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.7 (percent)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 350 (thousand per microliter)\n- Prothrombin time (PT): 29.2 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 4.0 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- Left ventricular Ejection fraction: 2.4EF(MOD-sp4) (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.9 (percent)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.58 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 72 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: N/A (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 394 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 291 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 77.6 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Body height: 5' 2.008\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: N/A (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 97 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.39 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.97 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: N/A (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Computed tomography, thorax, diagnostic; without contrast material\n- Occupational therapy evaluation\n- Other cystoscopy\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Physical therapy evaluation\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Computed tomography, head or brain; without contrast material\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Cardiac pacemaker procedure\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; subsequent\n- Nonoperative removal of heart assist system\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Implantation of heart assist system\n- Radiologic examination, chest; single view, frontal\n- Controlled ventilation procedure and therapy, initiation and management\n- Packed blood cell transfusion\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Insertion of catheter into artery\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Collection of venous blood by venipuncture\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Aphasia\n- Chronic total occlusion of coronary artery\n- Disorder of muscle\n- Electrocardiogram abnormal\n- Urinary tract infectious disease\n- Acute bronchitis\n- Acute myocardial infarction of inferior wall\n- Atelectasis\n- Atrial flutter\n- Diabetes mellitus without complication\n- Disorder of artery\n- Acute upper respiratory infection\n- Diabetic - poor control\n- Heart failure\n- Hyperlipidemia\n- Transient cerebral ischemia\n- Chronic ischemic heart disease\n- Coronary atherosclerosis\n- Neoplasm of uncertain behavior of bladder\n- Peripheral vascular disease\n- Primary cardiomyopathy\n- Pulmonary congestion and hypostasis\n- Disorder of carotid artery\n- Long QT syndrome\n- Viral pneumonia\n- Acidosis\n- Acute on chronic systolic heart failure\n- Primary diagnosis: Cardiogenic shock\n- Cerebrovascular disease\n- Respiratory insufficiency\n- Thoracic spondylosis without myelopathy\n- Acquired deformity of thoracic structure\n- Acute myocardial infarction\n- Acute myocardial infarction of lateral wall\n- Acute posthemorrhagic anemia\n- Acute subendocardial infarction\n- Congestive heart failure\n- Cough\n- Lung field abnormal\n- Osteoarthritis\n- Pleural effusion\n- Cardiomegaly\n- Coronary arteriosclerosis\n- Frank hematuria\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2014-03-22, presumably until 2014-03-24\n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2014-03-11, presumably until 2014-03-16\n- sildenafil 20 MG Oral Tablet, through Oral route, started on 2014-03-17, presumably until 2014-03-22\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-17\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2014-03-10, presumably until 2014-03-21\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-03-12, presumably until 2014-03-16\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-03-10, presumably until 2014-04-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-27\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2014-03-17, presumably until 2014-03-26\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2014-03-22, presumably until 2014-03-29\n- 24 HR ferrous sulfate 142 MG Extended Release Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-24\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2014-03-29, presumably until 2014-09-08, with intended 5 refill(s). Instructions: inject 0-12 Units subcutaneous (under the skin) 4 times a day before meals and bedtime.\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2014-03-11, presumably until 2014-03-11\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2014-03-14, presumably until 2014-03-16\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-03-16, presumably until 2014-06-29, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed.\n- candesartan cilexetil 4 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 4 mg by mouth daily.\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2014-03-17, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n- dipyridamole 75 MG Oral Tablet, through Oral route, started on 2014-03-28, presumably until 2014-04-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-22\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-03-10, presumably until 2014-03-10\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-04-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-29\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-03-10, presumably until 2014-05-10, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-04-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2014-03-22, presumably until 2014-04-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- ascorbic acid 1000 MG Oral Tablet, through Oral route, presumably until 2014-03-29. Instructions: take 1,000 mg by mouth every bedtime.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 5 mg by mouth 2 times a day.\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2014-03-13, presumably until 2014-03-24\n- 10 ML furosemide 10 MG/ML Injection, started on 2014-03-17, presumably until 2014-03-20\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2014-03-19, presumably until 2014-03-24\n- metformin hydrochloride 1000 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-06-19, with intended 3 refill(s). Instructions: take 1,000 mg by mouth 2 times a day.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-03-10, presumably until 2014-05-10, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime.\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-19\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-08-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-03-10, presumably until 2014-03-29\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-03-15, presumably until 2014-03-16\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-21\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 20 mg by mouth every bedtime.\n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-28\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-03-21, presumably until 2014-03-25\n- cefepime 2000 MG Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-18\n- bumetanide 0.5 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 0.5 mg by mouth daily.\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 3.125 mg by mouth daily.\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-19\n- digoxin 0.125 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-03-29. Instructions: take 0.125 mg by mouth daily.\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2014-02-16, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 25 mg by mouth daily.\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2014-03-29, presumably until 2014-09-08, with intended 5 refill(s). Instructions: inject 35 Units subcutaneous (under the skin) daily in the evening.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-03-16, presumably until 2014-03-27\n- warfarin sodium 2 MG Oral Tablet, started on 2014-03-29, presumably until 2014-04-04, with intended 3 refill(s). Instructions: Take 3.5 mg PO daily or as directed\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2014-03-17, presumably until 2014-03-20\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-18\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2014-03-12, presumably until 2014-03-27\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-22\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2014-03-11, presumably until 2014-03-16\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-03-23, presumably until 2014-04-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day before meals.\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2014-03-21, presumably until 2014-03-21\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-03-24, presumably until 2014-03-28\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-03-28, presumably until 2014-08-07, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2014-03-17, presumably until 2014-03-18\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-03-11, presumably until 2014-03-11\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-04-04, with intended 3 refill(s). Instructions: Take 3.5 mg PO daily or as directed\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-03-17, presumably until 2014-03-25\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2014-03-21, presumably until 2014-03-29\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-28\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2014-03-16, presumably until 2014-03-16\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-29. Instructions: take 81 mg by mouth daily.\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2014-03-16, presumably until 2015-03-29, with intended 0 refill(s). Instructions: take 4 Tabs by mouth as needed.\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-03-11, presumably until 2014-03-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-16 00:00:00, ended at 2014-03-16 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n\n### Condition\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Coronary atherosclerosis\n- Heart failure\n\n### Drug\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2014-03-16, presumably until 2014-03-16\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-03-16, presumably until 2014-03-16\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- cefepime 2000 MG Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 6-aminocaproic acid 250 MG/ML Injectable Solution, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- midazolam 1 MG/ML Injectable Solution, started on 2014-03-16, presumably until 2014-03-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-03-16 00:00:00, ended at 2014-03-16 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifampin 600 MG Injection, through Intravenous route, started on 2014-03-16, presumably until 2014-03-16\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2014-03-16, presumably until 2014-03-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-30 00:00:00, ended at 2014-03-30 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute on chronic systolic heart failure\n- Acute myocardial infarction\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-31 00:00:00, ended at 2014-03-31 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Acute myocardial infarction of anterior wall\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Electrocardiogram abnormal\n- Acute myocardial infarction\n- Acute myocardial infarction of inferior wall\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-31 11:58:00, ended at 2014-03-31 15:23:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.31 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.66 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 321 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.1 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 360 (thousand per microliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prothrombin time (PT): 17.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-31 15:24:00, ended at 2014-04-04 16:24:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.93 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.14 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 323 (unit per liter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 202 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 393 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: N/A (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Prothrombin time (PT): 21.4 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Body height: 5' 1\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n\n### Procedure\n- Prophylactic administration of vaccine against other diseases\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Computed tomography, head or brain; without contrast material\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cardiogenic shock\n- Congestive heart failure\n- Bleeding from nose\n- Disorder of function of stomach\n- Allergic disposition\n- Benign hypertensive renal disease with renal failure\n- Coag./bleeding tests abnormal\n- Disorder of carotid artery\n- Transient cerebral ischemia\n- Acute posthemorrhagic anemia\n- Acute subendocardial infarction\n- Cerebrovascular disease\n- Constipation\n- Chronic ischemic heart disease\n- Malaise\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Chronic kidney disease stage 2\n- Coronary arteriosclerosis\n- Gastrointestinal hemorrhage\n- Acute myocardial infarction\n- Chronic combined systolic and diastolic heart failure\n- Paroxysmal ventricular tachycardia\n\n### Drug\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2014-04-03, presumably until 2014-04-03\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-04-04, presumably until 2014-04-28, with intended 4 refill(s). Instructions: take 5 mg by mouth daily.\n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2014-04-02, presumably until 2015-04-04, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-04-01, presumably until 2014-07-31, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-04-03, presumably until 2014-04-04\n- dipyridamole 50 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-06, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 3 times a day.\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2014-04-01, presumably until 2014-04-04\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-04-02, presumably until 2014-04-02\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2014-04-03, presumably until 2014-04-04\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-01\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-03\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-03-31, presumably until 2014-04-04\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-03\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2014-04-04, presumably until 2014-04-04\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-04-01, presumably until 2014-04-04\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-04-03, presumably until 2014-04-06, with intended 2 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours.\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2014-04-03, presumably until 2014-04-03\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2014-03-31, presumably until 2014-04-04\n- ondansetron 4 MG Oral Film, through Oral route, started on 2014-04-04, presumably until 2014-05-10, with intended 1 refill(s). Instructions: take 4 mg by mouth 3 times a day as needed (before meals).\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-04-02, presumably until 2014-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2014-04-05 16:29:00, ended at 2014-04-05 17:57:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.73 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.55 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 366 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 71.1 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Prothrombin time (PT): 23.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Old myocardial infarction\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Bleeding from nose\n\n### Drug\n- oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray, through Nasal route, started on 2014-04-05, presumably until 2014-04-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-06 00:00:00, ended at 2014-04-06 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Chronic ischemic heart disease\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-06 08:08:55, ended at 2014-04-06 09:25:51\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- dipyridamole 75 MG Oral Tablet, started on 2014-04-06, presumably until 2014-04-07, with intended 3 refill(s). Instructions: Take 1 tab three times per day.\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2014-04-06, presumably until 2014-04-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ondansetron 4 MG Oral Tablet, started on 2014-03-29, presumably until 2014-05-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-06 09:39:00, ended at 2014-04-06 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.61 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 348 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Prothrombin time (PT): 22.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 222 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-07 10:09:00, ended at 2014-04-07 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.50 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 372 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.73 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 229 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.34 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Prothrombin time (PT): 21.8 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-07 10:38:01, ended at 2014-04-07 12:17:04\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Chronic ischemic heart disease\n- Electrocardiogram abnormal\n- Acute myocardial infarction of inferior wall\n- Acute on chronic systolic heart failure\n- Acute myocardial infarction\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Congestive heart failure\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-04-07, presumably until 2014-05-10, with intended 1 refill(s). Instructions: take 0.5 Tabs by mouth daily.\n- dipyridamole 50 MG Oral Tablet, started on 2014-04-07, presumably until 2014-06-15, with intended 3 refill(s). Instructions: Take 2 tab three times per day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-10 11:07:00, ended at 2014-04-10 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 340 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 227 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.76 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.88 (thousand per microliter)\n- Prothrombin time (PT): 25.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.2 (percent)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-14 11:04:00, ended at 2014-04-14 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 229 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.50 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.4 (percent)\n- Prothrombin time (PT): 25.9 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.73 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.1 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.00 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 319 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-14 11:24:45, ended at 2014-04-14 13:44:57\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n\n### Condition\n- Electrocardiogram abnormal\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Atrial fibrillation\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-20 14:26:00, ended at 2014-04-20 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.9 (percent)\n- MCV [Entitic volume] by Automated count: 92.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Prothrombin time (PT): 22.0 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.69 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 246 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.60 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 278 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-28 00:00:00, ended at 2014-04-28 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2014-04-28, presumably until 2014-06-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-28 13:08:00, ended at 2014-04-28 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Prothrombin time (PT): 19.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 241 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.54 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 233 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-28 13:27:31, ended at 2014-04-28 16:02:49\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n\n### Condition\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n\n### Drug\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-04-28, presumably until 2014-05-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2014-04-28, presumably until 2014-05-10, with intended 0 refill(s). Instructions: take 2 Caps by mouth One Time. Take 1 g of amoxicillin 30 minutes prior to the dental cleaning.\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-04-28, presumably until 2014-05-10, with intended 0 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-10 12:56:00, ended at 2014-05-10 13:55:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.99 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 186 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 223 (unit per liter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.3 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.28 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.6 (percent)\n- Prothrombin time (PT): 23.3 (second)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-10 13:56:00, ended at 2014-05-10 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Cardiomyopathy associated with another disorder\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-10 15:27:58, ended at 2014-05-10 17:12:01\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Electrocardiogram abnormal\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Old myocardial infarction\n- Acute myocardial infarction\n- Congestive heart failure\n\n### Drug\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-05-10, presumably until 2014-07-26, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily in the evening.\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-05-10, presumably until 2014-06-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-05-10, presumably until 2014-05-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-19 09:23:17, ended at 2014-05-19 10:23:19\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Transient cerebral ischemia\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-26 13:58:00, ended at 2014-05-26 14:14:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 19 (milligram per gram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.10 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.64 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.3 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Prothrombin time (PT): 24.6 (second)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 205 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 7 (milligram per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-26 14:56:18, ended at 2014-05-26 16:25:46\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Acute myocardial infarction\n- Congestive heart failure\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Electrocardiogram abnormal\n- Chronic ischemic heart disease\n\n### Drug\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-05-26, presumably until 2014-06-15, with intended 1 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-09 14:02:21, ended at 2014-06-09 15:49:36\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Congestive heart failure\n- Electrocardiogram abnormal\n- Acute myocardial infarction\n- Chronic ischemic heart disease\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-06-09, presumably until 2014-06-15, with intended 1 refill(s). Instructions: take 0.5 Tabs by mouth daily.\n- ondansetron 4 MG Oral Film, through Oral route, presumably until 2014-08-03. Instructions: take 4 mg by mouth 3 times a day as needed (Nausea).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2014-06-10 11:52:00, ended at 2014-06-15 15:56:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 32 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: 1.24 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 44 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: N/A (second)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 59 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Body height: 5' 1\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 19.9 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 376 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.7 (femtoliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.05 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 10.9 (micromole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.9 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Prothrombin time (PT): 26.4 (second)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 276 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomography, head or brain; without contrast material\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Cerebral perfusion analysis using computed tomography with contrast administration, including post-processing of parametric maps with determination of cerebral blood flow, cerebral blood volume, and mean transit time\n- Radiologic examination, chest; single view, frontal\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of extracranial arteries; complete bilateral study\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; 30 minutes or less\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Coag./bleeding tests abnormal\n- Old myocardial infarction\n- Umbilical hernia\n- Acute on chronic systolic heart failure\n- Solitary nodule of lung\n- Transient cerebral ischemia\n- Cardiomegaly\n- Electrocardiogram abnormal\n- Essential hypertension\n- Heart disease\n- Cerebrovascular disease\n- Disorder of brain\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Anemia\n- Aphasia\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n- Coronary arteriosclerosis\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Congestive heart failure\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-15\n- warfarin sodium 10 MG Oral Tablet, through Oral route, started on 2014-06-12, presumably until 2014-06-12\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-06-15, presumably until 2015-06-15, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily in the evening.\n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2014-06-13, presumably until 2014-06-14\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-06-14, presumably until 2014-06-15\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-06-13, presumably until 2014-06-15\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-13\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-06-10, presumably until 2014-06-13\n- dipyridamole 50 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-11\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-06-12, presumably until 2014-06-14\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-15\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2014-06-14, presumably until 2014-06-15\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-11\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-06-12, presumably until 2014-06-14\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-06-11, presumably until 2014-06-15\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-06-12, presumably until 2014-06-12\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-09-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-15\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2014-06-13, presumably until 2014-06-13\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-06-11, presumably until 2014-06-14\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-15\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-06-10, presumably until 2014-06-14\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2014-06-11, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-15 09:00:00, ended at 2014-06-15 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-19 00:00:00, ended at 2014-06-19 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, through Oral route, started on 2014-06-19, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-19 00:00:00, ended at 2014-06-19 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-20 00:00:00, ended at 2014-06-20 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-20 12:42:00, ended at 2014-06-20 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Unlisted diagnostic radiographic procedure\n- Screening mammography, bilateral (2-view study of each breast)\n\n### Condition\n- Postmenopausal state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-23 00:00:00, ended at 2014-06-23 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-29 07:45:00, ended at 2014-06-29 11:10:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Colonoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n- Colonoscopy\n\n### Condition\n- Old myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Primary cardiomyopathy\n\n### Drug\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-06-29, presumably until 2014-06-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-06-29, presumably until 2014-06-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-30 07:38:00, ended at 2014-06-30 09:49:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Cerebral infarction due to thrombosis of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-30 09:50:00, ended at 2014-06-30 11:41:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Acute myocardial infarction\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-30 11:42:00, ended at 2014-06-30 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 204 (thousand per microliter)\n- Prothrombin time (PT): 28.7 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 206 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.73 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Acute myocardial infarction\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-30 15:05:43, ended at 2014-06-30 15:05:54\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Electrocardiogram abnormal\n- Acute on chronic systolic heart failure\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Chronic ischemic heart disease\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-07 00:00:00, ended at 2014-07-07 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-07 12:00:00, ended at 2014-07-07 15:52:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-07 15:53:00, ended at 2014-07-07 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-14 14:37:00, ended at 2014-07-14 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Prothrombin time (PT): 26.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.36 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 193 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.79 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-14 15:23:22, ended at 2014-07-14 16:23:39\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n\n### Condition\n- Acute myocardial infarction of inferior wall\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Old myocardial infarction\n- Chronic ischemic heart disease\n- Electrocardiogram abnormal\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-20 08:01:00, ended at 2014-07-20 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 23.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-24 00:00:00, ended at 2014-07-24 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 5 MG Oral Tablet, started on 2014-07-24, presumably until 2014-07-24, with intended 3 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY IN THE EVENING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-26 00:00:00, ended at 2014-07-26 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-07-26, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily in the evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-31 00:00:00, ended at 2014-07-31 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2014-07-31, presumably until 2014-09-08, with intended 4 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-03 14:23:44, ended at 2014-08-03 15:57:30\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aphasia as late effect of cerebrovascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-08-07 00:00:00, ended at 2014-08-07 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-08-07, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-11 13:45:00, ended at 2014-08-11 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.30 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 87.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.8 (percent)\n- Prothrombin time (PT): 30.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.64 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 223 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-11 14:36:29, ended at 2014-08-11 16:15:21\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Interrogation of ventricular assist device (VAD), in person, with physician or other qualified health care professional analysis of device parameters (eg, drivelines, alarms, power surges), review of device function (eg, flow and volume status, septum sta\n\n### Condition\n- Acute myocardial infarction\n- Old myocardial infarction\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-08-21 00:00:00, ended at 2014-08-21 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2014-08-21, presumably until 2014-09-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-08-23 21:51:00, ended at 2014-09-08 16:44:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- CD19 cells [#/volume] in Blood: 206 (per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Body height: 5' 1\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 79.2 (millimeter mercury column)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.8 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 27.8 (millimole per liter)\n- CD19 cells/100 cells in Blood: 85 (percent)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.55 (thousand per microliter)\n- Oxygen [Partial pressure] in Blood: 75 (millimeter mercury column)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 24 (nanogram per milliliter)\n- Base excess in Blood by calculation: 3.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood: 10 (per microliter)\n- Carbon dioxide [Partial pressure] in Blood: 33.0 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: >300.0 (second)\n- Left ventricular Ejection fraction: 64.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- CD3 cells [#/volume] in Blood: 19 (per microliter)\n- CD3 cells/100 cells in Blood: 8 (percent)\n- CD3+CD4+ (T4 helper) cells [#/volume] in Blood: 7 (per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Prothrombin time (PT): 29.1 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.55 (milli-international unit per liter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 416 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 152 (millimole per liter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 24 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 120 (millimole per liter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n\n### Procedure\n- Insertion of pleural tube drain\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Noninvasive ventilation\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; subsequent\n- Transplantation of heart\n- Radiologic examination, chest; single view, frontal\n- Collection of venous blood by venipuncture\n- Operative external blood circulation\n- Biopsy of heart\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Duplex scan of extracranial arteries; complete bilateral study\n- Occupational therapy evaluation\n- Transfusion of other serum\n- Splitting of blood or blood products, each unit\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Removal of external heart assist system(s) or device(s)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Endomyocardial biopsy\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Insertion of catheter into artery\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Controlled ventilation procedure and therapy, initiation and management\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n\n### Condition\n- Acidosis\n- Cardiomegaly\n- Coronary arteriosclerosis\n- Pleural effusion\n- Pneumothorax\n- Secondary diabetes mellitus\n- Acute systolic heart failure\n- Atrial flutter\n- Disorder of carotid artery\n- Electrocardiogram abnormal\n- Late effects of cerebrovascular disease\n- Old myocardial infarction\n- Weakness of face muscles\n- Abnormal glucose level\n- Atrial fibrillation\n- Cardiac arrhythmia\n- Vitamin D deficiency\n- Dysphonia\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Acute posthemorrhagic anemia\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n- Lung field abnormal\n- Urinary tract infectious disease\n- Atelectasis\n- Dysarthria as late effects of cerebrovascular disease\n- Effect of exposure to physical force\n- Injury involving multiple body regions\n- Abnormal breathing\n- Congestive heart failure\n- Bacterial infection due to Klebsiella pneumoniae\n- Primary diagnosis: Cerebral infarction due to thrombosis of cerebral arteries\n- Chronic ischemic heart disease\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2014-08-25, presumably until 2014-08-25\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2014-08-30, presumably until 2014-11-07, with intended 2 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2014-09-05, presumably until 2014-09-08, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 8 hours.\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2014-08-28, presumably until 2014-08-28\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2014-08-30, presumably until 2015-04-13, with intended 11 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-08-27, presumably until 2014-10-19, with intended 11 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-30\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2014-09-05, presumably until 2014-09-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2014-08-25, presumably until 2014-08-27\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2014-09-01, presumably until 2014-09-29, with intended 3 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) 2 times a day. Or as directed.\n- 50 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-25\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2014-08-25, presumably until 2014-09-01\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2014-09-06, presumably until 2015-07-09, with intended 11 refill(s). Instructions: take 10 mL by mouth every morning with breakfast.\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-09-05, presumably until 2014-11-07, with intended 1 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n- ganciclovir 500 MG Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-26\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-08-24, presumably until 2014-08-24\n- magnesium chloride 535 MG Delayed Release Oral Tablet, through Oral route, started on 2014-09-03, presumably until 2014-09-08\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2014-08-24, presumably until 2014-08-24\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2014-09-01, presumably until 2015-02-09, with intended 3 refill(s). Instructions: inject 12 Units subcutaneous (under the skin) 3 times a day before meals. Additionally, inject 0-12 Units subcutaneously 4 times a day before meals and bedtime per sliding scale.\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2014-09-03, presumably until 2014-09-03\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-29\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2014-08-30, presumably until 2014-09-21, with intended 11 refill(s). Instructions: take 2 capsules by mouth 2 times a day. Or as directed.\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-09-01, presumably until 2014-11-07, with intended 2 refill(s). Instructions: take 1 tablet by mouth 2 times a day. Or as directed.\n- amphotericin B 50 MG Injection, started on 2014-08-25, presumably until 2014-09-08\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2014-09-04, presumably until 2014-09-05\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2014-08-27, presumably until 2015-09-01, with intended 11 refill(s). Instructions: take 1 lozenge by mouth 3 times a day.\n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-28\n- dabigatran etexilate 75 MG Oral Capsule, through Oral route, started on 2014-09-07, presumably until 2014-09-08\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-08-25, presumably until 2014-10-26, with intended 11 refill(s). Instructions: take 1 capsule by mouth 2 times a day as needed.\n- lidocaine 70 MG / tetracaine 70 MG Medicated Patch, through Topical route, started on 2014-08-31, presumably until 2014-08-31\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-09-07\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2014-08-26, presumably until 2014-09-08\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2014-09-08, presumably until 2015-09-08, with intended 3 refill(s). Instructions: take 1 tablet by mouth daily.\n- 10 ML furosemide 10 MG/ML Injection, started on 2014-08-24, presumably until 2014-09-02\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-09-02\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2014-08-27, presumably until 2015-07-09, with intended 11 refill(s). Instructions: take 1 tablet by mouth daily in the evening.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-08-25, presumably until 2014-08-28\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2014-09-01, presumably until 2014-09-21, with intended 2 refill(s). Instructions: take 1 tablet by mouth 2 times a day. Or as directed.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-08-26, presumably until 2014-09-08\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-08-26, presumably until 2014-09-01\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-29\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-08-25, presumably until 2014-08-25\n- amiodarone hydrochloride 50 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-29, presumably until 2014-08-29\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-08-24, presumably until 2014-08-24\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-08-27, presumably until 2014-08-27\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2014-08-25, presumably until 2014-11-07, with intended 11 refill(s). Instructions: take 1 capsule by mouth 2 times a day. Or as directed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-25, presumably until 2014-09-08\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-08-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-31\n- dabigatran etexilate 150 MG Oral Capsule, through Oral route, started on 2014-09-07, presumably until 2014-10-17, with intended 1 refill(s). Instructions: take 1 capsule by mouth 2 times a day.\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2014-08-29, presumably until 2014-08-29\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2014-09-02, presumably until 2014-09-02\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2014-09-02, presumably until 2014-09-05\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2014-08-25, presumably until 2014-09-07, with intended 11 refill(s). Instructions: take 1 tablet by mouth daily.\n- mupirocin 0.02 MG/MG Topical Ointment, through Topical route, started on 2014-09-01, presumably until 2014-09-08\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2014-08-27, presumably until 2014-09-03\n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2014-08-26, presumably until 2014-10-02, with intended 2 refill(s). Instructions: Take 200 mg (20 mL) by mouth every morning and 100 mg (10 mL) every evening on an empty stomach.\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-09-08, presumably until 2015-02-09, with intended 11 refill(s). Instructions: take 2 tablets by mouth Every Day.\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2014-09-01, presumably until 2015-09-01, with intended 11 refill(s). Instructions: take 1 tablet by mouth 2 times a day with meals.\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-08-25, presumably until 2014-09-03\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-08-27, presumably until 2014-09-03\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2014-09-01, presumably until 2014-09-01\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-08-23, presumably until 2014-08-23\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2014-08-26, presumably until 2014-09-08, with intended 0 refill(s). Instructions: take 1 tablet by mouth 2 times a day. Or as directed.\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2014-08-27, presumably until 2015-02-09, with intended 6 refill(s). Instructions: take 2 tablets by mouth daily. Or as directed.\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2014-08-29, presumably until 2014-10-17, with intended 11 refill(s). Instructions: take 2 tablets by mouth 2 times a day. Or as directed.\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2014-08-28, presumably until 2020-05-08, with intended 11 refill(s). Instructions: take 1 tablet by mouth every morning with breakfast.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-08-25, presumably until 2014-08-26\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2014-09-08, presumably until 2014-09-21, with intended 0 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2014-08-25, presumably until 2014-08-25\n- methylprednisolone 125 MG Injection, started on 2014-08-25, presumably until 2014-08-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-08-24 00:00:00, ended at 2014-08-24 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2014-08-24, presumably until 2014-08-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-08-24 00:00:00, ended at 2014-08-24 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Anesthesia for heart transplant or heart/lung transplant\n\n### Condition\n- Chronic ischemic heart disease\n- Transplanted heart present\n- Heart failure\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- anti-inhibitor coagulant complex 1 UNT Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2014-08-24, presumably until 2014-08-24\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 6-aminocaproic acid 250 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2014-08-24, presumably until 2014-08-24\n- midazolam 1 MG/ML Injectable Solution, started on 2014-08-24, presumably until 2014-08-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-08 00:00:00, ended at 2014-09-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2014-09-26, presumably until 2014-09-28, with intended 11 refill(s). Instructions: take 1 packet by mouth daily.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2014-09-22, presumably until 2014-09-29, with intended 11 refill(s). Instructions: take 0.5 tablets by mouth Every Day. Or as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-11 08:46:00, ended at 2014-09-11 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.75 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 277 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 12.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 332 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-11 09:42:26, ended at 2014-09-11 11:19:29\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-12 11:09:00, ended at 2014-09-12 12:38:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n\n### Condition\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-12 13:06:38, ended at 2014-09-12 13:25:01\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n- Effect of exposure to physical force\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-13 00:00:00, ended at 2014-09-13 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-14 07:30:00, ended at 2014-09-14 07:30:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Long-term drug therapy\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-14 07:31:00, ended at 2014-09-14 07:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 25.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 98.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.29 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 12.8 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.64 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 218 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Congestive heart failure\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-14 08:00:00, ended at 2014-09-14 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 1.6EF(MOD-sp4) (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-14 08:50:21, ended at 2014-09-14 15:04:02\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Primary diagnosis: Transplanted heart present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-21 00:00:00, ended at 2014-09-21 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 65.9 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-21 07:58:00, ended at 2014-09-21 08:47:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: N/A (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 215 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 25.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.94 (thousand per microliter)\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Acute on chronic systolic heart failure\n- Atrial fibrillation\n- Chronic ischemic heart disease\n- Essential hypertension\n- Late effect of medical and surgical care complication\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Congestive heart failure\n- Effect of exposure to physical force\n- Disorder affecting transplanted structure\n- Transplanted heart present\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-21 09:03:46, ended at 2014-09-21 16:30:51\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Electrocardiogram abnormal\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-21 10:00:00, ended at 2014-09-21 12:37:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-21 12:38:00, ended at 2014-09-21 13:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Effect of exposure to physical force\n- Primary diagnosis: Transplanted heart present\n- Acute myocardial infarction\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-09-21, presumably until 2014-09-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-21 14:00:00, ended at 2014-09-21 17:19:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n\n### Condition\n- Lung field abnormal\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-21 17:20:00, ended at 2014-09-21 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-25 00:00:00, ended at 2014-09-25 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-25 08:10:00, ended at 2014-09-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.02 (million per microliter)\n- MCV [Entitic volume] by Automated count: 99.5 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 13.1 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.35 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Effect of exposure to physical force\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-27 00:00:00, ended at 2014-09-27 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-28 07:10:00, ended at 2014-09-28 07:28:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 23.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.84 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 10.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Effect of exposure to physical force\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-28 07:29:00, ended at 2014-09-28 08:45:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-28 09:01:25, ended at 2014-09-28 11:03:29\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n- Essential hypertension\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-09-28, presumably until 2014-12-18, with intended 11 refill(s). Instructions: take 1 tablet by mouth daily. DISPENSE TABLETS PLEASE!\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-28 11:00:00, ended at 2014-09-28 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 62.2 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-28 11:54:29, ended at 2014-09-28 12:05:25\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Lung field abnormal\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-29 00:00:00, ended at 2014-09-29 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-29 15:58:34, ended at 2014-09-29 17:04:42\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Abnormal involuntary movement\n- Hyperlipidemia\n\n### Drug\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2014-11-07, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) Evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-02 07:46:00, ended at 2014-10-02 10:53:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.32 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.72 (milli-international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 191 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 14.0 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Effect of exposure to physical force\n- Type 2 diabetes mellitus without complication\n- Abnormal involuntary movement\n- Acute myocardial infarction\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-02 08:28:18, ended at 2014-10-02 10:48:57\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- itraconazole 10 MG/ML Oral Solution, started on 2014-10-02, presumably until 2014-11-23, with intended 2 refill(s). Instructions: Take 200 mg (20 mL) by mouth every morning and 100 mg (10 mL) every evening on an empty stomach.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-10-04 00:00:00, ended at 2014-10-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-04 08:14:00, ended at 2014-10-04 22:56:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 139 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood: 46 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.5 (picogram)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Body height: 5' 1\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Lactate [Moles/volume] in Blood: 1.2 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Coronary arteriography using two catheters\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Endomyocardial biopsy\n- Collection of venous blood by venipuncture\n- Intravascular imaging of coronary vessels\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n\n### Condition\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2014-10-04, presumably until 2014-10-04\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2014-10-04, presumably until 2014-10-04\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-10-04, presumably until 2014-10-04\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-10-04, presumably until 2014-10-04\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-10-04, presumably until 2014-10-04\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2014-10-04, presumably until 2014-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-05 08:37:00, ended at 2014-10-05 10:24:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.83 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 14.7 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Effect of exposure to physical force\n- Acute on chronic systolic heart failure\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-05 08:59:15, ended at 2014-10-05 10:23:05\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal breathing\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-05 10:25:00, ended at 2014-10-05 11:14:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 63.2 (percent)\n\n### Procedure\n- Long-term drug therapy\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-05 11:15:00, ended at 2014-10-05 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2014-10-08 12:05:00, ended at 2014-10-08 16:21:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 7.67 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Prothrombin time (PT): 15.0 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 161 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Hemorrhage of rectum and anus\n- Atrial fibrillation\n- Gastrointestinal hemorrhage\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Allergic disposition\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-09 07:55:00, ended at 2014-10-09 11:13:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 21.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.98 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.9 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.69 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myocardial infarction\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-09 11:14:00, ended at 2014-10-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-10-09, presumably until 2014-10-09\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-10-09, presumably until 2014-10-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-16 08:11:00, ended at 2014-10-16 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.5 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 14.3 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 3.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 87 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-16 08:45:08, ended at 2014-10-16 10:32:48\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Immune defect\n- Primary diagnosis: Transplanted heart present\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-10-17 00:00:00, ended at 2014-10-17 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Nausea\n- Diarrhea\n- Leukocytosis\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-10-17, presumably until 2014-12-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2014-10-17, presumably until 2014-11-07, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-19 07:45:00, ended at 2014-10-19 08:39:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.97 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 41 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Tacrolimus [Mass/volume] in Blood: 18.3 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 265 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.07 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Biopsy of heart\n- Echocardiography\n\n### Condition\n- Acute on chronic systolic heart failure\n- Mechanical complication due to heart valve prosthesis\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Nausea\n- Acute myocardial infarction\n- Disorder of diaphragm\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-19 10:35:00, ended at 2014-10-19 11:49:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 59.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-19 11:50:00, ended at 2014-10-19 12:12:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Nausea\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-19 12:13:00, ended at 2014-10-19 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-10-19, presumably until 2014-10-19\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-10-19, presumably until 2014-10-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-26 08:40:00, ended at 2014-10-26 08:54:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 13.23 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 209 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.88 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 15.8 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 91 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n- Effect of exposure to physical force\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Diarrhea\n- Nausea\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-26 08:55:00, ended at 2014-10-26 11:46:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-26 09:14:28, ended at 2014-10-26 11:37:22\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Essential hypertension\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-26 11:47:00, ended at 2014-10-26 12:18:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-26 12:19:00, ended at 2014-10-26 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Leukocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2014-10-27 09:54:00, ended at 2014-11-07 18:35:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 100 (percent)\n- Platelets [#/volume] in Blood by Automated count: 381 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Base excess in Blood by calculation: 6.0 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 16.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 48 (percent)\n- Lactate [Moles/volume] in Blood: 1.8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 38.3 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.51 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCV [Entitic volume] by Automated count: 97.4 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Body height: 5' 1\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 276 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.91 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 129 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 4.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 28.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 214 (millimeter mercury column)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Collection of venous blood by venipuncture\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Computed tomography, thorax, diagnostic; without contrast material\n- Arterial puncture, withdrawal of blood for diagnosis\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Central venous catheter placement with guidance\n\n### Condition\n- Acute on chronic systolic heart failure\n- Pressure ulcer of buttock\n- Primary diagnosis: Sepsis\n- Urinary tract infectious disease\n- Chronic ischemic heart disease\n- Essential hypertension\n- Hypervolemia\n- Muscle atrophy\n- Pressure ulcer stage 2\n- Sepsis due to Gram negative bacteria\n- Congestive heart failure\n- Disorder of diaphragm\n- Effect of exposure to physical force\n- Immune defect\n- Type 2 diabetes mellitus without complication\n- Acute posthemorrhagic anemia\n- Hypo-osmolality and or hyponatremia\n- Hypoxemia\n- Late effect of medical and surgical care complication\n- Lung field abnormal\n- Pressure ulcer\n- Acute myocardial infarction\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder affecting transplanted structure\n- Hyperlipidemia\n- Atrial fibrillation\n- Diarrhea\n- Malaise\n- Pneumothorax\n- Senility\n- Bacteremia\n- Bronchitis\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Dysphonia\n- Hyperkalemia\n- Transplanted heart present\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-11-07\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2014-11-03, presumably until 2015-05-24, with intended 11 refill(s). Instructions: take 3 Tabs by mouth daily in the evening.\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2014-10-28, presumably until 2014-11-07\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-11-06, presumably until 2015-11-07, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take 2 tablets by mouth in the morning and 1 tablet by mouth in the afternoon.\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2014-11-02, presumably until 2014-11-06\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-10-28\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-11-05\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-10-28, presumably until 2014-10-28\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2014-10-27, presumably until 2014-11-07\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2014-11-06, presumably until 2014-11-07\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2014-10-28, presumably until 2014-12-13, with intended 1 refill(s). Instructions: take 8 Tabs by mouth 2 times a day.\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2014-10-28, presumably until 2014-11-07\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2014-11-01, presumably until 2014-12-18, with intended 3 refill(s). Instructions: by Topical route as needed (at time of buttock dressing change).\n- 10 ML furosemide 10 MG/ML Injection, started on 2014-11-04, presumably until 2014-11-05\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-11-06\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-10-27, presumably until 2014-11-07\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2014-10-28, presumably until 2014-11-07\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-10-27, presumably until 2014-11-07\n- clotrimazole 10 MG/ML Topical Solution, through Topical route, started on 2014-10-27, presumably until 2014-11-06\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-10-28, presumably until 2014-11-03\n- cefepime 2000 MG Injection, through Intravenous route, started on 2014-10-27, presumably until 2014-10-29\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2014-10-29, presumably until 2014-11-20, with intended 11 refill(s). Instructions: Take 0.5 mg in the morning and 1 mg in the evening. Or as directed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-10-27, presumably until 2014-11-05\n- ceftriaxone 2000 MG Injection, through Intravenous route, started on 2014-11-07, presumably until 2014-11-23, with intended 0 refill(s). Instructions: 2 g by Intravenous route daily in the evening.\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2014-10-27, presumably until 2014-10-28\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-11-04, presumably until 2014-11-06\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-10-27, presumably until 2015-05-24, with intended 0 refill(s). Instructions: inject 18 Units subcutaneous (under the skin) Evening.\n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2014-10-27, presumably until 2014-11-07\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-11-07\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-10-27, presumably until 2014-11-07\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2014-10-28, presumably until 2014-11-06\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2014-10-28, presumably until 2014-11-07\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2014-10-27, presumably until 2014-11-07, with intended 11 refill(s). Instructions: take 2 Tabs by mouth Every Day. Take a total of 720 mg by mouth in the morning ( 2 tablets)\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2014-10-30, presumably until 2014-10-30\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-10-30, presumably until 2014-10-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-07 00:00:00, ended at 2014-11-07 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dabigatran etexilate 150 MG Oral Capsule, started on 2014-11-07, presumably until 2014-11-07, with intended 10 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-13 08:07:00, ended at 2014-11-13 09:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.20 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.4 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 214 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Erythrocyte sedimentation rate: 17 (millimeter per hour)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.34 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Diarrhea\n- Effect of exposure to physical force\n- Leukocytosis\n- Nausea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-13 09:10:15, ended at 2014-11-13 10:23:33\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Effect of exposure to physical force\n- Immune defect\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-13 10:00:00, ended at 2014-11-13 11:18:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 61.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Diarrhea\n- Leukocytosis\n- Nausea\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-13 11:19:00, ended at 2014-11-13 13:13:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Transplanted heart present\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-15 15:00:00, ended at 2014-11-15 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Effect of exposure to physical force\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-11-15, presumably until 2014-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-16 00:00:00, ended at 2014-11-16 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- furosemide 20 MG Oral Tablet, started on 2014-11-29, presumably until 2014-12-29, with intended 11 refill(s). Instructions: Take 2 tablets by mouth in the morning and 1 tablet by mouth in the afternoon.\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2014-11-20, presumably until 2014-12-19, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- tacrolimus 0.5 MG Oral Capsule, started on 2014-11-20, presumably until 2014-12-28, with intended 11 refill(s). Instructions: Take a total of 1.5 mg in the evening. Fax 999-999-9999\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-17 10:05:00, ended at 2014-11-17 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Leukocytosis\n- Diarrhea\n- Nausea\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-23 07:45:00, ended at 2014-11-23 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 226 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.6 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-23 08:20:46, ended at 2014-11-23 09:53:07\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-29 00:00:00, ended at 2014-11-29 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-30 07:48:00, ended at 2014-11-30 08:06:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 167 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- MCV [Entitic volume] by Automated count: 100.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.73 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.59 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 45 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Effect of exposure to physical force\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-30 08:07:00, ended at 2014-11-30 10:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Endomyocardial biopsy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n- Late effect of medical and surgical care complication\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-30 11:17:00, ended at 2014-11-30 11:58:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 62.4 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-30 11:59:00, ended at 2014-11-30 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-05 10:49:00, ended at 2014-12-05 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.75 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 29.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 192 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n- Chronic ischemic heart disease\n- Acute myocardial infarction\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-13 00:00:00, ended at 2014-12-13 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal glucose level\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2014-12-13, presumably until 2015-02-09, with intended 3 refill(s). Instructions: take 8 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-15 00:00:00, ended at 2014-12-15 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-15 09:53:00, ended at 2014-12-15 09:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 244 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 45 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.44 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Acute myocardial infarction\n- Effect of exposure to physical force\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-15 10:00:00, ended at 2014-12-15 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- 50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection, through Intravenous route, started on 2014-12-15, presumably until 2014-12-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-12-18 08:59:20, ended at 2014-12-18 10:01:13\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Essential hypertension\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-18 10:06:00, ended at 2014-12-18 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.10 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Acute on chronic systolic heart failure\n- Effect of exposure to physical force\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Acute myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-19 00:00:00, ended at 2014-12-19 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2014-12-19, presumably until 2015-02-09, with intended 11 refill(s). Instructions: 1 Spray by Nasal route daily. 1 spray each nare daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2014-12-19, presumably until 2015-02-09, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2014-12-19, presumably until 2014-12-29, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-12-20 12:39:07, ended at 2014-12-20 13:41:22\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-27 00:00:00, ended at 2014-12-27 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-28 09:05:00, ended at 2014-12-28 09:26:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 202 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 327 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.32 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <15 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-28 09:27:00, ended at 2014-12-28 12:29:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.5 (percent)\n\n### Procedure\n- Long-term drug therapy\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-28 12:30:00, ended at 2014-12-28 14:16:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n- Endomyocardial biopsy\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n- Essential hypertension\n- Lung field abnormal\n- Asthenia\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-29 00:00:00, ended at 2014-12-29 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-12-29, presumably until 2015-02-09, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. Fax 999-999-9999 with any questions.\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2014-12-29, presumably until 2015-02-13, with intended 11 refill(s). Instructions: take 0.5 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-01 11:18:00, ended at 2015-01-01 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.81 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n- Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-23 00:00:00, ended at 2015-01-23 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-31 00:00:00, ended at 2015-01-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-01 00:00:00, ended at 2015-02-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-01 07:26:00, ended at 2015-02-01 07:26:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 11.0 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 222 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.79 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction\n- Congestive heart failure\n- Effect of exposure to physical force\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-01 07:27:00, ended at 2015-02-01 07:50:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-01 07:51:00, ended at 2015-02-01 10:09:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-01 08:35:30, ended at 2015-02-01 09:41:12\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-01 10:10:00, ended at 2015-02-01 11:12:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-01 11:13:00, ended at 2015-02-01 15:05:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n- Biopsy of heart\n\n### Condition\n- Transplanted heart present\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-02-08 17:47:00, ended at 2015-02-13 19:22:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 18.9 (microgram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <15 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n- Lactate [Moles/volume] in Blood: 1.5 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Left ventricular Ejection fraction: 59.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.04 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.77 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.7 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Ultrasound, abdominal, real time with image documentation; complete\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Collection of venous blood by venipuncture\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Cachexia\n- Chronic kidney disease stage 2\n- Dehydration\n- Acute on chronic systolic heart failure\n- Cough\n- Electrocardiogram abnormal\n- Sepsis due to Streptococcus\n- Transplanted heart present\n- Atrial fibrillation\n- Allergic disposition\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Urinary tract infectious disease\n- Anemia\n- Chronic ischemic heart disease\n- Effect of exposure to physical force\n- Primary diagnosis: Nausea and vomiting\n- Acute posthemorrhagic anemia\n- Dysphonia\n- Essential hypertension\n- Sepsis\n- Type 2 diabetes mellitus without complication\n- Acute renal failure syndrome\n- Congestive heart failure\n- Hypogammaglobulinemia\n- Immune defect\n- Pneumothorax\n- Disorder of diaphragm\n- Hypervolemia\n- Severe protein-calorie malnutrition (Gomez: less than 60 percent of standard weight)\n- Acute myocardial infarction\n- Large liver\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2015-02-09, presumably until 2015-02-10\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-02-13, presumably until 2015-05-16, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every morning.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-02-13, presumably until 2015-02-28, with intended 11 refill(s). Instructions: 1 Spray by Nasal route daily.\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2015-02-08, presumably until 2015-02-11\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2015-02-09, presumably until 2015-02-13\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-02-08, presumably until 2015-05-24, with intended 0 refill(s). Instructions: take 2 mg by mouth 2 times a day.\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-02-08, presumably until 2015-02-12\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-02-11, presumably until 2015-02-13\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2015-02-08, presumably until 2015-02-13\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2015-02-10, presumably until 2015-02-13\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2015-02-08, presumably until 2015-03-28, with intended 0 refill(s). Instructions: take 4 mg by mouth 2 times a day.\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2015-02-08, presumably until 2015-02-12\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-02-09, presumably until 2015-02-22, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 3 times a day with meals. Inject additional 1unit for every 30 >130 BS.\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2015-02-13, presumably until 2015-02-20, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-02-12, presumably until 2016-02-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2015-02-11, presumably until 2015-12-24, with intended 0 refill(s). Instructions: take 3 Caps by mouth daily in the evening.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-02-08, presumably until 2015-02-13\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-02-08, presumably until 2015-02-08\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-04-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2015-02-08, presumably until 2015-02-11\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-03-28, with intended 1 refill(s). Instructions: take 450 mg by mouth 2 times a day.\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2015-02-09, presumably until 2015-02-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-16 00:00:00, ended at 2015-02-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-19 00:00:00, ended at 2015-02-19 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2015-02-20, presumably until 2015-04-12, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day before meals. For nausea. About 30 minutes prior to meals.Fax 999-999-9999.\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2015-02-20, presumably until 2015-12-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- estradiol 0.1 MG/ML Vaginal Cream, through Vaginal route, started on 2015-02-20, presumably until 2016-02-20, with intended 11 refill(s). Instructions: insert 2 g into the vagina daily.\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2015-02-20, presumably until 2015-08-29, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-19 08:50:00, ended at 2015-02-19 11:18:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Effect of exposure to physical force\n- Acute myocardial infarction\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-19 09:32:08, ended at 2015-02-19 11:07:48\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Pure hypercholesterolemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-19 11:19:00, ended at 2015-02-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-02-22 00:00:00, ended at 2015-02-22 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2015-02-22, presumably until 2015-05-24, with intended 10 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) 3 times a day with meals. Inject additional 1unit for every 30 >130 BS.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-28 10:02:46, ended at 2015-02-28 10:52:52\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted heart present\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-07 00:00:00, ended at 2015-03-07 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-08 08:53:00, ended at 2015-03-08 09:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.15 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute on chronic systolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Acute myocardial infarction\n- Effect of exposure to physical force\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-08 09:16:00, ended at 2015-03-08 12:04:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 31.6mlEF(MOD-bp) (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-08 09:57:44, ended at 2015-03-08 11:57:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-08 12:05:00, ended at 2015-03-08 12:25:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-08 12:27:00, ended at 2015-03-08 13:22:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Radiologic examination, hip, unilateral; 1 view\n\n### Condition\n- Joint pain of pelvic region\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-08 13:23:00, ended at 2015-03-08 14:56:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy of heart\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n- Nausea\n- Transplanted heart present\n- Disorder of kidney and/or ureter\n- Effect of exposure to physical force\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-12 00:00:00, ended at 2015-03-12 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2015-03-12, presumably until 2015-04-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-13 12:46:53, ended at 2015-03-13 15:04:08\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-14 00:00:00, ended at 2015-03-14 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-03-14, presumably until 2015-04-12, with intended 1 refill(s). Instructions: take 1 Cap by mouth as directed. Take 1 tablet 1 to 2 hrs prior to CT scan. May repeat x1.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-19 13:52:00, ended at 2015-03-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-28 00:00:00, ended at 2015-03-28 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2015-03-28, presumably until 2015-04-16, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-03-28, presumably until 2015-10-16, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-06 07:36:00, ended at 2015-04-06 10:16:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 104 (milligram per deciliter)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopic excision or destruction of lesion or tissue of stomach\n\n### Condition\n- Allergic disposition\n- Atrial fibrillation\n- Benign neoplasm of stomach\n- Gastritis\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Nausea and vomiting\n- Transplanted heart present\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2015-04-06, presumably until 2015-04-06\n- midazolam 1 MG/ML Injectable Solution, started on 2015-04-06, presumably until 2015-04-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-11 00:00:00, ended at 2015-04-11 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-11 00:00:00, ended at 2015-04-11 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-12 08:59:00, ended at 2015-04-12 08:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-12 09:00:00, ended at 2015-04-12 09:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 4.3 (microgram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n\n### Procedure\n- Long-term drug therapy\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-12 09:43:00, ended at 2015-04-12 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 1.6EF(MOD-sp4) (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-12 10:36:14, ended at 2015-04-12 12:23:36\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Essential hypertension\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-13 00:00:00, ended at 2015-04-13 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2015-04-13, presumably until 2016-02-12, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-15 00:00:00, ended at 2015-04-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2015-04-15, presumably until 2015-04-15, with intended 3 refill(s). Instructions: TAKE 2 TABLETS ORALLY TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-16 00:00:00, ended at 2015-04-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Urine finding\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2015-04-16, presumably until 2015-09-12, with intended 11 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-16 20:24:00, ended at 2015-04-16 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n- Urine finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-17 00:00:00, ended at 2015-04-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-04-17, presumably until 2015-05-24, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-17 00:00:00, ended at 2015-04-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-09 10:16:00, ended at 2015-05-09 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-09 10:40:49, ended at 2015-05-09 11:39:12\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Hyperlipidemia\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-05-15 00:00:00, ended at 2015-05-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-15 11:22:01, ended at 2015-05-15 12:45:14\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Urinary tract infectious disease\n- Bacterial infection due to Klebsiella pneumoniae\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-05-16 00:00:00, ended at 2015-05-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-05-16, presumably until 2015-08-15, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-17 07:43:00, ended at 2015-05-17 07:44:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.53 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 230 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Effect of exposure to physical force\n- Type 2 diabetes mellitus without complication\n- Anemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-17 07:45:00, ended at 2015-05-17 07:47:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-17 07:48:00, ended at 2015-05-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 2.8 (microgram per milliliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.9 (nanogram per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-17 08:14:01, ended at 2015-05-17 10:04:58\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2015-05-23 13:28:00, ended at 2015-05-24 14:08:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 190 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 215 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 244 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Tacrolimus [Mass/volume] in Blood: 8.4 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 3.1 (microgram per milliliter)\n- Base excess in Blood by calculation: 1 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.39 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 97.7 (femtoliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.3 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Acute on chronic systolic heart failure\n- Disorder of eye due to diabetes mellitus\n- Bacterial infection due to Klebsiella pneumoniae\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Dysphonia\n- Cardiac arrhythmia\n- Congestive heart failure\n- Effect of exposure to physical force\n- Essential hypertension\n- Vomiting\n- Acute posthemorrhagic anemia\n- Hyperlipidemia\n- Nausea and vomiting\n- Nonproliferative retinopathy due to diabetes mellitus\n- Old myocardial infarction\n- Primary diagnosis: Urinary tract infectious disease\n- Pneumothorax\n- Transplanted heart present\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Immune defect\n- Sepsis\n- Acute myocardial infarction\n- Atrial fibrillation\n- Electrocardiogram abnormal\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-10-16, with intended 1 refill(s). Instructions: take 3 Tabs by mouth every 12 hours at 10am and 10pm\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-05-24\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-05-24, presumably until 2015-05-24\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2015-05-24, presumably until 2015-10-16, with intended 10 refill(s). Instructions: 6-8 Units by Injection route 3 times a day inject 10 Units subcutaneous (under the skin) 3 times a day with meals. Inject additional 1unit for every 30 >130 BS.\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-05-23, presumably until 2016-02-05, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily in the morning\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-05-24\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-05-23\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-05-23, presumably until 2015-05-23\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2015-05-23, presumably until 2015-05-23\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-05-23, presumably until 2015-05-23\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-05-23, presumably until 2016-02-05, with intended 0 refill(s). Instructions: inject 16 Units subcutaneous (under the skin) Evening\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-05-24\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-05-23\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2015-05-23, presumably until 2015-08-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-31 07:58:00, ended at 2015-05-31 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 4.7 (microgram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n- Bacterial infection due to Klebsiella pneumoniae\n- Transplanted heart present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-07 09:44:00, ended at 2015-06-07 09:45:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Effect of exposure to physical force\n- Type 2 diabetes mellitus without complication\n- Urinary tract infectious disease\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-07 09:46:00, ended at 2015-06-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 5.0 (microgram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 8.6 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n\n### Procedure\n- Long-term drug therapy\n- Collection of venous blood by venipuncture\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n- Urinary tract infectious disease\n- Type 2 diabetes mellitus without complication\n- Bacterial infection due to Klebsiella pneumoniae\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-13 00:00:00, ended at 2015-06-13 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-06-14 00:00:00, ended at 2015-06-14 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-08-15, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-14 08:19:00, ended at 2015-06-14 11:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 64.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-14 11:01:00, ended at 2015-06-14 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Bacterial infection due to Klebsiella pneumoniae\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-15 00:00:00, ended at 2015-06-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-06-15, presumably until 2015-06-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days DO NOT take with AUGMENTIN. Fax 999-999-9999. Complete this course for 14 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-15 00:00:00, ended at 2015-06-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2015-06-15, presumably until 2015-10-16, with intended 11 refill(s). Instructions: take 1 Tab by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-22 09:12:00, ended at 2015-06-22 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-09 00:00:00, ended at 2015-07-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-07-09, presumably until 2015-09-12, with intended 11 refill(s). Instructions: take 10 mL by mouth every morning with breakfast ICD 9: 996.83; Fax: 999-999-9999\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2015-07-09, presumably until 2015-09-03, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-14 08:20:05, ended at 2015-08-14 09:11:09\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Immune defect\n- Primary diagnosis: Urinary tract infectious disease\n- Bacterial infection due to Klebsiella pneumoniae\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-15 00:00:00, ended at 2015-08-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-15 09:15:00, ended at 2015-08-15 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 2.1 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-15 10:09:16, ended at 2015-08-15 10:44:56\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disorder due to diabetes mellitus\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-24 00:00:00, ended at 2015-08-24 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 08:52:00, ended at 2015-08-29 09:12:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.6 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 228 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.3 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 0.3 (milligram per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.6 (nanogram per milliliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.9 (ratio)\n- Homocysteine [Moles/volume] in Serum or Plasma: 13.1 (micromole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 133 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.69 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 27.9 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.26 (micro-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 09:13:00, ended at 2015-08-29 09:54:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 09:55:00, ended at 2015-08-29 13:35:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.8 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-29 10:37:19, ended at 2015-08-29 13:27:06\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary hypertension\n- Pure hypercholesterolemia\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-30 08:11:00, ended at 2015-08-30 16:25:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 30 (percent)\n- INR in Blood by Coagulation assay: 1.2 (ratio)\n- Potassium [Moles/volume] in Blood: 4.7 (millimole per liter)\n- Body height: 5' 1\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.2 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 137 (millimole per liter)\n\n### Procedure\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of blood specimen from a completely implantable venous access device\n- Intravascular imaging of coronary vessels\n- Coronary arteriography using single catheter\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Chronic kidney disease\n- Allergic disposition\n- Primary diagnosis: Postprocedural state finding\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-08-30, presumably until 2015-08-30\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-30, presumably until 2015-08-30\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2015-08-30, presumably until 2015-08-30\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2015-08-30, presumably until 2015-08-30\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-08-30, presumably until 2015-08-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-08-30, presumably until 2015-08-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-03 00:00:00, ended at 2015-09-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2015-09-03, presumably until 2015-09-14, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-12 08:10:32, ended at 2015-09-12 09:02:30\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Hyperlipidemia\n- Primary diagnosis: Kidney disease\n- Transplanted heart present\n- Essential hypertension\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2015-09-12, presumably until 2015-12-01, with intended 2 refill(s). Instructions: take 500 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-14 00:00:00, ended at 2015-09-14 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2015-09-14, presumably until 2016-04-15, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-18 00:00:00, ended at 2015-09-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-18 00:00:00, ended at 2015-09-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercalcemia\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-25 00:00:00, ended at 2015-09-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-09-26, presumably until 2015-10-16, with intended 5 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-27 00:00:00, ended at 2015-09-27 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- repaglinide 0.5 MG Oral Tablet, through Oral route, started on 2015-09-28, presumably until 2015-11-23, with intended 1 refill(s). Instructions: take 0.5 mg by mouth 2 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-16 00:00:00, ended at 2015-10-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2015-10-16, presumably until 2015-12-25, with intended 11 refill(s). Instructions: take 3 Tabs by mouth every 12 hours at 10am and 10pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-16 09:31:18, ended at 2015-10-16 10:17:17\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Primary diagnosis: Urinary tract infectious disease\n- Transplanted heart present\n- Type 2 diabetes mellitus without complication\n- Immune defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-18 00:00:00, ended at 2015-10-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2015-10-18, presumably until 2016-10-18, with intended 1 refill(s). Instructions: take 4 Caps by mouth Every Day Take within 1hr of dental procedures\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-30 00:00:00, ended at 2015-10-30 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cefpodoxime 200 MG Oral Tablet, through Oral route, started on 2015-11-01, presumably until 2015-11-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-13 09:02:20, ended at 2015-11-13 10:07:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Fatigue\n- Malaise\n- Primary diagnosis: Urinary tract infectious disease\n- Transplanted heart present\n- Stomatitis\n- Disorder due to infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-13 10:16:00, ended at 2015-11-13 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n- Disorder due to infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-11-14 00:00:00, ended at 2015-11-14 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Stomatitis\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2015-11-14, presumably until 2015-11-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth 3 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-16 00:00:00, ended at 2015-11-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cytomegalovirus infection\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-17 00:00:00, ended at 2015-11-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cytomegalovirus infection\n- Transplanted heart present\n\n### Drug\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-11-17, presumably until 2015-12-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day for 30 days Please get specific dosing instructions including duration from your doctor.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-17 00:00:00, ended at 2015-11-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Transplanted heart present\n- Bacterial infection due to Klebsiella pneumoniae\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-17 11:37:00, ended at 2015-11-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.64 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 3.75 (log international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 5666 (international unit per milliliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cytomegalovirus infection\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Urinary tract infectious disease\n- Disorder due to infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-19 00:00:00, ended at 2015-11-19 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Cytomegalovirus infection\n- Neutropenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-21 10:46:00, ended at 2015-11-21 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder of immune function\n- Cytomegalovirus infection\n- Transplanted heart present\n- Disorder due to infection\n- Type 2 diabetes mellitus without complication\n- Hypercalcemia\n- Neutropenia\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-22 00:00:00, ended at 2015-11-22 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.29 (micro-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-23 00:00:00, ended at 2015-11-23 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n- repaglinide 0.5 MG Oral Tablet, started on 2015-11-26, presumably until 2016-02-18, with intended 10 refill(s). Instructions: TAKE 0.5 MG BY MOUTH 2 TIMES A DAY BEFORE MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-28 00:00:00, ended at 2015-11-28 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Cytomegalovirus infection\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-30 00:00:00, ended at 2015-11-30 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 20 MG Oral Tablet, started on 2015-12-19, presumably until 2015-12-19, with intended 3 refill(s). Instructions: TAKE 2 TABLETS ORALLY EVERY MORNING AND 1 TAB IN THE AFTERNOON\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-01 00:00:00, ended at 2015-12-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2015-12-05, presumably until 2016-02-18, with intended 6 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-04 00:00:00, ended at 2015-12-04 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, started on 2015-12-04, presumably until 2016-02-05, with intended 10 refill(s). Instructions: TAKE A TOTAL OF 1.5 MG IN THE EVENING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-10 00:00:00, ended at 2015-12-10 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-17 08:24:00, ended at 2015-12-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.63 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 164 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.67 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 6.7 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Urinary tract infectious disease\n- Disorder of immune function\n- Bacterial infection due to Klebsiella pneumoniae\n- Transplanted heart present\n- Disorder of transplanted heart\n- Cytomegalovirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-20 00:00:00, ended at 2015-12-20 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-21 00:00:00, ended at 2015-12-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 07:56:00, ended at 2015-12-24 10:14:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 59.9 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-24 08:49:59, ended at 2015-12-24 10:05:35\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, presumably until 2017-10-28, with intended 0 refill(s). Instructions: take by mouth 2 times a day Takes 2 tabs in the Am and 3 tabs in the pm\n- valganciclovir 450 MG Oral Tablet, through Oral route, presumably until 2016-02-05, with intended 0 refill(s). Instructions: take 450 mg by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 10:15:00, ended at 2015-12-24 10:34:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of immune function\n- Urinary tract infectious disease\n- Bacterial infection due to Klebsiella pneumoniae\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 10:35:00, ended at 2015-12-24 11:32:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 11:33:00, ended at 2015-12-24 12:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Endomyocardial biopsy\n\n### Condition\n- Late effect of complications of procedure\n- Transplanted heart present\n- Cardiac transplant rejection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-12-25 00:00:00, ended at 2015-12-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2015-12-25, presumably until 2016-02-12, with intended 11 refill(s). Instructions: take 2 Tabs by mouth every 12 hours at 10am and 10pm\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2015-12-25, presumably until 2016-03-28, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-26 00:00:00, ended at 2015-12-26 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-12-26, presumably until 2016-03-28, with intended 7 refill(s). Instructions: take 1-2 Caps by mouth 2 times a day Taking a total of 2mg in AM, 1.5mg in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-24 00:00:00, ended at 2016-01-24 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2016-01-24, presumably until 2016-06-05, with intended 3 refill(s). Instructions: inject 14 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-05 09:19:51, ended at 2016-02-05 10:02:23\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cytomegalovirus infection\n- Transplanted heart present\n- Urinary tract infectious disease\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-02-11 00:00:00, ended at 2016-02-11 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2016-02-11, presumably until 2016-03-05, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2016-02-11, presumably until 2016-03-05, with intended 3 refill(s). Instructions: TAKE 2 TABLETS TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Transplanted heart present\n- Type 2 diabetes mellitus\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2016-02-12, presumably until 2017-01-26, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every 12 hours at 10am and 10pm\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2016-02-12, presumably until 2016-02-14, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-02-13 00:00:00, ended at 2016-02-13 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2016-02-18, presumably until 2016-03-10, with intended 0 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY DAY, additional refills at next appt\n- repaglinide 0.5 MG Oral Tablet, started on 2016-02-18, presumably until 2016-03-05, with intended 0 refill(s). Instructions: TAKE 0.5 MG BY MOUTH 2 TIMES A DAY BEFORE MEALS, additional refills at next appt\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-14 00:00:00, ended at 2016-02-14 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2016-02-14, presumably until 2016-02-18, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-18 00:00:00, ended at 2016-02-18 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Primary diagnosis: Disorder of transplanted heart\n- Hyperglycemia due to type 2 diabetes mellitus\n- Transplanted heart present\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2016-02-18, presumably until 2016-12-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day Fax 999-999-9999 with questions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-05 10:01:02, ended at 2016-03-05 11:08:53\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- repaglinide 0.5 MG Oral Tablet, started on 2016-03-05, presumably until 2017-01-29, with intended 3 refill(s). Instructions: TAKE 0.5 MG BY MOUTH 2 TIMES A DAY BEFORE MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-07 07:45:05, ended at 2016-03-07 09:58:04\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 18 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n- Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-10 00:00:00, ended at 2016-03-10 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2016-03-13, presumably until 2016-08-17, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-12 00:00:00, ended at 2016-03-12 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-28 00:00:00, ended at 2016-03-28 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-03-28, presumably until 2016-04-25, with intended 3 refill(s). Instructions: take 1-2 Caps by mouth 2 times a day Taking a total of 2mg in AM, 1.5mg in PM\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2016-03-28, presumably until 2017-02-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2016-03-28, presumably until 2016-04-25, with intended 3 refill(s). Instructions: take 1 Cap by mouth PM Total dose of 2mg AM, 1.5mg PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-15 00:00:00, ended at 2016-04-15 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2016-04-15, presumably until 2017-02-18, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-24 00:00:00, ended at 2016-04-24 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-24 10:08:00, ended at 2016-04-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.45 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 190 (thousand per microliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.58 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 117 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.3 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Transplanted heart present\n- Disorder of transplanted heart\n- Illness\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-04-25 00:00:00, ended at 2016-04-25 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-04-25, presumably until 2017-01-26, with intended 3 refill(s). Instructions: take 2 Caps by mouth 2 times a day Taking a total of 2mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-02 00:00:00, ended at 2016-05-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-05 07:48:00, ended at 2016-05-05 11:06:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 59.6 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-05 11:07:00, ended at 2016-05-05 14:02:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.9 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.16 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.48 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n\n### Procedure\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Collection of venous blood by venipuncture\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Essential hypertension\n- Transplanted heart present\n- Disorder of immune function\n- Type 2 diabetes mellitus without complication\n- Disorder of transplanted heart\n- Bacterial infection due to Klebsiella pneumoniae\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-05 14:34:00, ended at 2016-05-05 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-09 00:00:00, ended at 2016-05-09 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-13 10:33:05, ended at 2016-05-13 11:08:22\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n- Transplanted heart present\n- Cytomegalovirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-27 00:00:00, ended at 2016-05-27 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-29 00:00:00, ended at 2016-05-29 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of respiratory system\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-05 00:00:00, ended at 2016-06-05 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2016-06-05, presumably until 2017-06-10, with intended 3 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) Evening Fax 999-999-9999, DM type II, s/p heart transplant.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-24 00:00:00, ended at 2016-06-24 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-30 10:22:43, ended at 2016-06-30 11:55:11\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .984\" (inch (US))\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion)\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n\n### Condition\n- Disorder of immune function\n- Primary diagnosis: Actinic keratosis\n- Benign neoplasm of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-17 00:00:00, ended at 2016-08-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2016-08-19, presumably until 2016-09-05, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-05 12:07:00, ended at 2016-09-05 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Complication due to diabetes mellitus\n- Cytomegalovirus infection\n- Disorder of immune function\n- Essential hypertension\n- Disorder of respiratory system\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Urinary tract infectious disease\n- Hyperlipidemia\n- Bacterial infection due to Klebsiella pneumoniae\n- Obesity\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-05 13:02:51, ended at 2016-09-05 13:54:33\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Creatinine [Mass/volume] in Urine: 54.50 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 16 (milligram per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Complication due to diabetes mellitus\n- Essential hypertension\n- Obesity\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2016-09-05, presumably until 2016-12-10, with intended 3 refill(s). Instructions: take 1,000 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-19 00:00:00, ended at 2016-09-19 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- acetylcysteine 600 MG Oral Capsule, through Oral route, started on 2016-09-19, presumably until 2016-09-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day Take 1 cap 12hrs before test, 1 cap before test, 1 cap 12hrs after test, 1 cap 24hrs after test\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-19 00:00:00, ended at 2016-09-19 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Fatigue\n- Disorder of transplanted heart\n- Type 2 diabetes mellitus\n- Pure hypercholesterolemia\n- Complication due to diabetes mellitus\n- Transplanted heart present\n\n### Drug\n- acetylcysteine 600 MG Oral Capsule, through Oral route, started on 2016-09-19, presumably until 2016-09-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day Take 1 cap 12hrs before test, 1 cap before test, 1 cap 12hrs after test, 1 cap 24hrs after test\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-23 09:23:00, ended at 2016-09-23 09:51:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 13.7 (micromole per liter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 33.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.21 (micro-international unit per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.38 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 98 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 0.6 (milligram per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 13.7 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.4 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 890 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 177 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.5 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of immune function\n- Disorder of transplanted heart\n- Urinary tract infectious disease\n- Transplanted heart present\n- Pure hypercholesterolemia\n- Type 2 diabetes mellitus\n- Complication due to diabetes mellitus\n- Bacterial infection due to Klebsiella pneumoniae\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-23 09:52:00, ended at 2016-09-23 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-23 10:27:00, ended at 2016-09-23 10:35:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 61.1 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Type 2 diabetes mellitus\n- Dyspnea\n- Fatigue\n- Complication due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-23 12:03:31, ended at 2016-09-23 13:36:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 136 (picogram per milliliter)\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Dyspnea\n- Type 2 diabetes mellitus\n- Pure hypercholesterolemia\n- Fatigue\n- Complication due to diabetes mellitus\n- Transplanted heart present\n\n### Drug\n- estradiol 0.1 MG/ML Vaginal Cream, through Vaginal route, presumably until 2017-10-05, with intended 0 refill(s). Instructions: insert 1 Application into the vagina every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-24 06:50:00, ended at 2016-09-24 12:43:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 167 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Collection of venous blood by venipuncture\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Ultrasonography of Single Coronary Artery, Intravascular\n- Endomyocardial biopsy\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n\n### Condition\n- Generalized ischemic myocardial dysfunction\n- Essential hypertension\n- Heart failure\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Transplanted heart present\n- Cardiac transplant rejection\n- Late effect of complications of procedure\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2016-09-24, presumably until 2016-09-24\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-09-24, presumably until 2016-09-24\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2016-09-24\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2016-09-24\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-09-24, presumably until 2016-09-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-09-24, presumably until 2016-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-22 13:07:32, ended at 2016-10-22 14:25:05\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized ischemic myocardial dysfunction\n- Type 2 diabetes mellitus without complication\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-10-28 00:00:00, ended at 2016-10-28 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-18 10:09:15, ended at 2016-11-18 10:50:39\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-28 10:04:00, ended at 2016-11-28 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computer-aided detection (computer algorithm analysis of digital image data for lesion detection) with further review for interpretation, with or without digitization of film radiographic images; screening mammography (List separately in addition to code \n- Screening digital breast tomosynthesis, bilateral (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-10 09:02:31, ended at 2016-12-10 09:31:35\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Obesity\n- Complication due to diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2016-12-10, presumably until 2018-01-06, with intended 4 refill(s). Instructions: take 1,500 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-10 09:38:00, ended at 2016-12-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-30 00:00:00, ended at 2016-12-30 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Hyperglycemia due to type 2 diabetes mellitus\n- Transplanted heart present\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, started on 2016-12-31, presumably until 2017-04-07, with intended 2 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-23 00:00:00, ended at 2017-01-23 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-01-26 00:00:00, ended at 2017-01-26 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-26 09:38:00, ended at 2017-01-26 12:16:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 10.1 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.25 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.10 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 128 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cytomegalovirus infection\n- Disorder of transplanted heart\n- Transplanted heart present\n- Bacterial infection due to Klebsiella pneumoniae\n- Urinary tract infectious disease\n- Complication due to diabetes mellitus\n- Disorder of immune function\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-26 10:17:42, ended at 2017-01-26 12:03:22\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2017-01-26, presumably until 2017-12-24, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every 12 hours at 10am and 10pm\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2017-01-26, presumably until 2017-09-01, with intended 3 refill(s). Instructions: take 2 Caps by mouth 2 times a day Taking a total of 2mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-26 12:17:00, ended at 2017-01-26 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-01-27 00:00:00, ended at 2017-01-27 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-01-28 00:00:00, ended at 2017-01-28 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- repaglinide 1 MG Oral Tablet, through Oral route, started on 2017-01-29, presumably until 2018-03-03, with intended 3 refill(s). Instructions: take 1 mg by mouth 2 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-30 09:55:00, ended at 2017-01-30 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 59.4 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-08 00:00:00, ended at 2017-02-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- lisinopril 5 MG Oral Tablet, started on 2017-02-11, presumably until 2017-11-08, with intended 2 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-10 00:00:00, ended at 2017-02-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, started on 2017-02-10, presumably until 2017-02-10, with intended 2 refill(s). Instructions: TAKE 1 TABLET DAILY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-11 16:04:34, ended at 2017-02-11 16:36:19\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute upper respiratory infection\n- Otitis media\n\n### Drug\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2017-02-11, presumably until 2017-03-20, with intended 0 refill(s). Instructions: take 5 mL by mouth 3 times a day as needed\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2017-02-11, presumably until 2017-02-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-18 00:00:00, ended at 2017-02-18 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2017-02-18, presumably until 2018-02-18, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-03 00:00:00, ended at 2017-03-03 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2017-03-03, presumably until 2017-09-01, with intended 3 refill(s). Instructions: TAKE 2 TABLETS ORALLY TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-09 00:00:00, ended at 2017-03-09 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-03-20 00:00:00, ended at 2017-03-20 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Osmolality of Urine: 406 (milliosmole per kilogram)\n- Sodium/Creatinine [Molar ratio] in Urine: 64 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 70.77 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypo-osmolality and or hyponatremia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-20 10:40:00, ended at 2017-03-20 11:22:55\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Type 2 diabetes mellitus\n- Obesity\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-20 11:28:00, ended at 2017-03-20 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Creatinine [Mass/volume] in Urine: 73.60 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.13 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Hypo-osmolality and or hyponatremia\n- Obesity\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Urinary tract infectious disease\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-03-24 00:00:00, ended at 2017-03-24 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-25 00:00:00, ended at 2017-03-25 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-25 12:52:59, ended at 2017-03-25 14:34:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left lower limb\n- Pain in right lower limb\n- Primary diagnosis: Peripheral vascular disorder due to diabetes mellitus\n- Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-25 12:53:00, ended at 2017-03-25 13:04:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in left lower limb\n- Peripheral vascular disorder due to diabetes mellitus\n- Arthralgia of the ankle and/or foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-03 09:43:00, ended at 2017-04-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-07 00:00:00, ended at 2017-04-07 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-07, presumably until 2018-06-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day Please provide 3 month supply as prescribed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-08 14:24:28, ended at 2017-04-08 14:55:28\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arteriosclerotic vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-08 13:25:56, ended at 2017-05-08 15:09:50\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 18 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Type 2 diabetes mellitus\n- Primary diagnosis: Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-02 09:54:03, ended at 2017-06-02 10:44:25\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .98\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-10 00:00:00, ended at 2017-06-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2017-06-10, presumably until 2018-06-15, with intended 4 refill(s). Instructions: inject 17 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 09:37:34, ended at 2017-06-24 10:32:57\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .748\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-24 10:41:00, ended at 2017-06-24 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 732 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Triglyceride [Moles/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 103 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.3 (ratio)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Obesity\n- Type 2 diabetes mellitus\n- Bacterial infection due to Klebsiella pneumoniae\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Transplanted heart present\n- Urinary tract infectious disease\n- Disorder of immune function\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Disorder of transplanted heart\n- Electrocardiogram abnormal\n- Transplanted heart present\n- Primary diagnosis: Pure hyperglyceridemia\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-31 00:00:00, ended at 2017-08-31 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-01 00:00:00, ended at 2017-09-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-01 09:24:00, ended at 2017-09-01 10:14:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.26 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 89.1 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 15.6 (micromole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 256 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 1.2 (milligram per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 105 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.1 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.55 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 29.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 11.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Transplanted heart present\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder of transplanted heart\n- Pure hyperglyceridemia\n- Disorder of immune function\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-01 10:15:00, ended at 2017-09-01 10:56:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-01 10:57:00, ended at 2017-09-01 10:57:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 66.2 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Transplanted heart present\n- Disorder of transplanted heart\n- Pure hyperglyceridemia\n- Disorder of immune function\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-01 12:50:39, ended at 2017-09-01 14:33:15\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- diphenhydramine hydrochloride 50 MG Oral Capsule, started on 2017-09-01, presumably until 2017-10-28, with intended 0 refill(s). Instructions: Take 50mg in morning prior to angiogram.\n- tacrolimus 1 MG Oral Capsule, started on 2017-09-01, presumably until 2018-05-19, with intended 3 refill(s). Instructions: Taking a 1.5mg in the morning and 2mg in the evening\n- tacrolimus 0.5 MG Oral Capsule, started on 2017-09-01, presumably until 2018-05-19, with intended 3 refill(s). Instructions: Take 1.5mg in the morning and 2mg in the evening.\n- prednisone 20 MG Oral Tablet, started on 2017-09-01, presumably until 2017-10-28, with intended 0 refill(s). Instructions: Take 60mg evening prior to angiogram and 60mg in morning prior to angiogram.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-02 06:11:00, ended at 2017-09-02 14:34:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 283 (milligram per deciliter)\n\n### Procedure\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Collection of blood specimen from a completely implantable venous access device\n- Collection of venous blood by venipuncture\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Ultrasonography of Single Coronary Artery, Intravascular\n\n### Condition\n- Hyperlipidemia\n- Transplanted heart present\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2017-09-02, presumably until 2017-09-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2017-09-02, presumably until 2017-09-02\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2017-09-02, presumably until 2017-09-02\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2017-09-02, presumably until 2017-09-02\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2017-09-02, presumably until 2017-09-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-09-02, presumably until 2017-09-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-18 09:58:00, ended at 2017-09-18 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 9.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-05 12:43:45, ended at 2017-10-05 14:36:37\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Menopause present\n- Primary diagnosis: Hypomagnesemia\n- Breast lump\n- Tetany\n- Transplanted heart present\n- Tremor\n\n### Drug\n- estradiol 0.1 MG/ML Vaginal Cream, through Vaginal route, started on 2017-10-05, presumably until 2019-05-09, with intended 2 refill(s). Instructions: insert 1 g into the vagina 2 times a week\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-13 13:04:00, ended at 2017-10-13 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited\n\n### Condition\n- Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-13 13:04:00, ended at 2017-10-13 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-21 14:09:00, ended at 2017-10-21 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Menopause present\n- Disorder of bone\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-28 00:00:00, ended at 2017-10-28 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-28 00:00:00, ended at 2017-10-28 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-10-28, presumably until 2017-11-02, with intended 12 refill(s). Instructions: take 2 Tabs by mouth 2 times a day Clarify-- patient should take 2 tabs in the am and 3 tabs in the pm for 5 total tabs per day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-28 09:26:37, ended at 2017-10-28 10:25:32\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .236\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal level of blood mineral\n- Obesity\n- Essential hypertension\n- Hyperlipidemia\n- Primary diagnosis: Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-28 10:33:00, ended at 2017-10-28 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 56 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 28 (picogram per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 56 (nanogram per milliliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Obesity\n- Hyperlipidemia\n- Type 2 diabetes mellitus\n- Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Tetany\n- Transplanted heart present\n- Abnormal level of blood mineral\n- Urinary tract infectious disease\n- Hyperglycemia due to type 2 diabetes mellitus\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder of immune function\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-02 00:00:00, ended at 2017-11-02 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2017-11-02, presumably until 2017-11-05, with intended 12 refill(s). Instructions: Patient should take 2 tabs in the am and 3 tabs in the pm for 5 total tabs per day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-05 00:00:00, ended at 2017-11-05 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2017-11-05, presumably until 2019-01-02, with intended 12 refill(s). Instructions: Patient should take 2 tabs in the am and 3 tabs in the pm for 5 total tabs per day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-08 00:00:00, ended at 2017-11-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- lisinopril 5 MG Oral Tablet, started on 2017-11-10, presumably until 2018-11-06, with intended 3 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-24 00:00:00, ended at 2017-12-24 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, started on 2017-12-24, presumably until 2018-11-05, with intended 3 refill(s). Instructions: TAKE 2 TABLETS EVERY 12 HOURS AT 10 A.M. AND 10 P.M.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-06 00:00:00, ended at 2018-01-06 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-01-07, presumably until 2019-04-03, with intended 4 refill(s). Instructions: TAKE 3 TABLETS (1500 MG) DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-14 00:00:00, ended at 2018-01-14 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-14 18:08:35, ended at 2018-01-14 18:45:53\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cough\n- Primary diagnosis: Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-15 00:00:00, ended at 2018-01-15 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-15 14:40:00, ended at 2018-01-15 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Fever\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-18 00:00:00, ended at 2018-01-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-19 00:00:00, ended at 2018-01-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-01-29 00:00:00, ended at 2018-01-29 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.4 (ratio)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 108 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypo-osmolality and or hyponatremia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-29 09:00:03, ended at 2018-01-29 10:03:20\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Tremor\n- Urinary tract infectious disease\n- Essential hypertension\n- Hypo-osmolality and or hyponatremia\n- Transplanted heart present\n- Obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-29 12:05:44, ended at 2018-01-29 13:10:18\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.91 (micro-international unit per milliliter)\n- Body height: 5' .276\" (inch (US))\n- Osmolality of Serum or Plasma: 287 (milliosmole per kilogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Essential hypertension\n- Hyperlipidemia\n- Hypo-osmolality and or hyponatremia\n- Obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-19 00:00:00, ended at 2018-02-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-22 08:54:00, ended at 2018-02-22 09:55:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.84 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.9 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Osmolality of Urine: 441 (milliosmole per kilogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 129 (millimole per liter)\n- Sodium/Creatinine [Molar ratio] in Urine: 39 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.56 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder of transplanted heart\n- Hyperglycemia due to type 2 diabetes mellitus\n- Transplanted heart present\n- Type 2 diabetes mellitus\n- Urinary tract infectious disease\n- Disorder of immune function\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Hypo-osmolality and or hyponatremia\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-22 09:56:00, ended at 2018-02-22 12:04:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 61.0 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Pure hypercholesterolemia\n- Hypomagnesemia\n- Urinary tract infectious disease\n- Fatigue\n- Transplanted heart present\n- Complication due to diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Hypo-osmolality and or hyponatremia\n- Bacterial infection due to Klebsiella pneumoniae\n- Disorder of immune function\n- Essential hypertension\n- Hypercalcemia\n- Type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-22 11:00:59, ended at 2018-02-22 11:50:15\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-22 12:05:00, ended at 2018-02-22 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-23 00:00:00, ended at 2018-02-23 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cortisol [Mass/volume] in Serum or Plasma: 9.0 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercalcemia\n- Primary diagnosis: Hypo-osmolality and or hyponatremia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-02-23 00:00:00, ended at 2018-02-23 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, started on 2018-02-23, presumably until 2018-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-03 00:00:00, ended at 2018-03-03 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- repaglinide 1 MG Oral Tablet, started on 2018-03-04, presumably until 2020-01-23, with intended 3 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY BEFORE MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-07 10:59:00, ended at 2018-04-07 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 45 (nanogram per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 45 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 38 (picogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Parathyrin related protein [Moles/volume] in Serum or Plasma: 0.7 (picomole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypercalcemia\n- Hyperglycemia due to type 2 diabetes mellitus\n- Disorder of immune function\n- Type 2 diabetes mellitus\n- Bacterial infection due to Klebsiella pneumoniae\n- Hypo-osmolality and or hyponatremia\n- Transplanted heart present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-09 00:00:00, ended at 2018-04-09 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-17 08:49:08, ended at 2018-05-17 10:20:42\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 17 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Primary diagnosis: Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-19 00:00:00, ended at 2018-05-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-05-19, presumably until 2018-09-30, with intended 3 refill(s). Instructions: Taking a 1.5mg in the morning and 2mg in the evening\n- tacrolimus 0.5 MG Oral Capsule, started on 2018-05-19, presumably until 2018-09-30, with intended 3 refill(s). Instructions: Take 1.5mg in the morning and 2mg in the evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-28 09:45:38, ended at 2018-05-28 10:23:53\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .394\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Transplanted heart present\n- Essential hypertension\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-28 10:27:00, ended at 2018-05-28 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 7 (milligram per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 27 (milligram per gram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 25.80 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 840 (picogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.95 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Bacterial infection due to Klebsiella pneumoniae\n- Obesity\n- Urinary tract infectious disease\n- Essential hypertension\n- Disorder of immune function\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-02 10:12:42, ended at 2018-06-02 11:39:23\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n\n### Condition\n- Intertrigo\n- Seborrheic dermatitis\n- Primary diagnosis: Actinic keratosis\n- Benign neoplasm of skin\n- Disorder of lip\n\n### Drug\n- hydrocortisone 0.025 MG/MG Topical Ointment, started on 2018-06-02, presumably until 2019-06-02, with intended 3 refill(s). Instructions: Apply topically to affected area twice daily as directed.\n- ketoconazole 20 MG/ML Topical Cream, started on 2018-06-02, presumably until 2019-05-15, with intended 3 refill(s). Instructions: Apply topically to affected area(s) twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-06 00:00:00, ended at 2018-06-06 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, started on 2018-06-07, presumably until 2019-06-05, with intended 3 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-08 10:12:36, ended at 2018-06-08 11:11:57\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-15 00:00:00, ended at 2018-06-15 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Disorder of transplanted heart\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-06-15, presumably until 2019-05-15, with intended 4 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-25 08:42:59, ended at 2018-06-25 16:07:12\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .394\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of immune function\n- Hyperlipidemia\n- Cerebral infarction\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Essential hypertension\n- Transplanted heart present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-20 09:16:17, ended at 2018-08-20 10:26:40\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .394\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-03 11:08:27, ended at 2018-09-03 11:44:13\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Essential hypertension\n- Obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-23 00:00:00, ended at 2018-09-23 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n- Blood glucose abnormal\n- Transplanted heart present\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-23 12:36:29, ended at 2018-09-23 13:59:29\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized ischemic myocardial dysfunction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-27 08:28:00, ended at 2018-09-27 09:14:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.0 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.8 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.19 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 41.88 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.31 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.71 (micro-international unit per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 122 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.51 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 214 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.6 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.68 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Blood glucose abnormal\n- Disorder of eye due to type 2 diabetes mellitus\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Fatigue\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-27 09:15:00, ended at 2018-09-27 09:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Blood glucose abnormal\n- Pure hypercholesterolemia\n- Fatigue\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-27 10:00:00, ended at 2018-09-27 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 72.9 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n- Blood glucose abnormal\n- Fatigue\n- Disorder of eye due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-27 10:47:59, ended at 2018-09-27 13:03:38\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Blood glucose abnormal\n- Fatigue\n- Pure hypercholesterolemia\n- Electrocardiogram abnormal\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- loratadine 10 MG Oral Tablet, through Oral route, started on 2018-09-27, presumably until 2018-09-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth One Time Take one tablet by mouth one hour before your procedure\n- prednisone 50 MG Oral Tablet, through Oral route, presumably until 2019-05-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed Take one tablet by mouth 13 hours, 7 hours, then one hour before your heart procedure,\n- diphenhydramine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2018-09-27, presumably until 2018-09-27, with intended 0 refill(s). Instructions: take 2 Tabs by mouth One Time Take 2 Tabs by mouth once before your heart catheterization procedure.\n- atorvastatin 40 MG Oral Tablet, through Oral route, presumably until 2018-09-30, with intended 11 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-09-28 00:00:00, ended at 2018-09-28 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-09-28, presumably until 2018-09-28\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-09-28, presumably until 2018-09-28\n- midazolam 1 MG/ML Injectable Solution, started on 2018-09-28, presumably until 2018-09-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-28 08:22:00, ended at 2018-09-28 18:25:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 243 (milligram per deciliter)\n- INR in Blood by Coagulation assay: 0.9 (ratio)\n\n### Procedure\n- Ultrasonography of Single Coronary Artery, Intravascular\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Collection of blood specimen from a completely implantable venous access device\n- Collection of venous blood by venipuncture\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Acute on chronic systolic heart failure\n- Congestive heart failure\n- Generalized ischemic myocardial dysfunction\n- Hypertensive heart failure\n- Type 2 diabetes mellitus without complication\n- Disorder of transplanted heart\n- Hyperlipidemia\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-09-28, presumably until 2018-09-28\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2018-09-28, presumably until 2018-09-28\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2018-09-28, presumably until 2018-09-28\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2018-09-28, presumably until 2018-09-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-09-28, presumably until 2018-09-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-30 00:00:00, ended at 2018-09-30 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-09-30, presumably until 2018-10-05, with intended 3 refill(s). Instructions: Taking a 1.5mg BID; Fax: 999-999-9999, Z94.1\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, presumably until 2018-10-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth every bedtime\n- tacrolimus 0.5 MG Oral Capsule, started on 2018-09-30, presumably until 2018-10-13, with intended 3 refill(s). Instructions: Take 1.5mg BID; Fax: 999-999-9999; Z94.1\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-01 00:00:00, ended at 2018-10-01 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Pure hypercholesterolemia\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-10-01, presumably until 2019-08-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-05 00:00:00, ended at 2018-10-05 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-10-05, presumably until 2018-10-13, with intended 3 refill(s). Instructions: Taking a 1.5mg BID; Fax: 999-999-9999, Z94.1\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-13 00:00:00, ended at 2018-10-13 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-10-13, presumably until 2019-05-09, with intended 3 refill(s). Instructions: Total dose 1.5mg BID; Fax: 999-999-9999, Z94.1\n- tacrolimus 0.5 MG Oral Capsule, started on 2018-10-13, presumably until 2019-05-09, with intended 3 refill(s). Instructions: Take 1.5mg BID; Fax: 999-999-9999; Z94.1\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-15 10:45:12, ended at 2018-10-15 13:25:51\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-19 13:28:58, ended at 2018-10-19 13:29:08\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized ischemic myocardial dysfunction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-27 00:00:00, ended at 2018-10-27 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Urinary tract infectious disease\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-05 00:00:00, ended at 2018-11-05 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, started on 2018-11-05, presumably until 2019-09-07, with intended 3 refill(s). Instructions: TAKE 2 TABLETS EVERY 12 HOURS AT 10 A.M. AND 10 P.M.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-06 00:00:00, ended at 2018-11-06 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- lisinopril 5 MG Oral Tablet, started on 2018-11-08, presumably until 2019-01-28, with intended 3 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-31 10:47:55, ended at 2018-12-31 11:23:16\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.024\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Hyperlipidemia\n- Primary diagnosis: Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-31 11:28:00, ended at 2018-12-31 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.7 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Obesity\n- Hyperlipidemia\n- Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Transplanted heart present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-02 00:00:00, ended at 2019-01-02 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2019-01-02, presumably until 2019-02-10, with intended 3 refill(s). Instructions: PATIENT SHOULD TAKE 2 TABS IN THE AM AND 3 TABS IN THE PM FOR 5 TOTAL TABS PER DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-03 00:00:00, ended at 2019-01-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Hypercalcemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-01-17 16:49:00, ended at 2019-01-18 16:16:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Potassium [Moles/volume] in 24 hour Urine: 33.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 32 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 59 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 119.31 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.87 (million per microliter)\n- Glucose [Mass/volume] in Blood: 196 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.48 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.99 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 127 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.3 (nanogram per milliliter)\n- Chloride [Moles/volume] in Urine: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n\n### Procedure\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordinat\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Radiologic examination, chest; 2 views\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Conjunctivitis\n- Hypo-osmolality and or hyponatremia\n- Transplanted heart present\n- Acute conjunctivitis\n- Fatigue\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Anemia\n- Chronic kidney disease stage 2\n- Dyspnea\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Bronchitis\n- Type 2 diabetes mellitus\n- Atrial fibrillation\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Cough\n- Edema\n- Hyperlipidemia\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Primary diagnosis: Pneumonia\n- Pure hypercholesterolemia\n\n### Drug\n- guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2019-01-18, presumably until 2019-05-15, with intended 2 refill(s). Instructions: take 10 mL by mouth every 4 hours as needed\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-01-17, presumably until 2019-01-18\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2019-01-18, presumably until 2019-01-23, with intended 0 refill(s). Instructions: take 2 Caps by mouth 3 times a day for 5 days Begin on same day as azithromycin\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2019-01-17, presumably until 2019-01-18\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-01-17, presumably until 2019-01-17\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-01-17, presumably until 2019-01-17\n- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2019-01-18, presumably until 2019-01-18\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-01-17, presumably until 2019-01-18\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2019-01-18, presumably until 2019-01-18\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2019-01-18, presumably until 2019-01-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 3 days Begin on same day as amoxicillin\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-01-18, presumably until 2019-01-18\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2019-01-17, presumably until 2019-01-18\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2019-01-17, presumably until 2019-01-18\n- 120 ACTUAT albuterol 0.1 MG/ACTUAT / ipratropium bromide 0.02 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2019-01-18, presumably until 2019-04-11, with intended 0 refill(s). Instructions: 1 Puff by Inhalation route 4 times a day as needed (wheezing cough)\n- polymyxin B 10000 UNT/ML / trimethoprim 1 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-01-18, presumably until 2019-01-23, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day Stop after five days of use.\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2019-01-17, presumably until 2019-01-17\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-01-17, presumably until 2019-01-17\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2019-01-18, presumably until 2019-01-18\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-01-18, presumably until 2019-01-18\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2019-01-17, presumably until 2019-01-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-28 10:19:49, ended at 2019-01-28 11:30:15\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.02\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Pneumonia\n- Essential hypertension\n- Disorder of eye due to type 2 diabetes mellitus\n- Disorder of immune function\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-01-28, presumably until 2019-04-11, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2019-01-28, presumably until 2019-04-11, with intended 3 refill(s). Instructions: take 1 Quan by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-31 09:53:48, ended at 2019-01-31 10:35:43\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tremor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-10 00:00:00, ended at 2019-02-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2019-02-10, presumably until 2019-04-12, with intended 12 refill(s). Instructions: Take 2 tablets orally in the monring and 3 tablets in the evening for 5 total tabs per day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Complication due to diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2019-04-05, presumably until 2020-06-14, with intended 4 refill(s). Instructions: Take 500 mg (1 tab) at lunch, take 1000 mg (2 tabs) at dinner.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-08 00:00:00, ended at 2019-04-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-11 09:52:00, ended at 2019-04-11 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 46.7 (picogram per milliliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 68 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 46 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.6 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.42 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 10.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 46 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.65 (thousand per microliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 227 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Essential hypertension\n- Hypercalcemia\n- Hyperlipidemia\n- Disorder of eye due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-11 10:47:27, ended at 2019-04-11 11:57:22\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n- Essential hypertension\n\n### Drug\n- lisinopril 5 MG Oral Tablet, through Oral route, presumably until 2019-04-12, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-12 00:00:00, ended at 2019-04-12 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2019-04-12, presumably until 2019-06-11, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2019-04-12, presumably until 2020-05-08, with intended 3 refill(s). Instructions: take 2 Tabs (266 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-15 00:00:00, ended at 2019-04-15 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tachycardia\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-18 00:00:00, ended at 2019-04-18 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-22 00:00:00, ended at 2019-04-22 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 7.4 (microgram per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-22 00:00:00, ended at 2019-04-22 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-25 00:00:00, ended at 2019-04-25 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-02 00:00:00, ended at 2019-05-02 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 10:13:10, ended at 2019-05-04 11:03:38\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.024\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Primary diagnosis: Type 2 diabetes mellitus\n- Essential hypertension\n- Hyperlipidemia\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Hypercalcemia\n\n### Drug\n- 3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector, through Subcutaneous route, started on 2019-05-04, presumably until 2019-06-11, with intended 3 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) every day Replaces Lantus\n- telmisartan 20 MG Oral Tablet, through Oral route, started on 2019-05-04, presumably until 2019-05-15, with intended 3 refill(s). Instructions: take 20 mg by mouth daily Replaces lisinopril.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-04 11:07:00, ended at 2019-05-04 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted heart present\n- Essential hypertension\n- Hyperglycemia due to type 2 diabetes mellitus\n- Obesity\n- Hypercalcemia\n- Type 2 diabetes mellitus\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-06 00:00:00, ended at 2019-05-06 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-09 00:00:00, ended at 2019-05-09 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-09 14:05:49, ended at 2019-05-09 15:17:04\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Essential hypertension\n- Disorder of transplanted heart\n- Disorder of immune function\n- Hyperlipidemia\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2019-05-09, presumably until 2019-10-05, with intended 3 refill(s). Instructions: 1 mg in morning and 1.5 mg in the evening\n- estradiol 0.1 MG/ML Vaginal Cream, through Vaginal route, started on 2019-05-09, presumably until 2021-12-11, with intended 12 refill(s). Instructions: insert 1 g into the vagina 2 times a week\n- tacrolimus 0.5 MG Oral Capsule, started on 2019-05-09, presumably until 2019-10-05, with intended 3 refill(s). Instructions: 1 mg in morning and 1.5 mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-11 00:00:00, ended at 2019-05-11 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, started on 2019-05-11, presumably until 2019-08-10, with intended 0 refill(s). Instructions: Take 2L by mouth night before and 2L morning of procedure. Stop fluids 4hr before procedure. Instructions are forwarded to patient.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 11:01:00, ended at 2019-05-13 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Screening digital breast tomosynthesis, bilateral (List separately in addition to code for primary procedure)\n- Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-16 00:00:00, ended at 2019-05-16 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-19 14:17:02, ended at 2019-05-19 15:38:45\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Primary diagnosis: Mild nonproliferative retinopathy due to type 2 diabetes mellitus\n- Nuclear senile cataract\n- Regular astigmatism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-20 00:00:00, ended at 2019-05-20 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-23 00:00:00, ended at 2019-05-23 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-25 00:00:00, ended at 2019-05-25 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-05-26 00:00:00, ended at 2019-05-26 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-06-11, presumably until 2020-05-28, with intended 4 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-30 00:00:00, ended at 2019-05-30 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-03 00:00:00, ended at 2019-06-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-05 00:00:00, ended at 2019-06-05 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, started on 2019-06-06, presumably until 2020-03-22, with intended 3 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-06 00:00:00, ended at 2019-06-06 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-10 00:00:00, ended at 2019-06-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-13 00:00:00, ended at 2019-06-13 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-14 10:07:49, ended at 2019-06-14 10:36:48\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-17 00:00:00, ended at 2019-06-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-20 00:00:00, ended at 2019-06-20 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-07 11:36:10, ended at 2019-07-07 12:53:46\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Verruca vulgaris\n- Epidermoid cyst of skin\n- Primary diagnosis: Intertrigo\n\n### Drug\n- ketoconazole 20 MG/ML Topical Cream, started on 2019-07-07, presumably until 2020-06-10, with intended 3 refill(s). Instructions: Apply topically to affected area(s) twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2019-07-26, presumably until 2019-07-26\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2019-07-26, presumably until 2019-07-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-26 09:25:00, ended at 2019-07-26 12:43:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 133 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Inspection of Lower Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n\n### Condition\n- Hemorrhoids\n- Obesity\n- Transplanted heart present\n- Congestive heart failure\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Hypertensive heart failure\n- Acute on chronic systolic heart failure\n\n### Drug\n- amoxicillin 500 MG Oral Capsule, started on 2019-05-14, presumably until 2021-06-03, with intended 0 refill(s). Instructions: TAKE 4 CAPS BY MOUTH 1 HOUR BEFORE PROCEDURE\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-10 10:05:14, ended at 2019-08-10 11:00:49\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.024\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Hypercalcemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-10 11:06:00, ended at 2019-08-10 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 57.2 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Hypercalcemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-27 00:00:00, ended at 2019-08-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-08-29, presumably until 2019-11-04, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-07 00:00:00, ended at 2019-09-07 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-07, presumably until 2020-05-08, with intended 3 refill(s). Instructions: take 2 Tabs (360 mg total) by mouth every 12 hours at 10am and 10pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2019-09-21, presumably until 2019-09-21, with intended 4 refill(s). Instructions: Take 500 mg (1 tab) at lunch, take 1000 mg (2 tabs) at dinner.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-21 00:00:00, ended at 2019-09-21 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-21 00:00:00, ended at 2019-09-21 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- telmisartan 20 MG Oral Tablet, through Oral route, started on 2019-09-21, presumably until 2019-10-05, with intended 3 refill(s). Instructions: take 1 Tab (20 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Hyperlipidemia\n- Transplanted heart present\n- Fatigue\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-23 08:34:00, ended at 2019-09-24 18:15:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Base excess in Blood by calculation: -3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 13.3 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.56 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.4 (percent)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Blood: 176 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.95 (thousand per microliter)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.12 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.46 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.5 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; limited\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Ultrasound, chest (includes mediastinum), real time with image documentation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordinat\n\n### Condition\n- Cardiomegaly\n- Disorder of immune function\n- Disorder of transplanted heart\n- Electrocardiogram abnormal\n- Transplanted heart present\n- Primary diagnosis: Acute pyelonephritis\n- Atrial fibrillation\n- Urinary tract infectious disease\n- Abdominal pain\n- Acute on chronic systolic heart failure\n- Hyperlipidemia\n- Hypertensive heart failure\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Pure hypercholesterolemia\n- Congestive heart failure\n- Nausea and vomiting\n\n### Drug\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-09-24\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2019-09-23, presumably until 2019-09-24\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-09-23\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2019-09-23, presumably until 2019-09-23\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2019-09-23, presumably until 2019-09-23\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-10-05, with intended 0 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed (nausea or vomiting)\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-09-23, presumably until 2019-09-24, with intended 0 refill(s). Instructions: take 2 Caps (500 mg total) by mouth 2 times a day for 7 days\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2019-09-24, presumably until 2019-09-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-09-23, presumably until 2019-09-24\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-09-24, presumably until 2019-09-24\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-09-24\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-09-24\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-24, presumably until 2019-09-24\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-24, presumably until 2019-09-24\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-09-24, presumably until 2019-10-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-09-25 16:03:00, ended at 2019-10-05 16:31:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.88 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Prothrombin time (PT): 14.2 (second)\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.27 (micro-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Left ventricular Ejection fraction: 73.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.0 (percent)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.22 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.98 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Base excess in Blood by calculation: -4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.52 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.6 (second)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Body height: 5' 1\" (inch (US))\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 443 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 257 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.027 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 15.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Excision of Stomach, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Radiologic examination, chest; 2 views\n- Radiologic examination, abdomen; 1 view\n\n### Condition\n- Abdominal pain\n- Chronic vascular insufficiency of intestine\n- Gastric polyp\n- Disorder of transplanted heart\n- Ischemia of kidney\n- Moderate nonproliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Nausea and vomiting\n- Acute ST segment elevation myocardial infarction\n- Electrocardiogram abnormal\n- Transplanted heart present\n- Vomiting\n- Cough\n- Disorder of upper gastrointestinal tract\n- Old myocardial infarction\n- Essential hypertension\n- Tubulointerstitial nephritis\n- Constipation\n- Disorder of immune function\n- Fever\n- Gastritis\n- Hypovolemia\n- Acute renal failure syndrome\n- Atrial fibrillation\n- Disorder of brain\n- Acute pyelonephritis\n- Diabetes mellitus without complication\n- Hyperlipidemia\n- Right lower quadrant pain\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-09-30, presumably until 2019-10-01\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2019-09-29, presumably until 2019-09-30\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2019-09-29, presumably until 2019-09-29\n- glycerin 995 MG/ML Topical Solution, through Topical route, started on 2019-09-29, presumably until 2019-09-30\n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2019-10-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2019-09-25, presumably until 2019-09-25\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-09-27, presumably until 2019-09-30\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-09-26\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2019-10-01, presumably until 2019-10-04\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-05, presumably until 2019-10-05\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-10-01, presumably until 2019-10-01\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2019-10-04\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2019-09-29, presumably until 2019-09-30\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2019-09-27, presumably until 2019-10-04\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2019-09-26, presumably until 2020-02-09, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2019-09-25, presumably until 2019-09-25\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-10-04, presumably until 2019-10-04\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2019-09-28, presumably until 2019-11-03, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day as needed for Constipation\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2019-09-27, presumably until 2019-10-01\n- gadobenate, through Intravenous route, started on 2019-09-28, presumably until 2019-09-28\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2020-05-04, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily as needed (constipation)\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2019-09-28, presumably until 2020-10-04, with intended 0 refill(s). Instructions: take 1 Packet (17 g total) by mouth daily as needed (constipation)\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-10-05, presumably until 2020-05-04, with intended 0 refill(s). Instructions: take 2 Tabs (8 mg total) by mouth every 8 hours as needed (nausea or vomiting)\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2019-09-26, presumably until 2020-02-09, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-09-25, presumably until 2019-09-30\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-10-03, presumably until 2019-10-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-09-27, presumably until 2019-10-04\n- sucralfate 100 MG/ML Oral Suspension, through Oral route, started on 2019-09-29, presumably until 2020-05-04, with intended 0 refill(s). Instructions: take 10 mL (1 g total) by mouth 4 times a day before meals and bedtime\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-09-26, presumably until 2019-10-04\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-10-05\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2019-09-27, presumably until 2019-09-30\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-10-04\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2019-09-29, presumably until 2019-09-30\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-10-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2019-09-25, presumably until 2019-10-02\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2019-09-30, presumably until 2019-10-05\n- mycophenolic acid 360 MG Delayed Release Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-10-05\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-09-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-09-29 00:00:00, ended at 2019-09-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2019-09-29 00:00:00, ended at 2019-09-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; not otherwise specified\n\n### Condition\n- Disorder of upper gastrointestinal tract\n- Nausea and vomiting\n- Morbid obesity\n- Gastric polyp\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-09-29, presumably until 2019-09-29\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2019-09-29, presumably until 2019-09-29\n- midazolam 1 MG/ML Injectable Solution, started on 2019-09-29, presumably until 2019-09-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-05 00:00:00, ended at 2019-10-05 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.3 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.23 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 48 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 14 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1776 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2467 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 470 (cells per microliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 5.3 (microgram per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-16 00:00:00, ended at 2019-10-16 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-17 14:52:32, ended at 2019-10-17 16:02:10\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 10.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.11 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of eye due to type 2 diabetes mellitus\n- Primary diagnosis: Nausea and vomiting\n- Constipation\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-03 08:47:00, ended at 2019-11-03 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 75 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.32 (micro-international unit per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 67 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.4 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.6 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.54 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.94 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Fatigue\n- Transplanted heart present\n- Abnormal urine\n- Diabetes mellitus without complication\n- Essential hypertension\n- Disorder of immune function\n- Disorder of transplanted heart\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-03 09:38:01, ended at 2019-11-03 11:29:39\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Disorder of immune function\n- Essential hypertension\n- Abnormal urine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-04 00:00:00, ended at 2019-11-04 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-11-04, presumably until 2020-05-08, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-07 00:00:00, ended at 2019-11-07 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysuria\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2019-11-07, presumably until 2019-11-14, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-17 12:52:51, ended at 2019-11-17 13:51:38\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-18 14:31:00, ended at 2019-11-18 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 65.3 (percent)\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n\n### Condition\n- Disorder of transplanted heart\n- Rheumatic tricuspid valve regurgitation\n- Cardiomegaly\n- Tachycardia\n\n### Drug\n- 250 ML dobutamine 1 MG/ML Injection, through Intravenous route, started on 2019-11-18, presumably until 2019-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-29 09:44:12, ended at 2019-11-29 10:26:48\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of immune function\n- Essential hypertension\n- Hyperlipidemia\n- Diarrhea\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n\n### Drug\n- telmisartan 20 MG Oral Tablet, through Oral route, presumably until 2020-03-27, with intended 0 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 14:17:37, ended at 2019-12-21 14:57:27\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .236\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea and vomiting\n- Constipation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-23 00:00:00, ended at 2020-01-23 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- repaglinide 1 MG Oral Tablet, through Oral route, started on 2020-01-23, presumably until 2020-05-04, with intended 1 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 2 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-30 11:03:04, ended at 2020-01-30 11:48:15\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tremor\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-08 10:20:55, ended at 2020-02-08 10:58:12\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.22\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 49.59 (milligram per deciliter)\n- Calcium [Mass/volume] in Urine: 11.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Obesity\n- Hypercalcemia\n- Transplanted heart present\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-08 11:03:00, ended at 2020-02-08 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 15 (milligram per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 44 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 44 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Urine: 49.50 (milligram per deciliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 46.6 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 30 (milligram per gram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Disorder of eye due to type 2 diabetes mellitus\n- Hypercalcemia\n- Hyperlipidemia\n- Transplanted heart present\n- Obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-09 00:00:00, ended at 2020-02-09 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2020-02-09, presumably until 2020-12-17, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n- tacrolimus 0.5 MG Oral Capsule, started on 2020-02-09, presumably until 2020-12-17, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-09 00:00:00, ended at 2020-02-09 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperparathyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-22 00:00:00, ended at 2020-03-22 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastro-esophageal reflux disease with esophagitis\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-03-22, presumably until 2021-02-22, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-26 00:00:00, ended at 2020-03-26 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-03-27 12:55:08, ended at 2020-03-27 14:35:54\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Primary diagnosis: Disorder of eye due to type 2 diabetes mellitus\n- Essential tremor\n- Essential hypertension\n- Disorder of immune function\n- Transplanted heart present\n\n### Drug\n- telmisartan 40 MG Oral Tablet, through Oral route, started on 2020-03-27, presumably until 2020-06-25, with intended 12 refill(s). Instructions: take 40 mg by mouth daily Note dose change\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-04 00:00:00, ended at 2020-05-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- repaglinide 1 MG Oral Tablet, through Oral route, started on 2020-05-04, presumably until 2021-01-25, with intended 3 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 2 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-07 00:00:00, ended at 2020-05-07 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-08 00:00:00, ended at 2020-05-08 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2021-01-24, with intended 3 refill(s). Instructions: take 2 Tabs (360 mg total) by mouth every 12 hours at 10am and 10pm\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2020-05-08, with intended 3 refill(s). Instructions: take 1 Tab (1,000 Units total) by mouth every day\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2020-05-08, with intended 3 refill(s). Instructions: take 2 Tabs (266 mg total) by mouth 2 times a day\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2021-02-02, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2020-05-08, with intended 11 refill(s). Instructions: take 1 Tab (81 mg total) by mouth every morning with breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-22 00:00:00, ended at 2020-05-22 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-23 00:00:00, ended at 2020-05-23 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-28 00:00:00, ended at 2020-05-28 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Disorder of transplanted heart\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-06-05, presumably until 2021-01-25, with intended 4 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-04 00:00:00, ended at 2020-06-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Disorder of transplanted heart\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-06-05, presumably until 2020-06-05, with intended 3 refill(s). Instructions: INJECT 20 UNITS UNDER THE SKIN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-04 00:00:00, ended at 2020-06-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-06-05, presumably until 2020-06-05, with intended 4 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-08 00:00:00, ended at 2020-06-08 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Obesity\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Essential hypertension\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-10 00:00:00, ended at 2020-06-10 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ketoconazole 20 MG/ML Topical Cream, started on 2020-06-12, presumably until 2020-09-28, with intended 3 refill(s). Instructions: Apply topically to affected area(s) twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-14 00:00:00, ended at 2020-06-14 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2020-06-21, presumably until 2021-01-25, with intended 4 refill(s). Instructions: Take 500 mg (1 tab) at lunch, take 1000 mg (2 tabs) at dinner.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-15 09:28:00, ended at 2020-06-15 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed\n- Screening digital breast tomosynthesis, bilateral (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-21 00:00:00, ended at 2020-06-21 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2020-06-21, presumably until 2020-06-21, with intended 4 refill(s). Instructions: Take 500 mg (1 tab) at lunch, take 1000 mg (2 tabs) at dinner.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-15 00:00:00, ended at 2020-07-15 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- repaglinide 1 MG Oral Tablet, through Oral route, started on 2020-07-27, presumably until 2020-07-27, with intended 1 refill(s). Instructions: TAKE 1 TAB (1 MG TOTAL) BY MOUTH 2 TIMES A DAY BEFORE MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-21 00:00:00, ended at 2020-09-21 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-21 10:32:41, ended at 2020-09-21 10:54:12\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Obesity\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperlipidemia\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-09-28 10:12:07, ended at 2020-09-28 10:43:06\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' .276\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Intertrigo\n- Transplant present\n\n### Drug\n- ketoconazole 20 MG/ML Topical Cream, started on 2020-09-28, presumably until 2021-10-04, with intended 3 refill(s). Instructions: Apply topically to affected area(s) twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-05 00:00:00, ended at 2020-10-05 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-22 00:00:00, ended at 2020-11-22 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 81 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.2 (ratio)\n- Triglyceride [Moles/volume] in Serum or Plasma: 159 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Blood glucose abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-29 00:00:00, ended at 2020-11-29 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Finding of frequency of urination\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-29 07:30:00, ended at 2020-11-29 07:37:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.11 (milligram per milligram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 4.0 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Creatinine [Mass/volume] in Urine: 37.24 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Blood glucose abnormal\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-29 07:38:00, ended at 2020-11-29 11:34:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 63.7 (percent)\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n\n### Condition\n- Transplanted heart present\n- Abnormal urine\n- Pure hypercholesterolemia\n- Blood glucose abnormal\n- Cardiomegaly\n- Dilatation of aorta\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- 250 ML dobutamine 1 MG/ML Injection, through Intravenous route, started on 2020-11-29, presumably until 2020-11-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-11-29 09:39:11, ended at 2020-11-29 11:24:13\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Transplanted heart present\n- Pure hypercholesterolemia\n- Blood glucose abnormal\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-29 11:35:00, ended at 2020-11-29 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Blood glucose abnormal\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-30 00:00:00, ended at 2020-11-30 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal urine\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- telmisartan 80 MG Oral Tablet, through Oral route, started on 2020-11-30, presumably until 2021-01-24, with intended 11 refill(s). Instructions: take 80 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-17 00:00:00, ended at 2020-12-17 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, started on 2020-12-17, presumably until 2021-02-28, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-17 00:00:00, ended at 2020-12-17 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2020-12-17, presumably until 2021-02-28, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE EVERY EVENING (TOTAL DOSE IS 0.5 MG IN THE MORNING AND 1 MG IN THE EVENING)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-21 00:00:00, ended at 2020-12-21 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, started on 2020-12-21, presumably until 2020-12-21, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE EVERY MORNING (TOTAL DOSE IS 0.5 MG IN THE MORNING AND 1 MG IN THE EVENING)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-24 00:00:00, ended at 2021-01-24 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- telmisartan 80 MG Oral Tablet, through Oral route, started on 2021-01-24, presumably until 2021-02-07, with intended 3 refill(s). Instructions: take 80 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-24 00:00:00, ended at 2021-01-24 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2021-01-25, presumably until 2021-04-08, with intended 3 refill(s). Instructions: take 2 Tabs (360 mg total) by mouth every 12 hours at 10am and 10pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-25 10:46:33, ended at 2021-01-25 11:13:21\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercalcemia\n- Hyperglycemia due to type 2 diabetes mellitus\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Complication due to diabetes mellitus\n- Disorder of transplanted heart\n- Primary diagnosis: Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2021-01-25, presumably until 2022-01-03, with intended 11 refill(s). Instructions: inject 22 Units subcutaneous (under the skin) Evening Injecting 22 units subcutaneous, Evening\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2021-01-25, presumably until 2022-01-03, with intended 3 refill(s). Instructions: take 1,000 mg by mouth 2 times a day\n- repaglinide 1 MG Oral Tablet, through Oral route, started on 2021-01-25, presumably until 2022-01-03, with intended 3 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 2 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-02 00:00:00, ended at 2021-02-02 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-02-06, presumably until 2022-01-28, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-06 00:00:00, ended at 2021-02-06 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- telmisartan 80 MG Oral Tablet, through Oral route, started on 2021-02-07, presumably until 2021-04-26, with intended 3 refill(s). Instructions: take 40 mg by mouth daily Pt decreased to 40mg daily on 1/21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-21 00:00:00, ended at 2021-02-21 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, started on 2021-02-21, presumably until 2021-02-21, with intended 3 refill(s). Instructions: 0.5 mg in morning and 1 mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-21 00:00:00, ended at 2021-02-21 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Gastro-esophageal reflux disease with esophagitis\n- Transplanted heart present\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2021-02-22, presumably until 2021-02-25, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-25 00:00:00, ended at 2021-02-25 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n- Gastro-esophageal reflux disease with esophagitis\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2021-02-25, presumably until 2022-02-06, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-27 00:00:00, ended at 2021-02-27 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2021-02-27, presumably until 2021-02-27, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE EVERY EVENING (TOTAL DOSE IS 0.5 MG IN THE MORNING AND 1 MG IN THE EVENING)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-28 00:00:00, ended at 2021-02-28 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2021-02-28, presumably until 2021-03-04, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE EVERY EVENING (TOTAL DOSE IS 0.5 MG IN THE MORNING AND 1 MG IN THE EVENING)\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2021-02-28, presumably until 2021-07-29, with intended 3 refill(s). Instructions: take 1 Drew (0.5 mg total) by mouth AM 0.5 mg in morning and 1 mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-04 00:00:00, ended at 2021-03-04 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2021-03-04, presumably until 2021-07-29, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE EVERY EVENING (TOTAL DOSE IS 0.5 MG IN THE MORNING AND 1 MG IN THE EVENING)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-08 00:00:00, ended at 2021-04-08 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2021-04-08, presumably until 2021-04-16, with intended 3 refill(s). Instructions: take 2 Tabs (360 mg total) by mouth every 12 hours at 10am and 10pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-16 00:00:00, ended at 2021-04-16 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- mycophenolic acid 180 MG Delayed Release Oral Tablet, through Oral route, started on 2021-04-16, presumably until 2021-12-17, with intended 3 refill(s). Instructions: take 2 Tabs (360 mg total) by mouth every 12 hours at 10am and 10pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-26 10:31:50, ended at 2021-04-26 11:20:27\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperlipidemia\n- Transplanted heart present\n- Essential hypertension\n- Disorder of transplanted heart\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Obesity\n\n### Drug\n- telmisartan 80 MG Oral Tablet, through Oral route, started on 2021-04-26, presumably until 2022-01-06, with intended 3 refill(s). Instructions: take 80 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-31 00:00:00, ended at 2021-05-31 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-03 09:29:25, ended at 2021-06-03 10:54:36\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Cerebral infarction within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of ischemic_stroke means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "fd10a204e488dee5466c3569a484df2a077bf3dbf97feabd8724d949eeafb686", "prompt_hash": "d1aea8d664c74ad5c6fb9c5929365af8c155efa5582fcb790aa9cfa6e4198071", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 0.0, "f1_gu_yn": [0, 1], "recall_gu_yn": [0, 1]}
